Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English
Coverage 253,601 Raw stories ingested 39,399 rewritten in CS_CZ • 0 to rewrite (last 7 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 32s ago
  • FMP Forex News Fetch every 5 min 32s ago
  • CoinGecko News Fetch every 5 min 32s ago
  • FIO Stock News Fetch every 10 min 1m ago
  • Patria Stock News Fetch every 10 min 1m ago
  • Editorial rewrite Rewrite every minute 32s ago
  • Asset sync Assets every 1 hour 57m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Details Date Content Source
2026-10-29 22:27 2d ago
2026-10-29 16:57 2d ago
Rivian says it's on track for $250 million Uber funding by year-end, R2 demand strong
RIVN Rivian Automotive
FMP Stock News
Original source text
Rivian CEO RJ Scaringe said on Thursday the EV maker ‌is "very confident" it will hit an autonomy milestone this year that unlocks a $250 million tranche of Uber's investment, and that demand for its
2026-10-29 22:27 2d ago
2026-10-29 17:21 2d ago
Why Chipotle Stock Popped Today
CMG Chipotle Mexican Grill
FMP Stock News
Original source text
Rising digital sales and price hikes are helping Chipotle offset inflation. The fast-casual leader plans to open as many as 385 new restaurants in 2027.
2026-10-29 22:27 2d ago
2026-10-29 17:53 2d ago
Chipotle stock soars after chain reveals menu price increases will reach 3% in fourth quarter as costs climb
CMG Chipotle Mexican Grill
FMP Stock News
Original source text
Chipotle shares surged nearly 9% Thursday after the burrito-and-bowl chain reported improving sales and revealed roughly 3% menu price hikes in the fourth quarter amid rising beef, freight and labor costs.

The fast-casual giant has been gradually raising prices market by market since late last year, seeking to offset inflation without driving away customers.

“On pricing, the impact in Q3 was around 2.7%. We anticipate it will increase to about 3% in Q4,” Chief Financial Officer Adam Rymer told Wall Street analysts during an earnings call Wednesday.

Chipotle expects the impact of its menu price increases to reach roughly 3% in the fourth quarter as rising costs squeeze the burrito chain. Felix Mizioznikov – stock.adobe.com
The 3% projection reflects the cumulative effect of price increases introduced in different markets, not a newly announced hike affecting every Chipotle restaurant.

The impact of Chipotle’s price increases has grown throughout 2026, climbing from 0.9% in the first quarter to 1.6% in the second and 2.7% in the third.

Chipotle initially expected menu pricing to rise 1% to 2% for the full year, even as its operating costs were projected to climb between 3% and 4%.

The company now expects pricing to contribute roughly 2% for the full year, with menu price increases catching up to inflation in the fourth quarter.

Higher beef and freight costs have squeezed the chain, which is also grappling with rising wages and additional expenses tied to restaurant staffing.

The fast-casual chain has been gradually raising menu prices across different markets to offset higher beef, freight and labor expenses. Agustin – stock.adobe.com
Food, beverage and packaging costs fell to 29.5% of revenue in the third quarter from 30% a year earlier, helped by menu price increases that partly offset higher beef and freight expenses.

Labor costs, meanwhile, rose to 25.7% of revenue from 25.2% a year earlier, driven by higher wages, performance bonuses, additional restaurant staffing and insurance expenses.

The pricing strategy comes as Chipotle works to win back customers following a stretch of sluggish demand.

Chipotle shares surged more than 11% this week as investors welcomed signs of improving sales and customer traffic.
Third-quarter revenue climbed 9.6% to $3.29 billion, while comparable restaurant sales rose 2.1%, helped by a 0.8% increase in customer transactions.

Investors appeared to focus on improving sales and customer traffic despite adjusted earnings of 27 cents per share falling short of Wall Street expectations of roughly 29 cents.

Chipotle has also stepped up advertising and promotions, including campaigns built around limited-time menu offerings, to boost customer traffic.

Marketing expenses accounted for a percentage of sales in the mid-3% range during the third quarter and are expected to climb into the high-3% range in the fourth as Chipotle promotes its smoked brisket offering.

Chipotle CEO Scott Boatwright said in April that the chain’s entrée prices were roughly 20% to 30% lower than those of competing fast-casual restaurants.

Chipotle’s fourth-quarter pricing impact is expected to reach approximately 3%, up from 2.7% in the third quarter. Jeffrey Greenberg/Universal Images Group via Getty Images
Still, higher menu prices haven’t spared Chipotle from continued pressure on its profit margins.

Chipotle expects fourth-quarter restaurant-level operating margins to fall to just under 22% from 23.4% a year earlier, as higher marketing expenses and weaker sales leverage squeeze profitability.

Several Wall Street firms cut their price targets, citing concerns about a slower recovery in profit margins despite signs of improving customer traffic.

Bernstein lowered its price target from $50 to $43, RBC from $45 to $40, and BMO from $52 to $50.

Chipotle expects comparable restaurant sales to rise approximately 2% in the fourth quarter as it continues testing price increases in individual markets to gauge customer resistance.
2026-10-29 22:26 2d ago
2026-10-29 16:19 2d ago
Stan Druckenmiller Just Backed Hyperliquid’s U.S. Push. Is It Too Late to Buy HYPE 4% From Its Record High?
CME CME Group
FMP Stock News
Original source text
Stan Druckenmiller just backed a regulated U.S. push for Hyperliquid, sending HYPE surging toward a record it has failed to break twice before. The question now is whether this time something is genuinely different, or whether sellers are once again…

Stan Druckenmiller, a renowned hedge fund manager, has endorsed a plan to introduce regulated U.S. perpetual futures for Hyperliquid (CRYPTO:HYPE). HYPE trades at $95, up 18.3% in 24 hours and 22.4% over the past week. The token is only 3.3% below its intraday record high of $98, achieved on September 23, 2026. HYPE ranks as the 11th largest cryptocurrency by market capitalization.

The recent price rally follows a report that Intercontinental Exchange (NYSE:ICE | ICE Price Prediction), the parent company of the New York Stock Exchange, plans to launch a U.S. market for Hyperliquid perpetual futures. These contracts do not expire, allowing traders to maintain leveraged positions as long as they provide collateral. ICE is collaborating with trade(xyz), a platform already operating Hyperliquid stock and index perpetual contracts.

Druckenmiller expressed his enthusiasm on X, saying, “I am excited to be an investor in trade(xyz) as they partner with ICE to bring 24/7 perpetual futures on Hyperliquid to the United States.”

HYPE has risen 272.3% in 2026 from a December 31, 2025 closing price of $25. The current $98 record is a key focus for investors. Whether it’s too late to buy HYPE at this price point will hinge on whether momentum can push it past this peak or if it fades like the last two attempts.

More Supply Means HYPE Needs More Investment to Reach New Highs

Market cap, calculated by multiplying price by circulating supply, shows why a lower price can still have a higher valuation. HYPE’s market cap stands at $22.67 billion at $95. On September 22, 2026, it closed at a record $97, with a market cap of $21.62 billion.

HYPE is valued higher despite a lower price because more tokens are in circulation. As of October 28, 2026, Hyperliquid’s circulating supply rose to about 239 million tokens from roughly 222 million after a scheduled unlock released tokens held by early contributors. A larger supply means buyers must spend more to keep the price stable, so a new high above $98 will require a larger market cap than September’s.

HYPE continues to trade above its recent averages: $80 for the 20-day average, $85 for the 50-day average, and $66 for the 200-day average, a trend that could favor buyers going forward.

Stan Druckenmiller and ICE Provide a Regulated Path for Hyperliquid in the U.S.

trade(xyz) operates on HIP-3, a Hyperliquid feature letting external developers build their own markets. Hyperliquid earns a share of every trading fee on HIP-3. While the U.S. market is still in the planning stages, opposition remains strong. Intercontinental Exchange and CME Group (NASDAQ:CME) have urged U.S. regulators to limit Hyperliquid’s operations.

CME’s Terry Duffy recently said that if Jeff Yan, Hyperliquid’s founder, intends to compete in the United States, he must understand how to operate within U.S. legal frameworks.

Arthur Firstov, chief business officer at Mercuryo, said traditional finance exchanges are watching closely, noting that incumbents are closely monitoring the introduction of perpetual contracts on regulated U.S. markets, complete with compliance and anti-money laundering measures.

Buybacks and Whale Activity Send Mixed Signals on Demand

Hyperliquid operates a cryptocurrency exchange and employs the trading fees it generates to buy back HYPE tokens on the open market through its Assistance Fund. This strategy helped drive HYPE’s price from a low of $21 on January 20, 2026, to its record close of $97 on September 22, 2026. Several U.S. trading platforms have also added HYPE trading, giving investors a secure way to participate alongside the volume ICE’s plan could bring.

Coin whales, or wallets with large amounts of HYPE, are split on the rally. According to reports from Lookonchain, five whales opened long positions that benefit from price increases, totaling 597,912 HYPE worth $52.7 million over a few hours. However, another whale sold 694,310 HYPE valued at $53.3 million over five days. This buying and selling nearly cancels out, leaving large holders divided on the rally.

HYPE Struggles to Maintain Its High After Two Previous Attempts

HYPE has attempted to remain within 5% of its record high on several occasions between September 18 and September 26, 2026, including the record close of $97. However, by September 29, it had dropped to $86.

A second attempt in October saw HYPE close at $94 on October 5 before it faltered again. It fell to $84 by October 8 and hit a 30-day low close of $76 on October 25. With sellers having thwarted two previous rallies at this level, HYPE will face significant pressure during its third attempt, as investors remain wary of past disappointments.

Is It Too Late to Buy HYPE Near Its Record High? Whether it’s a good time to buy crypto depends on more than just charts. Still, Hyperliquid’s trajectory toward a new high looks solid. ICE’s plan gives it a regulated U.S. channel it lacked at the September peak, making a new record close more likely by year-end. Anyone buying at $95 is paying up near a level that has pushed HYPE back twice already. Our Breakout Buyer’s Rulebook covers ten rules for situations like this.

For HYPE to close above $98, ICE and trade(xyz) must clear regulatory review. Higher fees would then feed more Assistance Fund buying. If HYPE fails to break through, it could drop below the 50-day average of $85, toward its 20-day average of $80 or the $76 October low. The clearest sign of a shift is a daily close above $98; holding that level could turn it into new support.

Contact [email protected] for any questions or corrections.
2026-10-29 22:22 2d ago
2026-10-29 16:15 2d ago
Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
A Agilent Technologies
FMP Stock News
Original source text
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2026 after the stock market closes on Monday, Nov. 23. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day.To join the listen-only conference-call webcast, click the link on the Events section of Agilent's Investor Relations website. A recording of the call will also be available on the website for 90 days.About Ag.
2026-10-29 22:18 2d ago
2026-10-29 16:15 2d ago
INCY Q3 Loss Narrower Than Expected, Sales Beat, FY'26 View Raised
INCY Incyte
FMP Stock News
Original source text
Key Takeaways Incyte's Q3 revenues rose 14% to $1.56 billion, beating estimates despite a $3.60 adjusted loss per share.Opzelura sales increased 36% to $254.9 million, while Niktimvo and Zynyz also delivered strong growth.Incyte raised 2026 net sales guidance to $5.21-$5.30 billion, driven by continued commercial momentum.
Incyte Corporation (INCY - Free Report) incurred a third-quarter 2026 adjusted loss of $3.60 per share, narrower than the Zacks Consensus Estimate of a loss of $3.99 per share. The company had reported adjusted earnings of $2.26 per share in the year-ago quarter. The loss was primarily due to higher in-process research and development expenses related to the acquisition of Vega Therapeutics.

Total revenues were $1.56 billion, up 14% year over year, driven primarily by the sustained performance of its lead drug, Jakafi (ruxolitinib) and other marketed products. The top line beat the Zacks Consensus Estimate of $1.48 billion.

All percentages mentioned below are on a reported basis.

INCY's Q3 Results in DetailIn the third quarter of 2026, total net product sales increased 14% year over year to $1.32 billion, driven by higher demand across marketed products.

Revenues from the sale of Jakafi, a first-in-class JAK1/JAK2 inhibitor approved for polycythemia vera, myelofibrosis and refractory acute graft-versus-host disease (GVHD), came in at approximately $827 million, up 4% from the year-ago quarter. Growth was primarily driven by a 12% increase in paid demand and higher sales across all indications. Jakafi's sales were in line with the Zacks Consensus Estimate of $827 million.

Opzelura (ruxolitinib) cream, approved for atopic dermatitis and vitiligo, generated $254.9 million in sales, which rose 36% year over year, beating the Zacks Consensus Estimate of $230 million. Growth was driven by increased patient demand across both indications and improved net pricing following the second-quarter 2026 settlement.

The hematology and oncology portfolio generated revenues of $235 million, up 38% year over year, driven by increased demand for Niktimvo, Zynyz and Monjuvi/Minjuvi.

The newly approved medicine Zynyz (retifanlimab-dlwr) generated sales of $58.3 million, reflecting a 157% increase and beating the Zacks Consensus Estimate of $49.7 million. Minjuvi's revenues totaled $54.6 million, up 30% from the year-ago quarter. The figure was in line with the Zacks Consensus Estimate of $55 million. Incyte gained exclusive global rights for tafasitamab from MorphoSys AG in 2024. The drug is marketed as Monjuvi in the United States and as Minjuvi in the ex-U.S. markets.

Incyte and partner Syndax Pharmaceuticals obtained FDA approval for axatilimab-csfr, an anti-CSF-1R antibody, for the treatment of GVHD after the failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg. The candidate was approved under the brand name Niktimvo. The drug is Incyte’s second approved treatment for chronic GVHD (third-line) and was launched in the United States during the first quarter of 2025. The drug recorded $67.4 million in sales in the third quarter of 2026, up 47% on a year-over-year basis, driven by strong uptake and beat the Zacks Consensus Estimate of $64 million.

Meanwhile, net product revenues of Iclusig were $33.5 million, down 11% year over year. The figure missed the Zacks Consensus Estimate of $35.2 million. Pemazyre sales declined 7% to $21.2 million and missed the Zacks Consensus Estimate of $23.5 million.

Shares of Incyte have rallied 18.3% year to date compared with the industry’s 7.2% growth.

Image Source: Zacks Investment Research

Jakafi is marketed by Incyte in the United States and by Novartis (NVS - Free Report) as Jakavi in ex-U.S. markets. Jakavi royalty revenues from Novartis for commercialization in ex-U.S. markets rose 5% year over year to $132.5 million. Jakavi royalties beat the Zacks Consensus Estimate of $131 million.

Incyte also receives royalties from the sales of Tabrecta (capmatinib) for the treatment of adult patients with metastatic non-small-cell lung cancer. Its partner, Novartis, has exclusive worldwide development and commercialization rights for Tabrecta. Royalty revenues from the drug’s sales amounted to $6.8 million, up 5% year over year. The reported figure missed the Zacks Consensus Estimate of $7.7 million.

Olumiant’s (baricitinib) product royalty revenues from Eli Lilly (LLY - Free Report) totaled $39.1 million, up 5% year over year. The figure missed the Zacks Consensus Estimate of $39.9 million. Incyte has a collaboration agreement with Eli Lilly for Olumiant. The drug is a once-daily oral JAK inhibitor discovered by Incyte and licensed to LLY. It is approved for several types of autoimmune diseases.

Adjusted research and development expenses totaled $1.75 billion, up 274% year over year, primarily due to the $1.23 billion one-time in-process R&D charge associated with the acquisition of Vega Therapeutics and continued investment in late-stage development assets.

Adjusted selling, general and administrative (SG&A) expenses increased 10% to $339.1 million, primarily due to pre-launch activities.

INCY’s cash, cash equivalents and marketable securities amounted to $3.9 billion as of Sept. 30, 2026 compared with $4.5 billion recorded as of June 30, 2026.

INCY Raises 2026 GuidanceIncyte raised its 2026 total net sales guidance to $5.21-$5.30 billion, up from the previously projected $5.13-$5.26 billion, reflecting continued commercial momentum.

While Incyte continues to expect Jakafi revenues in the range of $3.22-$3.27 billion in 2026, it expects Opzelura net product revenues to be in the range of $1.10-$1.12 billion, up from the previously guided range of $1.05-$1.10 billion.

Adjusted R&D and SG&A expenses are still expected to total $4.625-$4.695 billion in 2026, including acquisition-related costs.

INCY's Recent Product & Pipeline UpdatesIncyte’s Monjuvi/Minjuvi is under regulatory review globally for newly diagnosed diffuse large B-cell lymphoma (DLBCL), with potential U.S. approval and launch expected in the first quarter of 2027.

In July, the European Commission approved Opzelura for moderate atopic dermatitis in adults, marking its second approved indication in the European Union.

The Committee for Medicinal Products for Human Use issued a positive opinion recommending the approval of povorcitinib (Povofortay) for the treatment of active moderate to severe HS in adults who have responded inadequately to, or who are intolerant or contraindicated to, an anti-TNF therapy. A European regulatory decision is expected in the fourth quarter, while potential U.S. approval and launch are anticipated in the first quarter of 2027.

INCY's Zacks Rank & A Stock to ConsiderIncyte currently carries a Zacks Rank #4 (Sell).

A better-ranked stock in the biotech sector is TG Therapeutics (TGTX - Free Report) , sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Over the past 30 days, earnings per share estimates for TG Therapeutics have risen from 92 cents to 94 cents for 2026. During the same period, estimates for 2027 earnings per share have increased from $2.65 to $2.66. TGTX’s shares have risen 92.6% year to date.

TG Therapeutics’ earnings missed estimates in three of the trailing four quarters and beat in the remaining one, with the average surprise being 184.65%.
2026-10-29 22:18 2d ago
2026-10-29 16:15 2d ago
CubeSmart Reports Third Quarter 2026 Results
CUBE CubeSmart
FMP Stock News
Original source text
MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced its operating results for the three and nine months ended September 30, 2026.

“Third quarter results reflected strong execution across our operating platform, with positive same-store revenue and NOI growth supported by higher occupancy and improving rental activity,” commented President and Chief Executive Officer Christopher P. Marr. “We are encouraged by the broadening momentum across the portfolio, reinforcing our confidence in the trajectory of the business and our ability to generate durable growth.”

Key Highlights for the Third Quarter

Reported diluted earnings per share (“EPS”) attributable to the Company’s common shareholders of $0.42.Reported funds from operations (“FFO”), as adjusted, per diluted share of $0.66.Same-store (623 stores) net operating income (“NOI”) increased 2.1% year over year, resulting from a 1.9% increase in revenues and a 1.3% increase in operating expenses.Same-store occupancy averaged 90.5% during the quarter, ending at 89.9%.Repurchased 2.1 million common shares of beneficial interest through our share repurchase program for $83.9 million at an average purchase price of $39.09 per share.Redeemed $300 million of unsecured senior notes.Added 32 stores to our third-party management platform, bringing our total third-party managed store count to 882.
Financial Results

Net income attributable to the Company’s common shareholders was $94.4 million for the third quarter of 2026, compared with $82.9 million for the third quarter of 2025. Diluted EPS attributable to the Company’s common shareholders increased to $0.42 for the third quarter of 2026, compared with $0.36 for the same period last year.

FFO, as adjusted was $150.3 million for the third quarter of 2026 compared with $149.0 million for the third quarter of 2025. FFO, as adjusted, per diluted share increased 1.5% to $0.66 for the third quarter of 2026, compared with $0.65 for the same period last year.  

Investment Activity

Disposition Activity

The Company has agreed to contribute 15 wholly-owned stores to a newly-formed joint venture with an affiliate of Heitman Capital Management (“Heitman”) for an agreed-upon value of $197.0 million. Under the agreement, the Company will receive cash and own a 20% interest in the joint venture, while Heitman will contribute cash and own the remaining 80% interest. The stores subject to the agreement contain approximately 0.9 million square feet and are located in Connecticut (3), Georgia (1), North Carolina (2), Ohio (1), Texas (2), Utah (4) and Virginia (2). It is expected that the properties in the joint venture will be secured by a $99.7 million loan that matures in November 2033. The transaction is scheduled to close in the fourth quarter of 2026.

Development Activity

The Company, from time to time, enters into agreements with developers for the construction of self-storage properties in high-barrier-to-entry locations. As of September 30, 2026, the Company had one joint venture development property under construction. The Company anticipates investing a total of $28.0 million related to this project and had invested $10.8 million of that total as of September 30, 2026. The development property is located in New York and is expected to open during the third quarter of 2027.

Third-Party Management

As of September 30, 2026, the Company’s third-party management platform included 882 stores totaling 58.2 million rentable square feet. During the three and nine months ended September 30, 2026, the Company added 32 and 90 stores, respectively, to its third-party management platform.

Same-Store Results

The Company’s same-store portfolio as of September 30, 2026 included 623 stores containing 45.2 million rentable square feet, or approximately 93.3% of the aggregate rentable square feet of the Company’s 662 consolidated stores. These same-store properties represented approximately 94.7% of the Company’s property NOI for the three months ended September 30, 2026.

Same-store physical occupancy as of September 30, 2026 and 2025 was 89.9% and 89.0%, respectively. Same-store total revenues for the third quarter of 2026 increased 1.9% and same-store operating expenses increased 1.3% compared to the same quarter in 2025. Same-store NOI increased 2.1% from the third quarter of 2025 to the third quarter of 2026.

Operating Results

As of September 30, 2026, the Company’s total consolidated portfolio included 662 stores containing 48.5 million rentable square feet with physical occupancy of 89.7%.

Total revenues increased $8.9 million and property operating expenses increased $4.9 million for the third quarter of 2026, as compared to the same period in 2025. The increase in revenues was primarily attributable to higher occupancy and rental rates in our same-store portfolio, while the increase in property operating expenses was primarily attributable to increases in property taxes and personnel expenses.

Interest expense increased from $29.4 million during the three months ended September 30, 2025 to $31.1 million during the three months ended September 30, 2026, an increase of $1.7 million. The increase was attributable to an increase in the average outstanding debt balance and higher interest rates during the 2026 period compared to the 2025 period. The average outstanding debt balance increased from $3.44 billion during the three months ended September 30, 2025 to $3.55 billion during the three months ended September 30, 2026. The weighted average effective interest rate on our outstanding debt increased from 3.32% during the three months ended September 30, 2025 to 3.37% for the three months ended September 30, 2026.

Balance Sheet Activity

In September 2026 the Company used borrowings under its unsecured revolving credit facility to redeem $300 million of outstanding unsecured senior notes due September 2026. Additionally during the quarter, the Company repaid three mortgage loans with an aggregate balance of $40.3 million.

During the three months ended September 30, 2026, the Company repurchased 2.1 million common shares of beneficial interest through its share repurchase program for $83.9 million, resulting in an average purchase price of $39.09 per share. As of September 30, 2026, 8.0 million shares remained available for repurchase under this program.

Subsequent to September 30, 2026, the Company entered into a $300 million unsecured term loan (the “Term Loan”) that is scheduled to mature on January 10, 2031. At the Company’s current credit rating and leverage level, the effective interest rate is SOFR + 0.80%. Proceeds from the Term Loan were used to repay amounts drawn under the Company’s unsecured revolving credit facility.

Quarterly Dividend

On July 28, 2026, the Company declared a quarterly dividend of $0.53 per common share. The dividend was paid on October 15, 2026 to common shareholders of record on October 1, 2026.

2026 Financial Outlook

“The strength of our year-to-date performance supported improvements to all of our full-year same-store and FFO guidance ranges,” commented Chief Financial Officer Tim Martin. “Subsequent to the quarter, we advanced a series of liquidity-enhancing transactions that showcase our access to a wide range of capital sources and provide additional flexibility to allocate capital where we see compelling long-term value.”

The Company estimates that its fully diluted earnings per share for 2026 will be between $1.60 and $1.62, and that its fully diluted FFO per share, as adjusted, for 2026 will be between $2.58 and $2.60. Due to uncertainty related to the timing and terms of transactions, the impact of any potential future speculative investment activity is excluded from guidance. For 2026, the same-store pool consists of 623 properties totaling 45.2 million rentable square feet.

 Current Ranges for Current Ranges for2026 Full Year Guidance Range SummaryCurrent Ranges for Annual Assumptions Prior Guidance (1)Same-store revenue growth 1.00% to 1.40%  0.50% to 1.25%Same-store expense growth 2.80% to 3.80%  3.25% to 4.50%Same-store NOI growth 0.00% to 0.80%  (1.00%) to 0.25%              Property management fee income$39.0M to$41.0M $39.0M to$41.0MGeneral and administrative expenses$66.5M to$68.5M $66.5M to$68.5MInterest and loan amortization expense$126.5M to$128.5M $124.5M to$128.5MFull year weighted average shares and units227.5M 228.2M              Diluted earnings per share attributable to common                shareholders$1.60  to$1.62  $1.58  to$1.64 Plus: real estate depreciation and amortization 0.99    0.99   0.97    0.97 Less: gain from sale of real estate (0.01)   (0.01)  (0.01)   (0.01)FFO, as adjusted, per diluted share$2.58  to$2.60  $2.54  to$2.60  (1)Prior guidance as indicated in our second quarter earnings release dated July 30, 2026.   Conference Call

Management will host a conference call at 11:00 a.m. ET on Friday, October 30, 2026 to discuss financial results for the three months ended September 30, 2026.

A live webcast of the conference call will be available online from the investor relations page of the Company’s corporate website at investors.cubesmart.com. Telephone participants may join on the day of the call by dialing 1 (833) 461-5787 using conference ID number 488 082 528. Registered financial analysts participating on the call may avoid delays by pre-registering using the following link: https://events.q4inc.com/analyst/488082528?pwd=jzlZoG1C. A replay of the webcast will be available on the Company’s website following the live event.

Supplemental operating and financial data as of September 30, 2026 is available in the investor relations section of the Company’s corporate website.

About CubeSmart

CubeSmart is a self-administered and self-managed real estate investment trust (“REIT”). The Company's self-storage properties are designed to offer affordable, easily accessible and, in most locations, climate-controlled storage space for residential and commercial customers. According to the 2026 Self-Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the United States.

Non-GAAP Financial Measures

Funds from operations (“FFO”) is a widely used performance measure for real estate companies and is provided here as a supplemental measure of operating performance. The April 2002 National Policy Bulletin of the National Association of Real Estate Investment Trusts (the “White Paper”), as amended, defines FFO as net income (computed in accordance with GAAP), excluding gains (or losses) from sales of real estate and related impairment charges, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.

Management uses FFO as a key performance indicator in evaluating the operations of the Company's stores. Given the nature of its business as a real estate owner and operator, the Company considers FFO a key measure of its operating performance that is not specifically defined by accounting principles generally accepted in the United States. The Company believes that FFO is useful to management and investors as a starting point in measuring its operational performance because FFO excludes various items included in net income that do not relate to or are not indicative of its operating performance such as gains (or losses) from sales of real estate, gains from remeasurement of investments in real estate ventures, impairments of depreciable assets, and depreciation, which can make periodic and peer analyses of operating performance more difficult. The Company’s computation of FFO may not be comparable to FFO reported by other REITs or real estate companies.

FFO should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of the Company’s performance. FFO does not represent cash generated from operating activities determined in accordance with GAAP and is not a measure of liquidity or an indicator of the Company’s ability to make cash distributions. The Company believes that to further understand its performance, FFO should be compared with its reported net income and considered in addition to cash flows computed in accordance with GAAP, as presented in its consolidated financial statements.

FFO, as adjusted represents FFO as defined above, excluding the effects of acquisition related costs, gains or losses from early extinguishment of debt, and other non-recurring items, which the Company believes are not indicative of the Company’s operating results.

The Company defines net operating income, which it refers to as “NOI,” as total continuing revenues less continuing property operating expenses. NOI also can be calculated by adding back to net income (loss): interest expense on loans, loan procurement amortization expense, loss on early extinguishment of debt, acquisition related costs, equity in losses of real estate ventures, other expense, depreciation and amortization expense, general and administrative expense, and deducting from net income (loss): equity in earnings of real estate ventures, gains from sales of real estate, net, other income, gains from remeasurement of investments in real estate ventures and interest income. NOI is a measure of performance that is not calculated in accordance with GAAP.

Management uses NOI as a measure of operating performance at each of its stores, and for all of its stores in the aggregate. NOI should not be considered as a substitute for net income, cash flows provided by operating, investing and financing activities, or other income statement or cash flow statement data prepared in accordance with GAAP.

The Company believes NOI is useful to investors in evaluating operating performance because it is one of the primary measures used by management and store managers to evaluate the economic productivity of the Company’s stores, including the ability to lease stores, increase pricing and occupancy, and control property operating expenses. Additionally, NOI helps the Company’s investors meaningfully compare the results of its operating performance from period to period by removing the impact of its capital structure (primarily interest expense on outstanding indebtedness) and depreciation of the basis in its assets from operating results.

Forward-Looking Statements

This presentation, together with other statements and information publicly disseminated by CubeSmart (“we,” “us,” “our” or the “Company”), contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the “Exchange Act.” Forward-looking statements include statements concerning the Company’s plans, objectives, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions and other information that is not historical information. In some cases, forward-looking statements can be identified by terminology such as “believes,” “expects,” “estimates,” “may,” “will,” “should,” “anticipates,” or “intends” or the negative of such terms or other comparable terminology, or by discussions of strategy. Such statements are based on assumptions and expectations that may not be realized and are inherently subject to risks, uncertainties and other factors, many of which cannot be predicted with accuracy and some of which might not even be anticipated. Although we believe the expectations reflected in these forward-looking statements are based on reasonable assumptions, future events and actual results, performance, transactions or achievements, financial and otherwise, may differ materially from the results, performance, transactions or achievements expressed or implied by the forward-looking statements. As a result, you should not rely on or construe any forward-looking statements in this presentation, or which management or persons acting on their behalf may make orally or in writing from time to time, as predictions of future events or as guarantees of future performance. We caution you not to place undue reliance on forward-looking statements, which speak only as of the date of this presentation or as of the dates otherwise indicated in such forward-looking statements. All of our forward-looking statements, including those in this presentation, are qualified in their entirety by this statement.

There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in or contemplated by this presentation. Any forward-looking statements should be considered in light of the risks and uncertainties referred to in Item 1A. “Risk Factors” in our Annual Report on Form 10-K and in our other filings with the Securities and Exchange Commission (“SEC”).

These risks include, but are not limited to, the following:

adverse changes in economic conditions in the real estate industry and in the markets in which we own and operate self-storage properties;the effect of competition from existing and new self-storage properties and operators on our ability to maintain or raise occupancy and rental rates;the failure to execute our business plan;adverse consumer impacts and declines in general economic conditions from inflation, tariffs, changes in interest rates and wage stagnation, including impacts on the demand for self-storage, rental rates and fees and rent collection levels;reduced availability and increased costs of external sources of capital;financing risks, including rising interest rates, the risk of over-leverage and the corresponding risk of default on our mortgage and other debt and potential inability to refinance existing or future debt;counterparty non-performance related to the use of derivative financial instruments;risks related to our ability to maintain our qualification as a REIT for federal income tax purposes;the failure of acquisitions or developments of self-storage properties to close on expected terms, or at all, or to perform as expected;increases in taxes, fees and assessments from state and local jurisdictions;the failure of our joint venture partners to fulfill their obligations to us or their pursuit of actions that are inconsistent with our objectives;reductions in asset valuations and related impairment charges;negative publicity relating to our business or industry, which could adversely affect our reputation;increases in operating costs, including, without limitation, insurance, utility and other general expenses, which could adversely affect our financial results;cybersecurity breaches, cyber or ransomware attacks or a failure of our networks, systems or technology, which could adversely impact our business, customer and employee relationships or result in fraudulent payments;risks associated with generative artificial intelligence tools and large language models and the conclusions that these tools and models may draw about our business and prospects in connection with the dissemination of negative opinions, characterizations or disinformation;changes in real estate, zoning, use and occupancy laws or regulations;risks related to or consequences of earthquakes, hurricanes, windstorms, floods, wildfires, other natural disasters or acts of violence, pandemics, active shooters, terrorism, insurrection or war that impact the markets in which we operate;potential environmental and other material liabilities;governmental, administrative and executive orders, regulations and laws, which could adversely impact our business operations and customer and employee relationships;uninsured or uninsurable losses and the ability to obtain insurance coverage, indemnity or recovery from insurance against risks and losses;changes in the availability of and the cost of labor;other factors affecting the real estate industry generally or the self-storage industry in particular; andother risks identified in Item 1A of our Annual Report on Form 10-K and, from time to time, in other reports that we file with the SEC or in other documents that we publicly disseminate. Given these uncertainties, we caution readers not to place undue reliance on forward-looking statements. We undertake no obligation to publicly update or revise these forward-looking statements, whether as a result of new information, future events or otherwise except as may be required by securities laws. Because of the factors referred to above, the future events discussed in this presentation may not occur and actual results, performance or achievement could differ materially from that anticipated or implied in the forward-looking statements.

Contact:                               

CubeSmart
Josh Schutzer
Senior Vice President, Finance
(610) 535-5700

CUBESMART AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)                September 30, December 31,     2026
    2025
  (unaudited)          ASSETS      Storage properties $8,168,758  $8,134,189 Less: Accumulated depreciation  (1,889,960)  (1,758,340)Storage properties, net (includes VIE amounts of $381,351 and $373,687, respectively)  6,278,798   6,375,849 Cash and cash equivalents (including VIE amounts of $7,358 and $4,397, respectively)  14,311   5,782 Restricted cash (including VIE amounts of $47 and $2,552, respectively)  1,788   4,451 Loan procurement costs, net of amortization  6,312   1,803 Investment in real estate ventures, at equity  72,622   74,034 Other assets, net  172,054   181,274 Total assets $6,545,885  $6,643,193        LIABILITIES AND EQUITY      Unsecured senior notes, net $2,628,715  $2,925,103 Revolving credit facility  850,100   378,800 Mortgage loans and notes payable, net (including VIE amounts of $0 and $7,092, respectively)  56,996   98,859 Lease liabilities - finance leases  65,431   65,579 Accounts payable, accrued expenses and other liabilities  250,317   229,666 Distributions payable  119,477   121,519 Deferred revenue  43,124   41,591 Total liabilities  4,014,160   3,861,117        Noncontrolling interests in the Operating Partnership  36,987   36,167        Commitments and contingencies             Equity      Common shares $.01 par value, 400,000,000 shares authorized, 223,401,744 and 227,269,217 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively  2,234   2,273 Additional paid-in capital  4,314,197   4,302,554 Accumulated other comprehensive loss  (189)  (249)Accumulated deficit  (1,839,683)  (1,585,135)Total CubeSmart shareholders’ equity  2,476,559   2,719,443 Noncontrolling interests in subsidiaries  18,179   26,466 Total equity  2,494,738   2,745,909 Total liabilities and equity $6,545,885  $6,643,193  CUBESMART AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)               Three Months Ended  Nine Months Ended   September 30, September 30,     2026
    2025
    2026
    2025
             REVENUES            Rental income $247,757  $243,400  $729,899  $715,722 Other property related income  36,053   31,730   102,365   94,092 Property management fee income  10,158   9,950   30,119   30,605 Total revenues  293,968   285,080   862,383   840,419 OPERATING EXPENSES            Property operating expenses  95,789   90,848   281,875   262,810 Depreciation and amortization  55,947   66,688   173,224   192,332 General and administrative  16,502   16,506   50,937   47,471 Total operating expenses  168,238   174,042   506,036   502,613 OTHER (EXPENSE) INCOME            Interest:            Interest expense on loans  (31,082)  (29,380)  (91,254)  (84,570)Loan procurement amortization expense  (1,049)  (1,258)  (3,213)  (3,700)Equity in earnings of real estate ventures  604   648   1,767   1,574 Gain from sale of real estate, net  —   —   2,503   — Other  108   1,368   371   2,483 Total other expense  (31,419)  (28,622)  (89,826)  (84,213)NET INCOME  94,311   82,416   266,521   253,593 Net income attributable to noncontrolling interests in the Operating Partnership  (411)  (396)  (1,163)  (1,250)Net loss attributable to noncontrolling interests in subsidiaries  455   910   1,469   2,744 NET INCOME ATTRIBUTABLE TO THE COMPANY $94,355  $82,930  $266,827  $255,087              Basic earnings per share attributable to common shareholders $0.42  $0.36  $1.18  $1.12 Diluted earnings per share attributable to common shareholders $0.42  $0.36  $1.17  $1.11              Weighted average basic shares outstanding  225,637   228,791   226,732   228,731 Weighted average diluted shares outstanding  226,109   229,295   227,166   229,237               Same-Store Results (623 stores)
(in thousands, except percentages and per square foot data)
(unaudited)

                    Three Months Ended    Nine Months Ended    September 30, Percent   September 30, Percent       2026
    2025
    Change 2026
    2025
    Change                  REVENUES                 Rental income $233,454  $230,816  1.1%   $688,001  $683,629  0.6%Other property related income  13,254   11,349  16.8%   38,068   34,475  10.4%Total revenues  246,708   242,165  1.9%   726,069   718,104  1.1%                  OPERATING EXPENSES                 Property taxes (1)  28,934   27,823  4.0%    87,985   84,552  4.1%Personnel expense  15,340   14,712  4.3%    45,579   42,882  6.3%Advertising  7,313   8,193  (10.7)%    19,938   19,462  2.4%Repair and maintenance  3,809   3,485  9.3%   10,488   9,202  14.0%Utilities  6,365   6,056  5.1%    18,129   17,508  3.5%Property insurance  2,391   2,682  (10.9)%    7,719   9,225  (16.3)%Other expenses  9,916   10,170  (2.5)%    31,251   30,191  3.5%                  Total operating expenses  74,068   73,121  1.3%    221,089   213,022  3.8%                  Net operating income (2) $172,640  $169,044  2.1%   $504,980  $505,082  0.0%                  Gross margin  70.0%   69.8%     69.5%   70.3%                    Period end occupancy  89.9%  89.0%      89.9%   89.0%                     Period average occupancy  90.5%  89.9%      90.0%   89.9%                    Total rentable square feet  45,244         45,244                        Realized annual rent per occupied square foot (3) $22.81  $22.70  0.5%   $22.54  $22.40  0.6%                  Reconciliation of Same-Store Net Operating Income to Net Income                                   Same-store net operating income (2) $172,640  $169,044     $504,980  $505,082   Non same-store net operating income (2)  9,659   8,412      28,051   21,358   Indirect property overhead (4)  15,880   16,776      47,477   51,169   Depreciation and amortization  (55,947)  (66,688)     (173,224)  (192,332)  General and administrative expense  (16,502)  (16,506)     (50,937)  (47,471)  Interest expense on loans  (31,082)  (29,380)     (91,254)  (84,570)  Loan procurement amortization expense  (1,049)  (1,258)     (3,213)  (3,700)  Equity in earnings of real estate ventures  604   648      1,767   1,574   Gain from sale of real estate, net  -   -      2,503   -   Other  108   1,368      371   2,483                     Net income $94,311  $82,416     $266,521  $253,593    (1)For comparability purposes, current year amounts related to the expiration of certain real estate tax abatements have been excluded from the same-store portfolio results ($207k and $618k for the three and nine months ended September 30, 2026, respectively).(2)Net operating income (“NOI”) is a non-GAAP (“generally accepted accounting principles”) financial measure. The above table reconciles same-store NOI to GAAP Net income.(3)Realized annual rent per occupied square foot is calculated by dividing annualized rental income by the weighted average occupied square feet for the period.(4)Includes property management fee income earned in conjunction with managed properties.   Non-GAAP Measure – Computation of Funds From Operations
(in thousands, except percentages and per share and unit data)
(unaudited)                Three Months Ended  Nine Months Ended   September 30, September 30,   2026 2025 2026
 2025               Net income attributable to the Company's common shareholders $94,355 $82,930 $266,827  $255,087               Add (deduct):             Real estate depreciation and amortization:             Real property  54,036  64,207  167,567   185,014 Company's share of unconsolidated real estate ventures  1,533  1,438  4,504   4,681 Gain from sale of real estate, net (1)  —  —  (2,503)  — Net income attributable to noncontrolling interests in the Operating Partnership  411  396  1,163   1,250               FFO attributable to the Company's common shareholders and third-party OP unitholders $150,335 $148,971 $437,558  $446,032               Add:             Loss on early extinguishment of debt (2)  -  -  59   -               FFO, as adjusted, attributable to the Company's common shareholders and third-party OP unitholders $150,335 $148,971 $437,617  $446,032               Basic earnings per share attributable to common shareholders $0.42 $0.36 $1.18  $1.12 Diluted earnings per share attributable to common shareholders $0.42 $0.36 $1.17  $1.11 FFO per diluted share and unit $0.66 $0.65 $1.92  $1.94 FFO, as adjusted per diluted share and unit $0.66 $0.65 $1.92  $1.94               Weighted average basic shares outstanding  225,637  228,791  226,732   228,731 Weighted average diluted shares outstanding  226,109  229,295  227,166   229,237 Weighted average diluted shares and units outstanding  227,093  230,398  228,151   230,366               Dividends per common share and unit $0.53 $0.52 $1.59  $1.56 Payout ratio of FFO, as adjusted  80.3% 80.0% 82.8 % 80.4% (1)Relates to a gain from the sale of a land parcel adjacent to a Company store.(2)Relates to the write-off of unamortized loan procurement costs associated with the Company’s amendment and restatement of its unsecured revolving credit facility.
2026-10-29 22:18 2d ago
2026-10-29 16:24 2d ago
DKS DEADLINE ALERT: ROSEN, A TOP-RANKED LAW FIRM, Encourages DICK'S Sporting Goods, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - DKS
DKS Dick's Sporting Goods
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - October 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DICK'S Sporting Goods, Inc. (NYSE: DKS) between September 8, 2025 and August 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline.

SO WHAT: If you purchased DICK'S Sporting Goods common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the DICK'S Sporting Goods class action, go to https://rosenlegal.com/cases/dicks-sporting-goods/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 3, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Dick's cleanup efforts concerning Foot Locker's inventory were not complete, and, in fact, Foot Locker remained saddled with unproductive and stagnant legacy footwear; (2) Foot Locker heavily relied on legacy footwear products that were particularly vulnerable to intensifying promotional pressures across the athletic footwear industry; (3) in turn, Dick's was significantly exposed to an industry-wide environment of excess inventory and resulting promotional activity; (4) accordingly, Dick's was unable to achieve the sales growth, margins, and profits it touted to investors; and (5) as a result of the above, defendants' positive statements about Dick's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the DICK'S Sporting Goods class action, go to https://rosenlegal.com/cases/dicks-sporting-goods/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321686

Source: The Rosen Law Firm PA

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-10-29 22:17 2d ago
2026-10-29 16:05 2d ago
Viasat Sets November 5, 2026 for Second Quarter Fiscal Year 2027 Financial Results Conference Call and Webcast
VSAT ViaSat
FMP Stock News
Original source text
CARLSBAD, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications technology, today announced it will release its second quarter fiscal year 2027 financial results on Thursday, November 5, 2026, after market close. Results will be provided in a letter to shareholders, which will be posted to the Investor Relations section of the Company’s website.

Viasat will also host a conference call and webcast on Thursday, November 5, 2026, at 2:30 p.m. Pacific Time / 5:30 p.m. Eastern Time to discuss results.

To participate on the live conference call, please dial (800) 715-9871 (toll-free in the U.S. and Canada) or (646) 307-1963, and reference conference ID 7750494.

A live webcast will be available in Viasat’s Investor Relations section of Viasat’s website. A replay of the webcast will be archived following the conference call.

About Viasat 
Viasat is a global technology company that believes everyone and everything in the world can be connected. With offices in 24 countries around the world, our mission shapes how consumers, businesses, governments and militaries around the world communicate and connect. Viasat is developing the ultimate global communications network to power high-quality, reliable, secure, affordable, fast connections to positively impact people's lives anywhere they are—on the ground, in the air or at sea, while building a sustainable future in space. In May 2023, Viasat completed its acquisition of Inmarsat, combining the teams, technologies and resources of the two companies to create a new global communications partner. Learn more at www.viasat.com, the Viasat News Room or follow us on LinkedIn, X, Instagram, Facebook, Bluesky, Threads, and YouTube.

Copyright © 2026 Viasat, Inc. All rights reserved. Viasat, the Viasat logo and the Viasat Signal are registered trademarks in the U.S. and in other countries of Viasat, Inc. All other product or company names mentioned are used for identification purposes only and may be trademarks of their respective owners. 

Viasat, Inc. Contacts
David Pendery, Corporate Communications, [email protected]
Lisa Curran / Peter Lopez, Investor Relations, [email protected]
2026-10-29 22:17 2d ago
2026-10-29 16:10 2d ago
Coursera Reports Third Quarter 2026 Financial Results
COUR Coursera
FMP Stock News
Original source text
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coursera, Inc. (NYSE: COUR), a leading global online learning platform, today announced financial results for its third quarter ended September 30, 2026. A shareholder letter with additional discussion of the Company’s performance and outlook has been posted to the Investor Relations website at investor.coursera.com.

“Organizations are investing at extraordinary scale in AI infrastructure, but the return on that investment depends on the people who know how to use it,” said Greg Hart, Coursera CEO. “Closing that skills gap is the opportunity we are positioning Coursera and Udemy to address, and we are on track to deliver our original 24-month synergy plan in just eight months as we create greater capacity to invest in innovation. Project Helix brings together the complementary strengths of Coursera and Udemy on an AI-native platform designed to deliver more personalized learning, verified skills pathways, and stronger connections between human capabilities and business outcomes.”

Key Financial Results

($ millions, except per share data, unaudited)

Three Months Ended September 30,

2026

2025

YoY Change

GAAP Financial Measures

Revenue

$

376.7

$

194.2

94 %

Gross profit

$

220.1

$

106.0

108 %

Gross profit margin

58.4

%

54.6

%

380 bps

Net loss

$

(25.6

)

$

(8.6

)

(198) %

Net loss per share

$

(0.10

)

$

(0.05

)

(100) %

Net loss margin

(6.8

)%

(4.4

)%

(240) bps

Net cash provided by operating activities(1)

$

15.5

$

33.9

(54) %

Non-GAAP Financial Measures

Gross profit

$

240.0

$

108.0

122 %

Gross profit margin

63.7

%

55.6

%

810 bps

Net income

$

57.1

$

16.7

242 %

Net income per share

$

0.21

$

0.10

110 %

Adjusted EBITDA

$

61.5

$

15.6

294 %

Adjusted EBITDA Margin

16.3

%

8.0

%

830 bps

Free Cash Flow(1)

$

4.6

$

26.6

(83) %

For more information regarding the non-GAAP financial measures discussed in this press release, please see “Non-GAAP Financial Measures” and “Reconciliation of GAAP to Non-GAAP Financial Measures” below.

Segment Results

($ millions, unaudited)

Three Months Ended September 30,

2026

2025

YoY Change

Enterprise revenue

$

200.9

$

63.9

214 %

Enterprise gross profit

$

163.4

$

44.5

267 %

Enterprise gross profit margin

81.3

%

69.6

%

1170 bps

Consumer revenue

$

175.8

$

130.3

35 %

Consumer gross profit

$

115.5

$

79.7

45 %

Consumer gross profit margin

65.7

%

61.2

%

450 bps

Key Business Metrics(1)

Three Months Ended September 30,

2026

2025

YoY Change

Net Retention Rate for Enterprise Customers(2)

93

%

93

%

0 bps

September 30,

2026

2025

YoY Change

Enterprise Customers(3)

11,897

12,338

(4) %

Paid Subscribers (in thousands)

1,687

1,299

30 %

(1) Key Business Metrics presented above represent the combined metrics of Coursera and Udemy, reflecting a unified reporting methodology. Historical combined metrics have been conformed to this unified reporting methodology for comparability purposes, and, therefore, may not equal the sum of each company’s previously reported metrics or be comparable to the financial information presented in this press release, which reflects the completion of the Udemy transaction on May 11, 2026 and incorporates Udemy’s operating results from the date of acquisition. For more information regarding the metrics discussed in this press release, please see “Key Business Metrics Definitions” below.

(2) On a standalone basis for the three months ended September 30, 2025, Coursera reported Net Retention Rate of 89% and Udemy reported Net Dollar Retention Rate of 93%. These legacy as-reported figures were calculated using each respective company’s pre-merger defined reporting methodology and are provided solely for historical reference.

(3) On a standalone basis, Coursera reported 1,724 Paid Enterprise Customers and Udemy reported 17,111 Udemy Business Customers as of September 30, 2025. These legacy as-reported figures were calculated using each respective company’s pre-merger defined reporting methodology and are provided solely for historical reference.

Financial Outlook

Our guidance reflects the completion of the Udemy transaction on May 11, 2026 and incorporates Udemy's operating results from the date of acquisition. Guidance also reflects the expected pace of synergy realization during 2026, and therefore only a portion of the annual run-rate benefit is expected to be reflected in reported 2026 results.

Fourth quarter 2026: Revenue in the range of $358 million to $366 million Adjusted EBITDA in the range of $55 million to $59 million Full year 2026: Revenue in the range of $1.229 billion to $1.237 billion Adjusted EBITDA Margin target of approximately 14% Actual results may differ materially from Coursera’s Financial Outlook as a result of, among other things, the factors described under “Special Note on Forward-Looking Statements” below.

A reconciliation of our non-GAAP guidance measure (Adjusted EBITDA and Adjusted EBITDA Margin) to the corresponding GAAP guidance measure is not available on a forward-looking basis without unreasonable effort due to the uncertainty regarding, and the potential variability of, expenses that may be incurred in the future. Stock-based compensation expense-related charges, including employer payroll tax-related items on employee stock transactions, are impacted by the timing of employee stock transactions, the future fair market value of our common stock, and our future hiring and retention needs, all of which are difficult to predict and subject to constant change. We have provided a reconciliation of GAAP to non-GAAP financial measures in the financial statement tables for our historical non-GAAP financial results included in this press release.

Share repurchase

During the third quarter of 2026, Coursera repurchased approximately 18.1 million shares of its common stock for $102 million, including commissions. During the nine months ended September 30, 2026, Coursera repurchased approximately 34.6 million shares of its common stock for $192 million, including commissions. Including purchases after quarter-end, as of October 28, 2026, the Company had repurchased more than $215 million of its common stock since the program was announced in May 2026, with significant remaining capacity under its $500 million authorization.

Conference Call Details

As previously announced, Coursera will hold a conference call to discuss its third quarter 2026 performance today, October 29, 2026, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

A live audio webcast of the conference call and accompanying earnings materials will be available to the public on our investor relations page at investor.coursera.com. For those unable to listen to the broadcast live, an archived replay will be accessible in the same location for one year.

Disclosure Information

In compliance with disclosure obligations under Regulation FD, Coursera announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission (“SEC”), press releases, company blog posts, public conference calls, and webcasts, as well as via Coursera’s investor relations website.

About Coursera

Coursera was launched in 2012 by Andrew Ng and Daphne Koller with a mission to provide universal access to world-class learning. Coursera partners with leading university and industry partners to offer a broad catalog of content and credentials, including courses, Specializations, Professional Certificates, and degrees. Coursera’s platform innovations — including AI-powered personalized guide and features, like Role Play and Course Builder, and role-based solutions like Skills Tracks — enable instructors, partners, and companies to deliver scalable, personalized, and verified learning. Institutions worldwide rely on Coursera to upskill and reskill their employees, students, and citizens in high-demand fields such as GenAI, data science, technology, and business, while learners globally turn to Coursera to master the skills they need to advance their careers. Coursera is a Delaware public benefit corporation and a B Corp. Coursera recently combined with Udemy to create one of the world’s most comprehensive skills development platforms.

Key Business Metrics Definitions

Enterprise Customers

We count the total number of Enterprise Customers that are active on the Coursera or Udemy platforms at the end of each period. For purposes of determining our customer count, we treat each customer account that has a corresponding contract as a unique customer, and a single organization with multiple divisions, segments, or subsidiaries may be counted as multiple customers. We define an “Enterprise Customer” as a customer who purchases Coursera or Udemy solutions via our direct sales force or through reseller and channel partnerships. For purposes of determining our Enterprise Customer count, we exclude customers who do not purchase either via our direct sales force or through reseller and channel partnerships, including organizations engaging through our self service platforms.

Net Retention Rate (“NRR”) for Enterprise Customers

We calculate annual recurring revenue (“ARR”) by annualizing each customer’s monthly recurring revenue (“MRR”) for the most recent month at period end. We calculate “Net Retention Rate” for a period by starting with the ARR from all Enterprise Customers as of the 12 months prior to such period end, or Prior Period ARR. We then calculate the ARR from these same Enterprise Customers as of the current period end, or “Current Period ARR”. Current Period ARR includes expansion within Enterprise Customers and is net of contraction or attrition over the trailing 12 months but excludes the contribution from new Enterprise Customers in the current period. We then divide the total Current Period ARR by the total Prior Period ARR to arrive at our Net Retention Rate for Enterprise Customers.

Paid Subscribers

Paid Subscriber count is defined as the total number of unique subscribers with at least one paid Consumer subscription product that contributes to revenue as of the reporting period. For purposes of determining unique subscriber count, subscribers with multiple paid subscriptions are counted as a single Paid Subscriber.

Non-GAAP Financial Measures

In addition to financial information presented in accordance with GAAP, this press release includes non-GAAP gross profit, non-GAAP gross profit margin, non-GAAP net income, non-GAAP net income per share, Adjusted EBITDA, Adjusted EBITDA Margin, and Free Cash Flow, each of which is a non-GAAP financial measure. These are key measures used by our management to help us analyze our financial results, establish budgets and operational goals for managing our business, evaluate our performance, and make strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors. In addition, we believe these measures are useful for period-to-period comparisons of our business. We also believe that the presentation of these non-GAAP financial measures provides an additional tool for investors to use in comparing our core business and results of operations over multiple periods with other companies in our industry, many of which present similar non-GAAP financial measures to investors, and to analyze our cash performance. However, the non-GAAP financial measures presented may not be comparable to similarly titled measures reported by other companies due to differences in the way that these measures are calculated. These non-GAAP financial measures are presented for supplemental informational purposes only and should not be considered as a substitute for or in isolation from financial information presented in accordance with GAAP. These non-GAAP financial measures have limitations as analytical tools.

Non-GAAP Gross Profit, Non-GAAP Gross Profit Margin, Non-GAAP Net Income, and Non-GAAP Net Income Per Share

We define non-GAAP gross profit and non-GAAP net income as GAAP gross profit and GAAP net loss excluding: (1) merger, integration, and restructuring related costs; (2) stock-based compensation expense; (3) amortization of acquired intangible assets; (4) amortization of stock-based compensation expense capitalized as internal-use software costs; (5) payroll tax expense related to stock-based compensation; and (6) costs and settlement (gains) losses related to significant and non-recurring legal and regulatory matters, net of insurance recoveries. Non-GAAP gross profit margin reflects non-GAAP gross profit as a percentage of revenue. Non-GAAP net income per share is calculated by dividing non-GAAP net income by the diluted weighted average shares of common stock outstanding.

Adjusted EBITDA and Adjusted EBITDA Margin

We define Adjusted EBITDA as our GAAP net loss excluding: (1) merger, integration, and restructuring related costs; (2) stock-based compensation expense; (3) depreciation and amortization; (4) income tax expense; (5) other expense, net; (6) payroll tax expense related to stock-based compensation; (7) costs and settlement (gains) losses related to significant and non-recurring legal and regulatory matters, net of insurance recoveries; and (8) interest income, net. We define Adjusted EBITDA Margin as Adjusted EBITDA divided by revenue.

Free Cash Flow

We define Free Cash Flow as net cash provided by operating activities, less capitalized internal-use software costs, purchases of content assets, and purchases of property, equipment, and software as we consider these capital expenditures necessary to support our ongoing operations.

We believe the presentation of these adjusted operating results provides useful supplemental information to investors and facilitates the analysis and comparison of our operating results across reporting periods.

Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the financial statements below.

Special Note on Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. Any statements contained in this press release that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as: “accelerate,” “achieve,” “anticipate,” “believe,” “can,” “continue,” “could,” “demand,” “design,” “estimate,” “expand,” “expect,” “intend,” “may,” “might,” “mission,” “need,” “objective,” “ongoing,” “outlook,” “plan,” “position,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. These forward-looking statements include, but are not limited to, statements regarding the development, timing of launch and market adoption of Project Helix; our strategic investment, including the expected benefits or timing of our commercial collaborations; the expected benefits of the completed business combination with Udemy, such as the amount and expected timing of our annual run-rate net synergies and the expected pace of synergy realization during 2026, the outlook for the combined company’s results of operations and financial condition; our continued integration efforts for the combined company; the anticipated utility of our non-GAAP financial measures; our financial outlook, future financial and operational performance, and expectations, including our financial outlook for the fourth quarter of 2026 and full year 2026; and the timing, amount, and continuation of share repurchases under our share repurchase authorization, including our expectations regarding future cash generation and capital allocation priorities, among others. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the following: our ability to attract, engage, and retain learners; our ability to increase sales of our offerings; risks associated with our ability to develop, market and sell a more comprehensive and AI-native skills platform in a timely manner or at all, and risks related to its market adoption; risks related to market acceptance and demand for our offerings; our ability to maintain and expand our existing content creator relationships and to develop new partnerships with universities, industry leaders, and subject matter experts; our dependence on the supply of content created by our partners; risks related to our AI innovations and AI generally, including the rapid pace of technological change and the substantial and ongoing investment that may be required to successfully compete; risks related to the completed business combination with Udemy, including our ability to retain and hire key personnel and maintain relationships with customers, vendors and others with whom Coursera or Udemy do business, our ability to successfully integrate Coursera’s and Udemy’s operations and business on a timely basis or otherwise in accordance with the standards and obligations applicable to the combined company as a public benefit corporation and as a B Corp.; our ability to realize the anticipated benefits and synergies of the completed business combination with Udemy, including the expected amount and timing of net synergies, and the risk that integration may be more difficult, time-consuming, or costly than expected; the risk of impairment of goodwill and other intangible assets acquired in the business combination; fluctuations in the prices of Coursera stock; our ability to compete effectively against new and existing competitors, particularly as emerging and evolving technologies such as AI may lower barriers to entry, enable new products and business models, and alter industry dynamics; adverse impacts on our business and financial condition due to macroeconomic or market conditions; our ability to manage our growth; regulatory and/or policy matters or changes impacting us or our content creators; risks related to intellectual property; cybersecurity and privacy risks and regulations; potential disruptions to our platforms; risks related to operations, regulatory, economic, and geopolitical conditions; current and future legal and regulatory matters; the impact of actions to improve operational efficiencies and operating costs; our history of net losses and ability to achieve or sustain profitability; fluctuations in market conditions, our cash needs, and other factors affecting our ability to repurchase shares under our share repurchase authorization; our limited operating history; the relative nascency of online learning solutions and generative AI; natural disasters, public health crises, or other catastrophic events; as well as the risks and uncertainties discussed in our most recently filed annual and quarterly reports on Forms 10-K and 10-Q and subsequent filings and as detailed from time to time in our SEC filings. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. Such forward-looking statements relate only to events as of the date of this press release. We undertake no obligation to update any forward-looking statements except to the extent required by law.

Coursera Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except per share amounts)

  Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Revenue

$

376.7

$

194.2

$

871.0

$

560.6

Cost of revenue(2)

156.6

88.2

368.9

254.0

Gross profit

220.1

106.0

502.1

306.6

Operating expenses:

Research and development(2)

52.1

30.0

127.1

88.8

Sales and marketing(2)

129.5

67.4

302.8

187.8

General and administrative(1)(2)

36.6

24.2

90.5

76.0

Merger, integration, and restructuring related costs(1)(2)

30.8

—

120.6

(0.9

)

Total operating expenses

249.0

121.6

641.0

351.7

Loss from operations

(28.9

)

(15.6

)

(138.9

)

(45.1

)

Interest income, net

6.8

8.3

21.6

24.1

Other expense, net

(0.9

)

(0.5

)

(3.1

)

(0.1

)

Loss before income taxes

(23.0

)

(7.8

)

(120.4

)

(21.1

)

Income tax expense

2.6

0.8

6.1

3.1

Net loss

$

(25.6

)

$

(8.6

)

$

(126.5

)

$

(24.2

)

Net loss per share—basic and diluted

$

(0.10

)

$

(0.05

)

$

(0.57

)

$

(0.15

)

Weighted average shares used in computing net loss per share—basic and diluted

264.7

164.6

222.6

162.6

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Cost of revenue

$

1.1

$

0.6

$

2.7

$

1.9

Research and development

8.7

8.5

25.5

26.0

Sales and marketing

6.5

5.3

18.1

15.7

General and administrative

6.5

8.6

20.6

29.0

Merger, integration, and restructuring related costs

0.3

—

16.1

(1.6

)

Total stock-based compensation expense

$

23.1

$

23.0

$

83.0

$

71.0

Coursera Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions)

  September 30, 2026

December 31, 2025

Assets

Current assets:

Cash and cash equivalents

$

670.6

$

792.6

Marketable securities

104.9

—

Accounts receivable, net

140.0

65.4

Deferred costs, net

32.2

19.6

Prepaid expenses and other current assets

52.9

20.5

Total current assets

1,000.6

898.1

Property, equipment, and software, net

57.1

43.4

Intangible assets, net

410.3

27.1

Goodwill

182.7

—

Strategic investments(3)

110.0

1.7

Other assets

44.7

29.7

Total assets

$

1,805.4

$

1,000.0

Liabilities and Stockholders’ Equity

Current liabilities:

Content liabilities

$

120.7

$

100.0

Other accounts payable and accrued expenses

63.1

29.8

Accrued compensation and benefits

56.9

36.7

Deferred revenue, current

458.5

180.9

Other current liabilities

29.2

10.5

Total current liabilities

728.4

357.9

Deferred revenue, non-current

3.2

1.4

Other liabilities

16.5

5.0

Total liabilities

748.1

364.3

Stockholders’ equity:

Additional paid-in capital

2,095.0

1,546.9

Accumulated other comprehensive income

—

—

Accumulated deficit

(1,037.7

)

(911.2

)

Total stockholders’ equity

1,057.3

635.7

Total liabilities and stockholders’ equity

$

1,805.4

$

1,000.0

Coursera Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

  Nine Months Ended September 30,

2026

2025

Cash flows from operating activities:

Net loss

$

(126.5

)

$

(24.2

)

Adjustments to reconcile net loss to net cash provided by operating activities:

Depreciation and amortization

64.6

21.8

Stock-based compensation expense

83.0

71.0

Impairment losses

3.0

3.1

Other

1.5

(0.3

)

Changes in operating assets and liabilities:

Accounts receivable, net

22.0

1.0

Prepaid expenses and other assets

(16.0

)

6.2

Accounts payable and accrued expenses

9.7

9.1

Accrued compensation and other liabilities

4.1

(2.6

)

Deferred revenue

(35.1

)

17.8

Net cash provided by operating activities

10.3

102.9

Cash flows from investing activities:

Cash acquired from the Udemy merger

213.6

—

Purchases of strategic investments

(100.0

)

—

Purchases of marketable securities

(65.4

)

—

Proceeds from maturities of marketable securities

70.0

—

Purchases of content assets

(13.7

)

(8.0

)

Capitalized internal-use software costs

(20.8

)

(13.3

)

Purchases of property, equipment, and software

(0.8

)

(1.1

)

Net cash provided by (used in) investing activities

82.9

(22.4

)

Cash flows from financing activities:

Proceeds from exercise of stock options

0.7

8.6

Proceeds from employee stock purchase plan

2.7

2.8

Payments for repurchases of common stock

(190.7

)

—

Payments for tax withholding on vesting of restricted stock units

(25.8

)

(21.8

)

Net cash used in financing activities

(213.1

)

(10.4

)

Effect of foreign exchange rates on cash flows

(0.4

)

—

Net (decrease) increase in cash, cash equivalents, and restricted cash

(120.3

)

70.1

Cash, cash equivalents, and restricted cash—beginning of period

793.4

728.4

Cash, cash equivalents, and restricted cash—end of period

$

673.1

$

798.5

Coursera Inc.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited)

(In millions, except percentages and per share amounts)

  Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Gross profit

$

220.1

$

106.0

$

502.1

$

306.6

Amortization of acquired intangible assets

17.0

—

26.5

—

Stock-based compensation expense

1.1

0.6

2.7

1.9

Amortization of stock-based compensation capitalized as internal-use software costs

1.8

1.4

5.2

4.3

Payroll tax expense related to stock-based compensation

—

—

0.1

—

Non-GAAP gross profit

$

240.0

$

108.0

$

536.6

$

312.8

Gross profit margin

58.4

%

54.6

%

57.6

%

54.7

%

Non-GAAP gross profit margin

63.7

%

55.6

%

61.6

%

55.8

%

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Net loss

$

(25.6

)

$

(8.6

)

$

(126.5

)

$

(24.2

)

Merger, integration, and restructuring related costs

30.8

—

120.6

(0.9

)

Stock-based compensation expense

22.8

23.0

66.9

72.6

Amortization of acquired intangible assets

25.1

—

39.2

—

Amortization of stock-based compensation capitalized as internal-use software costs

1.8

1.4

5.2

4.3

Payroll tax expense related to stock-based compensation

0.7

0.8

2.1

2.4

Significant and non-recurring legal and regulatory matters

1.5

0.1

2.4

1.5

Non-GAAP net income

$

57.1

$

16.7

$

109.9

$

55.7

Weighted-average shares used in computing net loss per share—basic

264.7

164.6

222.6

162.6

Effect of dilutive securities

2.8

7.9

5.2

6.1

Weighted-average shares used in computing non-GAAP net income per share—diluted

267.5

172.5

227.8

168.7

Net loss per share—basic and diluted

$

(0.10

)

$

(0.05

)

$

(0.57

)

$

(0.15

)

Non-GAAP net income per share—diluted

$

0.21

$

0.10

$

0.48

$

0.33

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Net loss

$

(25.6

)

$

(8.6

)

$

(126.5

)

$

(24.2

)

Merger, integration, and restructuring related costs

30.8

—

120.6

(0.9

)

Stock-based compensation expense

22.8

23.0

66.9

72.6

Depreciation and amortization

34.6

7.3

64.6

21.8

Income tax expense

2.6

0.8

6.1

3.1

Other expense, net

0.9

0.5

3.1

0.1

Payroll tax expense related to stock-based compensation

0.7

0.8

2.1

2.4

Significant and non-recurring legal and regulatory matters

1.5

0.1

2.4

1.5

Interest income, net

(6.8

)

(8.3

)

(21.6

)

(24.1

)

Adjusted EBITDA

$

61.5

$

15.6

$

117.7

$

52.3

Net loss margin

(6.8

)%

(4.4

)%

(14.5

)%

(4.3

)%

Adjusted EBITDA Margin

16.3

%

8.0

%

13.5

%

9.3

%

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Net cash provided by operating activities(4)

$

15.5

$

33.9

$

10.3

$

102.9

Less: capitalized internal-use software costs

(7.8

)

(5.0

)

(20.8

)

(13.3

)

Less: purchases of content assets

(2.8

)

(2.1

)

(13.7

)

(8.0

)

Less: purchases of property, equipment, and software

(0.3

)

(0.2

)

(0.8

)

(1.1

)

Free Cash Flow

$

4.6

$

26.6

$

(25.0

)

$

80.5

Supplemental Data

Disaggregation of Revenue - The following table presents revenue disaggregated by product offering for each segment (in millions):

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Enterprise:

Subscription

199.8

63.6

405.2

189.2

Other

1.1

0.3

1.9

0.7

Enterprise revenue

$

200.9

$

63.9

$

407.1

$

189.9

Consumer:

Subscription

130.6

111.2

362.7

311.2

Transactional and other

32.8

4.8

60.4

14.0

Degrees

12.4

14.3

40.8

45.5

Consumer revenue

$

175.8

$

130.3

$

463.9

$

370.7

Total revenue

$

376.7

$

194.2

$

871.0

$

560.6

Source Code: COUR-IR

More News From Coursera
2026-10-29 22:17 2d ago
2026-10-29 17:14 2d ago
Targa Resources: Needs Balance Sheet Repairing First
TRGP Targa Resources
FMP Stock News
Original source text
Targa Resources Corp. is a major NGL infrastructure player with strong macro tailwinds but an overleveraged balance sheet. TRGP benefits from robust demand forecasts for natural gas and NGLs, highlighted by a 20-year deal with ExxonMobil and favorable U.S. Gulf Coast export dynamics. Despite segment margin strength and macro growth, TRGP's debt metrics—81.4% LT Debt/Total Capital and 516% Debt/Equity—are materially above sector norms.
2026-10-29 22:17 2d ago
2026-10-29 15:53 2d ago
KBRA Publishes Ratings for ACRES Commercial Realty Corp.
ACR Acres Commercial Realty
FMP Stock News
Original source text
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA publishes the issuer rating of BB, senior secured debt rating of BBB-, and preferred stock rating of BB- for ACRES Commercial Realty Corp. (NYSE: ACR, “ACRES”, or “the company”). The Outlook for the ratings is Stable. On August 5, 2026, these ratings were assigned on an unpublished basis. Key Credit Considerations On August 6, 2026, ACR, a real estate investment trust, acquired ACRES Capital Corp. (“ACC”), a commercial real estate (“CRE”) investment manager found.
2026-10-29 22:16 2d ago
2026-10-29 16:15 2d ago
Weyerhaeuser Reports Third Quarter 2026 Results
WY Weyerhaeuser
FMP Stock News
Original source text
, /PRNewswire/ -- Weyerhaeuser Company (NYSE: WY) today reported its third quarter 2026 financial results. The company's earnings release and associated materials are available on the Investors section of the company's website, www.weyerhaeuser.com. In addition, the earnings release has been furnished on a Form 8-K with the U.S. Securities and Exchange Commission and is available at www.sec.gov.

EARNINGS CALL INFORMATION
The company will hold a live webcast and conference call at 7 a.m. Pacific (10 a.m. Eastern) on October 30, 2026, to discuss third quarter results. To access the live webcast and presentation online, visit the Investors section on www.weyerhaeuser.com on October 30, 2026.

To join the conference call from within North America, dial 877-407-0792 (access code: 13755109) at least 15 minutes prior to the call. Those calling from outside North America should dial 201-689-8263 (access code: 13755109). Replays will be available for two weeks at 844-512-2921 (access code: 13755109) from within North America, and at 412-317-6671 (access code: 13755109) from outside North America.

ABOUT WEYERHAEUSER
Weyerhaeuser Company, one of the world's largest private owners of timberlands, began operations in 1900 and today owns or controls more than 10 million acres of timberlands in the U.S., as well as additional public timberlands managed under long-term licenses in Canada. Weyerhaeuser has been a global leader in sustainability for more than a century and manages 100 percent of its timberlands on a fully sustainable basis in compliance with internationally recognized sustainable forestry standards. Weyerhaeuser is also one of the largest manufacturers of wood products in North America and operates additional business lines around product distribution, climate solutions, real estate, and energy and natural resources, among others. In 2025, the company generated $6.9 billion in net sales and employed approximately 9,500 people who serve customers worldwide. Operated as a real estate investment trust, Weyerhaeuser's common stock trades on the New York Stock Exchange under the symbol WY. Learn more at www.weyerhaeuser.com.

For more information contact:
Analysts – Andy Taylor, 206-539-3907
Media – Nancy Thompson, 919-861-0342

SOURCE Weyerhaeuser Company
2026-10-29 22:15 2d ago
2026-10-29 16:30 2d ago
After Another Strong Quarter, XPO Sees More Room for Margin Improvements
XPO XPO Logistics
FMP Stock News
Original source text
XPO (XPO +0.73%), the less-than-truckload (LTL) carrier, delivered another strong earnings report Thursday morning, with double-digit revenue growth in North America, excluding fuel, and impressive margin improvement.

Overall, the quarter showed the company continuing to execute effectively with service improvements leading to higher prices and wider margins.

Total revenue rose $12.4% to $2.37 billion, which was slightly below estimates at $2.38 billion. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 26.6% to $433 million, and adjusted earnings per share jumped 59% to $1.70, ahead of the consensus of $1.57.

Adjusted operating ratio, a key industry metric and the inverse of adjusted operating margin, improved by 260 basis points in the quarter to 80.1%, driving the bottom-line improvement.

Image source: XPO.

What's behind XPO's growthXPO posted its strongest tonnage growth in years, up 5% per day, which Chief Strategy Officer Ali Faghri attributed to both market share gains and demand tailwinds as the industrial economy rebounds.

Faghri estimated that about two-thirds of the tonnage growth would come from market share gains, with the remainder from overall demand growth. The ISM's manufacturing purchasing managers' index (PMI) offers a good proxy for industrial demand, and that index has indicated an expansion since the start of 2026 after several years of decline.

XPO's pricing increased in the mid-single digits, driven by strong results in areas such as damage claims and on-time performance. Additionally, it's seeing strong growth with small and medium-sized businesses where new programs like grocery consolidation are helping it gain market share.

XPO's top-line growth contributed to its margin expansion, but cost efficiencies also helped. The company is leveraging AI in areas like labor and route optimization, and making pickups and deliveries more efficient. It also grew shipments in the quarter by 6% even though headcount was only up 1%, showing it's more efficiently using its personnel.

$183.01+$1.32 (+0.73%)

NYSE · As of 4:00 PM ET 10/29/26

What's next for XPOIn 2021, XPO outlined a set of goals for 2021-2027, including 11%-13% adjusted EBITDA compound annual growth rate (CAGR) in North America, revenue CAGR of 6%-8%, and adjusted operating ratio improvement of at least 600 basis points.

Faghri said the company was on track to achieve those goals a year early, and that's in an environment in which there's been a freight recession for four years.

XPO's adjusted operating ratio has fallen to 80%, but looking ahead, Faghri believes the company can get it down to the low 70's, especially if demand continues to grow. The company is gaining market share thanks to service improvements and a focus on small- and medium-sized businesses, and it has excess capacity to take advantage of a rebound in demand.

The future continues to look bright for XPO.
2026-10-29 22:14 2d ago
2026-10-29 16:05 2d ago
Dynagas LNG Partners LP Announces the Date of its 2026 Annual Meeting of Limited Partners
LNG Cheniere Energy
FMP Stock News
Original source text
 | Source: Dynagas LNG Partners LP

ATHENS, Greece, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (NYSE: “DLNG”) (the “Partnership”), an owner of liquefied natural gas carriers, announced today that its Board of Directors (the “Board”) has scheduled the Partnership’s 2026 Annual Meeting of Limited Partners (the “Meeting”) to be held on November 27, 2026 at 4:00 p.m., local time, at Poseidonos Avenue and Foivis 2 Street, 166-74 Glyfada, Athens, Greece. The Board has fixed a record date of October 27, 2026 (the “Record Date”) for the determination of the Limited Partners entitled to receive notice of and to vote at the Meeting or any adjournment thereof.

The Partnership’s Notice of the Meeting and Proxy Statement will be mailed on or about October 29, 2026 to Limited Partners of record as of the Record Date and will be furnished to the U.S. Securities and Exchange Commission (the “Commission”) and available on the Commission’s website at www.sec.gov. The Notice of the Meeting and Proxy Statement and the Partnership’s 2025 Annual Report are also available on the Partnership’s website at www.dynagaspartners.com.

Contact Information:
Dynagas LNG Partners LP
Attention: Michael Gregos
Tel. +30 210 8917960
Email: [email protected]

Investor Relations/ Financial Media:
Nicolas Bornozis / Markella Kara
Capital Link, Inc.
230 Park Avenue, Suite 1540
New York, NY 10169
Tel. (212) 661-7566
E-mail: [email protected]
2026-10-29 22:12 2d ago
2026-10-29 16:50 2d ago
KLX ENERGY SERVICES ANNOUNCES APPOINTMENT OF FRANKLIN S. EDMONDS, JR.
ATKR Atkore
FMP Stock News
Original source text
, /PRNewswire/ -- KLX Energy Services Holdings, Inc. (NASDAQ: KLXE) ("KLX" or the "Company") today announced the appointment of Franklin S. Edmonds, Jr. and E. Dirk Hallen to its Board of Directors (the "Board") as independent directors, effective October 29, 2026. They succeed John Collins and Tom McCaffrey who have resigned from the Board. Messrs. Edmonds and Hallen will both serve on the Board's Nominating and Governance Committee. Additionally, Mr. Edmonds will serve on the Audit Committee and Mr. Hallen will serve on the Compensation Committee.

"We are pleased to welcome Frank and Dirk to the KLX Board," said Chris Baker, President and Chief Executive Officer of KLX. "Frank's extensive background in investments, capital allocation and corporate governance, together with Dirk's substantial oilfield services, operational and strategic experience, will bring valuable and complementary perspectives to the Board as we continue to execute our business strategy and enhance long-term value for our shareholders."

Mr. Baker added, "On behalf of the Board and the Company, I thank John Collins and Tom McCaffrey for their many years of dedicated service and leadership. Their contributions have helped guide the Company during a challenging transition through the Covid era and a transformational capital rebalancing, and we are grateful for the lasting impact they have made. We wish them both continued success in their future endeavors." 

Franklin S. Edmonds, Jr.

Franklin S. Edmonds, Jr. brings more than three decades of experience across public and private investments, capital markets, corporate governance and strategic oversight. He served as an independent director and member of the Strategic Review Committee of Atkore Inc. (NYSE: ATKR) before its sale to Prysmian S.p.A in October 2026. He serves as a board member and investor in a number of privately held businesses and real estate ventures. From 2013 to 2019, Mr. Edmonds was as Co-Managing Partner and Head of Research at Panning Capital Management. He previously served as a Partner at King Street Capital, where he was one of five partners, served on the firm's Global Investment Committee and managed its global research team. Earlier in his career, he held investment positions with Oak Hill Advisors and Lehman Brothers. Mr. Edmonds currently serves on the board of the University of Virginia Investment Management Company, as Chair of the Jefferson Scholars Foundation and as a board member of the University of Virginia's Darden Graduate School of Business. He earned J.D. and M.B.A. degrees from the University of Virginia School of Law and the Darden Graduate School of Business and a Bachelor of Arts degree in American Studies from the University of Virginia.

E. Dirk Hallen

E. Dirk Hallen has more than 12 years of experience in completions-focused oilfield services, spanning frac sand, proppant logistics and pressure pumping, along with a background in strategy consulting, corporate transactions and business transformation. From 2024 to 2026, Mr. Hallen served as Chief Executive Officer and a director of HC Minerals, which was spun out of Hi-Crush Inc. to hold their Northern White sand and rail logistics platform before the assets were sold to Iron Oak Energy in 2025. From 2020 to 2024, he was Chief Executive Officer and a director of Hi-Crush Inc., an integrated provider of frac sand and logistics services for North American oil and gas completions. Mr. Hallen was tasked with leading Hi-Crush following its emergence from bankruptcy in 2020, focusing on reducing costs, driving operational excellence, improving safety performance, and accelerating growth. That turnaround culminated in the 2024 sale of the majority of the company's assets to Atlas Energy Solutions. As Hi-Crush's designee, he also served on the board of PropX, a provider of last-mile containerized proppant delivery solutions, through its sale to Liberty Energy in 2021. Previously, Mr. Hallen co-founded Pronghorn Logistics, a provider of outsourced frac sand supply-chain services to E&P operators, and served as its Chief Executive Officer from 2017 until Hi-Crush acquired it in 2019. Prior to that, he held senior roles at RockPile Energy Services, an oilfield services provider acquired by Keane Group in 2017. Earlier in his career, he was a management consultant in the energy practice of Booz & Company. Mr. Hallen holds an M.B.A. from the McCombs School of Business at The University of Texas at Austin and a B.S. from California Polytechnic State University, San Luis Obispo.

About KLX Energy Services

KLX is a growth-oriented provider of diversified oilfield services to leading onshore oil and natural gas exploration and production companies operating in both conventional and unconventional plays in all of the active major basins throughout the United States. The Company delivers mission critical oilfield services focused on drilling, completion, production, and intervention activities for technically demanding wells from over 60 service and support facilities located throughout the United States. KLX's complementary suite of proprietary products and specialized services is supported by technically skilled personnel and a broad portfolio of innovative in-house manufacturing, repair and maintenance capabilities. More information is available at www.klx.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. Actual results may differ materially from those expressed or implied by these forward-looking statements as a result of various risks and uncertainties. Readers are encouraged to review the Company's filings with the Securities and Exchange Commission for a discussion of factors that could affect future results.

Contacts:
KLX Energy Services
Geoffrey C. Stanford, SVP, Interim CFO & CAO
832-930-8066
[email protected]

Dennard Lascar Investor Relations
Ken Dennard / Natalie Hairston
(713) 529-6600
[email protected]

SOURCE KLX Energy Services Holdings, Inc.
2026-10-29 22:12 2d ago
2026-10-29 16:15 2d ago
Otis Declares Quarterly Dividend of $0.44 per Share
OTIS Otis Worldwide Corp
FMP Stock News
Original source text
, /PRNewswire/ -- The Otis Worldwide Corporation (NYSE: OTIS) Board of Directors today declared a quarterly dividend of $0.44 per share of Otis' common stock. The dividend will be payable on December 11, 2026, to shareholders of record at the close of business on November 13, 2026.

About Otis

Otis gives people freedom to connect and thrive in a taller, faster, smarter world. The global leader in the manufacture, installation, service and modernization of elevators and escalators, we move 2.5 billion people a day and maintain approximately 2.5 million customer units worldwide – the industry's largest Service portfolio. You'll find us in the world's most iconic structures, as well as residential and commercial buildings, transportation hubs and everywhere people are on the move. Headquartered in Connecticut, USA, Otis is 72,000 people strong, including 45,000 field professionals, all committed to manufacturing, installing and maintaining products to meet the diverse needs of our customers and passengers in more than 200 countries and territories. To learn more, visit www.otis.com and follow us on LinkedIn, YouTube, Instagram and Facebook @OtisElevatorCo.

Cautionary Statement

This release includes statements related to anticipated earnings, cash flow and dividends that constitute "forward-looking statements" under the securities laws. All forward-looking statements involve risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Past dividends provide no assurance as to future dividends. The payment and amount of future dividends could vary significantly from past amounts due to a number of risks and uncertainties. Risks and uncertainties include: (1) the effect of economic conditions in the industries and markets in which Otis and its businesses operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, future availability of credit and factors that may affect such availability or costs (including tighter credit conditions), levels of end market demand in construction, pandemic health issues, natural disasters and the financial condition of Otis' customers and suppliers; (2) risks associated with indebtedness; (3) challenges in the development and production of new products and services; and (4) the effect of changes in laws and regulations, political conditions and geopolitical conflicts in countries in which we operate and other factors beyond our control. The above list of factors is not exhaustive or necessarily in order of importance. For additional information on identifying factors that may cause actual results to vary from those stated in forward-looking statements, see the reports of Otis on Forms 10-K, 10-Q and 8-K filed with or furnished to the SEC from time to time. Any forward-looking statement speaks only as of the date on which it is made, and Otis assumes no obligation to update or revise such statement, whether as a result of new information, future events or otherwise, except as required by applicable law.

SOURCE Otis Worldwide Corporation
2026-10-29 22:10 2d ago
2026-10-29 16:48 2d ago
VICI Properties Inc. (VICI) Q3 2026 Earnings Call Transcript
VICI VICI Properties
FMP Stock News
Original source text
VICI Properties Inc. (VICI) Q3 2026 Earnings Call October 29, 2026 10:00 AM EDT

Company Participants

Samantha Gallagher - Executive VP, General Counsel & Secretary
John W. Payne - President & COO
Edward Pitoniak - CEO & Director
David Kieske - Executive VP, CFO & Treasurer
Gabriel Wasserman - MD of Business Development and VICI Experiential Credit Solutions (V.E.C.S.)

Conference Call Participants

Anthony Paolone - JPMorgan Chase & Co, Research Division
Barry Jonas - Truist Securities, Inc., Research Division
James Kammert - Evercore ISI Institutional Equities, Research Division
Caitlin Burrows - Goldman Sachs Group, Inc., Research Division
John DeCree - CBRE Securities, LLC, Research Division
Greg McGinniss - Scotiabank Global Banking and Markets, Research Division
Wesley Golladay - Robert W. Baird & Co. Incorporated, Research Division
Chris Darling - Green Street Advisors, LLC, Research Division
Todd Thomas - KeyBanc Capital Markets Inc., Research Division
Nicholas Joseph - Citigroup Inc., Research Division
Jordan Bender - Citizens JMP Securities, LLC, Research Division
David Katz - Jefferies LLC, Research Division
Daniel Guglielmo - Capital One Securities, Inc., Research Division
Haendel St. Juste - Mizuho Securities USA LLC, Research Division

Presentation

Operator

Good day, ladies and gentlemen. Thank you for standing by. Welcome to the VICI Properties Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded today, October 29, 2026. I will now turn the call over to Samantha Gallagher, General Counsel with VICI Properties.

Samantha Gallagher
Executive VP, General Counsel & Secretary

Thank you, operator, and good morning. Everyone should have access to the company's third quarter 2026 earnings release and supplemental information. The release and supplemental information can be found in the Investors section of the VICI Properties website at www.viciproperties.com. Some of our comments today will be forward-looking statements within the meaning of the federal securities laws. Forward-looking statements, which are usually identified by the use of words such as will, believe, expect, should, guidance, intends, outlook, projects or other similar phrases
2026-10-29 22:10 2d ago
2026-10-29 17:33 2d ago
VICI Properties: A $2 Billion Buyback At Under 10x AFFO
VICI VICI Properties
FMP Stock News
Original source text
VICI Properties authorized a $2 billion share buyback, representing 7.7% of shares, capitalizing on a 29% discount to intrinsic value. VICI's AFFO per share has grown consistently, with 2026 guidance at $2.475, and the payout ratio has declined to 74%, enhancing retained cash for buybacks. Despite a non-cash credit-loss allowance increase tied to Caesars, AFFO and dividends remain unaffected, and leverage stays within management's 5.0x–5.5x target.
2026-10-29 22:10 2d ago
2026-10-29 17:57 2d ago
EPR Properties: 7.7% On Preferred Shares, But We Would Wait A Bit More
EPR EPR Properties
FMP Stock News
Original source text
48.07K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-10-29 22:09 2d ago
2026-10-29 16:45 2d ago
Kaplan Fox & Kilsheimer LLP Encourages LKQ Corporation (LKQ) Investors to Contact the Firm Regarding Potential Securities Law Violations
LKQ LKQ Corporation
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - October 29, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against LKQ Corporation ("LKQ Corp" or the "Company") (NASDAQ: LKQ).

CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION

If you are a LKQ Corp investor and have suffered losses, or if you have information that could assist in the LKQ Corp investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.

On October 23, 2026, LKQ Corp reported preliminary third quarter 2026 results, as well as "leadership and operational actions," including the immediate departure of Justin Jude as CEO. The Company revealed a "[n]et loss of $16 million to $32 million, including $111 million of non-cash impairment charges" and withdrew its full-year 2026 guidance. According to the press release "the third quarter results primarily reflect underperformance in the Europe segment, including operational disruptions associated with the ERP implementation in Germany and volume declines in the United Kingdom and Benelux."

Following this news, the price of LKQ Corp stock fell $5.05 per share, or 22.47%, to close at $17.42 per share on October 23, 2026.

CLICK HERE TO LEARN MORE

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this investigation, please contact:

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/investors-of-lkq-lkq-class-action/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321655

Source: Kaplan Fox & Kilsheimer LLP

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-10-29 22:09 2d ago
2026-10-29 16:05 2d ago
SPX Reports Third Quarter 2026 Results
SPXC SPX Corp
FMP Stock News
Original source text
CHARLOTTE, N.C., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SPX Technologies, Inc. (NYSE:SPXC) (“SPX”, the “Company”, “we” or “our”) today reported results for the third quarter ended September 26, 2026.

Third Quarter Highlights (amounts presented for continuing operations; all comparisons against the third quarter of 2025, unless otherwise noted)

Revenue of $714.5 million, up 20.5%GAAP income from continuing operations of $82.3 million, up 30.4%GAAP net income of $81.9 million, up 30.6%GAAP EPS of $1.62, up 25.6%Adjusted EPS* of $2.21, up 20.1%Adjusted EBITDA* of $165.7 million, up 21.7% Updated 2026 Guidance (all comparisons against the full year 2025, unless otherwise noted)

Revenue range of $2.745 to $2.805 billion, up ~23% year-on-year at the midpoint (prior range: $2.705 to $2.765 billion).Adjusted EBITDA* range of $625 to $645 million, up ~25% year-on-year at the midpoint (prior range: $630 to $660 million).Adjusted EPS* range of $8.20 to $8.50, up ~24% year-on-year at the midpoint (prior range: $8.20 to $8.60). Gene Lowe, President and CEO, remarked, “We delivered another strong quarter, highlighted by robust revenue and earnings growth. HVAC continued to benefit from strong demand across key end markets, while Detection & Measurement delivered excellent profitability. Our results reflect the strength of our business model and the consistent execution of our teams.”

Mr. Lowe continued, “We also made meaningful progress across our strategic growth initiatives. Our HVAC capacity expansion projects remain on track to support approximately $1.1 billion of annual data center revenue capacity at full production, and we recently expanded our cooling platform through the acquisition of FIS Water, further strengthening our position in attractive adjacent markets.”

Mr. Lowe concluded, “Our updated guidance implies approximately 25% Adjusted EBITDA* growth at the midpoint for 2026, reflecting the momentum in our business and our confidence in the opportunities ahead.”

Third Quarter and Year-to-Date Financial Comparisons:

($ millions, except per share data) Q3 2026 Q3 2025 2026 YTD 2025 YTDRevenue $714.5  $592.8  $1,960.3  $1,627.8 HVAC segment income  120.8   94.4   319.2   264.1 Detection and Measurement segment income  52.6   51.7   156.6   128.3 Operating income  115.3   97.1   318.0   250.3 Income from continuing operations  82.3   63.1   226.0   167.3 GAAP net income  81.9   62.7   220.2   166.1 GAAP net income %  11.5%  10.6%  11.2%  10.2%GAAP EPS from continuing operations $1.62  $1.29  $4.47  $3.50          Adjusted operating income* $157.4  $130.5     Adjusted EBITDA*  165.7   136.1     Adjusted EBITDA %*  23.2%  23.0%    Adjusted EPS* $2.21  $1.84              Net operating cash flow from continuing operations $60.1  $106.8  $180.3  $139.8 Capital expenditures  (40.0)  (10.4)  (79.6)  (23.6)Adjusted free cash flow*  23.1   90.8   111.0   164.2  * Non-GAAP financial measure. See attached schedules for reconciliation of historical non-GAAP measures to most comparable GAAP financial measure. A reconciliation of non-GAAP guidance measures is not practicable and, accordingly, is not provided.

Segment Overview:

HVAC

  Three months ended($ millions) Q3 2026 Q3 2025Revenue $525.0  $387.4 •  Organic  22.3%  •  Inorganic  13.0%  •  Currency  0.2%  Total Growth  35.5%  Segment income $120.8  $94.4 as a percent of revenues  23.0%  24.4%Change in bps -140bps  
Third Quarter 2026
The revenue increase was primarily driven by:

an organic increase due primarily to (i) higher volumes of cooling equipment, mainly associated with increased data center demand, resulting from increased capacity, and (ii) higher volumes of our heating products; andan inorganic increase from the acquisitions of Thermolec, Crawford, Neptronic and FIS Water.  The segment income increase was due primarily to the revenue growth mentioned above. The decrease in segment margin was primarily due to (i) higher growth-related costs, largely labor and supply chain inefficiencies, associated with our volume increases and capacity expansion initiatives, and (ii) the impact of elevated input costs.

Detection and Measurement

  Three months ended($ millions) Q3 2026 Q3 2025Revenue $189.5  $205.4 •  Organic (7.9
)%  •  Currency  0.2%  Total Growth (7.7
)%  Segment income $52.6  $51.7 as a percent of revenues  27.8%  25.2%Change in bps 260bps  
Third Quarter 2026
The decrease in revenue was primarily driven by lower project volumes within our communications technologies business.

The segment income and segment margin increases were due primarily to (i) a more favorable product mix within our transportation and communication technologies businesses, and (ii) benefits related to our segment synergy initiatives, primarily within our location and inspection and rehabilitation businesses, partially offset by lower income resulting from the organic revenue decline noted above.

Liquidity and Financial Position:

($ millions) Q3 2026  Q4 2025 Total debt $1,334.7  $501.6 Total cash  120.8   366.0 
2026 Guidance:
For the full year 2026, SPX now anticipates segment and company performance as follows:

 RevenueSegment Income
Margin %Adjusted
EPS*Adjusted
EBITDA*/%HVAC$1,995-$2,035 million
($1,955-$1,995 million prior)23.10%-23.50%
(24.50%-25.00% prior)  Detection and Measurement$750-$770 million
($750-$770 million prior)27.00%-27.50%
(26.25%-26.75% prior)  Total SPX Adjusted$2.745-$2.805 billion
($2.705-$2.765 billion prior) $8.20-$8.50
($8.20-$8.60 prior)$625-$645 million / 22.75%-23.00%
($630-$660 million / 23.30%-23.80% prior)
Form 10-Q: The Company expects to file its quarterly report on Form 10-Q for the period ended September 26, 2026 with the Securities and Exchange Commission by November 5, 2026. This press release should be read in conjunction with that filing, which will be available on the Company's website at www.spx.com, in the Investor Relations section.

Conference Call: SPX will host a conference call at 4:45 p.m. (ET) today to discuss third quarter results. The call will be simultaneously webcast via the Company's website at www.spx.com and the slide presentation will be available in the Investor Relations section of the site.

Call Access Process: To access the call by phone, please use the following link to receive dial-in details https://register-conf.media-server.com/register/BI2bfa037fcc774566a26a889ed2c2a975. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time at www.spx.com.

About SPX Technologies, Inc: SPX Technologies, Inc. is a diversified, global supplier of highly engineered products and technologies, holding leadership positions in the HVAC and detection and measurement markets. Based in Charlotte, North Carolina, SPX Technologies, Inc. has operations in over 16 countries. SPX Technologies, Inc. is listed on the New York Stock Exchange under the ticker symbol “SPXC.” For more information, please visit www.spx.com.

Non-GAAP Presentation: This press release contains certain non-GAAP financial measures, including adjusted operating income, adjusted income from continuing operations before income taxes, adjusted earnings per share from continuing operations (or, adjusted EPS), EBITDA, adjusted EBITDA and margin, free cash flow from continuing operations and adjusted free cash flow from continuing operations (or, adjusted free cash flow). These non-GAAP financial measures do not provide investors with an accurate measure of, and should not be used as a substitute for, the comparable financial measures as determined in accordance with accounting principles generally accepted in the United States (“GAAP”). The Company believes these non-GAAP financial measures, when read in conjunction with the comparable GAAP financial measures, give investors a useful tool to assess and understand the Company’s overall financial performance, because they exclude items of income or expense that the Company believes are not reflective of its ongoing operating performance, allowing for a better period-to-period comparison of operations of the Company. Additionally, the Company’s management uses these non-GAAP financial measures as measures of the Company’s performance. The Company acknowledges that there are many items that impact a company’s reported results and the adjustments reflected in these non-GAAP measures are not intended to present all items that may have impacted these results. In addition, these non-GAAP measures are not necessarily comparable to similarly titled measures used by other companies.

Refer to the tables included in this press release for the components of each of the non-GAAP financial measures, and for the reconciliations of historical non-GAAP financial measures to their respective comparable GAAP measures. Our non-GAAP financial guidance excludes items, which would be included in our GAAP financial measures, that we do not consider indicative of our on-going performance; and are calculated in a manner consistent with the presentation of the similarly titled historical non-GAAP measures presented in this press release. These items include, but are not limited to, intangible asset amortization expense, acquisition and integration-related costs, costs associated with dispositions, and potential non-cash income or expense items associated with changes in market interest rates and actuarial or other data related to our pension and postretirement plans, as the ultimate aggregate amounts associated with these items are out of our control and/or cannot be reasonably predicted. Accordingly, a reconciliation of our non-GAAP financial guidance to the most comparable GAAP financial measures is not practicable. Full-year guidance excludes impacts from future acquisitions, dispositions and related transaction costs, incremental impacts of tariffs and trade tensions on market demand and costs subsequent to the date of this release, the impact of foreign exchange rate changes subsequent to September 26, 2026, and environmental and litigation charges.

Forward-looking Statements: Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. Please read these results in conjunction with the Company’s documents filed with the Securities and Exchange Commission, including the Company’s most recent annual report on Form 10-K and quarterly report on Form 10-Q. These filings identify important risk factors and other uncertainties that could cause actual results to differ from those contained in the forward-looking statements, including the following: cyclical changes and specific industry events in our markets; changes in anticipated capital investment and maintenance expenditures by customers; changes in economic conditions in relevant global and North American markets, including as a result of geopolitical conflicts, including the armed conflicts in the Middle East and related impacts on shipping in that region, the imposition, or threat of imposition of tariffs, including any new or increased tariffs announced by the U.S. government and any retaliatory tariffs announced in response thereto, and other trade barriers or international trade tensions; availability, limitations or cost increases of raw materials and/or commodities, including as a result of geopolitical conflicts or new or increased tariffs, as well as the potential impact of retaliatory tariffs and other penalties, that cannot be recovered in product pricing; the impact of competition on profit margins and our ability to maintain or increase market share; risks with respect to our contracts with the U.S. government, including the government’s ability to terminate contracts prior to completion or failure to appropriate amounts necessary to fund such contracts; inadequate performance by third-party suppliers and subcontractors for outsourced products, components and services and other supply-chain risks; the uncertainty of claims resolution with respect to environmental and other contingent liabilities; the impact of climate change and any legal or regulatory actions taken in response thereto; cyber-security risks; risks with respect to the protection of intellectual property, including with respect to our digitalization initiatives; the impact of overruns, inflation and the incurrence of delays with respect to long-term fixed-price contracts; defects or errors in current or planned products; the impact of pandemics and governmental and other actions taken in response; domestic economic, political, legal, accounting and business developments adversely affecting our business, including regulatory changes; uncertainties with respect to our ability to complete expansions to or the reconfiguration of our manufacturing footprint within the time periods and at costs we anticipate and whether we will realize the anticipated benefits of these activities; uncertainties with respect to our ability to identify acceptable acquisition targets; uncertainties surrounding timing and successful completion of acquisition transactions, including with respect to integrating acquisitions and achieving cost savings, synergistic sales or other benefits from acquisitions; the impact of retained liabilities of disposed businesses; potential labor disputes; and extreme weather conditions and natural and other disasters.

Actual results may differ materially from these statements. The words “guidance,” “believe,” “expect,” “anticipate,” “project” and similar expressions identify forward-looking statements. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct.

Statements in this press release speak only as of the date of this press release, and SPX Technologies, Inc. disclaims any responsibility to update or revise such statements, except as required by law.

Investor and Media Contact:
Johann Rawlinson, VP, Investor Relations
Phone: 980-228-6028
E-mail: [email protected]

Source: SPX Technologies, Inc.

SPX TECHNOLOGIES, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited; in millions, except per share amounts)         Three months ended Nine months ended September 26, 2026 September 27, 2025 September 26, 2026 September 27, 2025        Revenues$714.5  $592.8  $1,960.3  $1,627.8 Costs and expenses:       Cost of products sold 435.0   353.3   1,177.4   963.5 Selling, general and administrative 132.7   117.7   382.0   344.4 Selling, general and administrative — intangible amortization 31.5   24.6   81.1   68.9 Special charges, net —   0.1   1.8   0.2 Other operating expense, net —   —   —   0.5 Operating income 115.3   97.1   318.0   250.3         Other income (expense), net 1.5   (3.2)  (6.6)  (2.6)Interest expense (11.1)  (12.0)  (28.3)  (39.9)Interest income 0.6   1.1   2.8   3.0 Loss on amendment/refinancing of senior credit agreement —   (1.5)  —   (1.5)Income from continuing operations before income taxes 106.3   81.5   285.9   209.3 Income tax provision (24.0)  (18.4)  (59.9)  (42.0)Income from continuing operations 82.3   63.1   226.0   167.3         Income from discontinued operations, net of tax —   —   1.6   — Loss on disposition of discontinued operations, net of tax (0.4)  (0.4)  (7.4)  (1.2)Loss from discontinued operations, net of tax (0.4)  (0.4)  (5.8)  (1.2)        Net income$81.9  $62.7  $220.2  $166.1         Basic income per share of common stock:       Income from continuing operations$1.64  $1.31  $4.52  $3.55 Loss from discontinued operations —   (0.01)  (0.12)  (0.02)Net income per share$1.64  $1.30  $4.40  $3.53         Weighted-average number of common shares outstanding — basic 50.088   48.170   50.029   47.120         Diluted income per share of common stock:       Income from continuing operations$1.62  $1.29  $4.47  $3.50 Loss from discontinued operations —   (0.01)  (0.12)  (0.02)Net income per share$1.62  $1.28  $4.35  $3.48         Weighted-average number of common shares outstanding — diluted 50.645   48.919   50.611   47.794  SPX TECHNOLOGIES, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited; in millions)     September 26, 2026 December 31, 2025ASSETS   Current assets:   Cash and equivalents$119.2  $364.0 Accounts receivable, net 476.6   357.2 Contract assets 90.3   65.0 Inventories, net 422.9   302.2 Other current assets 48.3   55.3 Total current assets 1,157.3   1,143.7 Property, plant and equipment:   Land 28.3   26.9 Buildings and leasehold improvements 200.7   167.9 Machinery and equipment 407.2   338.1   636.2   532.9 Accumulated depreciation (262.5)  (242.1)Property, plant and equipment, net 373.7   290.8 Goodwill 1,612.7   1,043.4 Intangibles, net 1,503.0   868.2 Other assets 196.2   250.2 Deferred income taxes 2.9   2.2 Assets of DBT and Heat Transfer 5.8   6.1 TOTAL ASSETS$4,851.6  $3,604.6     LIABILITIES AND STOCKHOLDERS' EQUITY   Current liabilities:   Accounts payable$201.7  $145.2 Contract liabilities 117.6   115.8 Accrued expenses 194.7   185.2 Income taxes payable 26.1   10.0 Short-term debt 74.2   1.4 Current maturities of long-term debt 13.0   3.5 Total current liabilities 627.3   461.1     Long-term debt 1,247.5   496.7 Deferred and other income taxes 277.7   149.7 Other long-term liabilities 239.6   245.5 Liabilities of DBT and Heat Transfer 14.3   14.1 Total long-term liabilities 1,779.1   906.0     Stockholders' equity:   Common stock 0.6   0.6 Paid-in capital 1,940.8   1,938.2 Retained earnings 703.0   482.8 Accumulated other comprehensive income 239.9   260.5 Common stock in treasury (439.1)  (444.6)Total stockholders' equity 2,445.2   2,237.5 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$4,851.6  $3,604.6  SPX TECHNOLOGIES, INC. AND SUBSIDIARIESRESULTS OF REPORTABLE SEGMENTS(Unaudited; in millions)                   Three months ended     Nine months ended      September 26, 2026 September 27, 2025 Δ %/bps September 26, 2026 September 27, 2025 Δ %/bpsHVAC reportable segment                                 Revenues $525.0  $387.4  $137.6  35.5% $1,399.6  $1,087.1  $312.5  28.7%Cost of products sold  338.6   236.1   102.5     892.4   661.8   230.6   Selling, general and administrative expense  65.6   56.9   8.7     188.0   161.2   26.8   Income $120.8  $94.4  $26.4  28.0% $319.2  $264.1  $55.1  20.9%as a percent of revenues  23.0%  24.4%   -140bps  22.8%  24.3%   -150bps                 Detection and Measurement reportable segment                                 Revenues $189.5  $205.4  $(15.9) (7.7)% $560.7  $540.7  $20.0  3.7%Cost of products sold  95.4   116.6   (21.2)    281.7   300.3   (18.6)  Selling, general and administrative expense  41.5   37.1   4.4     122.4   112.1   10.3   Income $52.6  $51.7  $0.9  1.7% $156.6  $128.3  $28.3  22.1%as a percent of revenues  27.8%  25.2%   260bps  27.9%  23.7%   420bps SPX TECHNOLOGIES, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited; in millions)         Three months ended Nine months ended September 26, 2026 September 27, 2025 September 26, 2026 September 27, 2025Cash flows from (used in) operating activities:       Net income$81.9  $62.7  $220.2  $166.1 Less: Loss from discontinued operations, net of tax (0.4)  (0.4)  (5.8)  (1.2)Income from continuing operations 82.3   63.1   226.0   167.3 Adjustments to reconcile income from continuing operations to net cash from (used in) operating activities:       Special charges, net —   0.1   1.8   0.2 Gain on change in value of equity security (3.6)  —   (3.6)  (4.5)Loss on amendment/refinancing of senior credit agreement —   1.5   —   1.5 Amortization of compensation expense related to acquisition 2.4   6.5   8.7   17.4 Deferred and other income taxes (22.6)  17.1   (22.6)  14.8 Depreciation and amortization 41.4   32.4   109.2   91.9 Pension and other employee benefits 4.3   3.4   14.5   12.1 Long-term incentive compensation 4.3   4.2   12.3   11.8 Other, net, including allowance for doubtful accounts (2.3)  (0.5)  (2.5)  (0.4)Changes in operating assets and liabilities, net of effects from acquisitions and divestitures:       Accounts receivable and other assets (15.6)  (31.8)  (86.0)  (94.9)Contribution related to employee retention agreements for acquisition —   —   —   (46.5)Inventories (23.7)  (9.9)  (90.2)  (26.1)Accounts payable, accrued expenses and other (6.7)  21.4   13.2   (3.2)Cash spending on restructuring actions (0.1)  (0.7)  (0.5)  (1.6)Net cash from continuing operations 60.1   106.8   180.3   139.8 Net cash used in discontinued operations (0.8)  (0.3)  (0.8)  (1.7)Net cash from operating activities 59.3   106.5   179.5   138.1         Cash flows from (used in) investing activities:       Proceeds (repayments) related to company-owned life insurance policies, net 0.1   (33.4)  3.4   (30.3)Distribution from equity security 61.8   —   61.8   — Business acquisitions, net of cash acquired (847.0)  2.4   (1,286.6)  (445.3)Capital expenditures (40.0)  (10.4)  (79.6)  (23.6)Net cash used in continuing operations (825.1)  (41.4)  (1,301.0)  (499.2)Net cash from discontinued operations —   —   59.2   — Net cash used in investing activities (825.1)  (41.4)  (1,241.8)  (499.2)        Cash flows from (used in) financing activities:       Borrowings under senior credit facilities 835.0   500.0   1,049.9   978.0 Repayments under senior credit facilities (115.0)  (977.8)  (289.9)  (1,082.6)Borrowings under trade receivables arrangement 171.0   101.0   453.0   280.0 Repayments under trade receivables arrangement (171.0)  (141.0)  (380.0)  (289.0)Net borrowings (repayments) under other financing arrangements (0.3)  (0.1)  (0.4)  0.1 Minimum withholdings paid on behalf of employees for net share settlements, net of proceeds from the exercise of employee stock options (0.3)  0.8   (14.9)  (8.3)Proceeds of issuance of common stock in underwritten public offering, net of offering costs of $23.9 —   551.1   —   551.1 Financing fees paid —   (4.7)  —   (4.7)Net cash from continuing operations 719.4   29.3   817.7   424.6 Net cash from (used in) discontinued operations —   —   —   — Net cash from financing activities 719.4   29.3   817.7   424.6 Change in cash and equivalents due to changes in foreign currency exchange rates (1.0)  0.1   (0.6)  6.5 Net change in cash and equivalents (47.4)  94.5   (245.2)  70.0 Consolidated cash and equivalents, beginning of period 168.2   136.9   366.0   161.4 Consolidated cash and equivalents, end of period$120.8  $231.4  $120.8  $231.4   Nine Months Ended  September 26, 2026  September 27, 2025 Components of cash and equivalents:     Cash and equivalents$119.2  $229.4 Cash and equivalents included in assets of DBT and Heat Transfer 1.6   2.0 Total cash and equivalents$120.8  $231.4  SPX TECHNOLOGIES, INC. AND SUBSIDIARIESCASH AND DEBT RECONCILIATION(Unaudited; in millions)                        Nine months ended          September 26, 2026        Beginning cash and equivalents $366.0         Cash from continuing operations  180.3         Distribution from equity security  61.8         Capital expenditures  (79.6)        Proceeds related to company-owned life insurance policies, net  3.4         Business acquisitions, net of cash acquired  (1,286.6)        Borrowings under senior credit facilities  1,049.9         Repayments under senior credit facilities  (289.9)        Borrowings under trade receivables agreement  453.0         Repayments under trade receivables agreement  (380.0)        Net repayments under other financing arrangements  (0.4)        Minimum withholdings paid on behalf of employees for net share settlements, net of proceeds from the exercise of employee stock options  (14.9)        Cash from discontinued operations  58.4         Change in cash due to changes in foreign currency exchange rates  (0.6)        Ending cash and equivalents $120.8                                 Debt at       Debt at  December 31, 2025 Borrowings Repayments Other September 26, 2026Revolving loans $—  $1,049.9 $(289.9) $— $760.0 Term loan  500.0   —  —   —  500.0 Trade receivables financing arrangement  —   453.0  (380.0)  —  73.0 Other indebtedness  2.5   0.2  (0.6)  0.3  2.4 Less: Deferred financing costs associated with the term loan  (0.9)  —  —   0.2  (0.7)Totals $501.6  $1,503.1 $(670.5) $0.5 $1,334.7  SPX TECHNOLOGIES, INC. AND SUBSIDIARIES  ORGANIC REVENUE  (Unaudited)              Three months ended September 26, 2026    HVAC  Detection and
Measurement Consolidated  Net Revenue Growth (Decline) 35.5 %(7.7)%20.5 %          Exclude: Foreign Currency 0.2 %0.2 %0.2 %          Exclude: Acquisitions 13.0 %— %8.5 %          Organic Revenue Growth (Decline) 22.3 %(7.9)%11.8 % SPX TECHNOLOGIES, INC. AND SUBSIDIARIESNON-GAAP RECONCILIATION - ADJUSTED OPERATING INCOMEThree Months Ended(Unaudited; in millions)   September 26, 2026 September 27, 2025 GAAP Adjustments  Adjusted GAAP Adjustments  AdjustedHVAC segment income$120.8  $—  $120.8  $94.4  $—  $94.4               Detection and Measurement segment income 52.6   —   52.6   51.7   —   51.7               Corporate expense (1) (15.8)  3.9   (11.9)  (12.4)  0.4   (12.0)              Acquisition and integration-related costs (2) (5.5)  5.5   —   (7.7)  7.7   —               Long-term incentive compensation expense (3) (4.3)  0.2   (4.1)  (4.2)  0.7   (3.5)              Amortization of acquired intangible assets (4) (32.5)  32.5   —   (24.6)  24.6   —               Special charges, net —   —   —   (0.1)  —   (0.1)              Operating income$115.3  $42.1  $157.4  $97.1  $33.4  $130.5  as a percent of revenues 16.1%     22.0%  16.4%     22.0%              (1) For the three months ended September 26, 2026 and September 27, 2025, represents the removal of certain acquisition and integration-related costs of $3.9 and $0.4, respectively.              (2) For the three months ended September 26, 2026, represents (i) certain acquisition and integration-related costs of $3.1 and (ii) amortization of a deferred compensation asset of $2.4 related to the Kranze Technology Solutions (“KTS”) acquisition. For the three months ended September 27, 2025, represents (i) certain acquisition and integration-related costs of $0.6, (ii) amortization of a deferred compensation asset of $6.5 related to the KTS acquisition, and (iii) additional inventory step-up charges of $0.5 related to the KTS acquisition, and $0.1 related to the Sigma Heating and Cooling and Omega Heat Pump (“Sigma & Omega”) acquisition.              (3) For the three months ended September 26, 2026, represents the removal of $0.2 for long-term incentive compensation expense associated with acquisition-related equity grants. For the three months ended September 27, 2025, represents the removal of $0.7 for acceleration of long-term incentive compensation expense incurred as a result of immediate award vesting.              (4) Represents amortization expense associated with acquired intangible assets recorded within “Selling, general and administrative — intangible amortization” and “Cost of products sold.” SPX TECHNOLOGIES, INC. AND SUBSIDIARIESNON-GAAP RECONCILIATION - ADJUSTED EARNINGS PER SHAREThree Months Ended September 26, 2026(Unaudited; in millions, except per share values)             GAAP Adjustments AdjustedOperating income (1)$115.3  $42.1  $157.4       Other income (expense), net (2) 1.5   (2.1)  (0.6)Interest expense, net (10.5)  —   (10.5)Income from continuing operations before income taxes 106.3   40.0   146.3 Income tax provision (3) (24.0)  (10.2)  (34.2)Income from continuing operations 82.3   29.8   112.1       Diluted shares outstanding 50.645     50.645       Earnings per share from continuing operations$1.62    $2.21       (1) Adjustment represents the (i) removal of amortization expense associated with acquired intangible assets of $25.5 and $7.0 within the HVAC and Detection and Measurement reportable segments, respectively, (ii) the removal of certain acquisition and integration-related costs of $3.9 within corporate expense, (iii) the removal of acquisition and integration-related costs of $2.6 and $0.5 within the HVAC and Detection and Measurement reportable segments, respectively, (iv) amortization of a deferred compensation asset related to the KTS acquisition within the Detection and Measurement reportable segment of $2.4, and (v) the removal of $0.2 for long-term incentive compensation expense associated with acquisition-related equity grants. (2) Adjustment represents a gain on an equity security associated with a valuation adjustment of $3.6, partially offset by the removal of non-service pension and postretirement charges of $1.5.      (3) Adjustment represents the tax impact of items (1) and (2). SPX TECHNOLOGIES, INC. AND SUBSIDIARIESNON-GAAP RECONCILIATION - ADJUSTED EARNINGS PER SHAREThree Months Ended September 27, 2025(Unaudited; in millions, except per share values)             GAAP Adjustments AdjustedOperating income (1)$97.1  $33.4  $130.5       Other expense, net (2) (3.2)  1.0   (2.2)Interest expense, net (10.9)  —   (10.9)Loss on amendment/refinancing of senior credit agreement (3) (1.5)  1.5   — Income from continuing operations before income taxes 81.5   35.9   117.4 Income tax provision (4) (18.4)  (9.2)  (27.6)Income from continuing operations 63.1   26.7   89.8       Diluted shares outstanding 48.919     48.919       Earnings per share from continuing operations$1.29    $1.84       (1) Adjustment represents (i) the removal of amortization expense associated with acquired intangible assets of $14.7 and $9.9 within the HVAC and Detection and Measurement reportable segments, respectively, (ii) acquisition and integration-related costs of $0.5 and $0.1 within the HVAC and Detection and Measurement reportable segments, respectively, (iii) amortization of a deferred compensation asset of $6.5 related to the KTS acquisition within the Detection and Measurement reportable segment, (iv) inventory step-up charges of $0.5 related to the KTS acquisition within the Detection and Measurement reportable segment and $0.1 related to the Sigma & Omega acquisition within the HVAC reportable segment, (v) the removal of a charge of $0.7 from acceleration of long-term incentive compensation expense incurred as a result of immediate award vesting, and (vi) the removal of certain acquisition and integration-related costs within corporate expense of $0.4. (2) Adjustment represents the removal of (i) non-service pension and postretirement charges of $1.4 and (ii) a gain on settlement of our interest rate swap agreements of $0.4.      (3) Adjustment represents the removal of a non-cash charge to write-off previously deferred financing costs of $1.0 and certain expenses incurred in connection with an amendment to our senior credit agreement of $0.5.      (4) Adjustment represents the tax impact of items (1) through (3). SPX TECHNOLOGIES, INC. AND SUBSIDIARIESNON-GAAP RECONCILIATION - ADJUSTED EBITDA(Unaudited; in millions)            Three months ended  September 26, 2026 September 27, 2025Net income $81.9  $62.7      Exclude:    Income tax provision  (24.0)  (18.4)Interest expense, net  (10.5)  (10.9)Amortization expense (1)  (32.7)  (24.8)Depreciation expense  (8.7)  (7.6)Loss from discontinued operations, net of tax  (0.4)  (0.4)EBITDA  158.2   124.8      Exclude:    Acquisition and integration-related costs (2)  (9.4)  (8.1)Acquisition-related long-term incentive compensation expense (3)  (0.2)  — Long-term incentive compensation expense acceleration (4)  —   (0.7)Non-service pension and postretirement charges  (1.5)  (1.4)Valuation adjustment on an equity security  3.6   — Gain on settlement of interest rate swap  —   0.4 Loss on amendment/refinancing of senior credit agreement (5)  —   (1.5)Adjusted EBITDA $165.7  $136.1 as a percent of revenues  23.2%  23.0%     (1) Represents amortization expense associated with acquired intangible assets recorded within “Selling, general and administrative — intangible amortization” and amortization expense associated with acquired intangible assets and capitalized software costs recorded within “Cost of products sold.”
      (2) For the three months ended September 26, 2026, represents (i) certain acquisition and integration-related costs of $7.0, inclusive of acquisition and integration-related costs of $2.6 and $0.5 within the HVAC reportable segment and the Detection and Measurement reportable segment, respectively, and (ii) amortization of a deferred compensation asset of $2.4 related to the KTS acquisition within the Detection and Measurement reportable segment. For the three months ended September 27, 2025, represents (i) certain acquisition and integration-related costs of $1.0, inclusive of acquisition and integration-related costs of $0.1 and $0.5 within the Detection and Measurement and HVAC reportable segments, respectively, (ii) amortization of a deferred compensation asset of $6.5 related to KTS within the Detection and Measurement reportable segment, and (iii) inventory step-up charges of $0.5 related to the KTS acquisition within the Detection and Measurement reportable segment and $0.1 related to the Sigma & Omega acquisition within the HVAC reportable segment.     (3) For the three months ended September 26, 2026, represents the removal of $0.2 for long-term incentive compensation expense associated with acquisition-related equity grants.     (4) For the three months ended September 27, 2025, represents the removal of $0.7 for acceleration of long-term incentive compensation expense incurred as a result of immediate award vesting.     (5) Adjustment represents the removal of a non-cash charge to write-off previously deferred financing costs of $1.0 and certain expenses incurred in connection with an amendment to our senior credit agreement of $0.5. SPX TECHNOLOGIES, INC. AND SUBSIDIARIESNON-GAAP RECONCILIATION - ADJUSTED FREE CASH FLOW(Unaudited; in millions)            Three months ended  September 26, 2026 September 27, 2025Operating cash flow from continuing operations $60.1  $106.8      Include:    Capital expenditures  (40.0)  (10.4)Free cash flow from continuing operations  20.1   96.4      Exclude:    Acquisition and integration-related payments and other (1)  (3.0)  5.6 Adjusted free cash flow from continuing operations $23.1  $90.8      (1) For the three months ended September 26, 2026, represents the removal of the cash impact of (i) acquisition and integration-related costs of $6.2 and (ii) certain discrete income tax benefits that are considered non-recurring of $3.2. For the three months ended September 27, 2025, represents the removal of the cash impact of (i) certain discrete income tax benefits that are considered non-recurring of $6.3, (ii) acquisition and integration-related costs of $1.1 and (iii) cash received on the settlement of an interest rate swap of $0.4. SPX TECHNOLOGIES, INC. AND SUBSIDIARIESNON-GAAP RECONCILIATION - ADJUSTED FREE CASH FLOW(Unaudited; in millions)            Nine months ended  September 26, 2026 September 27, 2025Operating cash flow from continuing operations $180.3  $139.8      Include:    Capital expenditures  (79.6)  (23.6)Free cash flow from continuing operations  100.7   116.2      Exclude:    Acquisition and integration-related payments and other (1)  (10.3)  (48.0)Adjusted free cash flow from continuing operations $111.0  $164.2      (1) For the nine months ended September 26, 2026, represents the removal of the cash impact of (i) acquisition and integration-related costs of $13.5 and (ii) certain discrete income tax benefits that are considered non-recurring of $3.2. For the nine months ended September 27, 2025, represents the removal of the cash impact of (i) funded amounts associated with employee retention agreements assumed in the KTS acquisition of $46.5, (ii) acquisition and integration-related costs of $8.2, (iii) certain discrete income tax benefits that are considered non-recurring of $6.3 and (iv) cash received on the settlement of an interest rate swap of $0.4.
2026-10-29 22:09 2d ago
2026-10-29 16:21 2d ago
Stablecoin Development Corporation Reports Third Quarter 2026 Financial Results
SKY Skyline
FMP Stock News
Original source text
Staking revenue of $2.1 million for the quarter and $6.8 million for the first nine months of 2026Net income of $50.4 million, or $0.23 per basic and diluted share, driven by a $58.8 million non-cash unrealized gain on digital assets as the price of SKY increased approximately 49%SKY position grew to 2.32 billion tokens, representing approximately 10% of total SKY supplyReceived approximately $45.9 million of net proceeds under the at-the-market offering program (the “ATM Program”) subsequent to quarter end; no debt and no warrant liabilities WEST PALM BEACH, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stablecoin Development Corporation (NYSE American: SDEV) (the “Company” or “SDEV”), an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems and providing public market access to the stablecoin economy, today reported financial results for the third quarter and nine months ended September 30, 2026. The Company filed its Quarterly Report on Form 10-Q with the Securities and Exchange Commission today.

“Third quarter results reflect both drivers of our SKY position: price appreciation and staking rewards,” said Michael Kazley, Chief Executive Officer and Chairman of SDEV. “The approximately 49% increase in the price of SKY during the quarter drove a $58.8 million non-cash unrealized gain and net income of $50.4 million, and our staked position earned 34.6 million SKY in rewards, bringing our holdings to 2.32 billion tokens, or approximately 10% of total supply. Our SKY holdings remain unencumbered. Subsequent to quarter end, we received approximately $45.9 million of net proceeds through our ATM Program, building on a balance sheet with no debt and no warrant liabilities.”

Mr. Kazley continued, “We believe the fundamentals of the Sky Protocol ecosystem remain attractive, and SDEV offers public market access to that ecosystem. With no debt and a lean cost base, we believe we are positioned to continue executing with discipline and to evaluate opportunities, within the framework approved by our Board, that build long-term value for our shareholders.”

Third Quarter 2026 Highlights

Staking revenue of $2.1 million. Staking revenue was $2.1 million for the quarter and $6.8 million for the first nine months of 2026, reflecting rewards earned on the Company’s staked SKY holdings within the Sky Protocol ecosystem.Net income of $50.4 million, or $0.23 per basic and diluted share. The Company reported operating income of $56.0 million and net income of $50.4 million for the third quarter, driven by a $58.8 million non-cash unrealized gain on digital assets as the market price of SKY increased approximately 49% during the quarter. Net income reflects $5.6 million of income tax expense, substantially all of which is non-cash deferred income tax expense on the unrealized gain, which is not taxable until realized. No SKY tokens were sold during the quarter.SKY position of 2.32 billion tokens. The Company held 2,321,079,862 SKY tokens as of September 30, 2026, representing approximately 10% of total SKY supply, with a fair value of $180.2 million and a cost basis of $149.3 million.Earned 34.6 million SKY in staking rewards. The Company received 34,568,488 SKY tokens as staking rewards during the quarter, bringing cumulative staking rewards to 101,701,388 SKY tokens. The Company did not purchase or sell any SKY tokens during the quarter, and substantially all of its holdings remained staked in the Sky Protocol.No debt and no warrant liabilities. Total liabilities were $6.1 million at September 30, 2026, consisting primarily of a non-cash net deferred tax liability of $5.6 million, with no debt and no warrant liabilities outstanding. The January 2026 Pre-Funded Warrants, which are classified in stockholders’ equity, remained outstanding.Expanded the Board of Directors. On September 2, 2026, in connection with Sky Frontier Foundation’s designation of its nominee under the Investors’ Rights Agreement entered into in connection with the January 2026 Private Placement, the Board increased its size from five to six directors and appointed David Garcia Rios as an independent Class II director, and chartered the Investment Advisory Committee to provide strategic guidance, risk oversight, and expert recommendations to the Board with respect to the Company’s investment strategy. A summary of the Company’s SKY holdings as of October 26, 2026 appears under “Subsequent Events” below.

Third Quarter 2026 Financial Results

Staking revenue. Staking revenue was $2.1 million for the three months ended September 30, 2026 and $6.8 million for the nine months ended September 30, 2026, reflecting rewards earned on the Company’s SKY holdings through on-chain staking within the Sky Protocol ecosystem. Staking rewards are received in the form of SKY tokens.

Unrealized gain on digital assets. The Company recognized a non-cash unrealized gain on digital assets of $58.8 million for the third quarter and $30.9 million for the first nine months of 2026, reflecting an increase in the market price of SKY from $0.05215 per token at June 30, 2026 to $0.07764 per token at September 30, 2026. As a result, the Company’s SKY holdings moved from a cumulative unrealized loss at June 30, 2026 to a cumulative unrealized gain of $30.9 million at September 30, 2026. The Company did not sell or otherwise dispose of any SKY tokens during these periods. The unrealized gain is a non-cash accounting item and does not affect the Company’s cash position.

General and administrative expenses. General and administrative expenses were $5.0 million for the third quarter and $13.3 million for the first nine months of 2026. Third-quarter expenses included approximately $3.3 million of non-cash stock-based compensation, resulting in cash operating expenses, a non-GAAP measure (see “Non-GAAP Financial Measures” below), of approximately $1.8 million, compared with the Company’s staking revenue of $2.1 million for the quarter. Nine-month expenses included approximately $6.5 million of non-cash stock-based compensation, resulting in cash operating expenses of approximately $6.8 million, approximately equal to the Company’s staking revenue for the period.

Income tax expense. Income tax expense was $5.6 million for the third quarter and for the first nine months of 2026, substantially all of which is non-cash deferred income tax expense attributable to the unrealized gain on the Company’s SKY holdings recognized during the quarter. The unrealized gain is not taxable until realized and gave rise to a net deferred tax liability of $5.6 million as of September 30, 2026. The non-cash fair value gains and losses recognized in the first nine months of 2026 on the Company’s liability-classified pre-funded warrants are not recognized for income tax purposes and, accordingly, did not result in income tax expense. These amounts relate to the January 2026 Pre-Funded Warrants through their reclassification to equity in the first quarter of 2026 and the October 2025 Pre-Funded Warrants through their exercise in June 2026.

Net income. Net income for the third quarter of 2026 was $50.4 million, or $0.23 per basic and diluted share, after $5.6 million of income tax expense. For the first nine months of 2026, the Company reported GAAP net income of $561.7 million, or $3.33 per basic share and $2.65 per diluted share. Nine-month GAAP net income was driven almost entirely by non-cash warrant fair value items: a $5.3 billion non-cash day-one loss recognized on the January 2026 Pre-Funded Warrants, offset by approximately $5.8 billion of non-cash fair value gains on the Company’s pre-funded warrants through the dates on which they were reclassified to equity or exercised, for a net non-cash gain of approximately $544.3 million. These non-cash items are not indicative of the Company’s operating performance or cash flows. Shares of common stock issuable upon exercise of the January 2026 Pre-Funded Warrants and the October 2025 Pre-Funded Warrants, which are exercisable for nominal consideration, are included in the weighted average number of common shares outstanding used to compute basic net income per share beginning March 12, 2026, the date the Company obtained stockholder approval for the issuance of the underlying shares. As a result, diluted net income per share for the third quarter approximates basic net income per share.

SKY Holdings and Staking Activity

As of September 30, 2026, the Company held 2,321,079,862 SKY tokens, representing approximately 10% of the total supply of SKY, with a cost basis of $149.3 million and a fair value of $180.2 million. Substantially all of the Company’s SKY holdings were deployed in staking activities within the Sky Protocol ecosystem, and the Company’s staked SKY carries governance voting rights in the Sky Protocol.

Since the closing of the January 2026 Private Placement, SDEV has acquired approximately 1.3 billion additional SKY tokens through open market purchases at an average purchase price of approximately $0.066 per SKY token, in addition to tokens received as staking rewards. The Company holds its SKY as a long-term strategic position and has not monetized any SKY to date.

Balance Sheet and Capital Structure

As of September 30, 2026, the Company had cash and cash equivalents of $7.2 million and digital assets carried at fair value of $180.2 million and total assets of $188.2 million. Total liabilities were $6.1 million, consisting primarily of a net deferred tax liability of $5.6 million arising from the unrealized gain on the Company’s SKY holdings, and the Company had no warrant liabilities and no debt outstanding. Total stockholders’ equity was $182.2 million, and the Company had 51,751,359 shares of common stock outstanding. The January 2026 Pre-Funded Warrants, which are classified in stockholders’ equity, remained outstanding for 167,539,227 shares of common stock.

During the third quarter of 2026, the Company sold 1,160,636 shares of common stock under the ATM Program for net proceeds of approximately $1.3 million. During the first nine months of 2026, the Company sold 3,854,399 shares of common stock under the ATM Program for net proceeds of approximately $16.5 million, after deducting sales agent commissions and other offering costs. As of September 30, 2026, approximately $83.2 million of common stock remained available for issuance under the ATM Program.

Subsequent Events

SKY Holdings Summary (as of October 26, 2026). Subsequent to September 30, 2026 and through October 26, 2026, the Company continued to earn staking rewards on its SKY holdings and did not purchase, sell or otherwise dispose of any SKY tokens. As of October 26, 2026, the Company held approximately 2.33 billion SKY tokens, representing approximately 10% of total SKY supply, substantially all of which remained staked in the Sky Protocol; cumulative staking rewards received totaled approximately 111.7 million SKY tokens. Based on the price of SKY as of midnight UTC on October 26, 2026, as reported on Coinbase Exchange, of $0.06761 per SKY token, the aggregate market value of the Company’s SKY holdings as of October 26, 2026 was approximately $157.6 million. The price of SKY decreased approximately 13% from $0.07764 per token at September 30, 2026 to $0.06761 per token at October 26, 2026. These amounts are unaudited. The market value of the Company’s SKY holdings will continue to fluctuate, potentially significantly, with the market price of SKY and the number of tokens held, and the price of SKY as of any future date may be substantially lower.

ATM Program. Subsequent to September 30, 2026 and through October 26, 2026, the Company sold an aggregate of 15,801,547 shares of common stock under the ATM Program for aggregate net proceeds of approximately $45.9 million. As of October 26, 2026, approximately $36.4 million of common stock remained available for issuance under the ATM Program.

Pre-Funded Warrants. On October 13, 2026, Tether Investments, S.A. de C.V. exercised a portion of its January 2026 Pre-Funded Warrant on a cashless basis with respect to 5,743,762 shares of common stock. The Company withheld 197,652 shares in payment of the exercise price, resulting in the net issuance of 5,546,110 shares of common stock. On October 16, 2026, the second tranche, representing 30% of the total shares issuable, of the January 2026 Pre-Funded Warrants became exercisable in accordance with their terms. As of October 26, 2026, the Company had 73,117,016 shares of common stock outstanding, and the January 2026 Pre-Funded Warrants remained outstanding for 161,795,465 shares of common stock, subject to the beneficial ownership limitations applicable to the warrants.

Non-GAAP Financial Measures

This press release refers to cash operating expenses, a non-GAAP financial measure that represents the Company’s general and administrative expenses excluding non-cash stock-based compensation. The most directly comparable GAAP measure is general and administrative expenses. For the three months ended September 30, 2026, general and administrative expenses were $5.0 million, which included approximately $3.3 million of non-cash stock-based compensation, resulting in cash operating expenses of approximately $1.8 million. For the nine months ended September 30, 2026, general and administrative expenses were $13.3 million, which included approximately $6.5 million of non-cash stock-based compensation, resulting in cash operating expenses of approximately $6.8 million. Amounts are rounded and may not sum. The Company presents this measure because it believes it provides useful supplemental information to investors regarding the Company’s recurring cash operating cost base and the extent to which staking revenue offsets those cash costs.

This non-GAAP measure has limitations as an analytical tool, is not calculated in accordance with GAAP, and should not be considered in isolation from, or as a substitute for, the Company’s GAAP results. In addition, this non-GAAP measure may not be comparable to similarly titled measures reported by other companies. Staking rewards are received in the form of SKY tokens; accordingly, the coverage of cash operating expenses by staking revenue described in this press release is realized in cash only to the extent the Company monetizes such tokens. The Company did not sell any SKY tokens during the periods presented.

About the Sky Protocol

Sky Protocol is a decentralized finance platform that evolved from MakerDAO, one of the earliest projects in the digital asset ecosystem. The protocol is implemented through open-source smart contracts deployed on the Ethereum blockchain and enables the creation and use of USDS, a decentralized stablecoin designed to maintain a soft peg to the U.S. dollar, and serves as foundational financial infrastructure for lending, savings, and on-chain capital markets. SKY is the governance token of the Sky Protocol ecosystem; holders participate in protocol governance through an open, on-chain voting process. The protocol generates revenue from borrowing fees and other economic activity, a portion of which is used to fund open-market buybacks of SKY tokens that are allocated between distributions to staking participants, including the Company, and the protocol’s surplus buffer. The maximum and total supply of SKY is approximately 23.46 billion tokens. Financial and operational information about the Sky Protocol is published by the Sky ecosystem at insights.skyeco.com. The Company does not control that information, which is not incorporated into this press release.

Channels for Disclosure of Information

The Company intends to announce material information to the public through filings with the SEC, the investor relations page of its website (www.stabledev.com), press releases, public conference calls, public webcasts, its X (Twitter) account (@StableDev), and its LinkedIn page. The information disclosed through the foregoing channels could be deemed to be material information. The Company encourages investors, the media, and others to follow the channels listed above and to review the information disclosed through such channels.

About Stablecoin Development Corporation

Stablecoin Development Corporation (NYSE American: SDEV) is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems and providing public market access to the stablecoin economy. The Company’s initial digital asset focus is the Sky Protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, the Company seeks to generate protocol-level economic exposure while maintaining governance, risk management, and public-company discipline. The Company is headquartered in West Palm Beach, Florida. For more information, please visit www.stabledev.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy and capital allocation; its plans to hold, stake, and potentially monetize SKY tokens and other digital assets; the sufficiency of staking revenue to cover operating costs; the market value of the Company’s SKY holdings as of dates subsequent to quarter-end; the anticipated recognition of changes in fair value in future periods; its views regarding the stablecoin economy and related infrastructure; the variability of staking rewards and protocol governance parameters; its intentions regarding future SKY token acquisitions; and statements regarding the Sky Protocol ecosystem, including protocol revenue, surplus, reserves and stablecoin supply metrics. These statements are based on management’s current expectations and involve known and unknown risks and uncertainties, including risks related to the volatility of digital asset markets (including the price of SKY, which may decline substantially from the levels described herein), the concentration of the Company’s assets in a single digital asset, regulatory developments, changes in protocol governance parameters, cybersecurity and custody risks, the impact of non-cash fair value adjustments on reported results, the liquidity of SKY tokens and potential market impact of large transactions, dilution from the exercise of outstanding pre-funded warrants and sales under the ATM Program, limitations on the Company’s ability to access the capital markets and to maintain its NYSE American listing, the unremediated material weakness in the Company’s internal control over financial reporting, and the other risks described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as amended, its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, and its other SEC filings, including its Current Report on Form 8-K filed October 5, 2026. Actual results may differ materially. SDEV undertakes no obligation to update forward-looking statements except as required by law.

Company Contact

Investor Relations
Stablecoin Development Corporation
[email protected]
2026-10-29 22:08 2d ago
2026-10-29 16:05 2d ago
Olin Announces Third Quarter 2026 Results
OLN Olin Corporation
FMP Stock News
Original source text
Highlights

Third quarter 2026 net income of $14.4 million, or $0.13 per diluted shareQuarterly adjusted EBITDA of $191.4 millionExpect Olin and Huntsman merger to close first quarter 2027Substantial progress made with integration planning, /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced financial results for the third quarter ended September 30, 2026. Third quarter 2026 reported net income was $14.4 million, or $0.13 per diluted share, which compares to third quarter 2025 reported net income of $42.8 million, or $0.37 per diluted share. Third quarter 2026 adjusted EBITDA of $191.4 million excludes depreciation and amortization expense of $114.4 million, acquisition-related costs of $13.7 million, and restructuring charges of $1.7 million. Third quarter 2025 adjusted EBITDA was $222.4 million. Sales in the third quarter 2026 were $1,747.7 million, compared to $1,713.2 million in the third quarter 2025.

Ken Lane, President and Chief Executive Officer, said, "During the third quarter, Olin delivered adjusted EBITDA consistent with our expectations and restored normal operations at our vinyl chloride monomer (VCM) assets. Our Chlor Alkali Products and Vinyls business maintained disciplined market participation and stable domestic Electrochemical Unit values despite continued challenging global demand. Epoxy earnings improved as structural cost reductions and volume growth offset persistent demand weakness in Europe. Winchester delivered consistent year-over-year commercial volume growth through the third quarter, while pricing actions were implemented to offset higher metals and raw material costs.

"We also achieved two important milestones related to our proposed merger with Huntsman. Shareholders of both companies overwhelmingly approved the transaction, and the waiting period under the U.S. Hart-Scott-Rodino Act expired, satisfying a key closing condition. We continue to see good progress on the remaining regulatory approvals and now expect the transaction to close in first quarter 2027, subject to customary closing conditions. We are advancing permitted pre-close integration planning to prepare for an expeditious combination and realization of expected synergies.

"Our fourth-quarter outlook reflects normal seasonality, as well as elevated year-end customer destocking in Chemicals, higher feedstock costs, continued pressure from subsidized Asian exports and significant planned maintenance turnarounds. We remain focused on our value-first commercial approach amid volatile export markets. Fourth quarter 2026 adjusted EBITDA is expected to be in the range of $80 million to $100 million. Our priorities remain operating safely and reliably, delivering Beyond250 structural cost savings and generating cash," Lane concluded.

SEGMENT REPORTING

Olin defines segment earnings as income (loss) before interest expense, net, other operating income (expense), non-operating pension income, other income, and income taxes.

CHLOR ALKALI PRODUCTS AND VINYLS

Chlor Alkali Products and Vinyls sales for the third quarter 2026 were $850.8 million, compared to $924.0 million in the third quarter 2025. The decrease in sales was due to lower volumes, primarily resulting from lower trading volumes associated with Blue Water Alliance and lower VCM volumes, partially offset by higher pricing. The Blue Water Alliance joint venture concluded operations at the end of 2025. Third quarter 2026 segment earnings were $71.3 million, compared to $127.6 million in the third quarter 2025. Third quarter 2026 segment earnings included a $5.0 million pretax benefit compared to $32.0 million last year, primarily related to the clean hydrogen production tax credit under Section 45V as part of the Inflation Reduction Act of 2022. The remaining $29.3 million decrease in segment earnings was primarily due to previously announced operating issues with the VCM plant at our Freeport, Texas facility resulting in higher costs and reduced profit from lost sales ($32.1 million) partially offset by higher pricing, primarily caustic soda and ethylene dichloride. Chlor Alkali Products and Vinyls third quarter 2026 results included depreciation and amortization expense of $91.1 million compared to $109.0 million in the third quarter 2025.

EPOXY

Epoxy sales for the third quarter 2026 were $412.2 million, compared to $349.6 million in the third quarter 2025. The increase in sales was due to higher volumes and improved pricing. Third quarter 2026 segment earnings were $0.6 million, compared to a segment loss of ($32.2) million in the third quarter 2025. The $32.8 million increase in segment results was primarily due to higher volumes and lower operating costs. Product margins were comparable year-over-year with higher pricing offsetting higher raw material costs, primarily benzene and propylene. Epoxy third quarter 2026 results included depreciation and amortization expense of $11.1 million compared to $13.2 million in the third quarter 2025.

WINCHESTER

Winchester sales for the third quarter 2026 were $484.7 million, compared to $439.6 million in the third quarter 2025. The increase in sales was primarily due to higher commercial ammunition sales. Third quarter 2026 segment earnings were $33.8 million, compared to $19.3 million in the third quarter 2025. The $14.5 million increase in segment earnings was primarily due to higher commercial ammunition pricing and volume, partially offset by higher raw material costs, primarily commodity metal costs. Winchester third quarter 2026 results included depreciation and amortization expense of $9.0 million compared to $7.8 million in the third quarter 2025.

CORPORATE AND OTHER COSTS

Other corporate and unallocated costs in the third quarter of 2026 increased $0.8 million compared to the third quarter 2025 primarily due to an unfavorable impact from foreign currency, partially offset by lower stock-based compensation, which includes mark-to-market adjustments.

PROPOSED MERGER OF EQUALS

On June 16, 2026, Olin and Huntsman Corporation announced that they have entered into a definitive agreement to combine in an all-stock merger of equals to form a combined company, OlinHuntsman Corporation. Third quarter 2026 results included acquisition-related costs of $13.7 million related to this pending merger.

LIQUIDITY

The cash balance on September 30, 2026, was $214.8 million. Olin ended the third quarter 2026 with net debt of approximately $2.8 billion and a net debt to adjusted EBITDA ratio of 5.2 times. On September 30, 2026, Olin had available liquidity of approximately $1.3 billion, including unrestricted access to the undrawn portion of its revolving credit facility.

CONFERENCE CALL INFORMATION

Olin senior management will host a conference call to discuss third quarter 2026 financial results at 10:00 a.m. Eastern Time on Friday, October 30, 2026. Remarks will be followed by a question-and-answer session. Associated slides and the conference call webcast are accessible via Olin's website, www.olin.com, under the third quarter conference call icon. An archived replay of the webcast will also be available in the Investor Relations section of Olin's website beginning at 12:00 p.m. Eastern Time. A final transcript of the call will be posted the next business day.

COMPANY DESCRIPTION

Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, industrial cartridges, and clay targets, along with contracted U.S. military project revenue.

Visit www.olin.com for more information on Olin Corporation.

FORWARD-LOOKING STATEMENTS

This communication includes forward-looking statements. These statements relate to analyses and other information that are based on management's beliefs, certain assumptions made by management, forecasts of future results, and current expectations, estimates and projections about the markets and economy in which we and our various segments operate. These statements may include statements regarding our definitive agreement with Huntsman Corporation ("Huntsman") to combine in an all-stock merger of equals transaction ("Merger"), the expected timetable for completing the Merger, benefits and synergies of the Merger, and future opportunities for the combined company following the Merger. The statements contained in this communication that are not statements of historical fact may include forward-looking statements that involve a number of risks and uncertainties.

We have used the words "anticipate," "intend," "may," "expect," "believe," "should," "plan," "outlook," "project," "estimate," "forecast," "optimistic," "target," and variations of such words and similar expressions in this communication to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, actual outcomes and results may differ materially from those matters expressed or implied in such forward-looking statements. We undertake no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise. The payment of cash dividends is subject to the discretion of our Board of Directors and will be determined in light of then-current conditions, including our earnings, our operations, our financial conditions, our capital requirements and other factors deemed relevant by our Board of Directors. In the future, our Board of Directors may change our dividend policy, including the frequency or amount of any dividend, in light of then-existing conditions.

The risks, uncertainties and assumptions involved in our forward-looking statements, many of which are discussed in more detail in our filings with the SEC, including, without limitation, the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2025, and our Quarterly Reports on Form 10-Q and other reports furnished or filed with the SEC, include, but are not limited to, the following:

Business, Industry and Operational Risks

sensitivity to economic, business and market conditions in the United States and overseas, including economic instability or a downturn in the sectors served by us;declines in average selling prices for our products and the supply/demand balance for our products, including the impact of excess industry capacity or an imbalance in demand for our chlor alkali products;unsuccessful execution of our operating model, which prioritizes Electrochemical Unit (ECU) margins over sales volumes;failure to control costs and inflation impacts or failure to achieve targeted cost reductions;availability of and/or higher-than-expected costs of raw material, energy, transportation, and/or logistics;our reliance on a limited number of suppliers for specified feedstock and services and our reliance on third-party transportation;the occurrence of unexpected manufacturing interruptions and outages, including those occurring as a result of labor disruptions and production hazards;exposure to physical risks associated with climate-related events or increased severity and frequency of severe weather events;the failure or an interruption, including cyber-attacks, of our information technology systems;risks associated with our international sales and operations, including economic, political or regulatory changes;weak industry conditions affecting our ability to comply with the financial maintenance covenants in our debt agreements;our indebtedness and debt service obligations;failure to identify, attract, develop, retain and motivate qualified employees throughout the organization and ability to manage executive officer and other key senior management transitions;adverse conditions in the credit and capital markets, limiting or preventing our ability to borrow or raise capital;our inability to complete future acquisitions or joint venture transactions or successfully integrate them into our business;the effects of any declines in global equity markets on asset values and any declines in interest rates or other significant assumptions used to value the liabilities in, and funding of, our pension plans;our long-range plan assumptions not being realized, causing a non-cash impairment charge of long-lived assets;Legal, Environmental and Regulatory Risks

changes in, or failure to comply with, legislation or government regulations or policies, including changes regarding our ability to manufacture or use certain products and changes within the international markets in which we operate;new regulations or public policy changes regarding the transportation of hazardous chemicals and the security of chemical manufacturing facilities;unexpected outcomes from legal or regulatory claims and proceedings;costs and other expenditures in excess of those projected for environmental investigation and remediation or other legal proceedings;various risks associated with our Lake City U.S. Army Ammunition Plant contract and performance under other governmental contracts;Risks Relating to the Proposed Merger with Huntsman

factors relating to the satisfaction of the conditions to, and timely completion of, the proposed Merger with Huntsman, including required regulatory approvals;the possibility that the proposed Merger may not be completed on the anticipated terms, timing, or at all, including the possibility of circumstances that would require us to pay a termination fee;the possibility that the expected strategic benefits, cost savings, operational efficiencies and synergies of the proposed Merger may not be realized or may take longer to realize than expected;the effect of the proposed Merger on relationships with employees, customers, suppliers and other business partners and adverse effects on our ability to attract, retain and motivate key personnel, maintain commercial relationships and execute our business strategy;the diversion of management attention from day-to-day operations and other strategic opportunities;transaction, advisory, legal, accounting, consulting, regulatory, retention, integration planning costs and other costs associated with the proposed Merger;the Merger Agreement contains customary covenants that restrict our ability to undertake certain actions without Huntsman's consent prior to closing, which may limit operational flexibility and the ability to pursue certain business opportunities during the pendency of the Merger; andthe risk of litigation, regulatory proceedings relating to the proposed Merger, or the imposition of conditions, limitations, divestiture requirements or other remedies by governmental authorities.All of our forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of our forward-looking statements.

2026-14

Olin Corporation

Consolidated Statements of Operations(a)

Three Months Ended

September 30,

Nine Months Ended

September 30,

($ in millions, except per share amounts)

2026

2025

2026

2025

Sales

$ 1,747.7

$ 1,713.2

$ 5,072.6

$ 5,115.7

Operating Expenses:

Cost of Goods Sold

1,575.0

1,529.8

4,653.9

4,645.5

Selling and Administrative

98.4

98.1

346.1

294.3

Restructuring Charges

1.7

2.9

21.3

14.3

Acquisition-related Costs(b)

13.7

—

24.3

—

Other Operating Income

0.3

0.4

0.4

0.2

Operating Income

59.2

82.8

27.4

161.8

Losses of Non-consolidated Affiliates

(0.9)

(1.0)

(3.3)

(2.4)

Interest Expense, Net

(44.5)

(45.2)

(130.9)

(138.1)

Non-operating Pension Income

3.3

4.9

9.4

15.5

Income (Loss) before Taxes

17.1

41.5

(97.4)

36.8

Income Tax Provision (Benefit)

2.7

(2.2)

(15.5)

(5.3)

Net Income (Loss)

14.4

43.7

(81.9)

42.1

Net Income (Loss) Attributable to Noncontrolling Interests

—

0.9

—

(0.8)

Net Income (Loss) Attributable to Olin Corporation

$     14.4

$     42.8

$    (81.9)

$     42.9

Net Income (Loss) Attributable to Olin Corporation per Common Share:

Basic

$     0.13

$     0.37

$    (0.72)

$     0.37

Diluted

$     0.13

$     0.37

$    (0.72)

$     0.37

Dividends per Common Share

$     0.20

$     0.20

$     0.60

$     0.60

Average Common Shares Outstanding - Basic

114.0

114.4

113.9

114.9

Average Common Shares Outstanding - Diluted

115.0

115.1

113.9

115.6

(a)     Unaudited.

(b)     Acquisition-related costs for the three and nine months ended September 30, 2026 included advisory, legal, accounting, and other professional fees

         associated with our proposed merger with Huntsman Corporation. 

Olin Corporation

Segment Information(a)

Three Months Ended

September 30,

Nine Months Ended

September 30,

($ in millions)

2026

2025

2026

2025

Sales:

Chlor Alkali Products and Vinyls

$    850.8

$    924.0

$ 2,427.2

$ 2,828.0

Epoxy

412.2

349.6

1,189.9

1,012.5

Winchester

484.7

439.6

1,455.5

1,275.2

Total Sales

$ 1,747.7

$ 1,713.2

$ 5,072.6

$ 5,115.7

Income (Loss) before Taxes:

Chlor Alkali Products and Vinyls

$     71.3

$    127.6

$     80.2

$    270.8

Epoxy

0.6

(32.2)

13.7

(84.3)

Winchester

33.8

19.3

77.1

67.1

Corporate/Other:

Environmental Expense

(5.6)

(4.5)

(16.5)

(14.3)

Other Corporate and Unallocated Costs

(26.7)

(25.9)

(85.2)

(65.8)

Restructuring Charges

(1.7)

(2.9)

(21.3)

(14.3)

Acquisition-related Costs(b)

(13.7)

—

(24.3)

—

Other Operating Income

0.3

0.4

0.4

0.2

Interest Expense, Net

(44.5)

(45.2)

(130.9)

(138.1)

Non-operating Pension Income

3.3

4.9

9.4

15.5

Income (Loss) before Taxes

$     17.1

$     41.5

$    (97.4)

$     36.8

(a)     Unaudited.

(b)     Acquisition-related costs for the three and nine months ended September 30, 2026 included advisory, legal, accounting, and other professional fees

         associated with our proposed merger with Huntsman Corporation. 

Olin Corporation

Consolidated Balance Sheets(a)

September 30,

December 31,

September 30,

($ in millions, except per share data)

2026

2025

2025

Assets:

  Cash and Cash Equivalents

$        214.8

$        167.6

$        140.3

  Accounts Receivable, Net

973.4

844.5

1,000.2

  Income Taxes Receivable

50.5

66.6

77.7

  Inventories, Net

862.2

784.5

966.9

  Other Current Assets

97.9

107.9

79.7

    Total Current Assets

2,198.8

1,971.1

2,264.8

Property, Plant and Equipment (Less Accumulated Depreciation of

$5,643.6, $5,508.7 and $5,487.7)

2,053.2

2,196.9

2,205.1

  Operating Lease Assets, Net

375.5

298.6

298.3

  Deferred Income Taxes

45.7

47.2

53.0

  Other Assets

1,158.5

1,210.0

1,170.4

  Intangibles, Net

146.4

174.4

183.4

  Goodwill

1,427.6

1,427.6

1,425.9

Total Assets

$      7,405.7

$      7,325.8

$      7,600.9

Liabilities and Shareholders' Equity:

  Current Installments of Long-term Debt

$              —

$         109.7

$           19.2

  Accounts Payable

889.8

806.1

845.7

  Income Taxes Payable

11.9

23.9

18.9

  Current Operating Lease Liabilities

72.7

59.7

60.6

  Accrued Liabilities

537.4

630.1

507.9

    Total Current Liabilities

1,511.8

1,629.5

1,452.3

  Long-term Debt

3,013.1

2,717.6

2,974.2

  Operating Lease Liabilities

315.1

252.5

250.2

  Accrued Pension Liability

196.5

200.9

228.5

  Deferred Income Taxes

313.6

317.6

369.8

  Other Liabilities

336.5

337.1

332.2

Total Liabilities

5,686.6

5,455.2

5,607.2

Commitments and Contingencies

Shareholders' Equity:

Common Stock, $1.00 Par Value Per Share; Authorized 240.0 Shares;

Issued and Outstanding 114.0, 113.6 and 114.1 Shares

114.0

113.6

114.1

Additional Paid-in Capital

17.6

—

—

Accumulated Other Comprehensive Loss

(402.5)

(414.5)

(462.2)

Retained Earnings

1,989.6

2,139.8

2,310.3

Olin Corporation's Shareholders' Equity

1,718.7

1,838.9

1,962.2

Noncontrolling Interests

0.4

31.7

31.5

Total Equity

1,719.1

1,870.6

1,993.7

Total Liabilities and Equity

$      7,405.7

$      7,325.8

$      7,600.9

(a)     Unaudited.

Olin Corporation

Consolidated Statements of Cash Flows(a)

Nine Months Ended

September 30,

($ in millions)

2026

2025

Operating Activities:

Net (Loss) Income

$    (81.9)

$     42.1

Depreciation and Amortization

353.7

395.9

Losses of Non-consolidated Affiliates

3.3

2.4

Stock-based Compensation

16.8

15.6

Deferred Income Taxes

(5.6)

(54.1)

Qualified Pension Plan Contributions

(0.9)

(0.6)

Qualified Pension Plan Income

(8.2)

(13.5)

Changes in Assets and Liabilities:

Receivables

(133.4)

(33.1)

Income Taxes Receivable/Payable

3.6

(196.0)

Inventories

(81.0)

(100.1)

Other Current Assets

14.2

(7.4)

Accounts Payable and Accrued Liabilities

5.6

71.7

Other Assets

(9.8)

6.6

Other Noncurrent Liabilities

(3.9)

25.2

Other Operating Activities

(2.8)

(1.7)

Net Operating Activities

69.7

153.0

Investing Activities:

Capital Expenditures

(106.6)

(163.5)

Business Acquired in Purchase Transaction, Net of Cash Acquired

—

(55.8)

Investments in Non-consolidated Affiliates

(1.9)

(1.6)

Other Investing Activities

(1.2)

(4.7)

Net Investing Activities

(109.7)

(225.6)

Financing Activities:

Long-term Debt Borrowings, Net

185.3

155.8

Common Stock Repurchased and Retired

—

(40.4)

Stock Options Exercised

3.0

2.1

Dividends Paid

(68.3)

(68.8)

Distributions to Noncontrolling Interests

(31.3)

—

Debt Issuance Costs

(2.1)

(12.0)

Net Financing Activities

86.6

36.7

Effect of Exchange Rate Changes on Cash and Cash Equivalents

0.6

0.6

Net Increase (Decrease) in Cash and Cash Equivalents

47.2

(35.3)

Cash and Cash Equivalents, Beginning of Year

167.6

175.6

Cash and Cash Equivalents, End of Period

$    214.8

$    140.3

(a)     Unaudited. 

Olin Corporation

Non-GAAP Financial Measures - Adjusted EBITDA(a)

Olin's definition of Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is net income (loss) plus an add-back for depreciation and amortization, interest expense (income), income tax provision (benefit), other expense (income), restructuring charges (income) and certain other non-recurring items. Adjusted EBITDA is a non-GAAP financial measure. Management believes that this measure is meaningful to investors as a supplemental financial measure to assess the financial performance without regard to financing methods, capital structures, taxes or historical cost basis. The use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP and Adjusted EBITDA presented may not be comparable to similarly titled measures of other companies. Reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures are omitted from this release because Olin is unable to provide such reconciliations without the use of unreasonable efforts. This inability results from the inherent difficulty in forecasting generally and quantifying certain projected amounts that are necessary for such reconciliations. In particular, sufficient information is not available to calculate certain adjustments required for such reconciliations, including interest expense (income), income tax provision (benefit), other expense (income) and restructuring charges (income). Because of our inability to calculate such adjustments, forward-looking net income guidance is also omitted from this release. We expect these adjustments to have a potentially significant impact on our future GAAP financial results.

Three Months Ended

September 30,

Nine Months Ended

September 30,

($ in millions)

2026

2025

2026

2025

Reconciliation of Net Income (Loss) to Adjusted EBITDA:

Net Income (Loss)

$       14.4

$       43.7

$    (81.9)

$     42.1

Add Back:

Interest Expense, Net

44.5

45.2

130.9

138.1

Income Tax Provision (Benefit)

2.7

(2.2)

(15.5)

(5.3)

Depreciation and Amortization

114.4

133.8

353.7

395.9

EBITDA

176.0

220.5

387.2

570.8

Add Back:

Restructuring Charges

1.7

2.9

21.3

14.3

Environmental Recoveries

—

(1.0)

—

(1.0)

Legacy Litigation Matters

—

—

36.1

—

Acquisition-related Costs(b)

13.7

—

24.3

—

Adjusted EBITDA

$     191.4

$     222.4

$    468.9

$    584.1

(a)     Unaudited.

(b)     Acquisition-related costs for the three and nine months ended September 30, 2026 included advisory, legal, accounting, and other professional fees

         associated with our proposed merger with Huntsman Corporation. 

Olin Corporation

Non-GAAP Financial Measures - Net Debt to Adjusted EBITDA(a)

Olin's definition of Net Debt to Adjusted EBITDA is Net Debt divided by Adjusted EBITDA. Net Debt at the end of any reporting period is defined as the sum of our current installments of long-term debt and long-term debt, less cash and cash equivalents. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is net income (loss) plus an add-back for depreciation and amortization, interest expense (income), income tax provision (benefit), other expense (income), restructuring charges (income) and certain other non-recurring items. Net Debt to Adjusted EBITDA is a non-GAAP financial measure. Management believes that this measure is meaningful to investors as a measure of our ability to manage our indebtedness. The use of non-GAAP financial measures is not intended to replace any measures of indebtedness or liquidity determined in accordance with GAAP and Net Debt or Net Debt to Adjusted EBITDA presented may not be comparable to similarly titled measures of other companies.

September 30,

December 31,

September 30,

($ in millions)

2026

2025

2025

Current Installments of Long-term Debt

$              —

$         109.7

$           19.2

Long-term Debt

3,013.1

2,717.6

2,974.2

Total Debt

3,013.1

2,827.3

2,993.4

Less: Cash and Cash Equivalents

(214.8)

(167.6)

(140.3)

Net Debt

$      2,798.3

$      2,659.7

$      2,853.1

Trailing Twelve Months Adjusted EBITDA(b)

$         536.6

$         651.8

$         777.5

Net Debt to Adjusted EBITDA

5.2

4.1

3.7

(a)     Unaudited.

(b)     Trailing Twelve Months Adjusted EBITDA as of September 30, 2026 is calculated as the nine months ended September 30, 2026 plus the year ended

          December 31, 2025 less the nine months ended September 30, 2025. Trailing Twelve Months Adjusted EBITDA as of September 30, 2025 is calculated

          as the nine months ended September 30, 2025 plus the year ended December 31, 2024 less the nine months ended September 30, 2024.

SOURCE Olin Corporation
2026-10-29 22:08 2d ago
2026-10-29 16:30 2d ago
FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook
FMC FMC Corporation
FMP Stock News
Original source text
Company provides additional detail on financial impact of previously announced commercial actions

Third Quarter 2026 Highlights

Revenue of $106 million, down $436 million versus Q3 2025, including an approximately $639 million negative impact from previously announced commercial actionsConsolidated GAAP net loss of $2.07 billion, a decline of $1.50 billion versus Q3 2025 driven by non-cash adjustments recorded in connection with deferred tax assets and intangible assets, as well as the commercial actionsAdjusted EBITDA of negative $559 million, down $795 million versus Q3 2025, including an approximately $672 million negative impact from the commercial actionsConsolidated GAAP net loss of $15.54 per diluted share, down $11.02 versus Q3 2025Adjusted loss per diluted share of $4.41, down $5.30 versus Q3 2025GAAP cash from operations of $7 million, an increase of $191 million versus Q3 2025Free cash flow of negative $18 million, an improvement of $214 million versus Q3 2025Outlook1

Fourth quarter revenue excluding India lowered to a range of $1.04 billion to $1.14 billion, essentially flat at the midpoint versus 2025Fourth quarter Adjusted EBITDA lowered to a range of $210 million to $230 million, a decline of 22 percent at the midpointFourth quarter Adjusted earnings per diluted share lowered to a range of $0.56 to $0.70, a decline of 48 percent at the midpointFull year free cash flow now expected to be negative $350 million to negative $150 million, /PRNewswire/ --

FMC Corporation (NYSE: FMC) today reported third-quarter 2026 revenue of $106 million, compared with $542 million in the prior-year period. Third-quarter sales include a $639 million negative impact from the commercial actions announced on October 15, 2026, to modify the company's pricing and rebate model in North America and to address select higher-priced products held by channel customers in key markets.

"We are taking significant action to address elevated inventory values in the channel and improve the movement of FMC products to growers," said Pierre Brondeau, chairman, chief executive officer and president. "Our third-quarter results reflected both the substantial impact of these actions and weaker than expected demand. Our priority now is disciplined execution with our customers. We believe completing this work, together with the progress across our operational priorities, positions FMC for improved performance in 2027 and a stronger growth and earnings profile in 2028."

FMC Revenue

Q3 2026

Total Revenue Change (GAAP)

(80) %

      Less: Revenue for India held for sale business

9 %

Total Revenue Change (ex-India) (Non-GAAP)

(89) %

Less Commercial Actions

67 %

Like-for-Like Revenue Change (Before Commercial Actions) (Non-GAAP)

(22) %

Totals may not sum due to rounding

Third-quarter revenue, excluding India and the commercial actions, was $745 million, a decline of 22 percent versus the prior-year period which excluded India. Volume declined 21 percent due to challenging market conditions with channel customers in several key markets sharply reducing replenishment orders during the final weeks of the quarter. Price declined 2 percent. Foreign currency was a 1 percent tailwind.

FMC Regional Revenue ($M)

Q3 2026

Q3 2025

North America

(371)

244

Latin America

264

463

EMEA

121

155

Asia (excluding 2026 India)1

91

99

2026 India1

0

(419)

Total Revenue (GAAP)

106

542

Totals may not sum due to rounding

GAAP net loss was $2.07 billion, compared with a net loss of $569 million in the prior-year period, primarily due to non-cash adjustments recorded in connection with deferred tax assets and intangible assets, as well as the commercial actions taken in the third quarter. Third-quarter Adjusted EBITDA was negative $559 million, compared with $236 million in the prior-year period. Excluding the approximately $672 million negative impact of the commercial actions, underlying Adjusted EBITDA was $113 million.  This result was lower than the prior year with lower sales and an FX headwind partially offset by favorable costs.

On a GAAP basis, cash from operations was $7 million, compared to negative $184 million in the prior-year period. Free cash flow was negative $18 million including $23 million for restructuring spend.  The free cash flow improvement of $214 million versus third quarter 2025 is mainly due to favorable working capital dynamics.

Commercial Actions Update

The commercial actions announced on October 15 resulted in a total third-quarter negative impact of approximately $639 million to revenue and $672 million negative impact to Adjusted EBITDA. These actions were taken to address the elevated value of FMC inventory held by channel customers in key markets as they seek to operate with very low inventory values in response to high financing costs, the perception of ample supply and demand uncertainty. This creates a specific constraint for FMC, driven by two distinct issues: the existing price and rebate model in North America and select products already in the channel at prices above current market levels.

Approximately $500 million of the Adjusted EBITDA impact relates to the transition to a new pricing and rebate model in North America, which is intended to significantly reduce the gap between gross and net pricing. This amount consists of two components.

The first and larger component reflects the pricing and rebate adjustments associated with the transition to the new model. Under the previous model, rebates for the market year ended September 30 were paid in the fourth quarter, offset in part by continued fourth-quarter sales at the higher gross price. With the new model effective October 1, that cycle will not continue. As a result, the remaining adjustment to close out the historical model is reflected in third-quarter results.

The second component reflects adjustments needed to bring inventory already in the North America channel from the historic higher gross price to a price closer to the expected net price under the new model. FMC expects the new model to materially reduce the volatility associated with future rebate payments. It should also provide a simpler pricing structure for FMC and its customers, while allowing customers to manage the value of FMC inventory more closely with current market conditions.

The remaining approximately $175 million of the impact reflects pricing adjustments made on high-priced products held by channel customers in Brazil, the United States, Canada and Argentina.  These pricing adjustments are intended to support movement of the affected products downstream and future demand across the FMC portfolio. The adjustments apply only to products already held by channel customers and do not change FMC's current selling prices. The adjustments do not impact current period cash and are the only component of the Adjusted EBITDA charge expected to reduce future cash collections.

The estimated third-quarter financial impact of both actions is reflected in the company's reported results; however, implementation is ongoing. Discussions with customers are underway, and FMC expects the transition to occur over the next three quarters.

Commercial Action

Approximate Split of
EBITDA Charge

Cash Impact

Change in North America pricing and rebate model

Transition to new pricing modelImpact of adjusting gross price of existing channel inventory~$500 million

No change to forward
cash obligation

Reducing the price of high-priced products in
Brazil, Argentina, the U.S. and Canada to better
align value of that customer inventory to current
market pricing

~$175 million

Foregoing of future
cash collection of
subsequent quarters

Outlook1

Fourth-quarter revenue, excluding India, is expected to be in the range of $1.04 billion to $1.14 billion, essentially flat at the midpoint versus fourth-quarter 2025. A high-single digit price decline is expected to be offset by volume growth driven by increased direct-to-grower sales in Brazil, growth of new products and more competitive pricing of FMC products.   

Adjusted EBITDA is forecasted to be in the range of $210 million to $230 million, a decline of 22 percent at the midpoint versus the prior-year period.  Higher volume and cost favorability are expected to be more than offset by lower price and an FX headwind. FMC expects adjusted earnings per diluted share to be in the range of $0.56 to $0.70, a decline of 48 percent at the midpoint versus fourth-quarter 2025, mainly due to lower EBITDA and an increased share count following the investment from Tessenderlo Group which closed in September.

The company has updated its full-year 2026 outlook, including commercial actions, to reflect third-quarter results and revised fourth-quarter expectations. Full-year revenue, excluding India, is expected to be in the range of $2.75 billion to $2.85 billion, a decline of 28 percent at the midpoint versus 2025, excluding India from the prior-year period. Adjusted EBITDA is expected to be in the range of negative $124 million to negative $104 million, a decline of 114 percent at the midpoint versus 2025. Adjusted earnings per diluted share is expected to be in the range of negative $3.66 to negative $3.50, a decline of 221 percent at the midpoint versus the prior year.

Free cash flow is expected to be in the range of negative $350 million to negative $150 million. This includes approximately $180 million of restructuring spend.  The reduction versus prior guidance is mainly due to lower demand and the impacts of the commercial actions taken in Q3.

Full Year Outlook2

(excludes India)

Fourth Quarter Outlook2

(excludes India)

Revenue

$2.75 billion to

$2.85 billion

$1.04 billion to

$1.14 billion

Growth at midpoint vs. 2025

(28) %

0 %

Adjusted EBITDA

$(124) million to

$(104) million

$210 million to

$230 million

Growth at midpoint vs. 2025

(114) %

(22) %

Adjusted EPS^

$(3.66) to $(3.50)

$0.56 to $0.70

Growth at midpoint vs. 2025

(221) %

(48) %

^ EPS estimates assume 156.0 million diluted shares for Q4 and 135.2 million diluted shares for full year

*Percentages are calculated using whole numbers.  Minor differences may exist due to rounding. 

Supplemental Information

The company will post supplemental information on the web at https://investors.fmc.com, including its webcast slides for tomorrow's earnings call, definitions of non-GAAP terms and reconciliations of non-GAAP figures to the nearest available GAAP term.

Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. FMC and the FMC logo are trademarks of FMC Corporation or an affiliate.

About FMC

FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn®.

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:  FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders.

In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the projections, outlook and guidance for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement including but not limited to the impact of certain commercial actions. These statements are subject to numerous risks and uncertainties, including but not limited to risks related to business competition; impacts of climatic conditions; unexpected market conditions; changes in the regulatory environment; cost of commodities; changes in price availability of key raw materials; our ability to innovate and successfully introduce new products or technologies; ability to compete and protect our intellectual property rights; global and exchange rate fluctuations; and potential litigation and regulatory matters, and are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.  Forward-looking statements are qualified in their entirety by the above cautionary statement.

We specifically decline to undertake any obligation, and specifically disclaim any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.

This press release contains certain "non-GAAP financial terms" which are defined on our website www.fmc.com/investors. Such terms include Adjusted EBITDA, Adjusted earnings, free cash flow and organic revenue growth. In addition, we have also provided on our website reconciliations of non-GAAP terms to the most directly comparable GAAP terms.

Although we provide forecasts for adjusted earnings per share, Adjusted EBITDA, and free cash flow (non-GAAP financial measures), we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, our India held for sale business, and discontinued operations. As a result, no GAAP outlook is provided. Starting with the third quarter 2025 guidance, we provide forecasts for revenue excluding India (non-GAAP financial measure). We are not able to forecast the GAAP revenue due to potential actions we may take during the held for sale period to prepare the business for a potential buyer and other uncertainties, including customer reaction to the announcement of our intention to sell our India commercial business. In 2026, revenue, Adjusted EBITDA and Adjusted EPS outlooks provided exclude India results and variances are calculated versus 2025 results, which include India results in the first half of the year. Organic revenue growth (non-GAAP) excludes the impact of foreign currency changes and the removal of India.FMC CORPORATION

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(Unaudited)

Three Months Ended
September 30,

Nine Months Ended
September 30,

(In millions, except per share amounts)

2026

2025

2026

2025

Revenue

$        105.9

$        542.2

$     1,731.6

$     2,384.1

Costs of sales and services

507.5

413.3

1,544.5

1,532.2

Gross margin

$      (401.6)

$        128.9

$        187.1

$        851.9

Selling, general and administrative expenses

172.3

167.4

536.5

516.2

Research and development expenses

57.7

63.3

183.6

198.4

Restructuring and other charges (income)

480.6

294.5

779.9

349.0

Total costs and expenses

$     1,218.1

$        938.5

$     3,044.5

$     2,595.8

Income from continuing operations before non-operating
pension, postretirement, and other charges (income), interest
expense, net and income taxes

$   (1,112.2)

$      (396.3)

$   (1,312.9)

$      (211.7)

Non-operating pension, postretirement, and other charges (income)

2.1

5.6

8.8

15.4

Interest expense, net

73.6

64.1

209.7

175.2

Income (loss) from continuing operations before income taxes

$   (1,187.9)

$      (466.0)

$   (1,531.4)

$      (402.3)

Provision (benefit) for income taxes

840.6

82.2

951.2

110.1

Income (loss) from continuing operations

$   (2,028.5)

$      (548.2)

$   (2,482.6)

$      (512.4)

Discontinued operations, net of income taxes

(36.8)

(20.4)

(50.2)

(4.0)

Net income (loss)

$   (2,065.3)

$      (568.6)

$   (2,532.8)

$      (516.4)

Less: Net income (loss) attributable to noncontrolling interests

1.6

0.7

2.0

1.7

Net income (loss) attributable to FMC stockholders

$   (2,066.9)

$      (569.3)

$   (2,534.8)

$      (518.1)

Amounts attributable to FMC stockholders:

  Income (loss) from continuing operations, net of tax

$   (2,030.1)

$      (548.9)

$   (2,484.6)

$      (514.1)

  Discontinued operations, net of tax

(36.8)

(20.4)

(50.2)

(4.0)

  Net income (loss)

$   (2,066.9)

$      (569.3)

$   (2,534.8)

$      (518.1)

Basic earnings (loss) per common share attributable to FMC
stockholders:

  Continuing operations

$      (15.26)

$         (4.36)

$      (19.35)

$         (4.08)

  Discontinued operations

(0.28)

(0.16)

(0.39)

(0.03)

  Basic earnings per common share

$      (15.54)

$         (4.52)

$      (19.74)

$         (4.11)

Average number of shares outstanding used in basic earnings per
share computations

133.0

125.2

128.4

125.1

Diluted earnings (loss) per common share attributable to FMC
stockholders:

  Continuing operations

$      (15.26)

$         (4.36)

$      (19.35)

$         (4.08)

  Discontinued operations

(0.28)

(0.16)

(0.39)

(0.03)

  Diluted earnings per common share

$      (15.54)

$         (4.52)

$      (19.74)

$         (4.11)

Average number of shares outstanding used in diluted earnings per
share computations

133.0

125.2

128.4

125.1

Other Data:

Capital additions and other investing activities

$            8.1

$          24.3

$          17.4

$          71.5

Depreciation and amortization expense

$          40.9

$          43.4

$        124.0

$        130.5

FMC CORPORATION

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP) TO ADJUSTED AFTER-TAX EARNINGS FROM CONTINUING OPERATIONS, ATTRIBUTABLE TO FMC STOCKHOLDERS (NON-GAAP) (1)

(Unaudited)

Three Months Ended
September 30,

Nine Months Ended
September 30,

(In millions, except per share amounts)

2026

2025

2026

2025

Net income (loss) attributable to FMC stockholders (GAAP)

$   (2,066.9)

$       (569.3)

$  (2,534.8)

$      (518.1)

Corporate special charges (income):

Restructuring and other charges (income) (a)

467.1

79.4

709.8

133.9

Non-operating pension, postretirement, and other charges
(income) (b)

2.1

5.6

8.8

15.4

India held for sale business (c)

45.6

509.6

145.2

509.6

Income tax expense (benefit) on Corporate special charges (income) (d)

18.4

(16.4)

(30.3)

(27.6)

Discontinued operations attributable to FMC stockholders, net of
income taxes (e)

36.8

20.4

50.2

4.0

Tax adjustment (f)

909.9

83.1

1,068.3

104.3

Adjusted after-tax earnings (loss) from continuing operations
attributable to FMC stockholders (non-GAAP) (1)

$      (587.0)

$         112.4

$      (582.8)

$       221.5

Diluted earnings (loss) per common share (GAAP)

$      (15.54)

$         (4.52)

$      (19.74)

$        (4.11)

Corporate special charges (income) per diluted share, before tax:

Restructuring and other charges (income)

3.51

0.63

5.53

1.07

Non-operating pension, postretirement, and other charges
(income)

0.02

0.04

0.07

0.12

India held for sale business

0.34

4.06

1.13

4.06

Income tax expense (benefit) on Corporate special charges (income),
per diluted share

0.14

(0.13)

(0.24)

(0.22)

Discontinued operations attributable to FMC stockholders, net of
income taxes per diluted share 

0.28

0.16

0.39

0.03

Tax adjustments per diluted share

6.84

0.65

8.32

0.81

Diluted adjusted after-tax earnings (loss) from continuing
operations per share, attributable to FMC stockholders (non-GAAP)

$         (4.41)

$           0.89

$        (4.54)

$         1.76

Average number of shares outstanding used in diluted adjusted after-tax
earnings (loss) from continuing operations per share computations(2)

133.0

125.7

128.4

125.6

(1)

Referred to as Adjusted earnings. The Company believes that Adjusted earnings, a non-GAAP financial measure, and its presentation on a per share basis provides useful information about the Company's operating results to management, investors, and securities analysts. Adjusted earnings excludes the effects of corporate special charges, the India held for sale business, tax-related adjustments and the results of our discontinued operations. The Company also believes that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of its underlying business from period to period.

(2)

The average number of shares outstanding used in the three and nine months ended September 30, 2025 diluted adjusted after-tax earnings from continuing operations per share computation (Non-GAAP) includes 0.7 million and 0.6 million diluted shares, respectively. This differs from the average number of shares outstanding used in diluted earnings per share computations (GAAP) as we had a net loss from continuing operations attributable to FMC stockholders during each of the three and nine months ended September 30, 2025.

(a)

Three Months Ended September 30, 2026:

Restructuring and other charges (income) includes restructuring charges of $175.9 million primarily comprised of charges incurred in connection with Project Foundation, which is management's comprehensive plan to further optimize FMC's cost structure and organizational operations. The charges for Project Foundation include non-cash asset write-offs and accelerated depreciation costs of $86.8 million primarily associated with the planned exit of certain production activities; severance and employee separation costs of $36.2 million; and, other miscellaneous charges of $51.7 million, which includes contract exit costs and professional service provider costs. In response to revised expectations regarding future operating results and cash flows and the commercial actions implemented during the period, we performed an impairment test of certain indefinite-lived intangible assets and recorded a non-cash impairment charge of $287.5 million, which is included in other charges (income) during the three months ended September 30, 2026. Other charges (income) also includes $3.8 million of charges associated with our environmental sites.

Three Months Ended September 30, 2025:

Restructuring and other charges (income) includes restructuring charges of $62.1 million primarily related to Project Focus. Charges incurred related to Project Focus included $47.1 million of charges recorded in connection with a shutdown of a product line at one of our manufacturing locations, which includes $27.5 million of abandonment charges on assets identified for disposal. Stranded raw materials related charges of $12.2 million incurred in connection with this shutdown are recorded to "Cost of Sales and services" on the consolidated statements of income (loss) and are included in the restructuring and other charges line in the reconciliation above. Additionally, we recorded other Project Focus-related charges during the period including $3.5 million of professional service provider costs and other miscellaneous charges, $3.9 million of severance and employee separation costs, and write-offs of $7.5 million on assets identified for disposal. Other charges (income) of $17.3 million is comprised of $4.9 million of charges associated with our environmental sites, losses of $7.7 million related to the devaluation of the Argentine peso driven by government actions, and $4.6 million of other miscellaneous charges.

Nine Months Ended September 30, 2026:

Restructuring and other charges (income) includes restructuring charges of $409.9 million primarily related to charges incurred in connection with Project Foundation. The charges consist of non-cash asset write-offs and accelerated depreciation costs of $285.7 million primarily associated with the planned exit of certain production activities, which includes a write-off of $92.6 million for certain receivables primarily in Latin America; severance and employee separation costs of $47.7 million; and, other miscellaneous charges of $67.9 million, which includes contract exit costs and professional service provider costs partially offset by the cash proceeds from the sale of a legacy product line. During the nine months ended September 30, 2026, we also recorded Project Focus-related costs of $8.3 million primarily related to miscellaneous charges associated with previously implemented activities. Other charges (income) includes the non-cash impairment charge of $287.5 million recorded in connection with our indefinite-lived impairment test performed during the the third quarter and $13.1 million of charges associated with our environmental sites.

Nine Months Ended September 30, 2025

Restructuring and other charges (income) includes restructuring charges of $88.7 million primarily related to Project Focus. Charges incurred related to Project Focus include of $47.1 million of charges recorded in connection with a shutdown of a product line at one of our manufacturing locations, which includes $27.5 million of abandonment charges on assets identified for disposal. Stranded raw materials charges of $12.2 million incurred in connection with this shutdown are recorded to "Cost of Sales and services" on the consolidated statements of income (loss) and are included in the restructuring and other charges line in the reconciliation above. Additionally, we recorded other Project Focus-related charges during the period including $15.0 million of professional service provider costs and other miscellaneous charges, $13.5 million of severance and employee separation costs, and write-offs of $13.1 million on assets identified for disposal. Other charges (income) of $45.2 million is comprised of $15.8 million of charges associated with our environmental sites, a charge of $11.9 million due to changes in our estimate for Furadan disposal costs at our Middleport site, losses of $7.7 million related to the devaluation of the Argentine peso driven by government actions, and $9.7 million of other miscellaneous charges.

 (b)

Our non-operating pension, postretirement and other charges (income) includes those costs (benefits) related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These are excluded from our Adjusted earnings and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We continue to include the service cost and amortization of prior service cost in our Adjusted earnings results noted above. These elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.   

(c)

In July 2025, the Board of Directors approved a plan to divest the Company's commercial business in India in response to ongoing challenges in the country. In May 2026, the Company announced that it has signed a definitive agreement to sell the India commercial business to Crystal Crop Protection Limited for consideration of $252 million, subject to customary adjustments for cash, debt and working capital. The Company will continue to receive all cash generated from the ongoing operation of the India business until closing, primarily through monetization of working capital, and the sale is expected to close during 2026. The assets related to this business have been classified as held for sale since the third quarter of 2025. The business does not qualify for recognition as discontinued operations and will continue to be presented in the Company's reported GAAP results until a transaction is completed. Beginning with the third quarter of 2025, we have excluded the impact of various activities associated with the anticipated sale from our operating results for non-GAAP purposes. Refer to the table below for the adjustments related to the India held for sale business for the three and nine months ended September 30, 2026.

Three Months Ended
September 30,

Nine Months Ended
September 30,

Affected Line Item in the Consolidated
Statements of Income (Loss)

(In millions)

2026

2025

2026

2025

Operating results, substantially
intentional commercial actions

$           32.1

$         282.2

$           75.1

$         282.2

Revenue, Cost of sales and services,
and Selling, general and
administrative expenses

Asset impairment

13.5

226.8

57.1

226.8

Restructuring and other charges
(income)

Third party provider costs

—

0.6

13.0

0.6

Restructuring and other charges
(income)

India held for sale business

$           45.6

$         509.6

$         145.2

$         509.6

During the three months ended September 30, 2025, we recorded $509.6 million of charges and write-downs related to the India held for sale business, including charges of $282.2 million in connection with intentional commercial actions to position the India business for sales and an initial asset impairment charge of $226.8 million to record the assets held for sale to the estimated fair value at that time.

(d)

The income tax expense (benefit) on Corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the corporate special charge or income occurred and includes both current and deferred income tax expense (benefit) based on the nature of the non-GAAP performance measure.

(e)

Discontinued operations includes provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations and retained liabilities.

(f)

We exclude the GAAP tax provision, including discrete items, from the non-GAAP measure of income, and include a non-GAAP tax provision based upon the projected annual non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but are not limited to: income tax expenses or benefits that are not related to continuing operating results in the current year; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets and related interim accounting impacts; and changes in tax law. In 2024 and 2023, we recorded significant deferred tax assets due to various tax incentives granted to the Company's Swiss subsidiaries (the "Swiss Tax Incentives"). The initial recognition of these Swiss Tax Incentives did not impact our adjusted non-GAAP effective tax rate but will be considered annually as we realize the benefits. Management believes excluding these discrete tax items, as well as the impacts of the Swiss Tax Incentives annually as the related benefits are realized, assists investors and securities analysts in understanding the tax provision and the effective tax rate related to continuing operating results thereby providing investors with useful supplemental information about FMC's operational performance.

Three Months Ended
September 30,

Nine Months Ended
September 30,

(In millions)

2026

2025

2026

2025

Tax adjustments:

Revisions to valuation allowances of historical deferred tax assets

$          808.8

$           46.4

$         933.5

$           45.2

Net impact of Switzerland tax incentives

(0.9)

18.6

—

31.9

Foreign currency remeasurement and other discrete items

102.0

18.1

134.8

27.2

Total non-GAAP tax adjustments(i)

$          909.9

$           83.1

$      1,068.3

$         104.3

(i)

Primarily relates to valuation allowances recorded in Switzerland and the United States during the three and nine months ended September 30, 2026.

RECONCILIATION OF NET INCOME (LOSS) (GAAP) TO ADJUSTED EARNINGS FROM CONTINUING
OPERATIONS, BEFORE INTEREST, INCOME TAXES, DEPRECIATION AND AMORTIZATION, AND
NONCONTROLLING INTERESTS (NON-GAAP) (3)

(Unaudited)

Three Months Ended
September 30,

Nine Months Ended
September 30,

(In millions)

2026

2025

2026

2025

Net income (loss) (GAAP)

$   (2,065.3)

$      (568.6)

$  (2,532.8)

$      (516.4)

Restructuring and other charges (income) (1)

467.1

79.4

709.8

133.9

Non-operating pension, postretirement, and other charges (income)

2.1

5.6

8.8

15.4

India held for sale business (2)

45.6

509.6

145.2

509.6

Discontinued operations, net of income taxes

36.8

20.4

50.2

4.0

Interest expense, net

73.6

64.1

209.7

175.2

Depreciation and amortization

40.9

43.4

124.0

130.5

Provision (benefit) for income taxes

840.6

82.2

951.2

110.1

Adjusted earnings from continuing operations, before interest,
income taxes, depreciation and amortization, and noncontrolling
interests (non-GAAP) (3)

$      (558.6)

$        236.1

$      (333.9)

$       562.3

(1)

In the reconciliation above, charges recorded in connection with the India held for sale business of $13.5 million and $70.1 million for the three and nine months ended September 30, 2026, respectively, are presented in the India held for sale business line, as described in the reconciliation in note (c) above. Charges of $227.4 million are presented in the India held for sale business line for the three and nine months ended September 30, 2025. On the consolidated statements of income (loss), these adjustments are recorded to "Restructuring and other charges (income)." Restructuring and other charges (income) for the three and nine months ended September 30, 2025 in the reconciliation above also includes $12.3 million of charges related to Project Focus recorded to "Cost of Sales and services" on the consolidated statements of income (loss).

(2)

Beginning with the third quarter of 2025, we excluded the operating results of the India commercial business during the held for sale period for non-GAAP purposes. For further details on the charges and write-downs recorded in connection with the India held for sale business, refer to note (c) in the reconciliation above.

(3)

Referred to as Adjusted EBITDA. Defined as operating profit excluding restructuring and other charges (income), depreciation and amortization expense, and the India held for sale business.

RECONCILIATION OF CASH PROVIDED (REQUIRED) BY OPERATING ACTIVITIES OF
CONTINUING OPERATIONS (GAAP) TO FREE CASH FLOW (NON-GAAP) (2)

(Unaudited)

Three Months Ended
September 30,

Nine Months Ended
September 30,

(In millions)

2026

2025

2026

2025

Cash provided (required) by operating activities of continuing
operations (GAAP) (1)

$            6.6

$      (184.2)

$      (231.3)

$      (663.3)

Capital expenditures

(7.8)

(23.7)

(29.7)

(70.3)

Other investing activities

(0.3)

(0.6)

12.3

(1.2)

Capital additions and other investing activities

$          (8.1)

$        (24.3)

$        (17.4)

$        (71.5)

Cash provided (required) by operating activities of discontinued
operations

(19.9)

(24.0)

(54.2)

(53.7)

Divestiture transaction costs (2)

3.2

—

14.0

—

Free cash flow (non-GAAP) (3)

$        (18.2)

$      (232.5)

$      (288.9)

$      (788.5)

(1)

The three and nine months ended September 30, 2026 includes cash payments of $22.6 million and $115.1 million, respectively, for restructuring activities primarily related to the Project Focus and Project Foundation transformation programs. The three and nine months ended September 30, 2025 includes cash payments of $6.4 million and $77.0 million, respectively, made in connection with Project Focus.

(2)

Represents third party provider costs associated with the expected sale of our India commercial business. Proceeds from the sale of our India commercial business anticipated in 2026 will be excluded from free cash flow when received. Therefore, we have also excluded the related transaction costs from free cash flow.

(3)

Free cash flow is defined as cash provided (required) by operating activities of continuing operations (GAAP) adjusted for spending for capital additions and other investing activities as well as cash provided (required) by discontinued operations and divestiture transaction costs associated with the sale of our GSS business. We believe that this non-GAAP financial measure provides a useful basis for investors and securities analysts to evaluate the cash generated by routine business operations, including to assess our ability to repay debt, fund acquisitions and return capital to shareholders through share repurchases and dividends. Our use of free cash flow has limitations as an analytical tool and should not be considered in isolation or as a substitute for an analysis of our results under U.S. GAAP.

RECONCILIATION OF REVENUE (GAAP)

TO REVENUE EXCLUDING INDIA (NON-GAAP) (2)

(Unaudited)

Three Months Ended
September 30,

Nine Months Ended
September 30,

(In millions)

2026

2025

2026

2025

Revenue (GAAP)

$              105.9

$              542.2

$           1,731.6

$           2,384.1

Less: Revenue from India commercial business (1)

—

(419.1)

21.9

(419.1)

Revenue excluding India (non-GAAP) (2)

$              105.9

$              961.3

$           1,709.7

$           2,803.2

(1)

Beginning with the third quarter of 2025, revenue from the India commercial business is excluded from our adjusted results during the held for sale period for non-GAAP purposes. During the three and nine months ended September 30, 2025, we took several commercial actions to prepare the India commercial business for sale. Refer to note (c) above for further details.

(2)

Although the India held for sale business does not qualify for recognition as discontinued operations, we believe Revenue excluding India (non-GAAP) provides management and investors with useful supplemental information regarding our ongoing revenue performance.

RECONCILIATION OF REVENUE CHANGE (GAAP) TO

ORGANIC REVENUE CHANGE (NON-GAAP) (1)

(Unaudited)

Three Months Ended September
30, 2026 vs. 2025

Nine Months Ended September
30, 2026 vs. 2025

Total revenue (GAAP) change

(80) %

(27) %

Less: Revenue for India held for sale business for the three
and nine months ended September 30, 2026

9 %

12 %

Revenue excluding India (non-GAAP) change (1)

(89) %

(39) %

Less:  Foreign currency impact

1 %

3 %

Organic revenue (non-GAAP) change (2)

(90) %

(42) %

(1)

Beginning with the third quarter of 2025, revenue from the India commercial business is excluded from our adjusted results during the held for sale period for non-GAAP purposes. Refer to note (c) above for further details.

(2)

We believe organic revenue growth (non-GAAP) provides management and investors with useful supplemental information regarding our ongoing revenue performance and trends by presenting revenue growth excluding the impact of fluctuations in foreign exchange rates and the India held for sale business.

RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO

FMC STOCKHOLDERS (GAAP) TO RETURN ON INVESTED CAPITAL ("ROIC")

NUMERATOR (NON-GAAP) AND ADJUSTED ROIC (USING NON-GAAP NUMERATOR) (1)

(Unaudited)

Twelve Months Ended

(In millions, except percentages)

September 30, 2026

Net income (loss) attributable to FMC stockholders (GAAP)

$                    (4,255.6)

Interest expense, net, net of income taxes

233.0

Corporate special charges (income)

2,363.7

India held for sale business

157.3

Income tax expense (benefit) on Corporate special charges (income)

(160.8)

Discontinued operations attributable to FMC stockholders, net of income taxes

82.8

Tax adjustments

1,380.3

ROIC numerator (non-GAAP)

$                       (199.3)

September 30, 2026

September 30, 2025

Total debt

$                     4,177.7

$                         4,542.2

Total FMC stockholders' equity

(19.4)

3,773.8

Total debt and FMC stockholders' equity (GAAP)

$                     4,158.3

$                         8,316.0

ROIC denominator (2 yr average total debt and FMC stockholders' equity)

$                     6,237.2

ROIC (using Net income (loss) attributable to FMC stockholders (GAAP)
as numerator)

(68.23) %

Adjusted ROIC (using non-GAAP numerator) (1)

(3.20) %

(1)

We believe Adjusted ROIC (non-GAAP) provides management and investors with useful supplemental information regarding our utilization of capital provided by both equity and debt as well as our working capital and free cash flow management. Additionally, vesting of certain restricted stock awards granted to officers is connected to Adjusted ROIC as a performance metric.

FMC CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In millions)

September 30, 2026

December 31, 2025

Cash and cash equivalents

$                735.8

$                584.5

Trade receivables, net of allowance of $87.6 in 2026 and $43.3 in 2025

1,723.1

2,062.0

Inventories

1,326.5

1,219.6

Prepaid and other current assets

472.6

481.2

Assets held for sale (1)

319.4

611.7

Total current assets

$             4,577.4

$             4,959.0

Property, plant and equipment, net

491.9

707.4

Other intangibles, net

1,995.9

2,361.8

Deferred income taxes

435.0

1,215.6

Other long-term assets

409.6

443.4

Total assets

$             7,909.8

$             9,687.2

Short-term debt and current portion of long-term debt

$                222.8

$             1,305.1

Accounts payable, trade and other

723.9

771.0

Advanced payments from customers

67.8

453.1

Accrued and other liabilities

735.4

574.0

Accrued customer rebates

811.9

417.4

Guarantees of vendor financing

51.6

45.7

Accrued pensions and other postretirement benefits, current

3.3

3.3

Income taxes

105.0

24.0

Liabilities held for sale (1)

36.8

161.7

Total current liabilities

$             2,758.5

$             3,755.3

Long-term debt, less current portion

$             3,954.9

$             2,769.8

Long-term liabilities

1,186.9

1,063.2

Equity

9.5

2,098.9

Total liabilities and equity

$             7,909.8

$             9,687.2

(1)

The carrying value of the India held for sale business decreased from $450 million as of December 31, 2025 to $260 million as of September 30, 2026 primarily due to receivable collections during the period as well as an impairment charge of approximately $57 million. The carrying value of the held for sale business is comprised of $283 million of net assets held for sale as presented on the consolidated balance sheet and a gain of $23 million related to foreign currency translation in connection with the assets identified for disposal. The foreign currency translation gains are recorded in "Accumulated other comprehensive income (loss)" on the consolidated balance sheet and will be reclassified to the consolidated statement of income (loss) upon close of the sale.

FMC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Nine Months Ended September 30,

(In millions)

2026

2025

Cash provided (required) by operating activities of continuing operations

$               (231.3)

$               (663.3)

Cash provided (required) by operating activities of discontinued operations

(54.2)

(53.7)

Cash provided (required) by investing activities of continuing operations

(18.2)

(84.4)

Cash provided (required) by financing activities of continuing operations

457.8

932.1

Effect of exchange rate changes on cash

(2.8)

9.7

Increase (decrease) in cash and cash equivalents

$                 151.3

$                 140.4

Cash and cash equivalents, beginning of period

$                 584.5

$                 357.3

Cash and cash equivalents, end of period

$                 735.8

$                 497.7

SOURCE FMC Corporation
2026-10-29 22:08 2d ago
2026-10-29 16:05 2d ago
Cavco Industries Reports Fiscal 2027 Second Quarter Results
CVCO Cavco Industries
FMP Stock News
Original source text
PHOENIX, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) ("we," "our," the "Company" or "Cavco") today announced financial results for the second fiscal quarter ended September 26, 2026.

Quarterly Highlights

Net revenue was $656.4 million, up $100 million or 17.9% compared to $556.5 million in the second quarter of the prior year, primarily on home sales volume and average selling price per home growth.Home sales volume was up 15.3% and capacity utilization remained consistent year over year at approximately 75%.Factory-built housing Gross profit as a percentage of Net revenue was 21.1%, down from 22.9% in the same period in the prior year. Financial services Gross profit as a percentage of Net revenue was 60.2%, compared to Gross profit of 55.6% in the same period in the prior year.Selling, general and administrative expenses include a one-time $7 million benefit from a return of insurance premium which favorably impacts Net income per diluted share by $0.70.Income before income taxes was $73 million, up $6 million, or 9.1% compared to $67 million in the same period in the prior year. Net income per diluted share was $7.17, up 9%, compared to $6.55 in the prior year quarter. Backlogs totaled $348 million at the end of the quarter representing 8-10 weeks of production, up $50 million sequentially from $298 million.Stock repurchases were approximately $30 million in the quarter. At the end of the second quarter, $158 million remains available for repurchases under our previously announced Board authorizations. Commenting on the quarter, President and Chief Executive Officer Bill Boor said, "This is our second consecutive quarter of record revenue and unit volume. While orders were off the preceding quarter pace, they remained healthy and backlogs continued to grow. This positions us very well going into the seasonally slower winter months with the ability to adjust production depending on order trends. While materials inflation continued and is expected to remain a challenge going forward, during Q2, selling price increases were in excess of cost pressures, resulting in a small sequential Gross Margin improvement. Additionally, we began to see data center workforce housing orders and shipments during the quarter which are contributing to healthy backlogs."

He continued, "A highlight this quarter was showing Cavco’s Grande Arbor, the first off-chassis HUD-Code home, at HUD’s Innovative Housing Showcase in Washington DC. Increasing federal and state-level support through the ROAD to Housing Act and other reforms will be opening exciting opportunities for factory-built housing in the years ahead."

Financial Results

 Three Months Ended
     ($ in thousands, except revenue per home sold)September 26,
2026
 September 27,
2025
 ChangeNet revenue          Factory-built housing$633,736  $535,117  $98,619  18.4%Financial services 22,642   21,410   1,232  5.8% $656,378  $556,527  $99,851  17.9%           Factory-built modules sold 9,794   8,699   1,095  12.6%           Factory-built homes sold (consisting of one or more modules) 5,972   5,178   794  15.3%           Net factory-built housing revenue per home sold$106,118  $103,344  $2,774  2.7%            Six Months Ended      ($ in thousands, except revenue per home sold)September 26,
2026
 September 27,
2025
 ChangeNet revenue          Factory-built housing$1,219,708  $1,070,811  $148,897  13.9%Financial services 46,629   42,573   4,056  9.5% $1,266,337  $1,113,384  $152,953  13.7%           Factory-built modules sold 19,301   17,599   1,702  9.7%           Factory-built homes sold (consisting of one or more modules) 11,629   10,594   1,035  9.8%           Net factory-built housing revenue per home sold$104,885  $101,077  $3,808  3.8%                In the factory-built housing segment, Net revenue increased in both periods due to higher home sales volume driven by both the American Homestar acquisition in the third quarter of the prior year and organic volume growth in both periods, as well as an increase in Net revenue per home sold.Financial services segment Net revenue increased in both periods due to increased loan sale volume and increased retained insurance premium net of reinsurance payments.  Three Months Ended    ($ in thousands)September 26,
2026 September 27,
2025 ChangeGross profit       Factory-built housing$133,975  $122,493  $11,482  9.4%Financial services 13,637   11,914   1,723  14.5% $147,612  $134,407  $13,205  9.8%        Gross profit as % of Net revenue       Consolidated 22.5%  24.2% N/A (1.7)%Factory-built housing 21.1%  22.9% N/A (1.8)%Financial services 60.2%  55.6% N/A 4.6%        Selling, general and administrative expenses       Factory-built housing$69,625  $65,757  $3,868  5.9%Financial services 8,085   6,472   1,613  24.9% $77,710  $72,229  $5,481  7.6%        Income from operations       Factory-built housing$64,350  $56,736  $7,614  13.4%Financial services 5,552   5,442   110  2.0% $69,902  $62,178  $7,724  12.4%         Six Months Ended    ($ in thousands)September 26,
2026 September 27,
2025 ChangeGross profit       Factory-built housing$255,994  $243,338  $12,656  5.2%Financial services 26,208   20,575   5,633  27.4% $282,202  $263,913  $18,289  6.9%        Gross profit as % of Net revenue       Consolidated 22.3%  23.7% N/A (1.4)%Factory-built housing 21.0%  22.7% N/A (1.7)%Financial services 56.2%  48.3% N/A 7.9%        Selling, general and administrative expenses       Factory-built housing$143,595  $128,911  $14,684  11.4%Financial services 15,950   12,466   3,484  27.9% $159,545  $141,377  $18,168  12.9%        Income from operations       Factory-built housing$112,399  $114,427  $(2,028) (1.8)%Financial services 10,258   8,109   2,149  26.5% $122,657  $122,536  $121  0.1%                In the factory-built housing segment, Gross profit increased due to an increase in home sales volume and Net revenue per home sold, partially offset by higher input costs for both periods. Selling, general and administrative expenses were higher for both periods primarily due to the addition of American Homestar, partially offset by a one-time $7 million benefit from a return of insurance premium related to additional D&O insurance purchased in 2019.In the financial services segment, Gross profit increased primarily due to loan sales volume, higher retained insurance premium net of reinsurance premium and lower commissions on insurance policies written. Selling, general and administrative expenses increased in both periods primarily due to higher compensation on stronger results.  Three Months Ended
    ($ in thousands, except per share amounts)September 26,
2026
 September 27,
2025
 ChangeInterest income$3,595  $5,046  $(1,451) (28.8)%Net income$55,439  $52,381  $3,058  5.8%Diluted net income per share$7.17  $6.55  $0.62  9.5%                     Six Months Ended     ($ in thousands, except per share amounts)September 26,
2026
 September 27,
2025
 ChangeInterest Income$6,858  $10,149  $(3,291) (32.4)%Net income $97,710  $104,023  $(6,313) (6.1)%Diluted net income per share$12.59  $12.96  $(0.37) (2.9)%               Conference Call Details

Cavco's management will hold a conference call to review these results tomorrow, October 30, 2026, at 1:00 p.m. (Eastern Time). Interested parties can access a live webcast of the conference call on the Internet at https://investor.cavco.com or via telephone. To participate by phone, please register here to receive the dial in number and your PIN. An archive of the webcast and presentation will be available for 60 days at https://investor.cavco.com.

About Cavco

Headquartered in Phoenix, Arizona, Cavco Industries, Inc. (Nasdaq: CVCO) designs and builds manufactured homes and modular homes, distributed nationwide through a network of independent and Company-owned retailers. Cavco is one of the largest manufactured and modular home builders in the United States, based on reported wholesale shipments, and is also a leading producer of park model RVs, vacation cabins, and factory-built commercial structures. Cavco's finance subsidiary, CountryPlace Mortgage, is an approved Fannie Mae and Freddie Mac seller/servicer and a Ginnie Mae mortgage-backed securities issuer, offering manufactured home loans — including conforming, non-conforming, and home-only financing — to buyers of manufactured and modular homes. Cavco's insurance subsidiary, Standard Casualty, provides manufactured home insurance and other property and casualty coverage to manufactured homeowners. Learn more about Cavco's manufactured homes and modular homes at www.cavcohomes.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. These forward-looking statements reflect Cavco's current expectations and projections with respect to our expected future business and financial performance, including, among other things: (i) expected financial performance and operating results, such as revenue and gross margin percentage; (ii) our liquidity and financial resources; (iii) our outlook with respect to the Company and the manufactured housing business in general; (iv) the expected effect of certain risks and uncertainties on our business; and (v) the strength of Cavco's business model. These statements may be preceded by, followed by, or include the words "aim," "anticipate," "believe," "estimate," "expect," "forecast," "future," "goal," "intend," "likely," "outlook," "plan," "potential," "project," "seek," "target," "can," "could," "may," "should," "would," "will," the negatives thereof and other words and terms of similar meaning. A number of factors could cause actual results or outcomes to differ materially from those indicated by these forward-looking statements. These factors include, among other factors, Cavco's ability to manage: (i) customer demand and the availability of financing for our products; (ii) labor shortages and the pricing, availability, or transportation of raw materials; (iii) the impact of local or national emergencies; (iv) excessive health and safety incidents or warranty and construction claims; (v) increases in cancellations of home sales; (vi) information technology failures or cyber incidents; (vii) our ability to maintain the security of personally identifiable information of our customers; (viii) compliance with the numerous laws and regulations applicable to our business, including state, federal, and foreign laws relating to manufactured housing, privacy, the internet, and accounting matters; (ix) successful defense against litigation, government inquiries, and investigations, and (x) other risks and uncertainties indicated from time to time in documents filed or to be filed with the Securities and Exchange Commission (the "SEC") by Cavco. The forward-looking statements herein represent the judgment of Cavco as of the date of this release and Cavco disclaims any intent or obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise. This press release should be read in conjunction with the information included in the Company's other press releases, reports, and other filings with the SEC. Readers are specifically referred to the Risk Factors described in Item 1A of the Company's Annual Report on Form 10-K for the year ended March 28, 2026 as may be updated from time to time in future filings on Form 10-Q and other reports filed by the Company pursuant to the Securities Exchange Act of 1934, which identify important risks that could cause actual results to differ from those contained in the forward-looking statements. Understanding the information contained in these filings is important in order to fully understand Cavco's reported financial results and our business outlook for future periods.

 CAVCO INDUSTRIES, INC.
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except per share amounts)     September 26,
2026 March 28,
2026ASSETS(Unaudited)  Current assets   Cash and cash equivalents$271,911  $236,721 Restricted cash, current 25,386   20,306 Accounts receivable, net 139,244   108,288 Short-term investments 17,166   16,233 Current portion of consumer loans receivable, net 19,713   19,207 Current portion of commercial loans receivable, net 41,835   54,841 Current portion of commercial loans receivable from affiliates, net 1,510   1,836 Inventories 311,110   295,671 Prepaid expenses and other current assets 54,554   71,630 Total current assets 882,429   824,733 Restricted cash 585   585 Investments 43,416   38,151 Consumer loans receivable, net 17,474   18,974 Commercial loans receivable, net 65,715   55,801 Commercial loans receivable from affiliates, net 3,993   3,519 Property, plant and equipment, net 321,398   278,890 Goodwill 211,667   208,841 Other intangibles, net 26,859   28,067 Operating lease right-of-use assets 37,992   33,578 Total assets$1,611,528  $1,491,139 LIABILITIES AND STOCKHOLDERS' EQUITY   Current liabilities   Accounts payable$68,047  $44,168 Accrued expenses and other current liabilities 352,184   291,230 Total current liabilities 420,231   335,398 Operating lease liabilities 32,955   30,747 Other liabilities 6,977   7,096 Deferred income taxes 14,362   14,716 Total liabilities 474,525   387,957 Stockholders' equity   Preferred stock, $0.01 par value; 1,000,000 shares authorized; No shares issued or outstanding —   — Common stock, $0.01 par value; 40,000,000 shares authorized; Issued 9,509,421 and 9,474,288 shares, respectively; Outstanding 7,661,911 and 7,738,700, respectively 95   95 Treasury stock, at cost; 1,847,510 and 1,735,588 shares, respectively (646,225)  (585,865)Additional paid-in capital 298,032   300,208 Retained earnings 1,486,424   1,388,714 Accumulated other comprehensive (loss) income (1,323)  30 Total stockholders' equity 1,137,003   1,103,182 Total liabilities and stockholders' equity$1,611,528  $1,491,139           CAVCO INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF INCOME
(Dollars in thousands, except per share amounts)
(Unaudited)     Three Months Ended Six Months Ended September 26,
2026 September 27,
2025 September 26,
2026 September 27,
2025Net revenue$656,378  $556,527  $1,266,337  $1,113,384 Cost of sales 508,766   422,120   984,135   849,471 Gross profit 147,612   134,407   282,202   263,913 Selling, general and administrative expenses 77,710   72,229   159,545   141,377 Income from operations 69,902   62,178   122,657   122,536 Interest income 3,595   5,046   6,858   10,149 Interest expense (282)  (112)  (414)  (276)Other income, net 136   142   38   142 Income before income taxes 73,351   67,254   129,139   132,551 Income tax expense (17,912)  (14,873)  (31,429)  (28,528)Net income$55,439  $52,381  $97,710  $104,023         Net income per share       Basic$7.22  $6.62  $12.70  $13.12 Diluted$7.17  $6.55  $12.59  $12.96 Weighted average shares outstanding       Basic 7,679,380   7,909,326   7,693,552   7,931,589 Diluted 7,734,777   7,992,745   7,760,165   8,024,720                   CAVCO INDUSTRIES, INC.
OTHER OPERATING DATA
(Dollars in thousands)
(Unaudited)     Three Months Ended
 Six Months Ended
 September 26,
2026
 September 27,
2025
 September 26,
2026
 September 27,
2025
Capital expenditures$29,704  $9,861  $55,197  $18,870 Depreciation$6,282  $4,961  $12,368  $9,758 Amortization of other intangibles$603  $372  $1,208  $744                  For additional information, contact:

Mark Fusler
Corporate Controller and Investor Relations
[email protected]

Phone: 602-256-6263
On the Internet: www.cavcoindustries.com
2026-10-29 22:08 2d ago
2026-10-29 17:01 2d ago
TransMedics to Present at Upcoming Investor Conferences
TMDX TransMedics Group
FMP Stock News
Original source text
, /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in three upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the Stifel 2026 Healthcare Conference in New York on Tuesday, November 10, 2026, at 10:40 a.m. EST, the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 7:00 a.m. EST and the Piper Sandler 38th Annual Healthcare Conference in New York on Tuesday, December 1, 2026, at 4:30 p.m. EST.

Event: Stifel 2026 Healthcare Conference
Date: Tuesday, November 10, 2026
Time: 10:40 a.m. EST

Event: Jefferies Global Healthcare Conference
Date: Tuesday, November 17, 2026
Time: 7:00 a.m. EST

Event: Piper Sandler 38th Annual Healthcare Conference
Date: Tuesday, December 1, 2026
Time: 4:30 p.m. EST

A live and archived webcast of the fireside chats will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Hannah Jeffrey
332-895-3222
[email protected]

SOURCE TransMedics Group, Inc.
2026-10-29 22:08 2d ago
2026-10-29 17:38 2d ago
EMCOR Group, Inc. (EME) Q3 2026 Earnings Call Transcript
EME EMCOR Group
FMP Stock News
Original source text
EMCOR Group, Inc. (EME) Q3 2026 Earnings Call October 29, 2026 10:30 AM EDT

Company Participants

Lucas Sullivan - Director of Financial Planning & Analysis
Anthony Guzzi - Chairman, President & CEO
Jason Nalbandian - Senior VP, CFO & Chief Accounting Officer

Conference Call Participants

Adam Thalhimer - Thompson, Davis & Company, Inc., Research Division
Brent Thielman - Oppenheimer & Co. Inc., Research Division
Justin Hauke - Robert W. Baird & Co. Incorporated, Research Division
Brian Brophy - Stifel, Nicolaus & Company, Incorporated, Research Division
Avinatan Jaroslawicz - UBS Investment Bank, Research Division
Timothy Mulrooney - William Blair & Company L.L.C., Research Division
Manish Somaiya - Cantor Fitzgerald & Co., Research Division
Sangita Jain - KeyBanc Capital Markets Inc., Research Division
Adam Bubes - Goldman Sachs Group, Inc., Research Division

Presentation

Operator

Good morning. My name is Dave, and I will be your conference operator today. At this time, I would like to welcome everyone to the EMCOR Group Third Quarter 2026 Earnings Conference Call. [Operator Instructions]

I will now turn the call over to Lucas Sullivan, Director, Financial Planning & Analysis. Mr. Sullivan, you may begin.

Lucas Sullivan
Director of Financial Planning & Analysis

Thanks, Dave. Good morning, everyone, and welcome to EMCOR's Third Quarter 2026 Earnings Conference Call. For those of you joining us by webcast, we are at the beginning of our slide presentation that will accompany our remarks today. This presentation will be archived in the Investor Relations section of our website at emcorgroup.com.

With me today are Tony Guzzi, our Chairman, President and Chief Executive Officer; Jason Nalbandian, Senior Vice President and EMCOR's Chief Financial Officer; and Maxine Mauricio, Executive Vice President, Chief Administrative Officer and General Counsel.

For today's call, Tony will provide comments on our third quarter 2026 and discuss our RPOs. Jason will then review the third quarter numbers and then turn
2026-10-29 22:07 2d ago
2026-10-29 16:15 2d ago
Invesco Mortgage Capital Inc. Reports Third Quarter 2026 Financial Results
IVZ Invesco
FMP Stock News
Original source text
, /PRNewswire/ -- Invesco Mortgage Capital Inc. (NYSE: IVR) (the "Company") today announced financial results for the quarter ended September 30, 2026.

Net loss per common share of $0.92 compared to net income of $0.34 in Q2 2026Earnings available for distribution per common share(1) of $0.47 compared to $0.50 in Q2 2026Monthly common stock dividends totaling $0.36 per share, unchanged from Q2 2026Book value per common share(2) of $6.74 compared to $8.03 as of June 30, 2026Economic return(3) of (11.6)% compared to 3.8% in Q2 2026Debt-to-equity ratio of 7.6x compared to 6.3x as of June 30, 2026Economic debt-to-equity ratio(1) of 8.3x compared to 7.5x as of June 30, 2026Update from Kevin Collins, Chief Executive Officer

"Economic growth remained resilient during the third quarter, but financial conditions tightened as investors increasingly priced in additional Federal Reserve rate hikes. Short-term Treasury yields rose on expectations for further monetary policy tightening, while longer-term yields increased on stronger growth expectations and concerns over elevated fiscal deficits and Treasury supply. Interest rate volatility also rose from the subdued levels of the second quarter, weighing on investor risk appetite and contributing to materially wider Agency RMBS spreads and modestly wider Agency CMBS spreads.

"Against this backdrop, our portfolio generated negative returns relative to Treasuries, although the impact was partially offset by improvement in swap spreads. Book value declined by 16.1% to $6.74 at quarter end, and when combined with our monthly dividends, resulted in an economic return of (11.6)% for the quarter.

"At quarter end, our $8.0 billion investment portfolio consisted of $6.6 billion of Agency RMBS, $0.7 billion of Agency TBA, and $0.7 billion of Agency CMBS. Our economic debt-to-equity ratio was 8.3x, and we maintained a sizable balance of unrestricted cash and unencumbered investments totaling $401.3 million. During the latter part of the quarter, we reduced our Agency CMBS allocation and redeployed proceeds into Agency RMBS opportunities, as spread widening created increasingly attractive risk-adjusted return potential within the sector. Importantly, financing markets remained orderly despite elevated market volatility. Our strong liquidity position, diversified financing relationships, and disciplined risk-management framework continue to position the Company well during periods of market uncertainty.

"Our outlook for both Agency RMBS and Agency CMBS remains constructive. While uncertainty surrounding inflation, monetary policy, and geopolitical developments remains elevated, recent spread widening has enhanced the relative value and prospective return potential of both sectors. Looking ahead, we believe Agency RMBS is well positioned to benefit from increased participation by GSEs, banks, money managers, and other institutional investors as compelling risk-adjusted returns continue to attract capital. Agency CMBS also remains attractive, supported by elevated yields, stable cash flow characteristics, and meaningful diversification benefits.

"We believe an eventual de-escalation of geopolitical tensions in the Middle East, coupled with moderation in interest rate volatility, could provide an additional tailwind for our target assets. Until then, we remain focused on maintaining prudent leverage, ample liquidity, and strategic portfolio diversification. We believe our measured approach positions us well to navigate uncertainty while seeking to deliver attractive risk-adjusted returns and create long-term shareholder value."

(1) Earnings available for distribution (and by calculation, earnings available for distribution per common share) and economic debt-to-equity ratio are non-Generally Accepted Accounting Principles ("GAAP") financial measures. Refer to the section entitled "Non-GAAP Financial Measures" for important disclosures and a reconciliation to the most comparable U.S. GAAP measures.

(2) Book value per common share as of September 30, 2026 and June 30, 2026 is calculated as total stockholders' equity less the liquidation preference of the Company's Series C Preferred Stock ($168.1 million as of September 30, 2026 and $168.6 million as of June 30, 2026), divided by total common shares outstanding.

(3) Economic return for the quarter ended September 30, 2026 is defined as the change in book value per common share from June 30, 2026 to September 30, 2026 of ($1.29); plus dividends declared of $0.36 per common share; divided by the June 30, 2026 book value per common share of $8.03. Economic return for the quarter ended June 30, 2026 is defined as the change in book value per common share from March 31, 2026 to June 30, 2026 of ($0.05); plus dividends declared of $0.36 per common share; divided by the March 31, 2026 book value per common share of $8.08.

Key performance indicators for the quarters ended September 30, 2026 and June 30, 2026 are summarized in the table below.

$ in millions, except share amounts

Q3 2026

Q2 2026

Variance

Average Balances (1)

(unaudited)

(unaudited)

Average earning assets (at amortized cost)

$7,574.3

$6,631.0

$943.3

Average borrowings

$6,754.7

$5,927.7

$827.0

Average total stockholders' equity

$973.6

$966.9

$6.7

U.S. GAAP Financial Measures

Total interest income

$99.0

$85.4

$13.6

Total interest expense

$65.0

$55.3

$9.7

Net interest income

$33.9

$30.1

$3.8

Total expenses

$5.2

$5.5

($0.3)

Net income (loss) attributable to common stockholders

($98.8)

$31.8

($130.6)

Average earning asset yields

5.23 %

5.15 %

0.08 %

Average cost of funds

3.85 %

3.73 %

0.12 %

Average net interest rate margin

1.38 %

1.42 %

(0.04) %

Period-end weighted average asset yields (2)

5.28 %

5.29 %

(0.01) %

Period-end weighted average cost of funds

3.97 %

3.76 %

0.21 %

Period-end weighted average net interest rate margin

1.31 %

1.53 %

(0.22) %

Book value per common share (3)

$6.74

$8.03

($1.29)

Earnings (loss) per common share (basic)

($0.92)

$0.34

($1.26)

Earnings (loss) per common share (diluted)

($0.92)

$0.34

($1.26)

Debt-to-equity ratio

          7.6x 

          6.3x 

          1.3x 

Non-GAAP Financial Measures (4)

Earnings available for distribution

$50.3

$47.1

$3.2

Effective interest expense

$45.1

$34.6

$10.5

Effective net interest income

$53.9

$50.9

$3.0

Effective cost of funds

2.67 %

2.33 %

0.34 %

Effective interest rate margin

2.56 %

2.82 %

(0.26) %

Earnings available for distribution per common share

$0.47

$0.50

($0.03)

Economic debt-to-equity ratio

          8.3x 

          7.5x 

          0.8x 

(1) Average earning assets, average borrowings and average total stockholders' equity are calculated based on the weighted month-end balances of mortgage-backed securities at amortized cost, repurchase agreement borrowings and total U.S. GAAP stockholders' equity, respectively.

(2) Period-end weighted average asset yields are based on amortized cost as of period-end and incorporate future prepayment assumptions when appropriate.

(3) Book value per common share is calculated as total stockholders' equity less the liquidation preference of the Company's Series C Preferred Stock ($168.1 million as of September 30, 2026 and $168.6 million as of June 30, 2026), divided by total common shares outstanding.

(4) Earnings available for distribution (and by calculation, earnings available for distribution per common share), effective interest expense (and by calculation, effective cost of funds), effective net interest income (and by calculation, effective interest rate margin), and economic debt-to-equity ratio are non-GAAP financial measures. Refer to the section entitled "Non-GAAP Financial Measures" for important disclosures and a reconciliation to the most comparable U.S. GAAP measures of net income (loss) attributable to common stockholders (and by calculation, basic earnings (loss) per common share), total interest expense (and by calculation, cost of funds), net interest income (and by calculation, net interest rate margin) and debt-to-equity ratio.

Portfolio Composition

The following table summarizes certain characteristics of the Company's investment portfolio including TBAs as of September 30, 2026 and June 30, 2026.

As of

September 30, 2026

June 30, 2026

$ in thousands

Fair Value

Percentage of
Portfolio

Period-end
Weighted
Average Yield (1)

Fair Value

Percentage
of Portfolio

Period-end
Weighted
Average
Yield (1)

Agency RMBS:

30 year fixed-rate pass-through coupon:

2.5 %

39,229

0.5 %

4.42 %

—

— %

— %

3.0 %

141,913

1.8 %

4.54 %

—

— %

— %

4.5 %

1,180,562

14.8 %

4.87 %

1,257,214

15.4 %

4.87 %

5.0 %

1,996,091

25.1 %

5.20 %

1,590,480

19.5 %

5.18 %

5.5 %

1,958,635

24.6 %

5.48 %

1,901,626

23.4 %

5.47 %

6.0 %

1,309,387

16.4 %

5.91 %

1,234,309

15.1 %

5.91 %

Total 30 year fixed-rate pass-through

6,625,817

83.2 %

5.34 %

5,983,629

73.4 %

5.36 %

Agency CMO

—

— %

— %

64,386

0.8 %

8.83 %

Agency CMBS

681,179

8.5 %

4.68 %

901,894

11.1 %

4.62 %

Subtotal

7,306,996

91.7 %

5.28 %

6,949,909

85.3 %

5.29 %

TBAs, at implied market value (2)

Agency TBA coupon:

5.0 %

—

— %

542,191

6.6 %

5.5 %

157,748

2.0 %

251,228

3.1 %

6.0 %

441,847

5.5 %

407,603

5.0 %

6.5 %

60,299

0.8 %

—

— %

Total Agency TBAs

659,894

8.3 %

1,201,022

14.7 %

Total investment portfolio including TBAs

7,966,890

100.0 %

8,150,931

100.0 %

(1) Period-end weighted average yield is based on amortized cost as of September 30, 2026 and June 30, 2026 and incorporates future prepayment assumptions when appropriate.

(2) The presentation of TBAs in the table above represents management's view of the investment portfolio and does not reflect how the Company records TBAs on its condensed consolidated balance sheets under U.S. GAAP. Under U.S. GAAP, the Company records TBAs that it does not intend to settle on the contractual settlement date as derivative financial instruments. The Company values TBAs on its condensed consolidated balance sheets at net carrying value, which represents the difference between implied market value and implied cost basis of the TBAs.

The following table summarizes certain characteristics of the Company's borrowings as of September 30, 2026 and June 30, 2026.

As of

$ in thousands

September 30, 2026

June 30, 2026

Amount
Outstanding

Weighted
Average
Interest Rate

Weighted
Average
Remaining
Maturity (days)

Amount
Outstanding

Weighted
Average
Interest Rate

Weighted
Average
Remaining
Maturity (days)

Repurchase agreements - Agency
RMBS

6,182,973

3.97 %

19

5,352,131

3.76 %

26

Repurchase agreements - Agency
CMBS

659,974

4.00 %

26

858,272

3.76 %

23

Total borrowings

6,842,947

3.97 %

20

6,210,403

3.76 %

25

The following tables summarize certain characteristics of the Company's interest rate swaps whereby the Company pays fixed interest rates and receives floating interest rates based on the secured overnight financing rate as of September 30, 2026 and June 30, 2026.

$ in thousands

As of September 30, 2026

Maturities

Notional

Amount

Weighted
Average Fixed
Pay Rate

Weighted
Average Floating
Receive Rate

Weighted
Average Years to
Maturity

Less than 3 years

1,200,000

1.52 %

3.90 %

1.6

3 to 5 years

1,330,000

1.58 %

3.90 %

4.1

5 to 7 years

600,000

3.71 %

3.90 %

6.4

7 to 10 years

925,000

4.16 %

3.90 %

9.3

Greater than 10 years

1,130,000

3.62 %

3.90 %

18.9

Total

5,185,000

2.72 %

3.90 %

7.9

$ in thousands

As of June 30, 2026

Maturities

Notional

Amount

Weighted
Average Fixed
Pay Rate

Weighted
Average Floating
Receive Rate

Weighted
Average Years to
Maturity

Less than 3 years

1,925,000

1.28 %

3.68 %

1.7

3 to 5 years

1,150,000

1.14 %

3.68 %

4.2

5 to 7 years

545,000

3.66 %

3.68 %

6.6

7 to 10 years

595,000

3.98 %

3.68 %

9.2

Greater than 10 years

550,000

2.44 %

3.68 %

20.5

Total

4,765,000

1.99 %

3.68 %

6.0

The following table summarizes certain characteristics of the Company's U.S. Treasury futures contracts as of September 30, 2026 and June 30, 2026.

As of

September 30, 2026

June 30, 2026

$ in thousands

Notional Amount - Short

Notional Amount - Short

10 year U.S. Treasury futures

740,000

600,000

Ultra 10 year U.S. Treasury futures

525,000

375,000

30 year U.S. Treasury futures

340,000

305,000

Total

1,605,000

1,280,000

Capital Activities

Dividends

During the three months ended September 30, 2026, the Company declared monthly common stock dividends totaling $0.36 per share and a Series C Preferred Stock dividend of $0.46875 per share.

Issuances of Common Stock

During the three months ended September 30, 2026, the Company issued 6,706,923 shares of common stock for net proceeds of $51.0 million through its at-the-market program.

Repurchases of Preferred Stock

During the three months ended September 30, 2026, the Company repurchased and retired 17,415 shares of Series C Preferred Stock with a carrying value of $421,000.

About Invesco Mortgage Capital Inc.

The Company is a real estate investment trust that primarily focuses on investing in, financing and managing mortgage-backed securities and other mortgage-related assets. The Company is externally managed and advised by Invesco Advisers, Inc., a registered investment adviser and an indirect wholly-owned subsidiary of Invesco Ltd., an independent global investment management firm.

Earnings Call

Members of the investment community and the general public are invited to listen to the Company's earnings conference call on Friday, October 30, 2026, at 9:00 a.m. ET, by calling one of the following numbers:

North America Toll Free: 

888-982-7409

International: 

1-212-287-1625

Passcode: 

Invesco

An audio replay will be available until 5:00 p.m. ET on November 13, 2026 by calling:

866-363-1806 (North America) or 1-203-369-0194 (International)

The presentation slides that will be reviewed during the call will be available on the Company's website at www.invescomortgagecapital.com. In addition, investors and others should note that the Company may announce material information to the public about the Company, the Company's plans, and the Company's financial performance and outlook through a variety of means, including the Company's website, press releases, SEC filings, and social media at www.linkedin.com/company/invesco-mortgage-capital-inc. in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information made public in such locations as such information could be deemed to be material information.

Cautionary Notice Regarding Forward-Looking Statements

This press release, the related presentation and comments made in the associated conference call, may include statements and information that constitute "forward-looking statements" within the meaning of the U.S. securities laws as defined in the Private Securities Litigation Reform Act of 1995, and such statements are intended to be covered by the safe harbor provided by the same. Forward-looking statements include our views on the risk positioning of our portfolio, domestic and global market conditions (including the Agency RMBS, Agency CMBS and residential and commercial real estate markets), the market for our target assets, our expected financial performance, including our earnings available for distribution, economic return, comprehensive income and changes in our book value, our intention and ability to pay dividends, our ability to continue performance trends, the stability of portfolio yields, interest rates, spreads, prepayment trends, financing sources, cost of funds, our anticipated leverage, liquidity, capital structure and equity allocation. In addition, words such as "believes," "expects," "anticipates," "intends," "plans," "estimates," "projects," "forecasts," and future or conditional verbs such as "will," "may," "could," "should," and "would" as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements.

Forward-looking statements are not guarantees, and they involve risks, uncertainties and assumptions. There can be no assurance that actual results will not differ materially from our expectations. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks identified under the captions "Risk Factors," "Forward-Looking Statements" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our annual report on Form 10-K for the year ended December 31, 2025, which may be updated by subsequently filed quarterly reports on Form 10-Q or current reports on Form 8-K, which are available on the Securities and Exchange Commission's website at www.sec.gov.

All written or oral forward-looking statements that we make, or that are attributable to us, are expressly qualified by this cautionary notice. We expressly disclaim any obligation to update the information in any public disclosure if any forward-looking statement later turns out to be inaccurate.

INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

Three Months Ended

Nine Months Ended

$ in thousands, except share data

September 30,
2026

June 30,
2026

September 30,
2025

September 30,
2026

September 30,
2025

Interest income

98,961

85,408

72,916

264,010

217,386

Interest expense

65,035

55,308

55,302

172,936

163,222

Net interest income

33,926

30,100

17,614

91,074

54,164

Other income (loss)

Gain (loss) on investments, net

(402,062)

(21,226)

49,540

(478,228)

126,430

Gain (loss) on derivative instruments, net

277,682

31,584

(9,218)

322,145

(116,813)

Total other income (loss)

(124,380)

10,358

40,322

(156,083)

9,617

Expenses

Management fee – related party

3,626

3,329

2,662

9,929

8,489

General and administrative

1,557

2,125

1,803

5,599

5,507

Total expenses

5,183

5,454

4,465

15,528

13,996

Net income (loss)

(95,637)

35,004

53,471

(80,537)

49,785

Dividends to preferred stockholders

(3,153)

(3,165)

(3,261)

(9,508)

(9,899)

Gain (loss) on repurchase and retirement of preferred stock

(7)

3

(2)

(31)

44

Net income (loss) attributable to common stockholders

(98,797)

31,842

50,208

(90,076)

39,930

Other comprehensive income (loss)

Unrealized gain (loss) on mortgage-backed securities, net

—

—

—

—

229

Reclassification of unrealized (gain) loss on sale of mortgage-
backed securities to gain (loss) on investments, net

—

—

—

—

(402)

Total other comprehensive income (loss)

—

—

—

—

(173)

Comprehensive income (loss) attributable to common
stockholders

(98,797)

31,842

50,208

(90,076)

39,757

Earnings (loss) per share

Net income (loss) attributable to common stockholders

Basic

(0.92)

0.34

0.74

(0.95)

0.61

Diluted

(0.92)

0.34

0.74

(0.95)

0.61

INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

As of

$ in thousands, except share amounts

September 30, 2026

December 31, 2025

ASSETS

Mortgage-backed securities, at fair value (including pledged securities of $7,120,811 and
     $5,879,318, respectively)

7,306,996

6,276,609

Cash and cash equivalents

215,078

56,040

Restricted cash

211,453

110,391

Due from counterparties

13,648

—

Investment related receivable

33,099

27,848

Derivative assets, at fair value

13,845

4,412

Other assets

684

594

Total assets

7,794,803

6,475,894

LIABILITIES AND STOCKHOLDERS' EQUITY

Liabilities:

Repurchase agreements

6,842,947

5,619,255

Derivative liabilities, at fair value

15,491

—

Dividends payable

13,092

25,845

Accrued interest payable

13,791

28,664

Accounts payable and accrued expenses

2,212

1,580

Due to affiliate

3,902

3,006

Total liabilities

6,891,435

5,678,350

Stockholders' equity:

Preferred Stock, par value $0.01 per share; 50,000,000 shares authorized:

7.50% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock: 6,724,806 and
     6,854,131 shares issued and outstanding, respectively ($168,120 and $171,353 aggregate
     liquidation preference, respectively)

162,628

165,756

Common Stock, par value $0.01 per share; 134,000,000 shares authorized; 109,103,682 and
     71,790,532 shares issued and outstanding, respectively

1,091

718

Additional paid in capital

4,512,341

4,209,977

Retained earnings (distributions in excess of earnings)

(3,772,692)

(3,578,907)

Total stockholders' equity

903,368

797,544

Total liabilities and stockholders' equity

7,794,803

6,475,894

Non-GAAP Financial Measures

The table below shows the non-GAAP financial measures the Company uses to analyze its operating results and the most directly comparable U.S. GAAP measures. The Company believes these non-GAAP measures are useful to investors in assessing its performance as discussed further below.

Non-GAAP Financial Measure

Most Directly Comparable U.S. GAAP Measure

Earnings available for distribution (and by calculation,
earnings available for distribution per common share)

Net income (loss) attributable to common stockholders (and by
calculation, basic earnings (loss) per common share)

Effective interest expense (and by calculation, effective cost of
funds)

Total interest expense (and by calculation, cost of funds)

Effective net interest income (and by calculation, effective
interest rate margin)

Net interest income (and by calculation, net interest rate
margin)

Economic debt-to-equity ratio

Debt-to-equity ratio

The non-GAAP financial measures used by the Company's management should be analyzed in conjunction with U.S. GAAP financial measures and should not be considered substitutes for U.S. GAAP financial measures. In addition, the non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures of its peer companies.

Earnings Available for Distribution

The Company's business objective is to provide attractive risk-adjusted returns to its stockholders, primarily through dividends and secondarily through capital appreciation. The Company uses earnings available for distribution as a measure of its investment portfolio's ability to generate income for distribution to common stockholders and to evaluate its progress toward meeting this objective. The Company calculates earnings available for distribution as U.S. GAAP net income (loss) attributable to common stockholders adjusted for (gain) loss on investments, net; realized (gain) loss on derivative instruments, net; unrealized (gain) loss on derivative instruments, net; TBA dollar roll income and (gain) loss on repurchase and retirement of preferred stock. The Company may add and has added additional reconciling items to its earnings available for distribution calculation as appropriate.

By excluding the gains and losses discussed above, the Company believes the presentation of earnings available for distribution provides a consistent measure of operating performance that investors can use to evaluate its results over multiple reporting periods and, to a certain extent, compare to its peer companies. However, because not all of the Company's peer companies use identical operating performance measures, the Company's presentation of earnings available for distribution may not be comparable to other similarly titled measures used by its peer companies. The Company excludes the impact of gains and losses when calculating earnings available for distribution because when analyzed in conjunction with its U.S. GAAP results, earnings available for distribution provides additional detail of its investment portfolio's earnings capacity. In addition, certain gains and losses represent one-time events.

Furthermore, gains and losses have not been accounted for consistently under U.S. GAAP. Under U.S. GAAP, certain gains and losses may be reflected in net income whereas other gains and losses may be reflected in other comprehensive income. For example, a portion of the Company's mortgage-backed securities were historically classified as available-for-sale securities, and changes in the valuation of these securities were recorded in other comprehensive income on its condensed consolidated balance sheets. The Company elected the fair value option for its mortgage-backed securities purchased on or after September 1, 2016, and changes in the valuation of these securities are recorded in other income (loss) in the condensed consolidated statements of comprehensive income (loss).

To maintain qualification as a REIT, U.S. federal income tax law generally requires that the Company distribute at least 90% of its REIT taxable income annually. Because the Company views earnings available for distribution as a consistent measure of its investment portfolio's ability to generate income for distribution to common stockholders, earnings available for distribution is one metric, but not the exclusive metric, that is used to determine the amount, if any, of dividends on common stock. However, earnings available for distribution should not be considered as an indication of the Company's taxable income, a guaranty of its ability to pay dividends or as a proxy for the amount of dividends it may pay, as earnings available for distribution excludes certain items that impact its cash needs.

Earnings available for distribution is an incomplete measure of the Company's financial performance and there are other factors that impact the achievement of the Company's business objective. The Company cautions that earnings available for distribution should not be considered as an alternative to net income (determined in accordance with U.S. GAAP), or as an indication of the Company's cash flow from operating activities (determined in accordance with U.S. GAAP), a measure of the Company's liquidity, or as an indication of amounts available to fund its cash needs.

The table below provides a reconciliation of U.S. GAAP net income (loss) attributable to common stockholders to earnings available for distribution for the following periods:

Three Months Ended

Nine Months Ended

$ in thousands, except per share data

September 30,
2026

June 30,
2026

September 30,
2025

September 30,
2026

September 30,
2025

Net income (loss) attributable to common stockholders

(98,797)

31,842

50,208

(90,076)

39,930

Adjustments:

(Gain) loss on investments, net

402,062

21,226

(49,540)

478,228

(126,430)

Realized (gain) loss on derivative instruments, net (1)

(275,006)

32,412

49,189

(265,918)

198,313

Unrealized (gain) loss on derivative instruments, net (1)

17,274

(43,239)

(10,833)

6,058

4,348

TBA dollar roll income (2)

4,755

4,857

—

13,778

1,147

(Gain) loss on repurchase and retirement of preferred
stock

7

(3)

2

31

(44)

Subtotal

149,092

15,253

(11,182)

232,177

77,334

Earnings available for distribution

50,295

47,095

39,026

142,101

117,264

Basic income (loss) per common share

(0.92)

0.34

0.74

(0.95)

0.61

Earnings available for distribution per common share (3)

0.47

0.50

0.58

1.50

1.79

(1)

U.S. GAAP gain (loss) on derivative instruments, net on the condensed consolidated statements of comprehensive income (loss) includes the following components:

Three Months Ended

Nine Months Ended

$ in thousands

September 30,
2026

June 30,
2026

September 30,
2025

September 30,
2026

September 30,
2025

Realized gain (loss) on derivative instruments, net

275,006

(32,412)

(49,189)

265,918

(198,313)

Unrealized gain (loss) on derivative instruments, net

(17,274)

43,239

10,833

(6,058)

(4,348)

Contractual net interest income (expense) on interest
rate swaps

19,950

20,757

29,138

62,285

85,848

Gain (loss) on derivative instruments, net

277,682

31,584

(9,218)

322,145

(116,813)

(2)

A TBA dollar roll is a series of derivative transactions where TBAs with the same specified issuer, term and coupon but different settlement dates are simultaneously bought and sold. The TBA settling in the later month typically prices at a discount to the TBA settling in the earlier month. TBA dollar roll income represents the price differential between the TBA price for current month settlement compared to the TBA price for forward month settlement. The Company includes TBA dollar roll income in earnings available for distribution because it is the economic equivalent of interest income on the underlying Agency RMBS, less an implied financing cost, over the forward settlement period. TBA dollar roll income is a component of gain (loss) on derivative instruments, net on the Company's condensed consolidated statements of comprehensive income (loss).

(3)

Earnings available for distribution per common share is equal to earnings available for distribution divided by the basic weighted average number of common shares outstanding.

The table below presents the components of earnings available for distribution for the following periods:

Three Months Ended

Nine Months Ended

$ in thousands

September 30,
2026

June 30,
2026

September 30,
2025

September 30,
2026

September 30,
2025

Effective net interest income (1)

53,876

50,857

46,752

153,359

140,012

TBA dollar roll income

4,755

4,857

—

13,778

1,147

Total expenses

(5,183)

(5,454)

(4,465)

(15,528)

(13,996)

Subtotal

53,448

50,260

42,287

151,609

127,163

Dividends to preferred stockholders

(3,153)

(3,165)

(3,261)

(9,508)

(9,899)

Earnings available for distribution

50,295

47,095

39,026

142,101

117,264

(1)

See below for a reconciliation of net interest income to effective net interest income, a non-GAAP measure.

Effective Interest Expense/Effective Cost of Funds/Effective Net Interest Income/Effective Interest Rate Margin

The Company calculates effective interest expense (and by calculation, effective cost of funds) as U.S. GAAP total interest expense adjusted for contractual net interest income (expense) on its interest rate swaps that is recorded as gain (loss) on derivative instruments, net. The Company views its interest rate swaps as an economic hedge against increases in future market interest rates on its borrowings. The Company adds back the net payments or receipts on its interest rate swap agreements to its total U.S. GAAP interest expense because the Company uses interest rate swaps to add stability to interest expense.

The Company calculates effective net interest income (and by calculation, effective interest rate margin) as U.S. GAAP net interest income adjusted for contractual net interest income (expense) on its interest rate swaps that is recorded as gain (loss) on derivative instruments, net.

The Company believes the presentation of effective interest expense, effective cost of funds, effective net interest income and effective interest rate margin measures, when considered together with U.S. GAAP financial measures, provides information that is useful to investors in understanding the Company's borrowing costs and operating performance.

The following tables reconcile total interest expense to effective interest expense and cost of funds to effective cost of funds for the following periods:

Three Months Ended

September 30, 2026

June 30, 2026

September 30, 2025

$ in thousands

Reconciliation

Cost of Funds /
Effective
Cost of Funds

Reconciliation

Cost of Funds
/ Effective
Cost of Funds

Reconciliation

Cost of Funds
/ Effective
Cost of Funds

Total interest expense

65,035

3.85 %

55,308

3.73 %

55,302

4.52 %

Less: Contractual net interest expense
     (income) on interest rate swaps
     recorded as gain (loss) on derivative
     instruments, net

(19,950)

(1.18) %

(20,757)

(1.40) %

(29,138)

(2.38) %

Effective interest expense

45,085

2.67 %

34,551

2.33 %

26,164

2.14 %

Nine Months Ended September 30,

2026

2025

$ in thousands

Reconciliation

Cost of Funds /
Effective
Cost of Funds

Reconciliation

Cost of Funds
/ Effective
Cost of Funds

Total interest expense

172,936

3.83 %

163,222

4.53 %

Less: Contractual net interest expense (income) on interest rate swaps
     recorded as gain (loss) on derivative instruments, net

(62,285)

(1.38) %

(85,848)

(2.39) %

Effective interest expense

110,651

2.45 %

77,374

2.14 %

The following tables reconcile net interest income to effective net interest income and net interest rate margin to effective interest rate margin for the following periods:

Three Months Ended

September 30, 2026

June 30, 2026

September 30, 2025

$ in thousands

Reconciliation

Net Interest
Rate Margin /
Effective
Interest Rate
Margin

Reconciliation

Net Interest
Rate Margin /
Effective
Interest Rate
Margin

Reconciliation

Net Interest
Rate Margin /
Effective
Interest Rate
Margin

Net interest income

33,926

1.38 %

30,100

1.42 %

17,614

0.90 %

Add: Contractual net interest income
     (expense) on interest rate swaps
     recorded as gain (loss) on derivative
     instruments, net

19,950

1.18 %

20,757

1.40 %

29,138

2.38 %

Effective net interest income

53,876

2.56 %

50,857

2.82 %

46,752

3.28 %

Nine Months Ended September 30,

2026

2025

$ in thousands

Reconciliation

Net Interest
Rate Margin /
Effective
Interest Rate
Margin

Reconciliation

Net Interest
Rate Margin /
Effective
Interest Rate
Margin

Net interest income

91,074

1.41 %

54,164

0.94 %

Add: Contractual net interest income (expense) on interest rate swaps
     recorded as gain (loss) on derivative instruments, net

62,285

1.38 %

85,848

2.39 %

Effective net interest income

153,359

2.79 %

140,012

3.33 %

Economic Debt-to-Equity Ratio

The following table shows the Company's debt-to-equity ratio and the Company's economic debt-to-equity ratio as of September 30, 2026 and June 30, 2026. The Company's debt-to-equity ratio is calculated in accordance with U.S. GAAP and is the ratio of total debt to total stockholders' equity.

The Company presents an economic debt-to-equity ratio, a non-GAAP financial measure of leverage that considers the impact of the off-balance sheet financing of its investments in TBAs that are accounted for as derivative instruments under U.S. GAAP and the impact of receivables and payables for unsettled trades (if any). The Company includes these types of TBAs at implied cost basis in its measure of leverage because a forward contract to acquire Agency RMBS in the TBA market carries similar risks to Agency RMBS purchased in the cash market and funded with on-balance sheet liabilities. Similarly, a contract for the forward sale of Agency RMBS has substantially the same effect as selling the underlying Agency RMBS and reducing the Company's on-balance sheet funding commitments. The Company adjusts leverage for receivables and payables for unsettled trades (if any) because sales or purchases of MBS are recorded on the balance sheet on the trade date, while any corresponding changes to repurchase agreement borrowings are not recorded until the settlement date. The Company believes that presenting its economic debt-to-equity ratio, when considered together with its U.S. GAAP financial measure of debt-to-equity ratio, provides information that is useful to investors in understanding how management evaluates at-risk leverage and gives investors a comparable statistic to those of other mortgage REITs who present a similar non-GAAP measure of leverage.

As of

$ in thousands

September 30,
2026

June 30,
2026

Repurchase agreements

6,842,947

6,210,403

Total stockholders' equity

903,368

990,321

Debt-to-equity ratio (1)

7.6

6.3

Economic debt-to-equity ratio (2)

8.3

7.5

(1)

Debt-to-equity ratio is calculated as the ratio of total repurchase agreements to total stockholders' equity.

(2)

Economic debt-to-equity ratio is calculated as the ratio of (i) the sum of total repurchase agreement borrowings and TBAs at implied cost basis ($674.1 million as of September 30, 2026; $1.2 billion as of June 30, 2026) to (ii) total stockholders' equity.

Average Balances

The table below presents information related to the Company's average earning assets, average earning asset yields, average borrowings and average cost of funds for the following periods:

Three Months Ended

Nine Months Ended

$ in thousands

September 30,
2026

June 30,
2026

September 30,
2025

September 30,
2026

September 30,
2025

Average earning assets (1)

7,574,311

6,631,046

5,382,189

6,723,237

5,294,406

Average earning asset yields (2)

5.23 %

5.15 %

5.42 %

5.24 %

5.47 %

Average borrowings (3)

6,754,709

5,927,725

4,889,782

6,021,714

4,799,047

Average cost of funds (4)

3.85 %

3.73 %

4.52 %

3.83 %

4.53 %

(1)

Average balances for each period are based on weighted month-end balances. Average earning assets do not include TBAs that are treated as derivative instruments under U.S. GAAP.

(2)

Average earning asset yields for each period are calculated by dividing interest income, including amortization of premiums and discounts, by average earning assets based on the amortized cost of the investments. All yields are annualized.

(3)

Average borrowings for each period are based on weighted month-end balances. Average borrowings do not include the off-balance sheet financing component of TBAs that are treated as derivative instruments under U.S. GAAP.

(4)

Average cost of funds is calculated by dividing annualized interest expense by average borrowings.

Greg Seals,
Investor Relations
404-439-3323

SOURCE Invesco Mortgage Capital Inc.
2026-10-29 22:06 2d ago
2026-10-29 17:29 2d ago
Meritage Homes Corporation (MTH) Q3 2026 Earnings Call Transcript
MTH Meritage
FMP Stock News
Original source text
Meritage Homes Corporation (MTH) Q3 2026 Earnings Call October 29, 2026 11:00 AM EDT

Company Participants

Emily Tadano - Vice President of Investor Relations & ESG
Steven Hilton - Executive Chairman
Phillippe Lord - CEO, Executive VP & Director
Hilla Sferruzza - CFO & Executive VP

Conference Call Participants

Trevor Allinson - Wolfe Research, LLC
Alan Ratner - Zelman & Associates LLC
Stephen Kim - Evercore ISI Institutional Equities, Research Division
John Lovallo - UBS Investment Bank, Research Division
Susan Maklari - Goldman Sachs Group, Inc., Research Division
Rafe Jadrosich - BofA Securities, Research Division
Jonathan Bettenhausen - Truist Securities, Inc., Research Division
Michael Rehaut - Melius Research LLC
Jay McCanless - Citizens JMP Securities, LLC, Research Division

Presentation

Operator

Greetings, and welcome to the Third Quarter 2026 Meritage Homes Analyst Call. [Operator Instructions] Please be advised that today's conference is being recorded.

[Operator Instructions] I would now like to turn the call over to Emily Tadano, VP of Investor Relations and External Communications. Please go ahead.

Emily Tadano
Vice President of Investor Relations & ESG

Thank you, operator. Good morning, and welcome to our analyst call to discuss our third quarter 2026 results. We issued the press release yesterday after the market closed. You can find it along with the slides we'll refer to during this call on our website at investors.meritagehomes.com or by selecting the Investor Relations link at the bottom of our homepage.

Please refer to Slide 2, cautioning you that our statements during this call as well as in the earnings release and accompanying slides contain forward-looking statements. Those and any other projections represent the current opinions of management, which are subject to change at any time, and we assume no obligation to update them. Any forward-looking statements are inherently uncertain. Our actual results may be materially different than our expectations due to a wide variety of risk factors, which we have
2026-10-29 22:06 2d ago
2026-10-29 16:15 2d ago
CNO Financial Group Reports Third Quarter 2026 Results
CNO CNO Financial Group
FMP Stock News
Original source text
, /PRNewswire/ -- CNO Financial Group, Inc. (NYSE: CNO) today reported its third quarter 2026 financial results:

Raising 2026 operating earnings per share (EPS) guidance with the midpoint up 9% from our prior guidance.Net income was $161 million, or $1.71 per diluted share, and net operating income(1)  was $179 million, or $1.90 per diluted share. Significant items related to the comprehensive annual actuarial review had a $44.9 million net favorable impact on both net income and net operating income.Operating EPS grew 47% in the quarter and 43% year-to-date.Return on equity (ROE) of 16.4%; Operating ROE(5) of 14.1%, excluding significant items(5).Book value per share of $25.34; Book value per diluted share, excluding accumulated other comprehensive loss,(2) of $41.29, up 8%.Total new annualized premiums (NAP)(4) up for a 17th consecutive quarter; Continued growth in asset accumulation products.Consumer and Worksite delivered their 15th and 17th consecutive quarters of producing agent count growth, respectively.On October 1, 2026, closed a 3rd reinsurance transaction with CNO's wholly owned Bermuda affiliate, reinsuring approximately $270 million of inforce graded benefit life statutory reserves from Colonial Penn."CNO delivered an excellent quarter, with operating earnings per share up 47% and our 17th consecutive quarter of sales growth," said Gary C. Bhojwani, chief executive officer.

"Our momentum reflects disciplined execution across the business and continued improvement in profitability. Based on these results, we are raising our full-year operating earnings per share guidance. We also executed our 3rd reinsurance transaction with our Bermuda affiliate, supporting our focus on serving middle-income households. We remain committed to driving sustained, profitable growth and creating long-term value for our shareholders."

FINANCIAL SUMMARY
Quarter End
(Amounts in millions, except per share data)
(Unaudited)

Net operating income, a non-GAAP(a) financial measure, is used consistently by CNO's management to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes the non-operating items as defined in note (1), which are primarily non-economic accounting impacts and other non-operating items.  Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company's business.  Net income is the most directly comparable GAAP measure.

Significant items positively impacted both net income and net operating income(1) by $44.9 million, or $0.48 per diluted share, in 3Q26 compared to $32.2 million, or $0.33 per diluted share, in 3Q25.  Significant items are detailed in note (6).

Per diluted share

Quarter ended

Quarter ended

September 30,

September 30,

2026

2025

% change

2026

2025

% change

Income from insurance products (b)

$       1.83

$        1.52

20 %

$   172.0

$  149.5

15 %

Fee income

(0.01)

(0.04)

(75)

(1.1)

(3.9)

(72)

Investment income not allocated to product lines (c)

0.72

0.40

80

68.1

39.5

72

Expenses not allocated to product lines

(0.20)

(0.23)

(13)

(18.8)

(22.3)

(16)

Operating earnings before taxes

2.34

1.65

220.2

162.8

Income tax expense on operating income

(0.44)

(0.36)

22

(41.1)

(35.6)

15

Net operating income (1)

1.90

1.29

47

179.1

127.2

41

Net realized investment losses from disposals,
impairments and change in allowance for credit losses

(0.51)

(0.09)

(48.3)

(8.8)

Net change in market value of investments
recognized in earnings

(0.17)

0.06

(16.4)

5.8

Changes in fair value of embedded derivative
liabilities and market risk benefits

0.74

(0.18)

69.7

(18.1)

Expenses related to TechMod initiative

(0.11)

(0.07)

(10.1)

(7.2)

Goodwill and other asset impairment

—

(0.98)

—

(96.7)

Other

0.11

(0.02)

11.3

(1.6)

Non-operating income before taxes

0.06

(1.28)

6.2

(126.6)

Income tax expense:

On non-operating income

(0.02)

0.23

(2.1)

22.5

Valuation allowance for deferred tax assets

(0.23)

—

(22.1)

—

     Net non-operating income

(0.19)

(1.05)

(18.0)

(104.1)

Net income

$       1.71

$       0.24

$   161.1

$    23.1

Weighted average diluted shares outstanding

94.3

98.6

(a)

GAAP is defined as accounting principles generally accepted in the United States of America.

(b)

  Income from insurance products is the sum of the insurance product margins of the annuity, health and life product lines, less expenses allocated to the insurance product lines.  It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Insurance product margin is management's measure of the profitability of its annuity, health and life product lines' performance and consists of insurance policy income plus allocated investment income less insurance policy benefits, interest credited, commissions, advertising expense and amortization of acquisition costs.

(c)

  Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable, investment borrowings and financing arrangements; (iv) expenses related to the funding agreement-backed notes ("FABN")  program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders. Investment income not allocated to product lines includes investment income on investments in excess of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our Federal Home Loan Bank ("FHLB") investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from company-owned life insurance ("COLI") and alternative investment income not allocated to product lines), net of interest expense on corporate debt and financing arrangements. The spread earned from our FHLB investment borrowing and FABN programs includes the investment income on the matched assets less: (i) interest on investment borrowings related to the FHLB investment borrowing program; (ii) interest credited on funding agreements; and (iii) amortization of deferred acquisition costs related to the FABN program.

FINANCIAL SUMMARY (continued)
Management vs. GAAP Measures
(Dollars in millions, except per share data)
(Unaudited)

Shareholders' equity, excluding accumulated other comprehensive income (loss), and book value per share, excluding accumulated other comprehensive income (loss), are non-GAAP measures that are utilized by management to view the business without the effect of accumulated other comprehensive income (loss) which is primarily attributable to fluctuations in interest rates associated with fixed maturities, available for sale.  Management views the business in this manner because the Company has the ability and generally, the intent, to hold investments to maturity and meaningful trends can be more easily identified without the fluctuations.  In addition, shareholders' equity excludes net operating loss carryforwards in our non-GAAP return on equity measures as such assets are not discounted and, accordingly, will not provide a return to shareholders until after it is realized as a reduction to taxes that would otherwise be paid.  Management believes that excluding this value from the equity component of this measure enhances the understanding of the effect these non-discounted assets have on operating returns.

___________________________________________________________________________________________________ 

Quarter ended

September 30,

2026

2025

Trailing four quarters:

Net Income

$     417.6

$     319.3

Net operating income (a non-GAAP financial measure)

543.3

433.8

Net operating income, excluding significant items (a non-GAAP financial measure)

498.4

399.4

Average of each of the trailing four quarters average:

Shareholders' equity

$   2,548.9

$   2,560.6

Accumulated other comprehensive loss

1,211.9

1,245.2

Shareholders' equity, excluding accumulated other comprehensive loss

3,760.8

3,805.8

Net operating loss carryforwards

(238.1)

(225.8)

Shareholders' equity, excluding accumulated other comprehensive loss and net operating loss
carryforwards

$   3,522.7

$   3,580.0

Ratios:

Return on equity

16.4 %

12.5 %

Operating return on equity (a non-GAAP financial measure) (5)

15.4 %

12.1 %

Operating return on equity, excluding significant items (a non-GAAP financial measure) (5)

14.1 %

11.2 %

Shareholders' equity

$     2,323.7

$     2,611.0

Accumulated other comprehensive loss

1,545.8

1,118.9

Shareholders' equity, excluding accumulated other comprehensive loss

$     3,869.5

$     3,729.9

Basic shares outstanding

91,705,509

95,840,989

Diluted shares outstanding

93,720,626

97,902,763

Book value per share

$       25.34

$       27.24

Book value per diluted share

$       24.79

$       26.67

Accumulated other comprehensive loss per diluted share

16.50

11.43

Book value per diluted share, excluding accumulated other comprehensive loss (a non-GAAP financial
measure) (2)

$       41.29

$       38.10

Non-Operating Items
Net realized investment losses in 3Q26 were $48.3 million, including the unfavorable change in the allowance for credit losses of $5.4 million. Net realized investment losses in 3Q25 were $8.8 million, including the favorable change in the allowance for credit losses of $8.0 million.

During 3Q26 and 3Q25, we recognized a decrease in earnings of $16.4 million and an increase of $5.8 million, respectively, due to the net change in market value of investments.

During 3Q26 and 3Q25, we recognized an increase in earnings of $69.7 million and a decrease of $18.1 million, respectively, resulting from changes in the estimated fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities.  Such amounts include the impacts of changes in market interest rates and equity impacts used to determine the estimated fair values of the embedded derivatives and market risk benefits and the unfavorable impact resulting from our comprehensive annual actuarial review of $11.2 million and $14.3 million in 3Q26 and 3Q25, respectively.

During 3Q26 and 3Q25, we incurred $10.1 million and $7.2 million, respectively, of expense related to TechMod, our technology modernization initiative that began in 2025.

During 3Q26, other non-operating items primarily included a $10.0 million mark-to-market change in the agent deferred compensation plan liability, which was impacted by changes in the underlying actuarial assumptions used to value the liability.  We recognize the mark-to-market change in the estimated value of this liability through earnings as assumptions change.

During 3Q25, we recognized a $96.7 million non-operating charge for the impairment of goodwill and other assets related to the acquisitions of Web Benefits Design and DirectPath in 2019 and 2021, respectively. This reflected macroeconomic uncertainty and market conditions including the decline in the value of comparable publicly traded companies and revised financial projections for the business.

During 3Q26, we recognized a $22.1 million valuation allowance on deferred tax assets associated with capital loss carryforwards. The valuation allowance reflects realized capital losses generated primarily from asset sales in anticipation of executing the internal reinsurance transaction on October 1, 2026, portfolio optimization activities, and from capital loss allocations from partnership investments together with a reduction in unrealized capital gains available to support realization of those losses as interest rates increased.

Statutory (based on non-GAAP measures) and GAAP Capital Information
The consolidated statutory risk-based capital ratio of our U.S. based insurance subsidiaries was estimated at 374% at September 30, 2026, reflecting estimated 3Q26 statutory operating gain of $21.9 million.  There were no company dividends paid to the holding company during 3Q26.

During 3Q26, we repurchased $60.0 million of common stock under our securities repurchase program.  We repurchased 1.1 million common shares at an average cost of $54.52 per share.  As of September 30, 2026, we had 91.7 million shares outstanding and had authority to repurchase up to an additional $240.4 million of our common stock.  During 3Q26, dividends paid on common stock totaled $16.5 million.

Unrestricted cash and investments held by our holding company were $230.7 million at September 30, 2026 compared to $351.4 million at December 31, 2025.

Book value per common share was $25.34 at September 30, 2026 compared to $27.92 at December 31, 2025.  Book value per diluted share, excluding accumulated other comprehensive income (loss) (2), was $41.29 at September 30, 2026 compared to $38.81 at December 31, 2025. 

The debt-to-capital ratio was 36.5% and 33.6% at September 30, 2026 and December 31, 2025, respectively.  Our debt-to-total capital ratio, excluding accumulated other comprehensive income (loss)(3), was 25.7% and 26.2% at September 30, 2026 and December 31, 2025, respectively. 

Return on equity for the trailing four quarters ended September 30, 2026 and 2025 was 16.4% and 12.5%, respectively.  Operating return on equity, excluding significant items(5), for the trailing four quarters ended September 30, 2026 and 2025 was 14.1% and 11.2%, respectively.

In this news release, CNO includes non-GAAP measures to enhance investors' understanding of management's view of the business.  The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing a broader perspective.  CNO's definitions of non-GAAP measures may differ from other companies' definitions.  More detailed information including various GAAP and non-GAAP measurements are located at CNOinc.com in the Investors section under SEC Filings.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements within the meaning of federal securities laws.  These prospective statements reflect management's current expectations, but are not guarantees of future performance.  Accordingly, please refer to CNO's cautionary statement regarding forward-looking statements, and the business environment in which the Company operates, contained in the Company's Form 10-K for the year ended December 31, 2025 and any subsequent Form 10-Q or Form 10-K on file with the Securities and Exchange Commission and on the Company's website at CNOinc.com in the Investors section.  CNO specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

EARNINGS RELEASE CONFERENCE CALL WEBCAST:

The Company will host a conference call to discuss results on October 30, 2026 at 11:00 a.m. Eastern Time.  During the call, we will be referring to a presentation that will be available at the Investors section of the company's website.

To participate by dial-in, please register at https://register-conf.media-server.com/register/BI92346cd8ec894d29bcfdf06f719c8513.
Upon registering, you will be provided with call details and a unique PIN to join the call as well as an email confirmation with details.

For those investors who prefer to listen to the call online, we will be broadcasting the call live via webcast.  The event can be accessed through the Investors section of the company's website: ir.CNOinc.com.  Participants should go to the website at least 15 minutes before the event to register and download any necessary audio software.

ABOUT CNO FINANCIAL GROUP

CNO Financial Group, Inc. (NYSE: CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities and financial services through our family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. Our customers work hard to save for the future, and we help protect their health, income and retirement needs with 3.3 million policies and $39.3 billion in total assets. Our 3,200 associates, 5,100 exclusive agents and more than 6,500 independent partner agents guide individuals, families and businesses through a lifetime of financial decisions. For more information, visit CNOinc.com.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF OPERATIONS

(Dollars in millions, except per share data)

(unaudited)

Three months ended

Nine months ended

September 30,

September 30,

2026

2025

2026

2025

Revenues:

Insurance policy income

$         688.2

$      658.4

$      2,042.3

$       1,960.4

Net investment income:

General account assets

441.5

382.9

1,248.4

1,136.3

Policyholder and other special-purpose portfolios

6.1

116.8

126.3

158.6

Investment gains (losses):

Realized investment losses

(32.6)

(12.9)

(49.0)

(38.0)

Other investment (losses) gains

(32.1)

9.9

(53.1)

9.8

Total investment losses

(64.7)

(3.0)

(102.1)

(28.2)

Fee revenue and other income

14.9

33.6

85.9

117.2

Total revenues

1,086.0

1,188.7

3,400.8

3,344.3

Benefits and expenses:

Insurance policy benefits

565.1

702.1

1,884.2

1,930.5

Liability for future policy benefits remeasurement gain

(52.5)

(30.8)

(74.3)

(55.8)

Change in fair value of market risk benefits

(28.8)

(12.4)

(26.4)

(8.0)

Interest expense

58.1

56.6

164.3

177.7

Amortization of deferred acquisition costs and present value of future
profits 

76.8

69.9

225.9

205.9

Goodwill and other asset impairment

—

96.7

—

96.7

Gain on extinguishment of borrowings related to variable interest
entities

—

—

—

(1.5)

Other operating costs and expenses

240.9

270.4

792.6

816.8

Total benefits and expenses

859.6

1,152.5

2,966.3

3,162.3

Income before income taxes

226.4

36.2

434.5

182.0

Income tax expense

65.3

13.1

109.8

45.6

Net income

$         161.1

$       23.1

$        324.7

$        136.4

Earnings per common share:

Basic:

Weighted average shares outstanding

92,195,000

96,603,000

93,156,000

98,639,000

Net income

$          1.75

$       0.24

$         3.49

$          1.38

Diluted:

Weighted average shares outstanding

94,253,000

98,553,000

95,115,000

100,670,000

Net income

$          1.71

$       0.24

$         3.41

$          1.36

NOTES

(1)

Management believes that an analysis of net income applicable to common stock before the following items (each net of tax, except as noted) is important to evaluate the financial performance of the Company, and is a key measure commonly used in the life insurance industry: (i) net realized investment gains or losses from disposals, impairments and the change in allowance for credit losses; (ii) net change in market value of investments recognized in earnings; (iii) changes in fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities; (iv) fair value changes related to the agent deferred compensation plan; (v) gains or losses related to material reinsurance transactions; (vi) loss on extinguishment of debt; (vii) changes in the valuation allowance for deferred tax assets and other tax items; (viii) costs related to our three-year project to modernize certain elements of our technology ("TechMod") that are incremental to normal spend and will not recur following implementation; (ix) goodwill and other asset impairment expenses; (x) gains or losses related to divested business; and (xi) other non-operating items including earnings attributable to variable interest entities (collectively, "net operating income," a non-GAAP financial measure). The income tax expense or benefit allocated to the items included in net non-operating income (loss) represents the current and deferred income tax expense or benefit allocated to the items included in non-operating earnings.  Management believes this information provides a better understanding of the business and a more meaningful analysis of results of our insurance product lines.  A reconciliation of net operating income to net income applicable to common stock is provided in the table on page 2.  Additional information concerning this non-GAAP measure is included in our periodic filings with the Securities and Exchange Commission that are available on CNO's website, CNOinc.com, in the Investors section under SEC Filings.

(2)

Book value per diluted share reflects the potential dilution that could occur if outstanding stock options were exercised and restricted stock and performance units were vested.  The dilution from options, restricted shares and performance units is calculated using the treasury stock method.  Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the closing market price on the last day of the period.  In addition, the calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure.  Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments.

(3)

The calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure.  Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments.

(4)

Measured by new annualized premiums for life and health products, which includes 10% of single premium whole life deposits and 100% of all other premiums (excluding annuities).  Sales of third-party products are excluded.

(5)

Operating return on equity and operating return on equity, excluding significant items are calculated as follows: (i) operating return on equity is equal to the trailing four quarters of net operating income(1) divided by average shareholders' equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards; and (ii) operating return on equity, excluding significant items is equal to the trailing four quarters of net operating income(1), excluding significant items, divided by average shareholders' equity, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards, for the trailing four quarters. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive loss.  Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. In addition, our equity includes the value of significant net operating loss carryforwards (included in income tax assets on our consolidated balance sheet). In accordance with GAAP, these assets are not discounted, and accordingly will not provide a return to shareholders until after they are realized as a reduction to taxes that would otherwise be paid. Management believes that excluding this value from the equity component of this measure enhances the understanding of the effect these non-discounted assets have on operating returns and the comparability of these measures from period to period. However, this non-GAAP measure does not replace the corresponding GAAP measure.

The following summarizes: (i) net operating income; (ii) significant items; (iii) net operating income, excluding significant items; and (iv) net income (loss) (dollars in millions):

Net operating

Net operating

income,

income,

excluding

Net

excluding

significant

income -

Net operating

Significant

significant

items - trailing

Net

trailing

income

items

items (a)

four quarters

income (loss)

four quarters

4Q24

$          138.0

$             3.1

(b)

$          141.1

$          410.5

$          182.9

$          420.8

1Q25

81.1

(5.3)

(c)

75.8

428.8

21.5

330.0

2Q25

87.5

—

87.5

401.7

91.8

305.5

3Q25

127.2

(32.2)

(d)

95.0

399.4

23.1

319.3

4Q25

143.4

—

143.4

401.7

92.9

229.3

1Q26

101.3

—

101.3

427.2

37.7

245.5

2Q26

119.5

—

119.5

459.2

125.9

279.6

3Q26

179.1

(44.9)

(e)

134.2

498.4

161.1

417.6

(a)  See note (6) for additional information.

(b)  Comprised of $3.9 million of the unfavorable impact arising from our comprehensive annual actuarial review, net of tax expense of $0.8 million.

(c)  Comprised of $6.8 million of the favorable impact of an out-of-period adjustment which decreased reserves, net of tax expense of $1.5 million.

(d)  Comprised of $41.3 million of the net favorable impact arising from our comprehensive annual actuarial review, net of tax expense of $9.1 million.

(e)  Comprised of $56.3 million of the net favorable impact arising from our comprehensive annual actuarial review, net of tax expense of $11.4 million.

A reconciliation of pre-tax operating earnings (a non-GAAP financial measure) to net income is as follows (dollars in millions):

Trailing four quarters

3Q26

3Q25

Pre-tax operating earnings (a non-GAAP financial measure)

$       674.6

$        553.6

Income tax expense

(131.3)

(119.8)

Net operating income

543.3

433.8

Non-operating items:

Net realized investment losses from disposals, impairments and change in allowance for credit losses

(102.3)

(78.9)

Net change in market value of investments recognized in earnings

(26.3)

9.0

Changes in fair value of embedded derivative liabilities and market risk benefits

60.4

30.1

Fair value changes related to the agent deferred compensation plan

8.3

6.6

Expenses related to TechMod initiative

(43.4)

(10.4)

Goodwill and other asset impairment

(5.2)

(96.7)

Net loss related to divested business

(20.3)

—

Other

0.1

0.8

Non-operating loss before taxes

(128.7)

(139.5)

Income tax (expense) benefit:

    Income tax benefit on non-operating loss

25.1

25.0

    Valuation allowance for deferred tax assets

(22.1)

—

Net non-operating loss

(125.7)

(114.5)

Net income

$       417.6

$        319.3

A reconciliation of consolidated capital, excluding accumulated other comprehensive income (loss) and net operating loss carryforwards (a non-GAAP financial measure) to common shareholders' equity, is as follows (dollars in millions):

1Q24

2Q24

3Q24

4Q24

Consolidated capital, excluding accumulated other comprehensive

income (loss) and net operating loss carryforwards

(a non-GAAP financial measure)

$      3,536.8

$      3,596.7

$      3,529.9

$      3,810.0

Net operating loss carryforwards

311.2

296.5

273.9

76.6

Accumulated other comprehensive loss

(1,480.3)

(1,464.3)

(1,116.0)

(1,371.4)

Common shareholders' equity

$      2,367.7

$      2,428.9

$      2,687.8

$      2,515.2

1Q25

2Q25

3Q25

4Q25

Consolidated capital, excluding accumulated other comprehensive

income (loss) and net operating loss carryforwards

(a non-GAAP financial measure)

$      3,498.9

$      3,504.3

$      3,483.6

$      3,510.2

Net operating loss carryforwards

295.3

271.1

246.3

243.0

Accumulated other comprehensive loss

(1,239.1)

(1,252.7)

(1,118.9)

(1,115.0)

Common shareholders' equity

$      2,555.1

$      2,522.7

$      2,611.0

$      2,638.2

1Q26

2Q26

3Q26

Consolidated capital, excluding accumulated other comprehensive

income (loss) and net operating loss carryforwards

(a non-GAAP financial measure)

$      3,461.2

$      3,548.5

$      3,658.3

Net operating loss carryforwards

254.8

225.9

211.2

Accumulated other comprehensive loss

(1,217.6)

(1,182.8)

(1,545.8)

Common shareholders' equity

$      2,498.4

$      2,591.6

$      2,323.7

A reconciliation of consolidated capital, excluding accumulated other comprehensive loss and net operating loss carryforwards (a non-GAAP financial measure) to common shareholders' equity, is as follows (dollars in millions):

Trailing four quarter average

3Q26

3Q25

Consolidated capital, excluding accumulated other comprehensive

income (loss) and net operating loss carryforwards

(a non-GAAP financial measure)

$      3,522.7

$      3,580.0

Net operating loss carryforwards

238.1

225.8

Accumulated other comprehensive loss

(1,211.9)

(1,245.2)

Common shareholders' equity

$      2,548.9

$      2,560.6

(6)

The tables below summarize the financial impact of significant items on our net operating income for the quarters during the nine months ended September 30, 2026 and the year ended December 31, 2025 that had significant items impacting our net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results (dollars in millions, except per share data).

Three months ended

September 30, 2026

Actual
results

Significant
items

Excluding
significant

items

Insurance product margin

Annuity margin

$     87.9

$    (20.5)

(a)

$     67.4

Health margin

149.1

(7.8)

(a)

141.3

Life margin

96.0

(28.0)

(a)

68.0

Total insurance product margin

333.0

(56.3)

276.7

Allocated expenses

(161.0)

—

(161.0)

Income from insurance products

172.0

(56.3)

115.7

Fee income

(1.1)

—

(1.1)

Investment income not allocated to product lines

68.1

—

68.1

Expenses not allocated to product lines

(18.8)

—

(18.8)

Operating earnings before taxes

220.2

(56.3)

163.9

Income tax (expense) benefit on operating income

(41.1)

11.4

(29.7)

Net operating income

$    179.1

$    (44.9)

$    134.2

Net operating income per diluted share

$     1.90

$    (0.48)

$     1.42

(a)

Comprised of $56.3 million of the net favorable impact arising from our comprehensive annual actuarial review.

Three months ended

September 30, 2025

Actual
results

Significant
items

Excluding
significant

items

Insurance product margin

Annuity margin

$     72.9

$    (16.6)

(a)

$     56.3

Health margin

157.0

(21.1)

(a)

135.9

Life margin

70.6

(3.6)

(a)

67.0

Total insurance product margin

300.5

(41.3)

259.2

Allocated expenses

(151.0)

—

(151.0)

Income from insurance products

149.5

(41.3)

108.2

Fee income

(3.9)

—

(3.9)

Investment income not allocated to product lines

39.5

—

39.5

Expenses not allocated to product lines

(22.3)

—

(22.3)

Operating earnings before taxes

162.8

(41.3)

121.5

Income tax (expense) benefit on operating income

(35.6)

9.1

(26.5)

Net operating income

$    127.2

$    (32.2)

$     95.0

Net operating income per diluted share

$     1.29

$    (0.33)

$     0.96

(a)

Comprised of $41.3 million of the net favorable impact arising from our comprehensive annual actuarial review.

Three months ended

March 31, 2025

Actual
results

Significant
items

Excluding
significant

items

Insurance product margin

Annuity margin

$     54.5

$        —

$     54.5

Health margin

126.2

—

126.2

Life margin

68.2

(6.8)

(a)

61.4

Total insurance product margin

248.9

(6.8)

242.1

Allocated expenses

(161.2)

—

(161.2)

Income from insurance products

87.7

(6.8)

80.9

Fee income

(0.8)

—

(0.8)

Investment income not allocated to product lines

38.0

—

38.0

Expenses not allocated to product lines

(20.3)

—

(20.3)

Operating earnings before taxes

104.6

(6.8)

97.8

Income tax (expense) benefit on operating income

(23.5)

1.5

(22.0)

Net operating income

$     81.1

$      (5.3)

$     75.8

Net operating income per diluted share

$     0.79

$    (0.05)

$     0.74

(a)

Comprised of $6.8 million of the favorable impact of an out-of-period adjustment, which decreased reserves.

SOURCE CNO Financial Group
2026-10-29 22:04 2d ago
2026-10-29 16:15 2d ago
What MYR Group (MYRG) Said on Its Q3 Earnings Call
MYRG MYR Group
FMP Stock News
Original source text
2 Pick-and-Shovel Plays for Major Digital Infrastructure BuildoutMYR Group NASDAQ: MYRG reported record third-quarter revenue, net income, EBITDA and backlog for 2026, citing higher activity across its Commercial & Industrial and Transmission & Distribution businesses, contributions from the Valley Electric and Comet Electric acquisitions, and improved project productivity.

Third-quarter revenue rose 32% from a year earlier to $1.26 billion. Net income increased to a record $60 million, from $32 million in the prior-year period, while diluted earnings per share climbed 86% to $3.82. EBITDA reached a record $110 million, compared with $63 million a year earlier.

Get MYR Group alerts:

Construction activity suddenly booming, 3 stocks you can't miss“Our third quarter results reflect the strength of our business, the benefits of disciplined execution, and the continued demand for services we provide,” President and Chief Executive Officer Rick Swartz said. He pointed to investment in electrical infrastructure, grid modernization and electrification as continuing sources of opportunity.

Commercial and Industrial Revenue Drives Growth
Commercial & Industrial revenue increased 58% year over year to a record $704 million. Chief Financial Officer Kelly Huntington said the increase was driven primarily by greater fixed-price contract revenue, including incremental contributions from Valley and Comet, which were acquired July 1.

Transmission & Distribution revenue rose 10% to $555 million, supported by higher revenue across time-and-equipment, fixed-price and unit-price contracts. Work performed under master service agreements represented approximately 65% of T&D revenue in the quarter.

MYR Group’s consolidated gross margin expanded to 13.6%, from 11.8% a year earlier. Huntington said the improvement reflected favorable revisions to estimated gross profit on certain projects, better-than-anticipated productivity and favorable project closeouts. Those benefits were partly offset by inefficiencies on certain projects.

T&D operating income margin increased to 9.3% from 8.2% a year earlier.
C&I operating income margin increased to 8.7% from 6.4%.
C&I results included an additional $4.9 million of amortization expense related to intangible assets acquired with Valley and Comet.

Huntington said the company completed its purchase-price allocation work and now expects the acquired-intangible amortization to be less of a margin headwind than originally anticipated. She said the associated backlog is expected to burn over a period of slightly more than two years.

During the question-and-answer session, Swartz said C&I margins are expected to remain in the upper portion of the company’s stated 6% to 9% operating-margin range in the coming year. He attributed the outlook to strong project execution as well as more favorable contract terms and conditions.

Record Backlog and Growth Outlook
Total backlog stood at a record $3.68 billion as of Sept. 30, up 38% from a year earlier. T&D backlog was $1.29 billion, while C&I backlog totaled $2.39 billion.

Management said backlog can be uneven from quarter to quarter and encouraged investors to consider overall market activity and customer discussions alongside reported backlog. Swartz said the company expects some larger projects to enter backlog by the end of 2026 or by the end of the first quarter of the following year.

For the coming year, management said it expects C&I revenue growth of approximately 18% to 22%, including a full-year contribution from Valley and Comet and their continued growth. T&D revenue is expected to increase approximately 10% to 13%, with growth anticipated to be more weighted toward the second half of the year.

Swartz said T&D growth is expected to be supported by master service agreement work and small- and medium-sized projects as utility customers increase capital expenditures. He said large T&D projects are generally not expected to begin until the latter half of 2027, with more substantial activity expected in 2028 and beyond.

Brian Stern, senior vice president and chief operating officer of T&D, said the segment’s bidding activity remained consistent amid utility infrastructure needs. During the quarter, the company’s operating units won transmission, substation and line-rebuild work in states including Indiana, Virginia, Iowa, New Mexico, Washington, Texas, Massachusetts and New York.

Stern cited Power Insights’ latest report projecting transmission growth of roughly 10% annually through 2030, driven by load growth, aging infrastructure and resilience programs.

Market Activity and Capital Allocation
Don Egan, senior vice president and chief operating officer of C&I, said bidding activity remained healthy and backlog continued to grow. New awards included warehouse work in New Jersey, data-center and airport transportation work in Colorado, a light-rail extension in California, municipal and data-center work, and wastewater work in Seattle.

Swartz said C&I activity remained diversified beyond data centers, with customers increasingly discussing projects that extend into 2029 and 2030. He said some arrangements include “Part A and Part B” contracts, under which MYR Group may secure materials and work with customers on pricing and project development before later phases proceed.

SG&A expenses increased approximately $16 million year over year to $82 million, primarily reflecting costs associated with Valley and Comet, increased incentive compensation and employee-related expenses to support growth.

Third-quarter operating cash flow declined to $46 million from $96 million a year earlier, while free cash flow fell to $9 million from $65 million. Huntington attributed the decreases to timing of billings and payments related to project starts and completions, as well as higher capital expenditures. She added that customer payment terms have become a greater point of discussion in contract negotiations amid higher interest rates.

As of Sept. 30, MYR Group had approximately $298 million of working capital, $216 million of funded debt and $650 million of borrowing availability under its credit facility. Its funded debt-to-EBITDA leverage ratio was 0.63 times.

In September, the company amended and extended its credit facility, adding a $690 million revolving facility and term-loan facilities totaling a $150 million tranche and a Canadian-dollar 70 million tranche. Management said the amendment increased aggregate capacity by $400 million.

MYR Group’s board also authorized a new $100 million share-repurchase program, effective Nov. 4 and set to expire Nov. 3, 2027, unless the funds are used earlier. Huntington said the company views repurchases as an opportunistic component of its capital-allocation strategy alongside organic investment and acquisitions.

Swartz said the company’s acquisition pipeline remains active across both T&D and C&I, though management intends to remain selective. The company is focused on electrical services in C&I, while it may consider certain ancillary service capabilities in T&D.

About MYR Group (NASDAQ:MYRG)MYR Group Inc is a holding company that operates specialty electrical infrastructure contracting businesses in the United States and Canada. Its companies provide construction, maintenance, repair and emergency restoration services for electric power infrastructure and other complex electrical systems.

MYR Group operates through two primary segments: Transmission and Distribution and Commercial and Industrial. Its transmission and distribution work includes overhead and underground power lines, substations and related utility infrastructure.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in MYR Group Right Now?Before you consider MYR Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MYR Group wasn't on the list.

While MYR Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
2026-10-29 22:04 2d ago
2026-10-29 17:18 2d ago
MYR Group Inc. (MYRG) Q3 2026 Earnings Call Transcript
MYRG MYR Group
FMP Stock News
Original source text
MYR Group Inc. (MYRG) Q3 2026 Earnings Call October 29, 2026 10:00 AM EDT

Company Participants

Jennifer Harper - VP of Investor Relations & Treasurer
Richard Swartz - President, CEO & Director
Kelly Huntington - Senior VP & CFO
Brian Stern - Senior VP & COO of Transmission & Distribution
Don Egan - Senior VP and COO of Commercial & Industrial

Conference Call Participants

Caitlin Donohue - Goldman Sachs Group, Inc., Research Division
Sangita Jain - KeyBanc Capital Markets Inc., Research Division
Justin Hauke - Robert W. Baird & Co. Incorporated, Research Division
Manish Somaiya - Cantor Fitzgerald & Co., Research Division
Brent Thielman - Oppenheimer & Co. Inc., Research Division
Brian Russo - Jefferies LLC, Research Division
Brian Brophy - Stifel, Nicolaus & Company, Incorporated, Research Division

Presentation

Operator

Good morning, everyone, and welcome to the MYR Group Third Quarter 2026 Earnings Results Conference Call.

[Operator Instructions] Today's conference is being recorded.

I will now turn the call over to Jennifer Harper, Vice President of Investor Relations and Treasurer, for introductory remarks.

Jennifer Harper
VP of Investor Relations & Treasurer

Thank you, and good morning, everyone. I would like to welcome you to the MYR Group conference call to discuss the company's third quarter results for 2026, which were reported yesterday.

Joining us on today's call are Rick Swartz, President and Chief Executive Officer; Kelly Huntington, Senior Vice President and Chief Financial Officer; Brian Stern, Senior Vice President and Chief Operating Officer of MYR Group's Transmission and Distribution segment; and Don Egan, Senior Vice President and Chief Operating Officer of MYR Group's Commercial and Industrial segment. A copy of yesterday's press release announcing our third quarter results can be found on the MYR Group website at myrgroup.com under the Investors tab.

Please note, today's discussion may contain forward-looking statements. Any such statements are based upon information available to MYR
2026-10-29 22:03 2d ago
2026-10-29 17:19 2d ago
ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law
ENSG The Ensign Group
FMP Stock News
Original source text
, /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Ensign Group, Inc. ("Ensign" or "the Company") (NASDAQ: ENSG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of ENSG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: February 10, 2022 to June 18, 2026

DEADLINE: December 7, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Ensign's business model failed to provide appropriate care for elderly patients. The Company neglected residents of its facilities including failing to respond to those in distress. The Company covered its failings using self-reporting measures. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Ensign, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.             

CONTACT:
Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE Schall, Brown & Schwartz LLP
2026-10-29 22:03 2d ago
2026-10-29 17:23 2d ago
The Ensign Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ENSG
ENSG The Ensign Group
FMP Stock News
Original source text
, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against The Ensign Group, Inc. ("Ensign" or "the Company") (NASDAQ: ENSG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of ENSG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: February 10, 2022 to June 18, 2026

DEADLINE: December 7, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Ensign's business model failed to provide appropriate care for elderly patients. The Company neglected residents of its facilities including failing to respond to those in distress. The Company covered its failings using self-reporting measures. Based on these facts, Ensign's public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

 Eastchester, NY 10709

Phone: 914-206-9742

Email: [email protected]

SOURCE DJS Law Group LLP
2026-10-29 22:03 2d ago
2026-10-29 17:59 2d ago
ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
ENSG The Ensign Group
FMP Stock News
Original source text
, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Ensign Group, Inc. (NASDAQ: ENSG) between February 10, 2022 and June 18, 2026, both dates inclusive (the "Class Period"), of the important December 7, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

So what: If you purchased Ensign securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. 

What to do next: To join the Ensign class action, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Ensign's business model depends on the systematic and widespread neglect of elderly people who live in its facilities, including those with needs for high levels of care; (2) Ensign's abuse and neglect includes not giving residents enough food, medical attention, or even basic toiletries as well as failing to respond to residents in clear distress, which has resulted in resident deaths; (3) Ensign uses self-reporting measures as a way to cover up that it systematically neglects patients; (4) Ensign defrauds Medicaid and Medicare by taking federal funds to help patients who need high levels of care, and then neglecting those same patients; (5) Ensign falsifies the number of hours that Certified Nursing Assistants spend with residents; (6) Ensign engages in an illegal scheme to rent the licenses of Administrators who are not generally present at, nor actually managing, its facilities; (7) Ensign materially understated the reputational and litigation exposure that comes with a dangerous, abhorrent, and illegal business model; and (8) as a result, defendants' statements about Ensign's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Ensign class action, go to https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY  10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected] 
     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.
2026-10-29 22:02 2d ago
2026-10-29 16:03 2d ago
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
MMSI Merit Medical Systems
FMP Stock News
Original source text
Solo Pace, Inc. specializes in temporary pacing solutions and systems designed for transcatheter heart valve procedures, including transcatheter aortic valve replacement procedures  | Source: Merit Medical Systems, Inc.

SOUTH JORDAN, Utah, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in Minneapolis, Minnesota, Solo Pace manufactures temporary pacing technology designed to help physicians treat patients with aortic stenosis. Merit had previously invested in Solo Pace and on October 13, 2026, Merit acquired all remaining outstanding equity of Solo Pace for purchase consideration of approximately $45 million.

The acquisition expands Merit’s Cardiac Therapies platform with differentiated technologies, including SOLO PACE CONTROL™ and SOLO PACE FUSION™ systems, exclusively engineered for transcatheter aortic valve replacement (TAVR) and other transcatheter heart valve (THV) procedures. Prior to the acquisition, Merit served as the exclusive distributor of Solo Pace’s precision intraprocedural pacing technology. The acquisition builds on this existing commercial relationship and supports Merit’s strategy to expand its structural heart portfolio, with a focus on technologies designed to simplify procedural workflows and support physicians performing transcatheter heart valve procedures.

TAVR is a minimally invasive THV procedure that replaces the aortic valve in the heart. A treatment for aortic stenosis, or narrowing of the valve opening, TAVR is a rapidly growing procedure, with more than 100,000 performed annually in the United States alone.1 Temporary pacing is a critical component of TAVR procedures, supporting accurate valve deployment and helping physicians perform the procedure safely and efficiently.

SOLO PACE CONTROL and FUSION systems are designed to help physicians treat patients by simplifying pacing setup,2 reducing workflow variability,2,3 and standardizing pacing strategies for TAVR procedures.2–4 The systems can help physicians minimize communication-related pacing errors2–4 and decrease the risk of vascular complications.2,4,5–7

SOLO PACE FUSION is a single-use, sterile kit designed for temporary intracardiac pacing for TAVR and other THV procedures. Combining guide wire functionality, left ventricular pacing, and patient grounding in one device, SOLO PACE FUSION is designed to provide stable, reliable temporary pacing throughout pacing setup and delivery.2,8

Designed for use with the existing SOLO PACE CONTROL external pulse generator, SOLO PACE FUSION is engineered to improve procedural efficiency during TAVR procedures.8 In addition, it supports temporary pacing with operator-specific protocols, automated pace capture checks, sterile remote-control operation, and simple visual indicators.

“SOLO PACE CONTROL and FUSION systems have the potential to redefine pacing in transcatheter valve procedures,” said David V. Daniels, MD, Interventional Cardiologist and Founder of Solo Pace. “Seeing the technology embraced by physicians and having a meaningful impact on procedural efficiency has been incredibly gratifying. With Merit taking the lead, I’m excited for the difference the Solo Pace products can make in advancing patient care and market adoption.”

Solo Pace announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of the SOLO PACE FUSION system on April 17, 2025, and March 31, 2026, respectively.

“This acquisition expands our Cardiac Therapies platform and further strengthens our position in the structural heart market,” said Martha G. Aronson, Merit’s President and Chief Executive Officer. “Through our exclusive distribution relationship, we have seen a favorable response from clinicians. That experience reinforces our confidence in the technology and the opportunity to support its next phase of growth. We look forward to leveraging our commercial, clinical, and physician education capabilities to expand adoption in the United States and, over time, bring these solutions to more physicians and patients worldwide.”

Learn more about SOLO PACE CONTROL and SOLO PACE FUSION.

1. Cleveland Clinic. 2025. “How and Why Volumes Matter In Aortic Valve Replacement.” Last modified January 22, 2025.
2. Data on file.
3. Blusztein et al. 2023. Struct Heart. doi: 10.1016/j.shj.2023.100213.
4. Berman et al. 2024. Struct Heart. doi: 10.1016/j.shj.2024.100306.
5. Faurie et al. 2019. JACC Cardiovasc Interv. doi: 10.1016/j.jcin.2019.09.029.
6. Regueiro et al. 2023. JACC Cardiovasc Interv. doi: 10.1016/j.jcin.2023.10.035.
7. Arnold et al. 2014. Circ Cardiovasc Interv. doi: 10.1161/CIRCINTERVENTIONS.114.001395.
8. Pasupati. “First-in-Human Experience with LV Guidewire Pacing.” TCT, October 2025.

FINANCIAL SUMMARY
On October 13, 2026, Merit paid purchase consideration of approximately $45 million to acquire all remaining outstanding equity of Solo Pace. Merit previously owned approximately 18% of Solo Pace pursuant to various agreements executed between January 2023 and December 2025 under which Merit paid a total of $5 million to acquire shares of Solo Pace, an option to acquire all remaining outstanding equity of Solo Pace based on certain commercialization milestones, and exclusive rights to distribute the Solo Pace products upon commercialization.

From the acquisition effective date of October 13, 2026, through December 31, 2026, the acquisition is projected to be immaterial to Merit’s previously forecasted full-year 2026 total revenue, non-GAAP net income and non-GAAP earnings per share. The acquisition is expected to be immaterial to Merit’s previously forecasted full-year 2026 GAAP net income and GAAP earnings per share.

For the twelve months ending December 31, 2027, the acquisition is projected to be slightly accretive to non-GAAP net income and non-GAAP earnings per share, inclusive of approximately $1.5 million of lower interest income on cash balances used for the total purchase consideration and excluding approximately $3.2 million of non-cash and non-recurring transaction-related expenses. The acquisition is projected to be slightly dilutive to Merit’s GAAP net income and GAAP earnings per share in 2027 and accretive thereafter.

NON-GAAP FINANCIAL MEASURES
Merit generally does not provide guidance for GAAP reported financial measures (other than revenue) or a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP reported financial measures (other than revenue) because Merit is unable to predict with reasonable certainty the financial impact of various items which could impact Merit’s future financial results, such as expenses attributable to acquisitions or other extraordinary transactions, non-cash expenses related to amortization or write-off of previously acquired tangible and intangible assets, certain employee termination benefits, performance-based stock compensation expenses, expenses resulting from non-ordinary course litigation or administrative proceedings and resulting settlements, governmental proceedings, and changes in governmental or industry regulations. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. For the same reasons, Merit is unable to address the significance of the unavailable information, which could be material to future results. Specifically, Merit is not, without unreasonable effort, able to reliably predict the impact of these items, and Merit believes inclusion of a reconciliation of these forward-looking non-GAAP measures to their GAAP counterparts could be confusing to investors or cause undue reliance. Only information on the impacts to such measures from the proposed acquisition is included in this release. A reconciliation of the impacts on such financial measures to the impacts on their GAAP counterparts is not available without unreasonable effort.

ADVISORS
Parr Brown Gee & Loveless served as legal advisor to Merit in connection with the transaction.

ABOUT MERIT MEDICAL
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling approximately 900 individuals. Merit employs approximately 7,500 people worldwide.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others:

Statements proceeded or followed by, or that include the words, “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “intends,” “seeks,” “believes,” “estimates,” “projects,” “forecasts,” “potential,” “target,” “continue,” “upcoming,” “optimistic” or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology;Statements that address Merit’s future operating performance or events or developments that Merit’s management expects or anticipates will occur, including, without limitation, any statements regarding Merit’s projected revenues, revenue growth or other financial measures, Merit’s plans and objectives for future operations, Merit’s proposed new products or services, the integration, development or commercialization of the business or any assets acquired from other parties, future economic conditions or performance, the implementation of, and results which may be achieved through, Merit’s Continued Growth Initiatives Program or other business optimization initiatives, and any statements of assumptions underlying any of the foregoing; andStatements regarding Merit’s past performance, efforts, or results about which inferences or assumptions may be made, including statements proceeded or followed by the words "preliminary," "initial," "potential," "possible," "diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. The forward-looking statements contained in this release are based on Merit management’s current expectations and assumptions regarding future events or outcomes. If underlying expectations or assumptions prove inaccurate, or risks or uncertainties materialize, actual results will likely differ, and could differ materially, from Merit’s expectations reflected in any forward-looking statements. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Investors are cautioned not to unduly rely on any such forward-looking statements.

The following are some of the important risks and uncertainties that could cause Merit’s actual results to differ from Merit’s expectations in any forward-looking statements: risks and uncertainties associated with Merit’s acquisition of Solo Pace and SOLO PACE CONTROL and FUSION systems and related technology; risks and uncertainties associated with Merit’s integration of the Solo Pace business, assets and operations into its operations and its ability to achieve anticipated financial results, product development and other anticipated benefits of the acquisition; uncertainties as to whether Merit will achieve revenue or other financial performance consistent with its forecasts projected for the Solo Pace acquisition; risks and uncertainties regarding trade policies or related actions implemented by the United States or other countries, including existing, proposed, prospective or invalidated tariffs, duties or other measures; risks and uncertainties associated with Merit’s integration of businesses or assets acquired from third parties, including View Point Medical, Inc. in April 2026, the business and assets related to the C2 CryoBalloon™ device acquired from Pentax of America, Inc. in November 2025 and Biolife Delaware, L.L.C. in May 2025, and Merit’s ability to achieve the anticipated operating and financial results, product development and other anticipated benefits of such acquisitions; effects of Merit’s 3.00% Convertible Senior Notes due 2029 on Merit’s net income and earnings per share performance; disruptions in Merit’s supply chain, manufacturing or sterilization processes; U.S. and global political, economic, competitive, reimbursement and regulatory conditions; risks and uncertainties associated with Merit’s executive succession and leadership transition; modification or limitation of, or policies and procedures associated with, governmental or private insurance reimbursement policies; reduced availability of, and price increases associated with, components and other raw materials; increases in transportation expenses; risks relating to Merit’s potential inability to successfully manage growth through acquisitions generally, including the inability to effectively integrate acquired operations or products or commercialize technology developed internally or acquired through completed, proposed or future transactions; prospective financial obligations or other uncertainties associated with Merit’s divestiture of its DualCap® anti-microbial cap product line in February 2026; fluctuations in interest or foreign currency exchange rates and inflation; cybersecurity events; government scrutiny and regulation of the medical device industry; difficulties relating to development, testing and regulatory approval, clearance and maintenance of Merit’s products; the safety, efficacy and patient and physician adoption of Merit’s products; the ability to fully enroll and the outcomes of ongoing and future clinical trials and market studies relating to Merit’s products; litigation and other legal proceedings affecting Merit; the risk and possible effects of any failure to comply with U.S. and foreign laws and regulations; restrictions on Merit’s liquidity or business operations resulting from its debt agreements; infringement of Merit’s technology or the assertion that Merit’s technology infringes the rights of other parties; product recalls and product liability claims; potential for significant adverse changes in governing regulations;, changes in tax laws and regulations in the United States or other jurisdictions or exposure to additional tax liabilities which may adversely affect Merit’s effective tax rate; termination of relationships with Merit’s suppliers, or failure of such suppliers to perform; development of new products and technology that could render Merit’s existing or future products obsolete; market acceptance of new products; failure to comply with applicable environmental laws; changes in key personnel; labor shortages and increases in labor costs; price and product competition; extreme weather events; and geopolitical events. For a further discussion of the risks and uncertainties that may affect Merit’s business, operations and financial condition, see Part I, Item 1A. “Risk Factors” in Merit’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (SEC), Part II, Item 1A, “Risk Factors” in Merit’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed with the SEC and Merit’s other filings with the SEC.

All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Those estimates and all other forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by applicable law, Merit assumes no obligation to update or disclose revisions to estimates and all other forward-looking statements.

TRADEMARKS
Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.

CONTACTS 
PR/Media Inquiries 
Sarah Comstock
Merit Medical 
+1-801-432-2864 | [email protected] 

Investor Inquiries 
Mike Piccinino, CFA, IRC 
ICR Healthcare 
+1-443-213-0509 | [email protected]
2026-10-29 22:02 2d ago
2026-10-29 16:05 2d ago
Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance
MMSI Merit Medical Systems
FMP Stock News
Original source text
Financial Highlights†

Reported revenue of $416.2 million, up 8.4%Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectivelyGAAP operating margin of 14.1%, compared to 11.1% in prior year periodNon-GAAP operating margin* of 21.3%, compared to 19.7% in prior year periodGAAP EPS $0.70, up 51%Non-GAAP EPS* $1.12, up 22%Cash flow from operations of $175.2 million year-to-dateFree cash flow* generation of $129.5 million year-to-date † Comparisons above are calculated for the current quarter compared with the third quarter of 2025, unless otherwise specified. Amounts stated in this release are rounded, while percentages are calculated from the underlying amounts.

* Constant currency revenue; constant currency revenue, organic; non-GAAP gross profit and margin; non-GAAP operating income and margin; non-GAAP net income; non-GAAP EPS; and free cash flow figures (used here and below) are non-GAAP financial measures. A reconciliation of these financial measures to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.

SOUTH JORDAN, Utah, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced financial results for the three and nine-month periods ended September 30, 2026.

“Merit delivered third quarter financial results that exceeded the high end of our expectations, driven primarily by 9% organic, constant currency revenue growth, excluding the impact of a strategic divestiture,” said Martha G. Aronson, Merit’s President and CEO. “We experienced strong revenue growth trends in the U.S. and better-than-expected demand for Merit’s products across both our Foundational and our Therapeutic platforms. We also delivered strong growth in both our non-GAAP operating profit and our non-GAAP earnings per share, which increased 17% and 22%, respectively, year-over-year.” Ms. Aronson continued: “We have raised our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first nine months of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year. Our team remains focused on delivering our Continued Growth Initiative financial targets for the three-year period ending December 31, 2026, and, in parallel, we are finalizing our longer-term strategic plan focused on identifying opportunities to better position the company for sustainable growth, enhanced profitability and value creation for our shareholders.”

Merit’s revenue by product category for the three and nine-month periods ended September 30, 2026 and 2025 was as follows (unaudited; in thousands, except for percentages):

                     Three Months Ended  Reported    Constant Currency*  September 30,    Impact of foreign September 30,     2026 2025 % Change exchange 2026 % ChangeFoundational                  Access $157,922 $151,508 4 % $(1,018) $156,904 4 %OEM  46,278  41,499 12 %  47   46,325 12 %Procedural Solutions  27,162  32,287 (16)%  184   27,346 (15)%Vascular Intervention  42,367  35,391 20 %  (166)  42,201 19 %Other  2,006  221 808 %  547   2,553 1,055 %Total Foundational  275,735  260,906 6 %  (406)  275,329 6 %                   Therapeutic                  Cardiac Therapies  27,547  25,530 8 %  (53)  27,494 8 %Endoscopy  23,428  17,631 33 %  36   23,464 33 %OEM  13,089  9,953 32 %  (16)  13,073 31 %Oncology  27,085  23,263 16 %  (24)  27,061 16 %Renal Therapies  13,550  13,808 (2)%  (123)  13,427 (3)%Vascular Intervention  35,810  33,066 8 %  (496)  35,314 7 %Total Therapeutic  140,509  123,251 14 %  (676)  139,833 13 %                   Total $416,244 $384,157 8 % $(1,082) $415,162 8 %                      Nine Months Ended  Reported    Constant Currency *  September 30,    Impact of foreign September 30,     2026 2025 % Change exchange 2026 % ChangeFoundational                  Access $470,832 $438,028 7 % $(8,538) $462,294 6 %OEM  134,156  128,140 5 %  (217)  133,939 5 %Procedural Solutions  81,599  92,597 (12)%  166   81,765 (12)%Vascular Intervention  123,057  103,195 19 %  (1,638)  121,419 18 %Other  2,531  1,710 48 %  3,296   5,827 241 %Total Foundational  812,175  763,670 6 %  (6,931)  805,244 5 %                   Therapeutic                  Cardiac Therapies  83,461  69,019 21 %  (1,747)  81,714 18 %Endoscopy  68,767  52,582 31 %  56   68,823 31 %OEM  33,365  30,830 8 %  (66)  33,299 8 %Oncology  76,367  69,257 10 %  (550)  75,817 9 %Renal Therapies  37,775  40,014 (6)%  (515)  37,260 (7)%Vascular Intervention  105,054  96,598 9 %  (2,252)  102,802 6 %Total Therapeutic  404,789  358,300 13 %  (5,074)  399,715 12 %                   Total $1,216,964 $1,121,970 8 % $(12,005) $1,204,959 7 %
Financial Summary:

GAAP gross margin was 48.2%, compared to 48.5% for the third quarter of 2025. Non-GAAP gross margin* was 52.8%, compared to 53.6% for the third quarter of 2025.

GAAP operating margin was 14.1%, compared to 11.1% for the third quarter of 2025. Non-GAAP operating margin* was 21.3%, compared to 19.7% for the third quarter of 2025.

GAAP net income was $42.3 million, or $0.70 per share, compared to $27.8 million, or $0.46 per share, for the third quarter of 2025. Non-GAAP net income* was $67.4 million, or $1.12 per share, compared to $54.9 million, or $0.92 per share, for the third quarter of 2025.

As of September 30, 2026, Merit had cash and cash equivalents of $503.6 million and total debt obligations of $747.5 million, compared to cash and cash equivalents of $446.4 million and total debt obligations of $747.5 million as of December 31, 2025. Merit had available borrowing capacity of approximately $697 million as of September 30, 2026.

Fiscal Year 2026 Financial Guidance

Based upon the information currently available to Merit’s management, for the twelve-month period ending December 31, 2026, absent the potential impact of trade policies and related actions implemented by the U.S. and other countries subsequent to today’s date, material acquisitions, non-recurring transactions or other factors beyond Merit’s current expectations, Merit anticipates the following financial results:

Revenue and Earnings Guidance*

     Updated GuidancePrior Guidance(2)  Year Ending% Change Year Ending% Change Financial Measure December 31, 2026Y/YDecember 31, 2026Y/YTotal Revenue $1.635 - $1.642 billion8% - 8%$1.631 - $1.643 billion8% - 8%      Non-GAAP Earnings Per Share(1) $4.33 - $4.3713% - 14%$4.25 - $4.3511% - 14% *Percentage figures approximated; dollar figures may not foot due to rounding.

(1) Merit’s non-GAAP earnings per share reflect the dilutive impact of its 3.00% Convertible Senior Notes due 2029 (the “Convertible Notes”) calculated using the if-converted method of approximately $0.01 per share for the year ending December 31, 2026. Any offsetting impacts of the capped call associated with the Convertible Notes are not considered.

(2) “Prior Guidance” reflects Merit’s full-year 2026 financial guidance, previously introduced on July 30, 2026.

Merit does not provide guidance for GAAP reported financial measures (other than revenue) or a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP reported financial measures (other than revenue) because Merit is unable to predict with reasonable certainty the financial impact of various items which could impact Merit’s future financial results, such as expenses attributable to acquisitions or other extraordinary transactions, non-cash expenses related to amortization or write-off of previously acquired tangible and intangible assets, certain employee termination benefits, performance-based stock compensation expenses, expenses resulting from non-ordinary course litigation or administrative proceedings and resulting settlements, governmental proceedings, and changes in governmental or industry regulations. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. For the same reasons, Merit is unable to address the significance of the unavailable information, which could be material to future results. Specifically, Merit is not, without unreasonable effort, able to reasonably predict the amount and impact of these items and Merit believes inclusion of the most comparable GAAP financial measure, and a reconciliation of these forward-looking non-GAAP measures to their GAAP counterparts could be confusing to investors or cause undue reliance.

Merit’s financial guidance for the year ending December 31, 2026 is subject to risks and uncertainties identified in this release and Merit’s filings with the SEC. This guidance is based on information and estimates available to Merit as of October 29, 2026. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results will likely vary, and could vary materially, from past results and those anticipated, estimated or projected.

CONFERENCE CALL

As previously announced, Merit will hold its investor conference call today, Thursday, October 29, 2026, at 4:30 p.m., Eastern Time, to discuss its results for the third quarter and provide an operational update. To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details. A live webcast and slide deck will also be available at merit.com.

       CONSOLIDATED BALANCE SHEETS
(in thousands)         September 30, December 31,  2026  2025 ASSETS (Unaudited)   Current Assets      Cash and cash equivalents $503,551  $446,404 Trade receivables, net  221,866   203,710 Other receivables  37,875   17,773 Inventories  391,022   333,705 Prepaid expenses and other current assets  35,188   31,493 Prepaid income taxes  5,030   4,941 Income tax refund receivables  4,283   2,128 Total current assets  1,198,815   1,040,154        Property and equipment, net  437,347   428,401 Intangible assets, net  591,204   537,654 Goodwill  537,135   506,837 Deferred income tax assets  7,273   7,049 Right-of-use operating lease assets  84,379   87,600 Other assets  68,753   78,227 Total Assets $2,924,906  $2,685,922        LIABILITIES AND STOCKHOLDERS' EQUITY      Current Liabilities      Trade payables $66,286  $60,551 Accrued expenses  174,024   159,486 Short-term operating lease liabilities  10,382   10,876 Income taxes payable  14,391   8,851 Total current liabilities  265,083   239,764        Long-term debt  737,404   734,038 Deferred income tax liabilities  37,216   19,665 Liabilities related to unrecognized tax benefits  2,248   2,248 Deferred compensation payable  19,373   17,542 Deferred credits  1,321   1,398 Long-term operating lease liabilities  74,273   76,658 Other long-term obligations  43,437   10,306 Total liabilities  1,180,355   1,101,619        Stockholders' Equity      Common stock  808,930   763,909 Retained earnings  946,139   824,030 Accumulated other comprehensive loss  (10,518)  (3,636)Total stockholders' equity  1,744,551   1,584,303 Total Liabilities and Stockholders' Equity $2,924,906  $2,685,922               CONSOLIDATED STATEMENTS OF INCOME
(Unaudited, in thousands except per share amounts)               Three Months Ended Nine Months Ended  September 30, September 30,  2026  2025  2026  2025 Net sales $416,244  $384,157  $1,216,964  $1,121,970 Cost of sales  215,613   197,746   616,370   579,052 Gross profit  200,631   186,411   600,594   542,918              Operating expenses:            Selling, general and administrative  119,511   119,801   366,950   340,384 Research and development  22,393   23,966   70,391   70,811 Contingent consideration (benefit) expense  (36)  32   (70)  1,198 Total operating expenses  141,868   143,799   437,271   412,393              Income from operations  58,763   42,612   163,323   130,525              Other income (expense):            Interest income  4,128   3,615   11,780   11,166 Interest expense  (7,333)  (6,754)  (25,977)  (20,097)Other income (expense) — net  227   (933)  11,519   (1,717)Total other expense — net  (2,978)  (4,072)  (2,678)  (10,648)             Income before income taxes  55,785   38,540   160,645   119,877              Income tax expense  13,474   10,785   38,536   29,394              Net income $42,311  $27,755  $122,109  $90,483              Earnings per common share            Basic $0.71  $0.47  $2.05  $1.53 Diluted $0.70  $0.46  $2.03  $1.49              Weighted average shares outstanding            Basic  59,806   59,245   59,666   59,095 Diluted  60,379   59,919   60,134   60,604         CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)         Nine Months Ended  September 30,  2026  2025 CASH FLOWS FROM OPERATING ACTIVITIES:    Net income $122,109  $90,483 Adjustments to reconcile net income to net cash provided by operating activities:      Depreciation and amortization  93,383   91,629 Gain on disposition of a business  (12,557)  (249)Amortization of right-of-use operating lease assets  8,771   8,693 Fair value adjustments related to contingent consideration liabilities  (70)  1,198 Stock-based compensation expense  35,497   33,563 Other adjustments  6,950   5,123 Changes in operating assets and liabilities, net of acquisitions and divestitures  (78,853)  (31,579)Total adjustments  53,121   108,378 Net cash, cash equivalents, and restricted cash provided by operating activities  175,230   198,861        CASH FLOWS FROM INVESTING ACTIVITIES:      Capital expenditures for property and equipment  (45,686)  (57,252)Proceeds from asset and business dispositions  25,555   298 Cash paid for notes receivable and other investments  (9,242)  (14,936)Cash paid in acquisitions, net of cash acquired  (93,049)  (122,834)Other investing, net  (2,293)  (2,327)Net cash, cash equivalents, and restricted cash used in investing activities  (124,715)  (197,051)       CASH FLOWS FROM FINANCING ACTIVITIES:    Proceeds from issuance of common stock  16,272   22,179 Contingent payments related to acquisitions  (3,030)  (2,645)Payment of taxes related to an exchange of common stock  (6,973)  (8,597)Net cash, cash equivalents, and restricted cash provided by financing activities  6,269   10,937 Effect of exchange rates on cash  454   3,047 Net increase in cash, cash equivalents and restricted cash  57,238   15,794        CASH, CASH EQUIVALENTS AND RESTRICTED CASH:      Beginning of period  448,549   378,767 End of period $505,787  $394,561        RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEETS:      Cash and cash equivalents  503,551   392,457 Restricted cash reported in prepaid expenses and other current assets  2,236   2,104 Total cash, cash equivalents and restricted cash $505,787  $394,561 
Non-GAAP Financial Measures

Although Merit’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), Merit’s management believes that the non-GAAP financial measures referenced in this release may provide investors with useful information regarding the underlying business trends and performance of Merit’s ongoing operations and can be useful for period-over-period comparisons of such operations. Non-GAAP financial measures used in this release include:

constant currency revenue;constant currency revenue, organic;non-GAAP gross profit and margin;non-GAAP operating income and margin;non-GAAP net income;non-GAAP earnings per share; andfree cash flow.
Merit’s management team uses these non-GAAP financial measures to evaluate Merit’s profitability and efficiency, to compare operating and financial results to prior periods, to evaluate changes in the results of its operating segment, and to measure and allocate financial resources internally. However, Merit’s management does not consider such non-GAAP measures in isolation or as an alternative to measures determined in accordance with GAAP.

Readers should consider non-GAAP measures used in this release in addition to, not as a substitute for, financial reporting measures prepared in accordance with GAAP. These non-GAAP financial measures generally exclude some, but not all, items that may affect Merit’s net income. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which items are excluded. Merit believes it is useful to exclude such items in the calculation of non-GAAP gross profit and margin, non-GAAP operating income and margin, non-GAAP net income, and non-GAAP earnings per share (in each case, as further illustrated in the reconciliation tables below) because such amounts in any specific period may not directly correlate to the underlying performance of Merit’s business operations and can vary significantly between periods as a result of factors such as acquisition or other extraordinary transactions, non-cash expenses related to amortization or write-off of previously acquired tangible and intangible assets, certain employee termination benefits, expenses resulting from non-ordinary course litigation or administrative proceedings and resulting settlements, governmental proceedings or changes in tax or industry regulations, gains or losses on disposal of certain assets, equity method investment loss (income) from equity investees, and debt issuance costs. Merit may incur similar types of expenses in the future, and the non-GAAP financial information included in this release should not be viewed as a statement or indication that these types of expenses will not recur. Additionally, the non-GAAP financial measures used in this release may not be comparable with similarly titled measures of other companies. Merit urges readers to review the reconciliations of its non-GAAP financial measures to their most directly comparable GAAP financial measures included herein, and not to rely on any single financial measure to evaluate Merit’s business or results of operations.

Constant Currency Revenue

Merit’s constant currency revenue is prepared by converting the current-period reported revenue of subsidiaries whose functional currency is a currency other than the U.S. dollar at the applicable foreign exchange rates in effect during the comparable prior-year period and adjusting for the effects of hedging transactions on reported revenue, which are recorded in the U.S. dollar. The constant currency revenue adjustment of $(1.1) million and $(12.0) million to reported revenue for the three and nine-month periods ended September 30, 2026 was calculated using the applicable average foreign exchange rates for the three and nine-month periods ended September 30, 2025.

Constant Currency Revenue, Organic

Merit’s constant currency revenue, organic, is defined, with respect to prior fiscal year periods, as GAAP revenue less revenue from certain divestitures. For the three and nine-month periods ended September 30, 2025, Merit’s constant currency revenue, organic, excludes revenues attributable to the DualCap® product line which Merit sold to Health Line International Corporation (“Health Line”) on February 17, 2026 (the “DualCap Divestiture”).

With respect to current fiscal year periods, constant currency revenue, organic, is defined as constant currency revenue (as defined above), less revenue from certain acquisitions and divestitures. For the three-month period ended September 30, 2026, Merit’s constant currency revenue, organic, excludes revenues attributable to products acquired in connection with (i) Merit’s acquisition of View Point Medical, Inc. (“View Point”) in April 2026 (the “View Point Merger”) and (ii) the assets acquired from Pentax of America, Inc. related to the C2 CryoBalloon™ device in November 2025 (the “C2 Acquisition”). For the nine-month period ended September 30, 2026, Merit’s constant currency revenue, organic, excludes revenues attributable to products acquired in connection with (i) the View Point Merger, (ii) the C2 Acquisition and (iii) Merit’s acquisition of Biolife Delaware, L.L.C. (“Biolife”) in May 2025 (the “Biolife Merger”) and excludes revenues attributable to the DualCap Divestiture.

Non-GAAP Gross Profit and Margin

Non-GAAP gross profit is calculated by reducing GAAP cost of sales by amounts recorded for amortization of intangible assets and inventory mark-up related to acquisitions. Non-GAAP gross margin is calculated by dividing non-GAAP gross profit by reported net sales.

Non-GAAP Operating Income and Margin

Non-GAAP operating income is calculated by adjusting GAAP operating income for certain items which are deemed by Merit’s management to be outside of core operations and vary in amount and frequency among periods, such as expenses related to acquisitions or other extraordinary transactions, non-cash expenses related to amortization or write-off of previously acquired tangible and intangible assets, certain employee termination benefits, performance-based stock compensation expenses, expenses resulting from non-ordinary course litigation or administrative proceedings and resulting settlements, governmental proceedings, and changes in governmental or industry regulations, as well as other items referenced in the tables below. Non-GAAP operating margin is calculated by dividing non-GAAP operating income by reported net sales.

Non-GAAP Net Income

Non-GAAP net income is calculated by adjusting GAAP net income for the items set forth in the definition of non-GAAP operating income above, as well as for expenses related to Merit’s long-term debt, gains or losses on disposal of certain assets, equity method investment loss (income) from equity investees, and other items set forth in the tables below.

Non-GAAP EPS

Non-GAAP EPS is defined as non-GAAP net income divided by the diluted shares outstanding for the corresponding period.

Free Cash Flow

Free cash flow is defined as cash flow from operations calculated in accordance with GAAP, less capital expenditures for property and equipment calculated in accordance with GAAP, as set forth in the consolidated statement of cash flows.

Other Non-GAAP Financial Measure Reconciliations

The following tables set forth supplemental financial data and corresponding reconciliations of non-GAAP financial measures to Merit’s corresponding financial measures prepared in accordance with GAAP, in each case, for the three and nine-month periods ended September 30, 2026 and 2025. The non-GAAP income adjustments referenced in the following tables do not reflect non-performance-based stock compensation expense of $6.4 million and $4.6 million for the three-month periods ended September 30, 2026 and 2025, respectively, and $15.9 million and $13.9 million for the nine-month periods ended September 30, 2026 and 2025, respectively.

Reconciliation of GAAP Net Income to Non-GAAP Net Income
(Unaudited, in thousands except per share amounts)

  Three Months Ended  September 30, 2026  Pre-Tax Tax Impact After-Tax Per Share ImpactGAAP net income $55,785  $(13,474) $42,311  $0.70              Non-GAAP adjustments:            Cost of Sales            Amortization of intangibles  18,996   (4,484)  14,512   0.24 Operating Expenses            Contingent consideration benefit  (36)  (14)  (50)  (0.00)Amortization of intangibles  2,540   (600)  1,940   0.03 Performance-based share-based compensation (a)  7,173   (665)  6,508   0.11 Corporate restructuring (b)  301   (71)  230   0.00 Acquisition-related  280   (11)  269   0.00 Medical Device Regulation expenses (c)  519   (123)  396   0.01 Other (Income) Expense            Long-term debt costs (e)  1,414   (334)  1,080   0.02 Other non-operating loss (f)  254   (60)  194   0.00              Non-GAAP net income $87,226  $(19,836) $67,390  $1.12              Diluted shares           60,379    
Three Months Ended  September 30, 2025  Pre-Tax Tax Impact After-Tax Per Share ImpactGAAP net income $38,540  $(10,785) $27,755  $0.46              Non-GAAP adjustments:            Cost of Sales            Amortization of intangibles  19,212   (4,539)  14,673   0.24 Inventory mark-up related to acquisitions  183   (43)  140   0.00 Operating Expenses            Contingent consideration expense  32   (5)  27   0.00 Amortization of intangibles  2,560   (604)  1,956   0.03 Performance-based share-based compensation (a)  9,028   (1,413)  7,615   0.13 Corporate restructuring (b)  286   (67)  219   0.00 Acquisition-related  (68)  16   (52)  (0.00)Medical Device Regulation expenses (c)  1,655   (391)  1,264   0.02 Other (d)  74   (17)  57   0.00 Other (Income) Expense            Long-term debt costs (e)  1,414   (334)  1,080   0.02 Other non-operating loss (f)  260   (61)  199   0.00              Non-GAAP net income $73,176  $(18,243) $54,933  $0.92              Diluted shares           59,919  _____________________
Note: Certain per-share impacts may not sum to totals due to rounding.

Reconciliation of GAAP Net Income to Non-GAAP Net Income
(Unaudited, in thousands except per share amounts)

  Nine Months Ended  September 30, 2026  Pre-Tax Tax Impact After-Tax Per Share ImpactGAAP net income $160,645  $(38,536) $122,109  $2.03              Non-GAAP adjustments:            Cost of Sales            Amortization of intangibles  55,941   (13,206)  42,735   0.71 Operating Expenses            Contingent consideration benefit  (70)  (9)  (79)  (0.00)Amortization of intangibles  7,490   (1,768)  5,722   0.10 Performance-based share-based compensation (a)  19,602   (1,727)  17,875   0.30 Corporate restructuring (b)  2,460   (581)  1,879   0.03 Acquisition-related  7,091   (916)  6,175   0.10 Medical Device Regulation expenses (c)  2,589   (611)  1,978   0.03 Other (Income) Expense            Long-term debt costs (e)  9,305   (2,197)  7,108   0.12 Gain on disposal of business unit  (12,502)  1,520   (10,982)  (0.18)Other non-operating loss (f)  1,079   (267)  812   0.01              Non-GAAP net income $253,630  $(58,298) $195,332  $3.25              Diluted shares           60,134    
Nine Months Ended  September 30, 2025  Pre-Tax Tax Impact After-Tax Per Share ImpactGAAP net income $119,877 $(29,394) $90,483  $1.49              Non-GAAP adjustments:            Cost of Sales            Amortization of intangibles  55,798  (13,184)  42,614   0.70 Inventory mark-up related to acquisitions  250  (59)  191   0.00 Operating Expenses            Contingent consideration expense  1,198  29   1,227   0.02 Amortization of intangibles  7,497  (1,771)  5,726   0.09 Performance-based share-based compensation (a)  19,681  (2,344)  17,337   0.29 Corporate restructuring (b)  2,873  (678)  2,195   0.04 Acquisition-related  2,088  (2)  2,086   0.03 Medical Device Regulation expenses (c)  4,883  (1,153)  3,730   0.06 Other (d)  103  (24)  79   0.00 Other (Income) Expense            Long-term debt costs (e)  4,242  (1,002)  3,240   0.05 Other non-operating loss (f)  11  (61)  (50)  (0.00)             Non-GAAP net income $218,501 $(49,643) $168,858  $2.79              Diluted shares           60,604  _____________________
Note: Certain per-share impacts may not sum to totals due to rounding.

Reconciliation of Reported Operating Income to Non-GAAP Operating Income
(Unaudited, in thousands except percentages)

  Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended  September 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025  Amounts % Sales Amounts % Sales Amounts % Sales Amounts % SalesNet Sales as Reported $416,244     $384,157     $1,216,964     $1,121,970                            GAAP Operating Income  58,763  14.1 %  42,612  11.1 %  163,323  13.4 %  130,525 11.6%Cost of Sales                        Amortization of intangibles  18,996  4.6 %  19,212  5.0 %  55,941  4.6 %  55,798 5.0%Inventory mark-up related to acquisitions  —  —    183  0.0 %  —  —    250 0.0%Operating Expenses                        Contingent consideration (benefit) expense  (36) (0.0)%  32  0.0 %  (70) (0.0)%  1,198 0.1%Amortization of intangibles  2,540  0.6 %  2,560  0.7 %  7,490  0.6 %  7,497 0.7%Performance-based share-based compensation (a)  7,173  1.7 %  9,028  2.4 %  19,602  1.6 %  19,681 1.8%Corporate restructuring (b)  301  0.1 %  286  0.1 %  2,460  0.2 %  2,873 0.3%Acquisition-related  280  0.1 %  (68) (0.0)%  7,091  0.6 %  2,088 0.2%Medical Device Regulation expenses (c)  519  0.1 %  1,655  0.4 %  2,589  0.2 %  4,883 0.4%Other (d)  —  —    74  0.0 %  —  —    103 0.0%                         Non-GAAP Operating Income $88,536  21.3 % $75,574  19.7 % $258,426  21.2 % $224,896 20.0% _____________________
Note: Certain percentages may not sum to totals due to rounding.
  (a)Represents performance-based share-based compensation expense, including stock-settled and cash-settled awards.(b)Includes employee termination benefits associated with activities related to corporate restructuring initiatives and costs to terminate certain distribution contracts from the Biolife Merger.(c)Represents incremental expenses incurred to comply with the E.U. Medical Device Regulation.(d)Represents costs to comply with Merit’s corporate integrity agreement with the U.S. Department of Justice.(e)Represents costs associated with the Convertible Notes including the amortization of debt issuance costs and, for the nine-months ended September 30, 2026, a one-time charge for additional interest incurred pursuant to Merit's obligation to remove restrictive legends.(f)Includes equity method investment loss from equity investees.
Reconciliation of Reported Revenue to Constant Currency Revenue (Non-GAAP), and Constant Currency Revenue, Organic (Non-GAAP)
(Unaudited, in thousands except percentages)

    Three Months Ended   Nine Months Ended    September 30,   September 30,  % Change 2026  2025  % Change 2026  2025 Reported Revenue 8.4%$416,244  $384,157  8.5%$1,216,964  $1,121,970                  Add: Impact of foreign exchange    (1,082)  —     (12,005)  —                  Constant Currency Revenue (a) 8.1%$415,162  $384,157  7.4%$1,204,959  $1,121,970                  Less: Revenue from certain acquisitions    (2,634)  —     (16,338)  — Less: Revenue from divestitures (b)    —   (5,228)    (1,644)  (15,440)                 Constant Currency Revenue, Organic (a) 8.9%$412,528  $378,929  7.3%$1,186,977  $1,106,530  _____________________
(a)A non-GAAP financial measure. For a definition of this and other non-GAAP financial measures, see the section of this release entitled “Non-GAAP Financial Measures.”(b)On February 17, 2026, Merit consummated the DualCap Divestiture for consideration of $28 million, of which $25.5 million was paid to Merit at closing.
Reconciliation of Reported Gross Margin to Non-GAAP Gross Margin (Non-GAAP)
(Unaudited, as a percentage of reported revenue)

  Three Months Ended Nine Months Ended  September 30, September 30,  2026  2025  2026  2025 Reported Gross Margin 48.2% 48.5% 49.4% 48.4%             Add back impact of:            Amortization of intangibles 4.6% 5.0% 4.6% 5.0%Inventory mark-up related to acquisitions —% 0.0% —% 0.0%             Non-GAAP Gross Margin 52.8% 53.6% 53.9% 53.4% _____________________
Note: Certain percentages may not sum to totals due to rounding.

Reconciliation of Reported Cash Flow from Operations to Free Cash Flow (Non-GAAP)
(Unaudited, in thousands)

  Nine Months Ended  September 30,  2026  2025 Reported Cash Flow from Operations $175,230  $198,861        Less: Capital Expenditures  (45,686)  (57,252)       Free Cash Flow $129,544  $141,609 
Reconciliation of 2026 Net Sales Guidance - % Change from Prior Year (Constant Currency)

  Updated Guidance Prior Guidance(1)  Low High Low High2026 Net Sales Guidance - % Change from Prior Year (GAAP) 7.9% 8.4% 7.6% 8.4%Estimated impact of foreign currency exchange rate fluctuations (0.8%) (0.8%) (0.8%) (0.8%)2026 Net Sales Guidance - % Change from Prior Year (Constant Currency) 7.0% 7.5% 6.8% 7.6% _____________________
Note: Certain percentages may not sum to totals due to rounding.

(1) “Prior Guidance” reflects Merit’s full-year 2026 financial guidance, previously introduced on July 30, 2026.

ABOUT MERIT

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling approximately 900 individuals. Merit employs approximately 7,500 people worldwide.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others:

statements preceded or followed by, or that include the words, “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “intends,” “seeks,” “believes,” “estimates,” “projects,” “forecasts,” “potential,” “target,” “continue,” “upcoming,” “optimistic” or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology;statements that address Merit’s future operating performance or events or developments that Merit’s management expects or anticipates will occur, including, without limitation, any statements regarding Merit’s projected revenues, earnings or other future financial measures, Merit’s plans and objectives for future operations, Merit’s proposed new products or services, the integration, development or commercialization of the business or any assets acquired from other parties, future economic conditions or performance, the implementation of, and results which may be achieved through, Merit’s Continued Growth Initiatives Program or other business optimization initiatives, and any statements of assumptions underlying any of the foregoing; andstatements regarding Merit’s past performance, efforts, or results about which inferences or assumptions may be made, including statements preceded or followed by the words "preliminary," "initial," "potential," "possible," "diligence," "industry-leading," "compliant," "indications" or "early feedback" or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology.
The forward-looking statements contained in this release are based on Merit management’s current expectations and assumptions regarding future events or outcomes. If underlying expectations or assumptions prove inaccurate, or risks or uncertainties materialize, actual results will likely differ, and may differ materially, from Merit’s expectations reflected in any forward-looking statements. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Investors are cautioned not to unduly rely on any such forward-looking statements.

The following are some of the important risks and uncertainties that could cause Merit’s actual results to differ from management’s expectations in any forward-looking statements: risks and uncertainties arising from the conflict among the United States, Israel and Iran and related geopolitical instability; risks and uncertainties associated with Merit’s acquisition of Solo Pace, Inc. (“Solo Pace”) and SOLO PACE CONTROL and FUSION systems and related technology in October 2026; risks and uncertainties associated with Merit’s integration of the Solo Pace business, assets and operations into its operations and its ability to achieve anticipated financial results, product development and other anticipated benefits of the acquisition; uncertainties as to whether Merit will achieve revenue or other financial performance consistent with its forecasts projected for the Solo Pace acquisition; risks and uncertainties regarding trade policies or related actions implemented by the United States or other countries, including existing, proposed, prospective or invalidated tariffs, duties or other measures; risks and uncertainties associated with Merit’s integration of businesses or assets acquired from third parties, including the View Point Merger in April 2026, the C2 Acquisition in November 2025 and the Biolife Merger in May 2025, and Merit’s ability to achieve the anticipated operating and financial results, product development and other anticipated benefits of such acquisitions; effects of Merit’s 3.00% Convertible Senior Notes due 2029 on Merit’s net income and earnings per share performance; disruptions in Merit’s supply chain, manufacturing or sterilization processes; U.S. and global political, economic, competitive, reimbursement and regulatory conditions; risks and uncertainties associated with Merit’s executive succession and leadership transition; modification or limitation of, or policies and procedures associated with, governmental or private insurance reimbursement policies; reduced availability of, and price increases associated with, components and other raw materials; increases in transportation expenses; risks relating to Merit’s potential inability to successfully manage growth through acquisitions generally, including the inability to effectively integrate acquired operations or products or commercialize technology developed internally or acquired through completed, proposed or future transactions; prospective financial obligations or other uncertainties associated with Merit’s divestiture of its DualCap® anti-microbial cap product line in February 2026; fluctuations in interest or foreign currency exchange rates and inflation; cybersecurity events; government scrutiny and regulation of the medical device industry; difficulties relating to development, testing and regulatory approval, clearance and maintenance of Merit’s products; the safety, efficacy and patient and physician adoption of Merit’s products; the ability to fully enroll and the outcomes of ongoing and future clinical trials and market studies relating to Merit’s products; litigation and other legal proceedings affecting Merit; risks and possible effects of any failure to comply with U.S. and foreign laws and regulations; restrictions on Merit’s liquidity or business operations resulting from its debt agreements; infringement of Merit’s technology or the assertion that Merit’s technology infringes the rights of other parties; product recalls and product liability claims; potential for significant adverse changes in governing regulations;, changes in tax laws and regulations in the United States or other jurisdictions or exposure to additional tax liabilities which may adversely affect Merit’s effective tax rate; termination of relationships with Merit’s suppliers, or failure of such suppliers to perform; development of new products and technology that could render Merit’s existing or future products obsolete; market acceptance of new products; failure to comply with applicable environmental laws; changes in key personnel; labor shortages and increases in labor costs; price and product competition; extreme weather events; and geopolitical events. For a further discussion of the risks and uncertainties and other factors that may affect Merit’s business, operations and financial condition, see Part I, Item 1A. “Risk Factors” in Merit’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC, which Merit updated in Part II, Item 1A. “Risk Factors” in Merit’s Quarterly Reports on Form 10-Q for each of the quarters ended March 31, 2026, June 30, 2026 and September 30, 2026.

All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results will likely differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Those estimates and all other forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by applicable law, Merit assumes no obligation to update or disclose revisions to estimates and all other forward-looking statements.

TRADEMARKS

Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.

   Contacts:
  PR/Media Inquiries:
Sarah Comstock
Merit MedicalInvestor Inquiries:
Mike Piccinino, CFA, IRC
ICR Healthcare +1-801-432-2864+1-443-213-0509 [email protected]@icrhealthcare.com    
2026-10-29 22:02 2d ago
2026-10-29 16:05 2d ago
Schneider National, Inc. Announces Third Quarter 2026 Results
SNDR Schneider National
FMP Stock News
Original source text
GREEN BAY, Wis.--(BUSINESS WIRE)--Schneider National, Inc. (NYSE: SNDR, “Schneider” or the “Company”), a leading transportation and logistics services company, today announced results for the three months ended September 30, 2026. “Our third-quarter performance demonstrates how our strategy has positioned the enterprise to convert improving market conditions into stronger earnings and margins,” said Jim Filter, President and Chief Executive Officer of Schneider. “Disciplined revenue management,.
2026-10-29 22:02 2d ago
2026-10-29 17:41 2d ago
Schneider National Q3 2026 Earnings Call Transcript
SNDR Schneider National
FMP Stock News
Original source text
Schneider National (NYSE:SNDR) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.
2026-10-29 22:01 2d ago
2026-10-29 17:40 2d ago
Lost Money on Alnylam Pharmaceuticals, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Continues Investigating Possible Securities Fraud After 28.31% Share Price Drop
ALNY Alnylam Pharmaceuticals
FMP Stock News
Original source text
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Investors who lost money on Alnylam Pharmaceuticals, Inc. ("Alnylam" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") continues its securities fraud investigation on behalf of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) investors into whether the Company may have violated the federal securities laws. The investigation follows the July 30, 2026 disclosure regarding Alnylam Pharmaceuticals, Inc.

Investors who lost money on Alnylam Pharmaceuticals, Inc. securities can submit their Alnylam Pharmaceuticals, Inc. loss information to learn about potentially pursuing claims to recover their losses.

Key facts in the Alnylam Pharmaceuticals, Inc. investigation

Disclosure date: July 30, 2026Stock price decline: $81.14 per share, or 28.31%Closing price after the decline: $205.48 on July 30, 2026 What happened?

On July 30, 2026, Alnylam announced second quarter 2026 financial results. Among other things, the Company reported it has “lowered our TTR product sales guidance for full-year 2026 to reflect learnings from the initial phase of our launch in the evolving ATTR-CM market, in particular the normalization of growth in second line volume after satisfying pent-up demand from patients waiting for a new therapy.” As a result, the Company lowered its total projected TTR net product revenues by approximately $200 million.

On this news, shares of Alnylam fell as much as $81.14 or 28.31%, to close at $205.48 on July 30, 2026, thereby injuring investors.

Then, on October 29, 2026, the Company reported third quarter 2026 financial results. Among other things, the Company reported U.S. TTR demand growth was $81 million, versus $129 million in the prior quarter. Management now expects full year 2026 TTR revenue at the low end of its already-reduced guidance and acknowledged that expanded physician engagement has not translated into demand as quickly as anticipated.

On this news, Alnylam shares are down as much as $58.10 or 25%, in intraday trading on October 29, 2026, thereby further injuring investors.

"The price of Alnylam Pharmaceuticals, Inc. shares fell 28.31% following the July 30, 2026 disclosure that Alnylam had lowered its full-year 2026 TTR product sales guidance, reducing projected TTR net product revenues by approximately $200 million, citing normalization of second line volume growth in the ATTR-CM market. Investors who suffered losses deserve to know whether they were given complete and accurate information prior to the disclosure, and our investigation seeks to answer that question," said Charles H. Linehan, Partner at Glancy Prongay Wolke & Rotter LLP.

What's the next step?

Glancy is investigating potential claims on behalf of Alnylam Pharmaceuticals, Inc. investors. Investors who lost money can contact Glancy about the Alnylam Pharmaceuticals, Inc. investigation, email [email protected], or call 310-201-9150 (toll-free: 888-773-9224).

Frequently Asked Questions

Who is eligible? Investors who bought Alnylam Pharmaceuticals, Inc. securities and lost money may have claims, and can contact Glancy to learn whether they are affected by the Alnylam Pharmaceuticals, Inc. investigation.

What is a securities fraud investigation? In the Alnylam Pharmaceuticals, Inc. investigation, Glancy is reviewing whether the Company or its executives may have made false or misleading statements to investors in violation of the federal securities laws.

Has a lawsuit been filed? This release announces Glancy's investigation, not a lawsuit. If a securities class action is later filed against Alnylam Pharmaceuticals, Inc., investors may have the opportunity to seek appointment as lead plaintiff.

Does it cost anything to contact Glancy or participate in this investigation? Glancy represents Alnylam Pharmaceuticals, Inc. investors on a contingency fee basis, so investors pay no attorneys' fees out of pocket. Any attorneys' fees and litigation expenses are paid only from a recovery, if one is obtained, and are subject to court approval.

Why work with Glancy on the Alnylam Pharmaceuticals, Inc. investigation? Glancy Prongay Wolke & Rotter LLP is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Contact Glancy about the Alnylam Pharmaceuticals, Inc. investigation. Prior results do not guarantee a similar outcome.

Whistleblower notice

Persons with non-public information about Alnylam Pharmaceuticals, Inc. should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information that leads to a successful SEC enforcement action may receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Charles H. Linehan at 310-201-9150 or 888-773-9224, or email [email protected].

About Glancy Prongay Wolke & Rotter LLP

Glancy was named one of Law360's Securities Groups of the Year and ranked second in total investor recoveries by ISS Securities Class Action Services in 2025.

Glancy's successes have been widely covered by leading news and industry publications, including The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money.

Prior results do not guarantee a similar outcome.

Related links

Alnylam Pharmaceuticals, Inc. investigation page, Glancy Prongay Wolke & Rotter LLPpress releaseAlnylam Pharmaceuticals, Inc. SEC filings index, EDGARSEC Whistleblower ProgramGlancy Prongay Wolke & Rotter LLP Contact

Charles H. Linehan

Glancy Prongay Wolke & Rotter LLP

1925 Century Park East, Suite 2100

Los Angeles, CA 90067

Email: [email protected] 

Telephone: 310-201-9150 | Toll-free: 888-773-9224

www.glancylaw.com

Follow Glancy on LinkedIn, X, or Facebook.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
2026-10-29 22:01 2d ago
2026-10-29 16:15 2d ago
Mohawk Industries Reports Q3 2026 Results
MHK Mohawk Industries
FMP Stock News
Original source text
HIGHLIGHTS:

Q3 2026 Net Sales of $2.8 billion, up approximately 1% with growth in Global Ceramic and Flooring North America; adjusted Net Sales nearly flat with the prior yearQ3 2026 Net Earnings of $163 million or 5.9% of Net Sales; adjusted EBITDA of approximately $353 million, adjusted EBITDA margin of 12.7%Q3 2026 Diluted EPS of $2.72, adjusted EPS of $2.72, up approximately 2%Q3 2026 Net Cash Provided by Operating Activities of $471 million; Q3 2026 Free Cash Flow of $390 million; YTD Q3 2026 Free Cash Flow of $626 million up 78%Returned $261 million to shareholders during the third quarter and $34 million during the fourth quarter, reducing shares outstanding by approximately 4%Expecting Q4 2026 Adjusted EPS of $1.35 to $1.45 CALHOUN, Ga., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK), the world’s largest flooring and design surfaces company, today announced earnings for the third quarter of 2026. Commenting on the Company’s third quarter performance, Chief Executive Officer Paul De Cock stated, “We delivered a solid third quarter in a weak demand environment. We grew net sales as we executed price increases in response to rising inflation, we offset inflation with price, mix and productivity, and we are efficiently converting our earnings to strong cash flow. We are returning cash to shareholders, and our share repurchases in the third quarter were more than double what we completed in the first half of the year. Although we expect demand conditions to remain challenging and higher costs to persist, our teams are focused on serving our customers and delivering solid fourth quarter results.”

THIRD QUARTER 2026 RESULTS

Net sales for the third quarter of 2026 were $2.8 billion, up approximately 1% and approximately flat on an adjusted basis. An additional shipping day benefitted sales by approximately 1%. Volumes declined approximately 4% on an adjusted basis, primarily due to soft market demand. Price and mix improved sequentially and contributed approximately 4% to sales growth, benefitting from price increases taken to offset the impacts of inflation, along with positive mix. Net earnings were $163 million or 5.9% of net sales and adjusted EBITDA was approximately $353 million, with an adjusted EBITDA margin of 12.7%. Operating income was $188 million, up approximately $51 million from prior year, and adjusted operating income was $200 million, down approximately $5 million versus the prior year, primarily due to lower volume and higher inflation. Price, mix and productivity collectively of approximately $132 million more than offset higher underlying inflation of approximately $117 million. Diluted EPS for the third quarter of 2026 was $2.72, up approximately 55%, and adjusted EPS was $2.72, up approximately 2%, with operating results in line with the Company’s guidance assumptions.

SEGMENT RESULTS

Global Ceramic: Net sales were $1.1 billion, up approximately 2% and up approximately 1% on an adjusted basis. Currency was slightly favorable and an additional shipping day benefitted sales by approximately 1%. Excluding the benefit of the additional shipping day, volumes were down approximately 1%, and price and mix contributed approximately 2%, benefitting from price and other actions in response to higher inflation, as well as mix. Global Ceramic operating income was $66 million, or 5.8% of net sales, down approximately $6 million from the prior year. Adjusted operating income was $74 million, down $16 million versus the prior year, as higher underlying inflation and lower volumes were partially offset by productivity and price and mix.

Flooring North America: Net sales were $950 million, up approximately 1% and approximately flat on an adjusted basis. An additional shipping day benefitted sales by approximately 2%. Excluding the benefit of the additional shipping day, volumes declined approximately 3% and price and mix contributed approximately 3%, benefitting from price and other actions in response to higher inflation, as well as mix. Flooring North America operating income was $72 million or 7.6% of net sales, up approximately $18 million from the prior year. Adjusted operating income was $77 million, up $9 million, primarily due to productivity, price and mix partially offset by lower volumes and higher underlying inflation.

Flooring Rest of the World: Net sales were $707 million, down approximately 1% as reported; unfavorable currency was less than 1% and an additional shipping day benefitted sales by approximately 2%. Adjusted net sales declined approximately 2%, with volumes down approximately 10%, primarily due to soft market demand across categories. Price and mix was up approximately 7%, a sequential improvement benefitting from price increases implemented earlier in the year to offset the impact of higher inflation. Flooring Rest of the World operating income was $66 million or 9.3% of net sales, up approximately $22 million from the prior year. Adjusted operating income was $66 million, up $6 million, driven by favorable price and mix partially offset by higher inflation and lower volumes.

CASH FLOW AND CAPITAL DEPLOYMENT

For the three months ended October 3, 2026, cash from operations was $471 million and capital expenditures were $81 million, resulting in free cash flow of $390 million. For the nine months ended October 3, 2026, free cash flow was $626 million. The Company now anticipates full-year capital expenditures of approximately $445 million versus its previous expectation of $460 million, and expects free cash flow during the fourth quarter of 2026 to follow typical seasonality.

During the third quarter, the Company repurchased 2.0 million shares, returning $261 million of cash to shareholders and reducing outstanding shares by more than 3%. To date during the fourth quarter, the Company returned an additional $34 million to shareholders, bringing the reduction to approximately 4% during the second half of the year and completing the Company’s previous share repurchase authorization. The Company's Board of Directors has authorized a new share repurchase program of up to $500 million, which is described, together with the Company's strategic framework and capital deployment priorities, in a separate press release, issued today. Net debt to adjusted EBITDA ended the quarter at 0.7x. 

FOURTH QUARTER 2026 OUTLOOK & GUIDANCE

Looking ahead to the fourth quarter, which has four fewer shipping days versus the prior year and three fewer shipping days versus the third quarter of the current year, the Company assumes flooring market conditions will be softer relative to the third quarter and expects low single-digit growth in adjusted net sales versus the prior year. Management also anticipates that the underlying cost of sales inflation headwind on a year-over-year basis will be similar to the third quarter and expects to fully offset this through pricing, mix and productivity. Given management's current input cost expectations and actions to date, the Company expects a similar dynamic in the first quarter of 2027. For the fourth quarter of 2026, the Company expects adjusted EPS in the range of $1.35 to $1.45. Assumptions included in the Company’s guidance are:

Adjusted Net Interest Expense of approximately $4 to $5 millionAdjusted Depreciation & Amortization Expense of approximately $148 millionAdjusted Tax Rate of approximately 23.5%Weighted Average Diluted Share Count of approximately 58.5 million ABOUT MOHAWK INDUSTRIES

Over the past two decades, Mohawk Industries has transformed its business into the world’s largest flooring and design surfaces company with leading positions in North America, Europe, South America and Oceania. Mohawk’s vertically integrated manufacturing and distribution operations provide a competitive advantage in the production of ceramic tile, carpet and laminate, wood, vinyl and hybrid flooring products. Mohawk’s industry-leading innovation has yielded designs and performance enhancements that differentiate its collections in the marketplace and satisfy all residential and commercial remodeling and new construction requirements. The Company’s brands are among the most recognized and respected in the industry and include American Olean, Daltile, Durkan, Eliane, Elizabeth, Feltex, Godfrey Hirst, Karastan, Marazzi, Mohawk, Mohawk Group, Mohawk Home, Mohawk Performance Accessories, Pergo, Quick-Step, Unilin and Vitromex.

Certain of the statements in this press release, particularly those anticipating future performance, business prospects, growth and operating strategies, and similar matters, and those that include the words “could,” “should,” “believes,” “anticipates,” “expects” and “estimates” or similar expressions constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. For those statements, Mohawk Industries, Inc. (“Mohawk” or the “Company”) claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Management believes that these forward-looking statements are reasonable as and when made; however, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. There can be no assurance that the forward-looking statements will be accurate because they are based on many assumptions, which involve risks and uncertainties. Important factors that could cause future results to differ from historical experience and our present expectations or projections include, but are not limited to, the following: changes in economic or industry conditions, including interest rates, availability of credit and residential and commercial construction and remodeling activity; the impact of tariffs and other trade restrictions; competition; inflation and deflation in raw material prices, freight and other input costs; inflation and deflation in consumer markets; currency fluctuations; rising energy costs and changes in the level of supply thereof; supply chain disruption and the availability of raw materials and sourced products; labor availability and costs; timing and level of capital expenditures; timing and implementation of price increases for the Company’s products; impairment charges; identification and consummation of acquisitions on favorable terms, if at all; integration of acquisitions; international operations; introduction of new products; rationalization of operations; tax and tax reform, product and other claims; litigation; geopolitical conflicts; sanctions and import and export restrictions; regulatory and political changes in the jurisdictions in which the Company does business; security breaches and other cybersecurity incidents; emerging issues related to the Company's integration and use of AI; and other risks identified in Mohawk’s United States Securities and Exchange Commission reports and public announcements.

Conference call Friday, October 30, 2026, at 11:00 AM Eastern Time

To participate in the conference call via the Internet, please visit https://ir.mohawkind.com/events/event-details/mohawk-industries-inc-3rd-quarter-2026-earnings-call. To participate in the conference call via telephone, register in advance at https://dpregister.com/sreg/10211917/104de4a22d1 to receive a unique personal identification number. You may also dial 1-833-630-1962 (U.S./Canada) or 1-412-317-1843 (international) on the day of the call for operator assistance. For those unable to listen at the designated time, the call will remain available for replay through November 27, 2026, by dialing 1-855-669-9658 (U.S./Canada) or 1-412-317-0088 (international) and entering Replay Access Code 7228212. The call will be archived and available for replay for one year under the “Investors” tab of mohawkind.com.

INVESTOR CONTACT
Joe Ahlersmeyer, CFA
VP, Finance & Investor Relations
[email protected]

 MOHAWK INDUSTRIES, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)  Three Months Ended Nine Months Ended(In millions, except per share data) October 3, 2026 September 27, 2025 October 3, 2026 September 27, 2025         Net sales $2,786.0 2,757.9  8,506.1 8,085.7Cost of sales  2,076.3 2,103.0  6,359.3 6,133.2Gross profit  709.7 654.9  2,146.8 1,952.5Selling, general and administrative expenses  522.0 518.2  1,593.5 1,531.0Operating income  187.7 136.7  553.3 421.5Interest expense  1.6 5.0  8.5 16.6Other (income) and expense, net  2.8 (0.4) 4.7 2.2Earnings before income taxes  183.3 132.1  540.1 402.7Income tax expense (benefit)  20.1 23.3  63.6 74.8Net earnings including noncontrolling interests  163.2 108.8  476.5 327.9Less: Net earnings attributable to noncontrolling interests  0.1 —  0.1 —Net earnings attributable to Mohawk Industries, Inc.  163.1 108.8  476.4 327.9         Basic earnings per share attributable to Mohawk Industries, Inc. $2.73 1.75  7.86 5.26Weighted-average common shares outstanding - basic  59.8 62.0  60.6 62.3         Diluted earnings per share attributable to Mohawk Industries, Inc. $2.72 1.75  7.82 5.24Weighted-average common shares outstanding - diluted  60.0 62.3  60.9 62.6          Other Financial Information          Three Months Ended Nine Months Ended(In millions) October 3, 2026 September 27, 2025 October 3, 2026 September 27, 2025Net cash provided by operating activities $471.2 386.6 897.8 596.6Less: Capital expenditures  80.8 76.3 271.5 245.6Free cash flow $390.4 310.3 626.3 351.0         Depreciation and amortization $151.3 170.3 492.5 476.3  MOHAWK INDUSTRIES, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)(In millions)October 3, 2026 December 31, 2025ASSETS   Current assets:   Cash and cash equivalents$816.8 856.1Receivables, net 2,125.0 1,924.1Inventories 2,591.6 2,661.7Prepaid expenses and other current assets 539.8 525.2Total current assets 6,073.2 5,967.1Property, plant and equipment, net 4,491.4 4,772.0Right of use operating lease assets 409.8 408.7Goodwill 1,171.0 1,210.3Intangible assets, net 782.5 813.2Deferred income taxes and other non-current assets 507.2 516.0Total assets$13,435.1 13,687.3LIABILITIES AND STOCKHOLDERS' EQUITY   Current liabilities:   Short-term debt and current portion of long-term debt$621.9 289.3Accounts payable and accrued expenses 2,442.5 2,310.4Current operating lease liabilities 116.7 122.4Total current liabilities 3,181.1 2,722.1Long-term debt, less current portion 1,160.8 1,741.2Non-current operating lease liabilities 310.4 304.4Deferred income taxes and other long-term liabilities 476.4 540.9Total liabilities 5,128.7 5,308.6Total stockholders' equity 8,306.4 8,378.7Total liabilities and stockholders' equity$13,435.1 13,687.3          Segment Information          Three Months Ended Nine Months Ended(In millions) October 3, 2026 September 27, 2025 October 3, 2026 September 27, 2025Net sales:        Global Ceramic $1,128.6  1,104.7   3,435.7  3,219.3 Flooring NA  949.9  936.8   2,806.0  2,746.0 Flooring ROW  707.5  716.4   2,264.4  2,120.4 Consolidated net sales $2,786.0  2,757.9   8,506.1  8,085.7          Operating income (loss):        Global Ceramic $65.6  71.6   211.1  201.5 Flooring NA  71.9  54.4   173.4  116.3 Flooring ROW  66.0  43.8   215.2  168.3 Corporate and intersegment eliminations  (15.8) (33.1)  (46.4) (64.6)Consolidated operating income $187.7  136.7   553.3  421.5                Three Months Ended(In millions)     October 3, 2026 December 31, 2025Assets:        Global Ceramic     $5,321.7  5,155.0 Flooring NA      3,740.0  3,832.6 Flooring ROW      3,913.2  3,989.2 Corporate and intersegment eliminations      460.2  710.5 Consolidated assets     $13,435.1  13,687.3   Reconciliation of Net Earnings Attributable to Mohawk Industries, Inc. to Adjusted Net Earnings Attributable to Mohawk Industries, Inc. and Adjusted Diluted Earnings Per Share Attributable to Mohawk Industries, Inc.           Three Months Ended Nine months ended(In millions, except per share data) October 3, 2026 September 27, 2025 October 3, 2026 September 27, 2025Net earnings attributable to Mohawk Industries, Inc. $163.1  108.8  476.4  327.9 Adjusting items:        Restructuring, acquisition and integration-related and other costs  12.4  47.2  89.0  102.9 Software implementation cost write-off  —  —  —  (0.4)Assets sale  —  —  (2.6) — Legal settlements, reserves and fees  —  21.6  0.1  27.1 Adjustments of indemnification asset  6.6  (0.3) 4.6  (0.5)Income taxes - adjustments of uncertain tax position  (6.6) 0.3  (4.6) 0.5 Other tax related items(1)  (7.5) —  (38.2) — Income tax effect of adjustments  (4.9) (11.1) (21.0) (22.1)Adjusted net earnings attributable to Mohawk Industries, Inc. $163.1  166.5  503.7  435.4          Adjusted diluted earnings per share attributable to Mohawk Industries, Inc. $2.72  2.67  8.27  6.96 Weighted-average common shares outstanding - diluted  60.0  62.3  60.9  62.6  (1) Includes a one-time U.S. tax benefit associated with a legal entity restructuring initiative, tax credits issued by the Brazilian government related to prior years and a non-recurring tax benefit related to a U.S. tax election.

  Reconciliation of Total Debt to Net Debt (In millions)October 3, 2026Short-term debt and current portion of long-term debt$621.9Long-term debt, less current portion 1,160.8Total debt 1,782.7Less: Cash and cash equivalents 816.8Net debt$965.9        Reconciliation of Net Earnings to Adjusted EBITDA                Trailing Twelve  Three Months Ended Months Ended(In millions)December 31,
2025 April 4,
2026 July 4,
2026 October 3,
2026 October 3,
2026Net earnings including noncontrolling interests$42.0  117.1  196.1  163.2 518.4 Interest expense 1.2  2.4  4.8  1.6 10.0 Income tax expense (benefit) 24.0  (8.9) 52.3  20.1 87.5 Depreciation and amortization(1) 176.3  181.8  159.3  151.3 668.7 EBITDA 243.5  292.4  412.5  336.2 1,284.6 Restructuring, acquisition and integration-related and other costs 25.6  7.6  29.0  10.6 72.8 Assets sale (5.1) —  (2.6) — (7.7)Inventory capitalization (6.2) —  —  — (6.2)Impairment of goodwill and indefinite-lived intangibles 19.9  —  —  — 19.9 Legal settlements, reserves and fees 23.8  0.1  —  — 23.9 Adjustments of indemnification asset (0.3) (0.3) (1.7) 6.6 4.3 Adjusted EBITDA$301.2  299.8  437.2  353.4 1,391.6            Net debt to adjusted EBITDA        0.7  (1) Includes accelerated depreciation of $25.9 for Q4 2025, $30.0 for Q1 2026, $10.0 for Q2 2026 and $1.8 for Q3 2026.

 Reconciliation of Net Sales to Adjusted Net Sales  Three Months Ended Nine Months Ended(In millions) October 3, 2026 October 3, 2026Mohawk ConsolidatedNet sales $2,786.0  8,506.1 Adjustment for constant shipping days  (37.5) (167.5)Adjustment for constant exchange rates  (2.1) (190.1)Adjusted net sales $2,746.4  8,148.5       Three Months Ended  October 3, 2026Global CeramicNet sales $1,128.6 Adjustment for constant shipping days  (11.5)Adjustment for constant exchange rates  (5.4)Adjusted net sales $1,111.7    Flooring NA  Net sales $949.9 Adjustment for constant shipping days  (14.9)Adjusted net sales $935.0    Flooring ROW  Net sales $707.5 Adjustment for constant shipping days  (11.1)Adjustment for constant exchange rates  3.2 Adjusted net sales $699.6   Reconciliation of Gross Profit to Adjusted Gross Profit  Three Months Ended(In millions) October 3, 2026 September 27, 2025Gross Profit $709.7 654.9 Adjustments to gross profit:    Restructuring, acquisition and integration-related and other costs  10.4 44.1 Adjusted gross profit $720.1 699.0      Adjusted gross profit as a percent of net sales  25.8
%
 25.3%  Reconciliation of Selling, General and Administrative Expenses to Adjusted Selling, General and Administrative Expenses  Three Months Ended(In millions) October 3, 2026 September 27, 2025Selling, general and administrative expenses $522.0  518.2 Adjustments to selling, general and administrative expenses:    Restructuring, acquisition and integration-related and other costs  (2.0) (3.1)Legal settlements, reserves and fees  —  (21.6)Adjusted selling, general and administrative expenses $520.0  493.5      Adjusted selling, general and administrative expenses as a percent of net sales18.7%  17.9%  Reconciliation of Operating Income to Adjusted Operating Income  Three Months Ended(In millions) October 3, 2026 September 27, 2025Mohawk Consolidated    Operating income $187.7  136.7 Adjustments to operating income:    Restructuring, acquisition and integration-related and other costs  12.4  47.2 Legal settlements, reserves and fees  —  21.6 Adjusted operating income $200.1  205.5      Adjusted operating income as a percent of net sales  7.2% 7.5%     Global Ceramic    Operating income $65.6  71.6 Adjustments to segment operating income:    Restructuring, acquisition and integration-related and other costs  7.9  18.2 Adjusted segment operating income $73.5  89.8      Adjusted segment operating income as a percent of net sales  6.5% 8.1%     Flooring NA    Operating income $71.9  54.4 Adjustments to segment operating income:    Restructuring, acquisition and integration-related and other costs  4.9  13.5 Adjusted segment operating income $76.8  67.9      Adjusted segment operating income as a percent of net sales  8.1% 7.2%      Three Months Ended  October 3, 2026 September 27, 2025Flooring ROW    Operating income $66.0  43.8 Adjustments to segment operating income:    Restructuring, acquisition and integration-related and other costs  (0.4) 15.5 Adjusted segment operating income $65.6  59.3         Adjusted segment operating income as a percent of net sales  9.3% 8.3%          Corporate and intersegment eliminations         Operating (loss)   $(15.8
) (33.1)Adjustments to segment operating (loss):         Legal settlements, reserves and fees    —
  21.6 Adjusted segment operating (loss)   $(15.8
) (11.5)  Reconciliation of Earnings Before Income Taxes to Adjusted Earnings Before Income Taxes  Three Months Ended(In millions) October 3, 2026 September 27, 2025Earnings before income taxes $183.3 132.1 Adjustments to earnings including noncontrolling interests before income taxes:    Restructuring, acquisition and integration-related and other costs  12.4 47.2 Legal settlements, reserves and fees  — 21.6 Adjustments of indemnification asset  6.6 (0.3)Adjusted earnings before income taxes $202.3 200.6   Reconciliation of Income Tax Expense to Adjusted Income Tax Expense  Three Months Ended(In millions) October 3, 2026 September 27, 2025Income tax expense (benefit) $20.1  23.3 Adjustments to income tax expense:    Income taxes - adjustments of uncertain tax position  6.6  (0.3)Other tax related items  7.5  — Income tax effect of adjusting items  4.9  11.1 Adjusted income tax expense $39.1  34.1      Adjusted income tax expense to adjusted earnings before income taxes  19.3% 17.0%         US GAAP to non-GAAP presentation

The Company supplements its condensed consolidated financial statements, which are prepared and presented in accordance with US GAAP, with certain non-GAAP financial measures. As required by the Securities and Exchange Commission rules, the tables above present a reconciliation of the Company’s non-GAAP financial measures to the most directly comparable US GAAP measure.  Each of the non-GAAP measures set forth above should be considered in addition to the comparable US GAAP measure, and may not be comparable to similarly titled measures reported by other companies. The Company believes these non-GAAP measures, when reconciled to the corresponding US GAAP measure, help its investors as follows: Non-GAAP revenue measures that assist in identifying growth trends and in comparisons of revenue with prior and future periods and non-GAAP profitability measures that assist in understanding the long-term profitability trends of the Company's business and in comparisons of its profits with prior and future periods.

The Company excludes certain items from its non-GAAP revenue measures because these items can vary dramatically between periods and can obscure underlying business trends. Items excluded from the Company’s non-GAAP revenue measures include: foreign currency transactions and translation; more or fewer shipping days in a period and the impact of acquisitions.

The Company excludes certain items from its non-GAAP profitability measures because these items may not be indicative of, or are unrelated to, the Company's core operating performance. Items excluded from the Company's non-GAAP profitability measures include: restructuring, acquisition and integration-related and other costs, legal settlements, reserves and fees, impairment of goodwill and indefinite-lived intangibles, acquisition purchase accounting, including inventory step-up from purchase accounting, adjustments of indemnification asset, adjustments of uncertain tax position and European tax restructuring.
2026-10-29 22:01 2d ago
2026-10-29 16:17 2d ago
Mohawk Industries Introduces Strategic and Capital Allocation Framework and Announces New $500 Million Share Repurchase Authorization
MHK Mohawk Industries
FMP Stock News
Original source text
 | Source: Mohawk Industries, Inc.

CALHOUN, Ga., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK), the world’s largest flooring and design surfaces company, today introduced the strategic and capital allocation framework that will guide the Company’s priorities and shareholder value creation approach over the long term.

The framework was developed by management in collaboration with the Board of Directors, which has approved the plan. Consistent with the framework’s priorities, the Board has also approved a new share repurchase program authorizing the Company to repurchase up to $500 million of its common stock. Management will discuss the framework in more detail on the Company’s third quarter 2026 earnings conference call on Friday, October 30, 2026.

Commenting on the updates, CEO Paul De Cock stated, “Mohawk’s strengths – our leading market positions, our recognized brands, our innovation expertise, our customer relationships, and the scale and efficiency of our manufacturing and distribution – remain firmly in place. Amplifying our strengths with a clear and defined strategic and capital allocation framework will sharpen our focus, support disciplined execution, and underpin strong cash generation. We will strategically invest to grow and will deploy excess free cash to create value for shareholders through buybacks.”

STRATEGIC FRAMEWORK

The Company is aligning its actions and investments around a strategic framework comprising four pillars:

Outperforming our MarketsProduct Innovation and Brand StrengthProfitability and Operational ExcellenceCash Generation and Capital Discipline These goals and underlying actions are in support of delivering more value to customers and more value per share to investors.

CAPITAL ALLOCATION FRAMEWORK

To support the Company's strategy execution, management is also introducing a capital allocation framework based on the following priorities:

Organic Investment: Invest in the highest-returning organic opportunities that sustain its core strengths, with limited need for additional capacity and baseline capital expenditures expected to be approximately $375 million annually for at least the next several years.Inorganic Investment: Disciplined evaluation of bolt-on acquisitions, executed only where they generate the highest returns and bring strategic value beyond the financial return.Share Repurchases: Consistent return to shareholders, through share repurchases, of capital not deployed in support of these priorities. In addition, the Company seeks to maintain a strong and efficient balance sheet with a long-term net debt to adjusted EBITDA target of up to 2.0x, subject to a continuous assessment of cyclical risk and the Company’s commitment to its investment-grade credit ratings.

SHARE REPURCHASE AUTHORIZATION

The Company is announcing a new $500 million share repurchase program, effective immediately, which follows the completion of its prior $500 million authorization, approved in July 2025.

Under the prior program, the Company repurchased approximately 7% of shares outstanding at an average price of approximately $119 per share, including $261 million of repurchases in the third quarter of 2026 and $34 million in the fourth quarter to date.

Under the new authorization, the Company may purchase common stock in open market transactions, block or privately negotiated transactions, pursuant to trading plans in accordance with Rule 10b5-1 and Rule 10b-18 under the Securities Exchange Act of 1934, as amended, or by any combination of such methods. The timing and amount of repurchases will depend on the Company’s cash generation, net leverage, market conditions, the price of the Company’s common stock and other factors. No time limit has been set for completion of the program, which does not obligate the Company to repurchase any specific number of shares and may be suspended or discontinued at any time.

ABOUT MOHAWK INDUSTRIES

Over the past two decades, Mohawk Industries has transformed its business into the world’s largest flooring and design surfaces company with leading positions in North America, Europe, South America and Oceania. Mohawk’s vertically integrated manufacturing and distribution operations provide a competitive advantage in the production of ceramic tile, carpet and laminate, wood, vinyl and hybrid flooring products. Mohawk’s industry-leading innovation has yielded designs and performance enhancements that differentiate its collections in the marketplace and satisfy all residential and commercial remodeling and new construction requirements. The Company’s brands are among the most recognized and respected in the industry and include American Olean, Daltile, Durkan, Eliane, Elizabeth, Feltex, Godfrey Hirst, Karastan, Marazzi, Mohawk, Mohawk Group, Mohawk Home, Mohawk Performance Accessories, Pergo, Quick-Step, Unilin and Vitromex.

Certain of the statements in this press release, particularly those anticipating future performance, business prospects, growth and operating strategies, and similar matters, and those that include the words “could,” “should,” “believes,” “anticipates,” “expects” and “estimates” or similar expressions constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. For those statements, Mohawk Industries, Inc. (“Mohawk” or the “Company”) claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Management believes that these forward-looking statements are reasonable as and when made; however, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. There can be no assurance that the forward-looking statements will be accurate because they are based on many assumptions, which involve risks and uncertainties. Important factors that could cause future results to differ from historical experience and our present expectations or projections include, but are not limited to, the following: changes in economic or industry conditions, including interest rates, availability of credit and residential and commercial construction and remodeling activity; the impact of tariffs and other trade restrictions; competition; inflation and deflation in raw material prices, freight and other input costs; inflation and deflation in consumer markets; currency fluctuations; rising energy costs and changes in the level of supply thereof; supply chain disruption and the availability of raw materials and sourced products; labor availability and costs; timing and level of capital expenditures; timing and implementation of price increases for the Company’s products; impairment charges; identification and consummation of acquisitions on favorable terms, if at all; integration of acquisitions; international operations; introduction of new products; rationalization of operations; tax and tax reform, product and other claims; litigation; geopolitical conflicts; sanctions and import and export restrictions; regulatory and political changes in the jurisdictions in which the Company does business; security breaches and other cybersecurity incidents; emerging issues related to the Company’s integration and use of AI; and other risks identified in Mohawk’s United States Securities and Exchange Commission reports and public announcements.

Conference call Friday, October 30, 2026, at 11:00 AM Eastern Time

To participate in the conference call via the Internet, please visit https://ir.mohawkind.com/events/event-details/mohawk-industries-inc-3rd-quarter-2026-earnings-call. To participate in the conference call via telephone, register in advance at https://dpregister.com/sreg/10211917/104de4a22d1 to receive a unique personal identification number. You may also dial 1-833-630-1962 (U.S./Canada) or 1-412-317-1843 (international) on the day of the call for operator assistance. For those unable to listen at the designated time, the call will remain available for replay through November 27, 2026, by dialing 1-855-669-9658 (U.S./Canada) or 1-412-317-0088 (international) and entering Replay Access Code 7228212. The call will be archived and available for replay for one year under the “Investors” tab of mohawkind.com.

INVESTOR CONTACT
Joe Ahlersmeyer, CFA
VP, Finance & Investor Relations
[email protected]
2026-10-29 22:01 2d ago
2026-10-29 16:09 2d ago
California Water Service Group (CWT) Q3 2026 Earnings Call Transcript
CWT California Water Service Group
FMP Stock News
Original source text
California Water Service Group ( CWT ) Q3 2026 Earnings Call October 29, 2026 11:00 AM EDT Company Participants James Lynch - Senior VP, CFO, Principal Financial Officer & Treasurer Martin Kropelnicki - Chairman, President & CEO Conference Call Participants Davis Sunderland - Robert W. Baird & Co. Incorporated, Research Division Agnieszka Storozynski - Seaport Research Partners Presentation Operator Ladies and gentlemen, welcome to the California Water Service Group Q3 2026 Earnings Call.
2026-10-29 22:00 2d ago
2026-10-29 16:05 2d ago
Itron Announces Participation at Upcoming Investor Conferences
ITRI Itron
FMP Stock News
Original source text
 | Source: Itron, Inc.

LIBERTY LAKE, Wash., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, announced today that it will participate in the following upcoming conferences:

Baird Global Industrial Conference, Nov. 11, 2026, Chicago – Joel Vach, vice president of tax, treasury and merger, divestitures and acquisitions, will participate in a fireside chat and investor meetings.Stephens Annual Investment Conference, Nov. 17, 2026, Nashville – John Marcolini, senior vice president for Networked Solutions will participate in a fireside chat and investor meetings. About Itron

Itron is transforming how the world manages energy, water and city services. Our trusted intelligent infrastructure solutions help utilities and cities improve efficiency, build resilience and deliver safe, reliable and affordable service. With edge intelligence, we connect people, data insights and devices so communities can better manage the essential resources they rely on to live and thrive. Join us as we create a more resourceful world: www.itron.com.

Itron® and the Itron Logo are registered trademarks of Itron, Inc. in the United States and other countries and regions. All third-party trademarks are property of their respective owners, and any usage herein does not suggest or imply any relationship between Itron and the third party unless expressly stated.

For additional information, contact:

Itron, Inc.

Paul Vincent
Vice President, Investor Relations
512-560-1172

Stephanie Tarlton, CFA
Principal, Investor Relations
(512) 676-8365
[email protected]

Itron, Inc.

LinkedIn: www.linkedin.com/company/itronincX: https://x.com/ItronIncNewsroom: https://na.itron.com/newsroomBlog: https://blogs.itron.com
2026-10-29 21:59 2d ago
2026-10-29 17:29 2d ago
Polaris Declares Regular Cash Dividend
PII Polaris Industries
FMP Stock News
Original source text
, /PRNewswire/ -- Polaris Inc. (NYSE: PII) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.68 per share payable on December 15, 2026 to shareholders of record at the close of business on December 1, 2026.

About Polaris 
As the global leader in powersports, Polaris Inc. (NYSE: PII) has been defining and redefining outdoor adventure since 1954. Polaris delivers industry-shaping off-road vehicles, snowmobiles, boats, military, quadricycles, and commercial transportation vehicles, along with an expansive portfolio of parts, garments, and accessories. Its lineup includes some of the most iconic brands in powersports including the RANGER, RZR, Polaris XPEDITION, Bennington pontoons, Slingshot, and more. Headquartered in Minnesota and serving customers in nearly 100 countries, Polaris continues to set the standard for performance, quality, and unmatched service. Explore more at www.polaris.com.

SOURCE Polaris Inc.
2026-10-29 21:59 2d ago
2026-10-29 16:15 2d ago
DXC Technology Reports Second Quarter Fiscal Year 2027 Results
DXC DXC Technology
FMP Stock News
Original source text
Total revenue for Q2 FY27 of $3.03 billion, down 4.0% YoY, down 4.0% on an organic basis(1)Q2 FY27 EBIT margin of 2.2%, and adjusted EBIT(2) margin of 6.2%Q2 FY27 Diluted earnings per share of $0.15; Non-GAAP diluted earnings per share(3) of $0.67, down 20.2% YoYFree cash flow(4) for the first half of FY27 was $405 million, compared to $337 million last yearQ2 FY27 Bookings of $2.4 billion, trailing twelve month book to bill ratio of 1.0xRepurchased $60 million of shares, /PRNewswire/ -- DXC Technology (NYSE: DXC) today reported results for the second quarter fiscal 2027.

"On the quarter, we delivered revenue, adjusted EBIT, and Non-GAAP diluted EPS above our expectations, while making progress with the agentic and AI-based solutions that we expect will contribute to future growth. The revenue ramp for agentic solutions is more clear in terms of average deal size, close cycle timing, and pace of follow-on work," said Raul Fernandez, CEO of DXC Technology. "While our core revenue recovery will take time, I am confident that our role operating mission-critical systems gives DXC a differentiated position as enterprises look to deploy AI at scale."

Financial Highlights - Second Quarter Fiscal Year 2027

Total revenue was $3.03 billion, down 4.0% year-over-year (down 4.0% on an organic basis).(1)EBIT was $66 million, down 52.2% year-over-year with a corresponding margin of 2.2%. Adjusted EBIT(2) was $187 million, down 26.4% year-over-year, with a corresponding margin(2) of 6.2%.Diluted earnings per share was $0.15. Non-GAAP diluted earnings per share(3) was $0.67, down 20.2% year-over-year.Cash generated from operations was $217 million, down 46.9% year-over-year. Free cash flow(4) was $91 million, compared to $240 million in the second quarter of fiscal year 2026. Free cash flow(4) for the first half of FY27 was $405 million, compared to $337 million last year.Bookings of $2.4 billion declined 10% year-over-year, with a book to bill ratio of 0.80x.Returned $60 million of capital to shareholders by repurchasing approximately 5.7 million shares.DXC acknowledges ongoing discussions regarding a possible sale of its insurance business.(1)

Revenue growth on an organic basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period's foreign currency exchange rates, adjusted for the impact of acquisitions and divestitures. A reconciliation of GAAP to non-GAAP measure are attached to this release.

(2)

Adjusted EBIT and Adjusted EBIT margin are non-GAAP measures. Reconciliations of GAAP Net Income to such measures are attached to this release.

(3)

Non-GAAP diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to non-GAAP diluted per share is attached to this release.

(4)

Free cash flow is a non-GAAP measure, calculated by subtracting capital expenditures (Purchase of Property, Plant & Equipment, Transition and Transformation Contract Costs and Software Purchased or Developed) from cash flow from operations.

Segment Highlights - Second Quarter Fiscal Year 2027

Consulting and Engineering Services ("CES")

Revenue was $1,213 million, down 3.3% year-over-year (down 3.3% on an organic basis).(1)Segment profit was $125 million, down 13.8% year-over-year, with a corresponding margin of 10.3%.Bookings declined 17.0% year-over-year, with a book to bill ratio of 0.79x.Global Infrastructure Services ("GIS")

Revenue was $1,427 million, down 10.0% year-over-year (down 10.0% on an organic basis).(1)Segment profit was $66 million, down 45.9% year-over-year, with a corresponding margin of 4.6%.Bookings declined 12.7% year-over-year, with a book to bill ratio of 0.80x.Insurance Software & Services ("Insurance")

Revenue was $394 million, up 23.1% year-over-year (up 23.1% on an organic basis).(1) Organic revenue growth includes a favorable contract modification entered into during the second quarter of fiscal 2027.Segment profit was $45 million, up 60.7% year-over-year, with a corresponding margin of 11.4%.Bookings increased 43.5% year-over-year, with a book to bill ratio of 0.79x.Full Fiscal Year 2027 and Third Quarter Fiscal Year 2027 Guidance

Full Fiscal Year 2027

Total revenue in the range of $11.91 billion and $11.98 billion, a decline of 5.5% to 5.0% year-over-year on an organic basis.(1)Adjusted EBIT margin(2) in the range of 5.75% to 6.25%.Non-GAAP diluted EPS(3) in the range of $2.25 to $2.50. Free Cash Flow(4) of ~$600 million.Third Quarter Fiscal 2027

Total revenue of ~$2.98 billion, a decline of ~6.0% year-over-year on an organic basis.(1)Adjusted EBIT margin(2) of ~6.0%.Non-GAAP Diluted EPS(3) of ~$0.55.Additional metrics for the third quarter and full fiscal year 2027 guidance are presented in the table below.

Revenue

Q3 FY27

Guidance

FY27 Guidance

Low

High

YoY Organic Revenue %

~(6.0)%

(5.5) %

(5.0) %

Acquisition & Divestitures Revenues %

— %

— %

Foreign Exchange Impact on Revenues %

(0.8) %

(0.3) %

Others

Non-GAAP Net Interest Expense ($M)*

~$15

~$54

Non-GAAP Tax Rate

~44%

~42%

Foreign Exchange Assumptions

Current Estimate

Current Estimate

$/Euro Exchange Rate

$1.12

$1.14

$/GBP Exchange Rate

$1.32

$1.33

$/AUD Exchange Rate

$0.70

$0.70

_________

* Excludes $46 million of interest income from the full year for the TCS litigation judgment

DXC does not provide reconciliations of non-GAAP measures included in its guidance because certain key information necessary for such reconciliations—most notably the impact of significant non-recurring items—is unavailable without unreasonable effort or may not be available at all. As a result, DXC believes any such reconciliation would not be meaningful.

Earnings Conference Call and Webcast

DXC Technology senior management will host a conference call and webcast to discuss second quarter fiscal 2027 results at 5:00 p.m. ET on October 29, 2026. The dial-in number for domestic callers is 833-461-5787. Callers who reside outside of the United States should dial +1-585-542-9983. The passcode for all participants is 964068. The webcast audio and any presentation slides will be available through a link posted on DXC Technology's Investor Relations website.

A replay of the conference call will be available until 11:59 p.m. ET on November 5, 2026, at 833-309-1852. The replay passcode is 964068. A transcript of the conference call will be posted on DXC Technology's Investor Relations website.

About DXC Technology

DXC Technology (NYSE: DXC) is a leading enterprise technology and innovation partner delivering software, services, and solutions to global enterprises and public sector organizations — helping them harness AI to drive outcomes at a time of exponential change with speed.  With deep expertise in Managed Infrastructure Services, Application Modernization, and Industry-Specific Software Solutions, DXC modernizes, secures, and operates some of the world's most complex technology estates. Learn more at DXC.com.

Forward-Looking Statements

Except for historical information, statements in this document may constitute "forward-looking statements" based on our current assumptions regarding future performance. These statements involve numerous risks, uncertainties, and other factors outside our control that could cause actual results to differ materially, including: inability to effectively manage our sales organization, including execution, pipeline, and talent management; our inability to expand service offerings to address emerging technological trends and competitive pressures; failure to attract and retain key personnel, including artificial intelligence (AI) and technical experts, or maintain partner relationships; risks associated with AI, including adoption, deployment, and governance, reliance on third-party platforms, cybersecurity, privacy, evolving regulations, and competitive displacement; inability to accurately estimate contract costs and timelines, or failure by us or third parties to deliver on commitments; systems failures, catastrophic events, and resulting service interruptions; liability or reputational damage from security breaches, cyber-attacks, or disclosure of confidential or personal data; failure to comply with new or existing laws, regulations, and customer contracts, including those relating to data privacy, economic sanctions, export controls, AI, and environmental, social, and governance (ESG) expectations; failure to maintain our credit rating, manage indebtedness, or raise capital, adversely affecting our liquidity and borrowing costs; risks associated with international operations, including exchange rate fluctuations and geopolitical conflicts (such as in Russia/Ukraine and the Middle East); macroeconomic challenges, including inflation, reduced customer spending, and economic slowdowns affecting deal closures and cost-takeout efforts; inability to compete effectively, maintain customer relationships, collect receivables, or comply with government contracting regulations; failure to succeed in strategic transactions, acquisitions, or partnerships; securities price volatility; supply chain disruptions, supplier non-performance, or increased procurement costs due to trade tensions, tariffs, or hostilities; climate change, natural disasters, and increased scrutiny of ESG initiatives; infringement of intellectual property rights, or inability to procure necessary third-party licenses; failure to achieve expected benefits of restructuring plans, workforce reductions, and automation/AI reliance; failure to maintain effective disclosure controls and internal control over financial reporting; asset impairment charges, including but not limited to intangibles and deferred tax assets; inability to pay dividends or repurchase shares; pending investigations, claims, and disputes; changes in tax rates, tax laws, and the timing and outcome of tax examinations; and risks related to completed strategic transactions. For a written description of these factors, see our most recently filed Annual Report on Form 10-K, and any updating information in subsequent SEC filings. Forward-looking statements speak only as of the date made. Except as required by law, we assume no obligation to update or revise any forward-looking statements.

About Non-GAAP Measures

In an effort to provide investors with supplemental financial information, in addition to the preliminary and unaudited financial information presented on a GAAP basis, we also disclose in this press release preliminary non-GAAP information including: earnings before interest and taxes ("EBIT"), EBIT margin, adjusted EBIT, adjusted EBIT margin, non-GAAP diluted EPS, organic revenues, organic revenue growth, free cash flow, and non-GAAP tax rate.

We believe EBIT, adjusted EBIT, non-GAAP income before income taxes, non-GAAP net income, non-GAAP net income attributable to DXC common stockholders, and non-GAAP EPS provide investors with useful supplemental information about our operating performance after excluding certain categories of expenses as well as gains and losses on certain dispositions and certain tax adjustments.

We believe constant currency revenues provides investors with useful supplemental information about our revenues after excluding the effect of currency exchange rate fluctuations for currencies other than U.S. dollars in the periods presented. See below for a description of the methodology we use to present constant currency revenues.

One category of expenses excluded from adjusted EBIT, non-GAAP income before income tax, non-GAAP net income, non-GAAP net income attributable to DXC common stockholders, and non-GAAP EPS, incremental amortization of intangible assets acquired through business combinations, if included, may result in a significant difference in period over period amortization expense on a GAAP basis. We exclude amortization of certain acquired intangible assets as these non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Although DXC management excludes amortization of acquired intangible assets, primarily customer-related intangible assets, from its non-GAAP expenses, we believe it is important for investors to understand that such intangible assets were recorded as part of purchase accounting and support revenue generation. Any future transactions may result in a change to the acquired intangible asset balances and associated amortization expense.

Another category of expenses excluded from adjusted EBIT, non-GAAP income before income tax, non-GAAP net income, non-GAAP net income attributable to DXC common stockholders, and non-GAAP EPS is impairment losses, which, if included, may result in a significant difference in period-over-period expense on a GAAP basis. We exclude impairment losses as these non-cash amounts reflect generally an acceleration of what would be multiple periods of expense and are not expected to occur frequently. Further, assets such as goodwill may be significantly impacted by market conditions outside of management's control.

Selected references are made to revenue growth on an "organic basis" in order that certain financial results can be viewed without the impact of fluctuations in foreign currency rates and without the impacts of acquisitions and divestitures, thereby providing comparisons of operating performance from period to period of the business that we have owned during both periods presented. Organic revenue growth is calculated by dividing the year-over-year change in GAAP revenues attributed to organic growth by the GAAP revenues reported in the prior comparable period. Organic revenue is calculated as constant currency revenue excluding the impact of mergers, acquisitions or similar transactions until the one-year anniversary of the transaction and excluding revenues of divestitures during the reporting period. This approach is used for all results where the functional currency is not the U.S. dollar. We believe organic revenue growth provides investors with useful supplemental information about our revenues after excluding the effect of currency exchange rate fluctuations for currencies other than U.S. dollars and the effects of acquisitions and divestitures in both periods presented.

Free cash flow represents cash flow from operations, less capital expenditures. Free cash flow is utilized by our management, investors, and analysts to evaluate cash available for normal business operations, to pay debt, repurchase shares, and provide further investment in the business.

There are limitations to the use of the non-GAAP financial measures presented in this report. One of the limitations is that they do not reflect complete financial results. We compensate for this limitation by providing a reconciliation between our non-GAAP financial measures and the respective most directly comparable financial measure calculated and presented in accordance with GAAP. Additionally, other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes between companies. Selected references are made on a "constant currency basis" so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby providing comparisons of operating performance from period to period. Financial results on a "constant currency basis" are non-GAAP measures calculated by translating current period activity into U.S. Dollars using the comparable prior period's currency conversion rates. This approach is used for all results where the functional currency is not the U.S. Dollar.

Condensed Consolidated Statements of Operations
(preliminary and unaudited)

Three Months Ended

Six Months Ended

(in millions, except per-share amounts)

September 30,

2026

September 30,

2025

September 30,

2026

September 30,

2025

Revenues

$           3,034

$           3,161

$           6,033

$             6,320

Costs of services

2,374

2,383

4,762

4,771

Selling, general and administrative

319

366

647

760

Depreciation and amortization

286

295

553

599

Restructuring costs

23

35

49

72

Interest expense

57

53

112

107

Interest income

(45)

(46)

(134)

(92)

Other income, net

(34)

(56)

(251)

(95)

Total costs and expenses

2,980

3,030

5,738

6,122

Income before income taxes

54

131

295

198

Income tax expense

41

91

156

140

Net income

13

40

139

58

Less: net (loss) income attributable to non-controlling

interest, net of tax

(11)

4

(7)

6

Net income attributable to DXC common stockholders

$              24

$              36

$             146

$                52

Income per common share:

Basic

$            0.15

$            0.20

$            0.91

$              0.29

Diluted

$            0.15

$            0.20

$            0.89

$              0.29

Weighted average common shares outstanding for:

   Basic EPS

158.16

177.43

160.50

179.26

   Diluted EPS

161.99

179.15

164.39

181.76

Selected Condensed Consolidated Balance Sheet Data
(preliminary and unaudited)

As of

(in millions)

September 30, 2026

March 31, 2026

Assets

Cash and cash equivalents

$              1,599

$              1,737

Receivables, net

2,815

2,973

Prepaid expenses

447

526

Other current assets

119

126

Total current assets

4,980

5,362

Intangible assets, net

1,370

1,612

Operating right-of-use assets, net

601

663

Goodwill

527

527

Deferred income taxes, net

785

802

Property and equipment, net

1,083

1,122

Other assets

2,864

2,802

Total Assets

$             12,210

$             12,890

Liabilities

Short-term debt and current maturities of long-term debt

$                935

$                520

Accounts payable

614

561

Accrued payroll and related costs

568

564

Operating lease liabilities

231

232

Accrued expenses and other current liabilities

1,222

1,261

Deferred revenue and advance contract payments

667

748

Income taxes payable

112

53

Total current liabilities

4,349

3,939

Long-term debt, net of current maturities

2,124

3,032

Non-current deferred revenue

468

559

Non-current operating lease liabilities

403

463

Non-current income tax liabilities and deferred tax liabilities

375

502

Other long-term liabilities

1,172

1,186

Total Liabilities

8,891

9,681

Total Equity

3,319

3,209

Total Liabilities and Equity

$             12,210

$             12,890

Condensed Consolidated Statements of Cash Flows
(preliminary and unaudited)

Six Months Ended

(in millions)

September 30,

2026

September 30,

2025

Cash flows from operating activities:

Net income

$                139

$                 58

Adjustments to reconcile net income to net cash provided by operating activities:

 Depreciation and amortization

560

611

 Goodwill impairment losses

—

14

 Operating right-of-use expense

140

153

 Share-based compensation

33

46

 Deferred taxes

13

22

 Loss (gain) on dispositions

7

(5)

 Provision for losses on accounts receivable

1

3

 Unrealized foreign currency exchange gain

(6)

(38)

 Impairment losses and contract write-offs

39

3

 Other non-cash charges, net

(5)

(8)

Changes in assets and liabilities:

 Decrease in assets

119

211

 Decrease in operating lease liability

(140)

(153)

 Decrease in other liabilities

(265)

(322)

Net cash provided by operating activities

635

595

Cash flows from investing activities:

 Purchases of property and equipment

(133)

(87)

 Payments for transition and transformation contract costs

(49)

(58)

 Software purchased and developed

(48)

(113)

 Proceeds from sale of assets

32

23

 Other investing activities, net

11

13

Net cash used in investing activities

(187)

(222)

Cash flows from financing activities:

 Principal payments on long-term debt

(400)

—

 Payments on finance leases and borrowings for asset financing

(73)

(107)

 Taxes paid related to net share settlements of share-based compensation awards

(11)

(13)

 Repurchase of common stock

(132)

(124)

 Other financing activities, net

(2)

(2)

Net cash used in financing activities

(618)

(246)

Effect of exchange rate changes on cash and cash equivalents

32

(35)

Net (decrease) increase in cash and cash equivalents

(138)

92

Cash and cash equivalents at beginning of year

1,737

1,796

Cash and cash equivalents at end of period

$              1,599

$              1,888

Reconciliation of Non-GAAP Financial Measures

Our non-GAAP adjustments include:

Restructuring costs – includes costs, net of reversals, related to workforce and real estate optimization and other similar charges.Transaction, separation and integration-related ("TSI") costs – includes third party costs related to integration, separation, planning, financing and advisory fees and other similar charges associated with mergers, acquisitions, strategic investments, joint ventures, and dispositions and other similar transactions incurred within one year of such transactions closing, except for costs associated with related disputes, which may arise more than one year after closing.Amortization of acquired intangible assets – includes amortization of intangible assets acquired through business combinations.Merger-related indemnification – represents the Company's estimate of potential net liability for tax related indemnifications.Gain on litigation award – reflects a gain related to the TCS Litigation judgment.Gains and losses on real estate and facility sales – gains and losses related to dispositions of real property.Gains and losses on dispositions – gains and losses related to dispositions of businesses, strategic assets and interests in less than wholly-owned entities.Impairment losses – non-cash charges associated with the permanent reduction in the value of the Company's assets (e.g., impairment of goodwill and other long-term assets including fixed assets and impairments to deferred tax assets for discrete changes in valuation allowances). Future discrete reversals of valuation allowances are likewise excluded.Tax adjustments – discrete tax adjustments to impair or recognize certain deferred tax assets, adjustments for changes in tax legislation and the impact of merger and divestitures. Income tax expense of all other (non-discrete) non-GAAP adjustments is based on the difference in the GAAP annual effective tax rate (AETR) and overall non-GAAP provision (consistent with the GAAP methodology).Non-GAAP Results

A reconciliation of reported results to non-GAAP results is as follows:

Three Months Ended September 30, 2026

(in millions, except per-share amounts)

As

Reported

Restructuring

Costs

Transaction,

Separation

and

Integration-

Related

Costs

Amortization

 of Acquired

Intangible

Assets

(Gains) and

Losses on

Real Estate,

Facility Sales

and 

Dispositions

Tax

Adjustment

Non-GAAP

Results

Income before income taxes

$       54

$        23

$         3

$        86

$         9

$         —

$      175

Income tax expense

41

7

1

28

3

(2)

78

Net income

13

16

2

58

6

2

97

Less: net income attributable to non-controlling interest, net of tax

(11)

—

—

—

—

—

(11)

Net income attributable to DXC common stockholders

$       24

$        16

$         2

$        58

$         6

$         2

$      108

Effective Tax Rate

75.9 %

44.6 %

Basic EPS from continuing operations

$     0.15

$       0.10

$       0.01

$       0.37

$       0.04

$       0.01

$     0.68

Diluted EPS from continuing operations

$     0.15

$       0.10

$       0.01

$       0.36

$       0.04

$       0.01

$     0.67

Weighted average common shares outstanding for:

Basic EPS

158.16

158.16

158.16

158.16

158.16

158.16

158.16

Diluted EPS

161.99

161.99

161.99

161.99

161.99

161.99

161.99

Six Months Ended September 30, 2026

(in millions, except per-share amounts)

As

Reported

Restructuring

Costs

Transaction,

Separation

and

Integration-

Related

Costs

Amortization

 of Acquired

Intangible

Assets

Gain on

Litigation

Award

(Gains) and

Losses on

Real Estate,

Facility Sales

and

Dispositions

Tax

Adjustment

Non-GAAP

Results

Income before income taxes

$      295

$        49

$         3

$       173

$       (214)

$         7

$         —

$      313

Income tax expense

156

19

1

68

(99)

2

(2)

145

Net income

139

30

2

105

(115)

5

2

168

Less: net income attributable to non-controlling

interest, net of tax

(7)

—

—

—

—

—

—

(7)

Net income attributable to DXC common stockholders

$      146

$        30

$         2

$       105

$       (115)

$         5

$         2

$      175

Effective Tax Rate

52.9 %

46.3 %

Basic EPS from continuing operations

$     0.91

$       0.19

$       0.01

$       0.65

$      (0.72)

$       0.03

$       0.01

$     1.09

Diluted EPS from continuing operations

$     0.89

$       0.18

$       0.01

$       0.64

$      (0.70)

$       0.03

$       0.01

$     1.06

Weighted average common shares outstanding for:

Basic EPS

160.50

160.50

160.50

160.50

160.50

160.50

160.50

160.50

Diluted EPS

164.39

164.39

164.39

164.39

164.39

164.39

164.39

164.39

Three Months Ended September 30, 2025

(in millions, except per-share amounts)

As

Reported

Restructuring

Costs

Transaction,

Separation

and

Integration-

Related

Costs

Amortization

 of Acquired

Intangible

Assets

Merger

Related

Indemnification

(Gains) and

Losses on

Real Estate,

Facility Sales

and

Dispositions

Tax

Adjustment

Non-GAAP

Results

Income before income taxes

131

35

1

88

—

(8)

—

247

Income tax expense

91

6

—

15

(2)

(1)

(16)

93

Net income

40

29

1

73

2

(7)

16

154

Less: net income attributable to non-controlling interest,

net of tax

4

—

—

—

—

—

—

4

Net income attributable to DXC common stockholders

$       36

$          29

$            1

$          73

$            2

$           (7)

$          16

$      150

Effective Tax Rate

69.5 %

37.7 %

Basic EPS

$     0.20

$       0.16

$       0.01

$       0.41

$       0.01

$      (0.04)

$       0.09

$     0.85

Diluted EPS

$     0.20

$       0.16

$       0.01

$       0.41

$       0.01

$      (0.04)

$       0.09

$     0.84

Weighted average common shares outstanding for:

Basic EPS

177.43

177.43

177.43

177.43

177.43

177.43

177.43

177.43

Diluted EPS

179.15

179.15

179.15

179.15

179.15

179.15

179.15

179.15

Six Months Ended September 30, 2025

(in millions, except per-share

amounts)

As

Reported

Restructuring

Costs

Transaction,

Separation

and

Integration-

Related

Costs

Amortization

 of Acquired

Intangible

Assets

Merger

Related

Indemnification

(Gains) and
Losses on
Real Estate,
Facility Sales
and
Dispositions

Impairment

Losses

Tax

Adjustment

Non-GAAP

Results

Income before income taxes

198

72

2

175

2

(8)

14

—

455

Income tax expense

140

15

—

35

(2)

(1)

4

(18)

173

Net income

58

57

2

140

4

(7)

10

18

282

Less: net income attributable to non-

controlling interest, net of tax

6

—

—

—

—

—

—

—

6

Net income attributable to DXC

common stockholders

$       52

$        57

$         2

$       140

$         4

$        (7)

$        10

$        18

$      276

Effective Tax Rate

70.7 %

38.0 %

Basic EPS

$     0.29

$       0.32

$       0.01

$       0.78

$       0.02

$      (0.04)

$       0.06

$       0.10

$     1.54

Diluted EPS

$     0.29

$       0.31

$       0.01

$       0.77

$       0.02

$      (0.04)

$       0.06

$       0.10

$     1.52

Weighted average common shares outstanding for:

Basic EPS

179.26

179.26

179.26

179.26

179.26

179.26

179.26

179.26

179.26

Diluted EPS

181.76

181.76

181.76

181.76

181.76

181.76

181.76

181.76

181.76

The above tables serve to reconcile the non-GAAP financial measures to the most directly comparable GAAP measures. Please refer to the "About Non-GAAP Measures" section of the press release for further information on the use of these non-GAAP measures.

Year-over-Year Organic Revenue Growth

Three Months Ended

Six Months Ended

September 30,

2026

September 30,

2025

September 30,

2026

September 30,

2025

Total revenue growth

(4.0) %

(2.5) %

(4.5) %

(2.4) %

Foreign currency

— %

(1.9) %

(0.8) %

(2.0) %

Acquisitions and Divestitures

— %

0.2 %

— %

0.1 %

Organic revenue growth

(4.0) %

(4.2) %

(5.3) %

(4.3) %

CES revenue growth

(3.3) %

(1.9) %

(2.3) %

(2.3) %

Foreign currency

— %

(1.9) %

(0.8) %

(2.0) %

Acquisitions and Divestitures

— %

0.4 %

— %

0.4 %

CES organic revenue growth

(3.3) %

(3.4) %

(3.1) %

(3.9) %

GIS revenue growth

(10.0) %

(4.2) %

(9.7) %

(3.9) %

Foreign currency

— %

(2.1) %

(0.9) %

(2.1) %

Acquisitions and Divestitures

— %

— %

— %

— %

GIS organic revenue growth

(10.0) %

(6.3) %

(10.6) %

(6.0) %

Insurance revenue growth

23.1 %

4.6 %

12.6 %

5.0 %

Foreign currency

— %

(1.0) %

(0.2) %

(1.4) %

Acquisitions and Divestitures

— %

— %

— %

— %

Insurance organic revenue growth

23.1 %

3.6 %

12.4 %

3.6 %

Segment Profit

Segment profit is defined as segment revenues less costs of services, selling, general and administrative, depreciation and amortization, and other segment items. The Company does not allocate to its segments certain operating expenses managed at the corporate level. These unallocated expenses generally include certain corporate function costs, pension and OPEB actuarial and settlement gains and losses, restructuring costs, transaction, separation, and integration-related costs, amortization of acquired intangible assets, impairment losses, gains/(losses) on dispositions of businesses, gains/(losses) on real estate and facility sales, and other costs that do not reflect ongoing segment operating performance. As part of the transition to the new segment structure, the Company updated the assumptions that define which expenses remain in corporate post allocation. The tables below reflect those revised assumptions.

Three Months Ended

Six Months Ended

(in millions)

September 30,

2026

September 30,

2025

September 30,

2026

September 30,

2025

CES profit

$              125

$              145

$              225

$              250

GIS profit

66

122

104

219

Insurance profit

45

28

79

61

Corporate expenses

(49)

(41)

(71)

(60)

Adjusted EBIT

187

254

337

470

Restructuring costs

(23)

(35)

(49)

(72)

Transaction, separation and integration-related

costs

(3)

(1)

(3)

(2)

Amortization of acquired intangible assets

(86)

(88)

(173)

(175)

Merger related indemnification

—

—

—

(2)

Gain on litigation award

—

—

168

—

(Losses) gains on real estate, facility sales and

dispositions

(9)

8

(7)

8

Impairment losses

—

—

—

(14)

EBIT

66

138

273

213

Interest income

45

46

134

92

Interest expense

(57)

(53)

(112)

(107)

Income before income taxes

54

131

295

198

Income tax expense

(41)

(91)

(156)

(140)

Net income

13

40

139

58

Segment profit margins

CES

10.3 %

11.6 %

9.2 %

10.0 %

GIS

4.6 %

7.7 %

3.6 %

6.9 %

Insurance

11.4 %

8.8 %

11.1 %

9.6 %

Total Company margins

Adjusted EBIT margin

6.2 %

8.0 %

5.6 %

7.4 %

EBIT margin

2.2 %

4.4 %

4.5 %

3.4 %

SOURCE DXC Technology Company
2026-10-29 21:59 2d ago
2026-10-29 17:05 2d ago
Glen Burnie Bancorp Reports 2026 Third Quarter Results
TBBK The Bancorp
FMP Stock News
Original source text
GLEN BURNIE, Md., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Glen Burnie Bancorp ("Company") (OTCQX: GLBZ), the bank holding company for The Bank of Glen Burnie ("Bank"), today reported net income of $205 thousand, or approximately $0.07 per diluted common share, for the third quarter of 2026, compared to a net loss of $272 thousand, or $(0.09) per diluted common share, for the second quarter of 2026, and net income of $125 thousand, or $0.04 per diluted common share, for the third quarter of 2025.

For the nine months ended September 30, 2026, the Company reported net income of $17 thousand, or approximately $0.01 per diluted common share, compared to net income of $66 thousand, or approximately $0.02 per diluted common share, for the first nine months of 2025.

Pre-tax pre-provision income was $299 thousand for the third quarter of 2026, compared to $117 thousand for the second quarter and $131 thousand for the third quarter of 2025. For the nine months ended September 30, 2026, pre-tax pre-provision income was $538 thousand, an improvement of approximately $1.2 million from a pre-tax pre-provision loss of $662 thousand for the first nine months of 2025.

Third-quarter results reflected meaningful improvement in the Company's underlying operating performance as earlier balance-sheet growth began to translate into higher net interest income and improved operating leverage. Net interest income and net interest margin increased, loan yields improved, retail deposit growth exceeded period-end loan growth, and asset quality remained stable. These improvements were partially offset by higher funding and operating costs. Higher market interest rates also increased unrealized losses in the investment securities portfolio, reducing GAAP stockholders' equity and tangible book capital.

Third Quarter 2026 Highlights

Return to quarterly profitability and improved underlying earnings. Net income was $205 thousand for the third quarter of 2026, compared to a net loss of $272 thousand for the second quarter and net income of $125 thousand for the third quarter of 2025. Pre-tax pre-provision income increased to $299 thousand from $117 thousand linked quarter and $131 thousand for the third quarter of 2025. The linked-quarter improvement reflected higher net interest income, lower provision expense and higher noninterest income, partially offset by higher noninterest expense.

Net interest income and margin improved. Net interest income increased $217 thousand, or 7.3%, to $3.2 million for the third quarter from $3.0 million for the second quarter. Compared to the third quarter of 2025, net interest income increased $365 thousand, or 12.9%. The Bank's net interest margin increased to 3.19% from 3.11% linked quarter as the yield on earning assets increased faster than the cost of funds. Loan yield increased to 5.82% from 5.63%, while the overall cost of funds increased to 1.61% from 1.52%.

Continued loan growth with stronger retail deposit growth. Total loans increased $7.5 million, or 2.8%, during the third quarter to $275.1 million at September 30, 2026, compared to $267.6 million at June 30, 2026. For the first nine months of 2026, total loans increased $43.9 million, or 19.0%, from $231.2 million at December 31, 2025. Retail deposits increased $11.9 million, or 3.5%, during the third quarter to $355.1 million. Because retail deposit growth exceeded period-end loan growth, wholesale funding declined $3.9 million to $24.4 million, or approximately 6.1% of total assets, from $28.2 million, or 7.1% of total assets, at June 30, 2026.

Lower provision expense with stable asset quality. The provision for credit losses decreased to $94 thousand for the third quarter of 2026 from $569 thousand for the second quarter. The decrease primarily reflected slower loan growth and changes in reserves associated with purchased consumer loans and unfunded commitments. Asset quality remained stable. Nonperforming loans declined to $625 thousand, or 0.23% of total loans, at September 30, 2026, from $669 thousand, or 0.25%, at June 30, 2026. The allowance for credit losses was $3.2 million, or 1.15% of total loans, at September 30, 2026.

Improved operating leverage. Total noninterest expense increased $88 thousand, or 2.6%, to $3.5 million for the third quarter from $3.4 million for the second quarter. Over the same period, the combined increase in net interest income and noninterest income was approximately $270 thousand. As a result, the Company's efficiency ratio improved to approximately 92.2% from 96.7% linked quarter. The Company's net operating expense ratio improved modestly to 2.89% from 3.00%. While these measures remain above management's longer-term objectives, the quarter reflected progress in generating revenue growth faster than operating expense growth.

Noninterest income increased. Noninterest income increased $53 thousand to $637 thousand for the third quarter from $584 thousand for the second quarter. The increase was primarily attributable to higher interchange income associated with the Maryland Renaissance Festival, partially offset by lower mortgage commission income from VA Wholesale Mortgage. Mortgage commission income totaled $307 thousand for the third quarter, compared to $353 thousand for the second quarter, while related mortgage commission expense declined to $193 thousand from $255 thousand.

Sufficient liquidity. At September 30, 2026, the Bank maintained approximately $53.0 million of cash and unencumbered investment securities and approximately $75.6 million of available secured and unsecured borrowing capacity. Total on- and off-balance-sheet liquidity was approximately $128.6 million, or 32.3% of total assets.

Tangible book value. Stockholders' equity declined to $16.8 million at September 30, 2026 from $21.3 million at June 30, 2026, primarily due to a $4.7 million increase in accumulated other comprehensive loss associated with the market value of available-for-sale investment securities. The unrealized loss on the securities portfolio increased to approximately $27.7 million from $21.1 million, and tangible book value per share declined to approximately $5.62 from $7.16. Although accumulated other comprehensive loss does not affect regulatory capital under the Bank's AOCI opt-out election, it reduces GAAP and tangible book capital and can limit balance-sheet flexibility.

Capital Flexibility and Special Meeting of Stockholders.

The Company has called a Special Meeting of Stockholders (the “Special Meeting”) for December 9, 2026 to consider amendments to its Articles of Incorporation. See the following sections below: “Capital Position and Special Meeting,” “Additional Information and Where to Find It” and, “Participants in the Solicitation.” Stockholders are urged to read the proxy statement and any other relevant materials carefully to understand the potential benefits and risks of the proposals submitted for consideration.

"We saw meaningful progress in the third quarter as the balance-sheet growth generated earlier this year began to translate into improved earnings," said Mark C. Hanna, President and Chief Executive Officer. "Net interest income, margin and pre-tax pre-provision income all improved, while retail deposit growth exceeded loan growth and asset quality remained stable. We remain focused on building sustainable earnings, improving operating leverage and maintaining sufficient liquidity and capital to support our strategy.”

Hanna added, “Higher market rates increased unrealized losses in the securities portfolio and reduced tangible book value, underscoring the importance of maintaining financial flexibility. If approved, the proposals at our December Special Meeting would provide the Company greater flexibility to access the capital markets if and when appropriate and expand the range of capital options available as market conditions and opportunities evolve.”

Operating Results

Net interest income increased $217 thousand to $3.2 million for the third quarter of 2026 from $3.0 million for the second quarter. Compared to the third quarter of 2025, net interest income increased $365 thousand, or 12.9%.

Total interest income increased $382 thousand linked quarter to $4.7 million. Interest and fees on loans increased $433 thousand to approximately $4.0 million from $3.5 million for the second quarter. The increase reflected a $19.0 million, or 7.6%, increase in average loan balances and improved loan yields. Loan yield increased to 5.82% from 5.63%.

Total interest expense increased $165 thousand to $1.5 million for the third quarter from $1.4 million for the second quarter. The increase reflected higher average funding balances and higher funding costs. The overall cost of funds increased to 1.61% from 1.52%. Despite the higher funding cost, the yield on earning assets increased to 4.71% from 4.54%, resulting in an improvement in net interest margin to 3.19% from 3.11%.

Noninterest income increased to $637 thousand for the third quarter from $584 thousand for the second quarter. The linked-quarter increase was primarily attributable to higher interchange income associated with the Maryland Renaissance Festival, partially offset by lower mortgage commission income from VA Wholesale Mortgage. Mortgage commission income, net of related mortgage commission expense, increased modestly to approximately $114 thousand from $98 thousand linked quarter.

Noninterest expense increased to $3.5 million for the third quarter from $3.4 million for the second quarter. Compensation, employee benefits and mortgage commission expense increased approximately $19 thousand on a combined basis, while all other operating expenses increased approximately $69 thousand. The increase in operating expenses was more than offset by growth in net interest income and noninterest income, producing improved operating leverage during the quarter.

The Company's efficiency ratio improved to approximately 92.2% for the third quarter from 96.7% for the second quarter. For the first nine months of 2026, the efficiency ratio improved to approximately 95.0% from approximately 107.3% for the first nine months of 2025. The Company's net operating expense ratio improved to 2.89% for the third quarter from 3.00% for the second quarter. Although these trends are favorable, management believes additional revenue growth and efficiency initiatives remain necessary to create better operating leverage that leads to sustainable profitability and acceptable returns.

Pre-tax pre-provision income increased to $299 thousand for the third quarter from $117 thousand for the second quarter and $131 thousand for the third quarter of 2025. For the first nine months of 2026, pre-tax pre-provision income was $538 thousand compared to a loss of $662 thousand for the same period of 2025.

Nine-month net income remained below the prior-year period despite the substantial improvement in pre-tax pre-provision performance. The first nine months of 2025 benefited from a $498 thousand release of the allowance for credit losses, compared with provision expense of $749 thousand during the first nine months of 2026.

Balance Sheet and Funding

Total assets increased to $398.8 million at September 30, 2026 from $395.0 million at June 30, 2026 and $359.9 million at December 31, 2025.

Total loans increased to $275.1 million at September 30, 2026 from $267.6 million at June 30, 2026 and $231.2 million at December 31, 2025. Average loans increased approximately 7.6% linked quarter to $269.9 million from $250.9 million. Period-end loans exceeded third-quarter average loans by approximately $5.2 million. To the extent these balances are maintained, the higher ending balance provides a modest favorable starting point for fourth-quarter loan-interest income.

Total deposits were approximately $360.5 million at September 30, 2026, compared with approximately $357.0 million at June 30, 2026 and $332.4 million at December 31, 2025. At the Bank level, retail deposits increased $11.9 million during the third quarter to $355.1 million, while wholesale funding declined $3.9 million to $24.4 million.

The mix of customer deposits shifted toward interest-bearing products during the quarter, including approximately $6.0 million that migrated from noninterest-bearing deposits to the Bank's Community Advantage Plus Interest Checking Account. The Bank also experienced growth in money market, local certificate-of-deposit and reciprocal deposit balances.

Loans-to-retail deposits decreased modestly to 77.5% at September 30, 2026 from 78.0% at June 30, 2026, while loans-to-total funding increased modestly to 72.5% from 72.0%. Management believes the Bank continues to maintain sufficient liquidity and funding flexibility while using wholesale funding prudently as a supplemental source to support balance-sheet management and attractive lending opportunities.

Asset Quality

Asset quality remained stable during the third quarter. Nonperforming loans declined to $625 thousand, or 0.23% of total loans, at September 30, 2026 from $669 thousand, or 0.25%, at June 30, 2026.

The allowance for credit losses was $3.2 million, or 1.15% of total loans, at September 30, 2026 compared to $3.2 million, or 1.18%, at June 30, 2026. Management believes the reduction in third-quarter provision expense primarily reflected slower loan growth and changes in reserve requirements associated with purchased consumer loans and unfunded commitments rather than deterioration in credit quality.

Net charge-offs were approximately $148 thousand during the third quarter, compared to $108 thousand during the second quarter and $94 thousand during the third quarter of 2025. Annualized net charge-offs represented approximately 0.22% of average loans in the third quarter, compared with 0.17% in both the second quarter of 2026 and the third quarter of 2025. For the first nine months of 2026, net charge-offs were approximately $310 thousand, or 0.16% of average loans on an annualized basis, compared with $143 thousand, or 0.09%, for the first nine months of 2025.

Capital Position and Special Meeting

Stockholders' equity totaled $16.8 million at September 30, 2026, compared to $21.3 million at June 30, 2026 and $21.4 million at December 31, 2025. The linked-quarter decline was primarily attributable to a $4.7 million increase in accumulated other comprehensive loss associated with higher market interest rates and the resulting decline in the fair value of available-for-sale investment securities.

Accumulated other comprehensive loss increased to $20.0 million at September 30, 2026 from $15.3 million at June 30, 2026. Tangible book value per share declined to approximately $5.62 from $7.16 over the same period. Although the Bank's AOCI opt-out election excludes changes in accumulated other comprehensive income or loss from regulatory capital, the change reduces GAAP and tangible book capital and can limit balance-sheet flexibility. The Bank remains well capitalized with regulatory capital ratios above regulatory minimum requirements at September 30, 2026 with tier 1 leverage and risk-based capital ratios of 8.54% and 11.68%, respectively, and a total risk-based capital ratio of 12.78%.

Continued balance-sheet growth and the decline in tangible book capital reinforce the importance of maintaining financial flexibility. Management remains focused on preserving sufficient liquidity and capital while maintaining the ability to respond to changing market conditions, attractive growth opportunities and other strategic alternatives.

On October 23, 2026, the Company began mailing proxy materials for the Special Meeting, to be held virtually on December 9, 2026. Stockholders of record at the close of business on October 15, 2026 are entitled to vote. At the Special Meeting, stockholders will be asked to approve amendments to the Company's Articles of Incorporation to (1) increase the number of authorized shares of common stock from 5,000,000 to 15,000,000, (2) authorize the Board of Directors to classify or reclassify unissued shares of stock, and (3) reduce the stockholder vote required to approve future charter amendments from two-thirds to a majority of all votes entitled to be cast. Stockholders will also be asked to approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies. The proposals do not themselves issue any shares, and the Company currently has no plans, understandings or arrangements to issue any of the additional authorized shares. Stockholders are urged to read the proxy statement carefully. See “Additional Information and Where to Find It” below.

Results for the third quarter of 2026 reflected meaningful progress in converting the Company's recent balance sheet growth into improved operating performance. The Company returned to quarterly profitability, increased net interest income and margin, improved pre-tax pre-provision earnings and operating efficiency, maintained stable asset quality and strengthened the mix of period-end funding. Management remains focused on building sustainable earnings and operating leverage while maintaining sufficient liquidity and capital to support the Company's long-term strategy.

Glen Burnie Bancorp Information

Glen Burnie Bancorp is a bank holding company headquartered in Glen Burnie, Maryland. Founded in 1949, The Bank of Glen Burnie is a locally owned community bank with six branch offices serving Anne Arundel County and a loan production office in Annapolis, Maryland. The Bank is engaged in commercial and retail banking, including the acceptance of demand and time deposits and the origination of loans to individuals, associations, partnerships, non-profits and corporations. The Bank's real estate financing includes residential first and second mortgage loans, home equity lines of credit and commercial mortgage loans. The Bank also originates automobile loans through arrangements with local automobile dealers. Additional information is available at www.thebankofglenburnie.com.

Non-GAAP Financial Measures

This press release and the accompanying financial tables include certain financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"), including pre-tax pre-provision income, tangible book value per share, the tangible capital ratio, the efficiency ratio, core loan yield and core net interest margin. "Core loan yield" and "core net interest margin" are calculated in the same manner as loan yield and net interest margin, respectively, except that they exclude nonrecurring loan interest recognized, which management does not consider representative of the Company's ongoing loan portfolio performance. Pre-tax pre-provision income is income (loss) before income taxes plus the provision (or less the release) of the allowance for credit losses. Tangible book value per share and the tangible capital ratio excludes goodwill. Management believes these measures provide useful supplemental information for evaluating the Company's underlying operating performance and capital position. These measures should not be considered in isolation or as a substitute for the most directly comparable GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

Forward-Looking Statements

Certain statements contained in this press release that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding future loan and deposit growth, net interest income and margin, operating leverage, asset quality, liquidity, capital, the Special Meeting and the Company's ability to access capital. These statements are based on management's current expectations and beliefs and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Forward-looking statements are often identified by words such as "anticipate," "believe," "expect," "intend," "plan," "may," "should," or similar expressions. Factors that could cause actual results to differ materially include, among others: changes in market interest rates, including their effect on net interest margin, funding costs and the fair value of the Company's investment securities portfolio and accumulated other comprehensive loss; deposit competition, changes in deposit mix and the availability and cost of wholesale funding and other sources of liquidity; credit quality deterioration, including in purchased consumer loans, and the adequacy of the allowance for credit losses; concentration of the Company's business in Anne Arundel County and the surrounding Maryland market and changes in local economic and real estate conditions; the Company's ability to maintain capital levels sufficient to support growth and satisfy regulatory requirements, and the availability and terms of any future capital; whether stockholders approve the proposals at the Special Meeting and the potential dilutive effect of any future issuance of stock; changes in mortgage origination and interchange volumes and other sources of noninterest income; the Company's ability to control operating expenses and achieve improved operating leverage; changes in laws, regulations, accounting standards and the policies and examination priorities of bank regulatory agencies; cybersecurity incidents, fraud and other operational risks; and the Company's ability to attract and retain key personnel. These statements are not guarantees of future performance and involve known and unknown risks and uncertainties. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Additional Information and Where to Find It

This press release may be deemed to be solicitation material in respect of the Special Meeting. On or about October 23, 2026, the Company began mailing a definitive proxy statement and proxy card to its stockholders of record as of October 15, 2026. STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND ANY OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSALS. Stockholders may obtain free copies of the Notice of Special Meeting, proxy statement and form of proxy at http://www.edocumentview.com/GLBZ, or by contacting Glen Burnie Bancorp, 101 Crain Highway, S.E., Glen Burnie, Maryland 21061, Attention: Corporate Secretary, (410) 766-3300. Stockholders who have questions or need help voting may contact the Company's proxy solicitor, Laurel Hill Advisory Group, at (888) 742-1305.

Participants in the Solicitation

The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the Company's stockholders in connection with the Special Meeting. As of October 15, 2026, the Company's directors and executive officers as a group (14 individuals) beneficially owned 441,787 shares of the Company's common stock, or approximately 15.06% of the outstanding shares. Information about the names of the Company's directors and executive officers and their beneficial ownership of the Company's common stock is set forth under “Security Ownership of Certain Beneficial Owners and Management” in the proxy statement. Stockholders may obtain additional information about the direct and indirect interests of the participants by reading the proxy statement.

GLEN BURNIE BANCORP AND SUBSIDIARY          CONSOLIDATED BALANCE SHEETS - 5 QUARTERS          (dollars in thousands, except shares outstanding)                                     September 30, June 30, March 31, December 31, September 30,    2026   2026   2026   2025   2025    (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) ASSETS           Cash and due from banks $2,415  $1,639  $1,714  $1,777  $2,359  Interest-bearing deposits in other financial institutions  5,063   3,566   13,340   3,728   9,868     Total Cash and Cash Equivalents  7,478   5,205   15,054   5,505   12,227              Investment securities available for sale, at fair value  93,951   102,090   103,040   103,469   104,141  Restricted equity securities, at cost  993   941   252   441   251              Loans  275,102   267,629   242,568   231,221   215,320     Less: Allowance for credit losses  (3,152)  (3,164)  (2,792)  (2,716)  (2,568)    Loans, net  271,950   264,465   239,776   228,505   212,752              Premises and equipment, net  2,194   2,258   2,315   2,393   2,463  Bank owned life insurance  9,144   9,099   9,055   9,012   8,966  Deferred tax assets, net  9,295   7,496   7,737   7,524   7,475  Accrued interest receivable  1,753   1,569   1,458   1,288   1,340  Accrued taxes receivable  207   199   19   -   310  Prepaid expenses  612   489   523   400   434  Goodwill  317   317   317   317   317  Other assets  900   902   995   1,062   1,118     Total Assets $ 398,794  $ 395,030  $ 380,541  $ 359,916  $ 351,794              LIABILITIES           Noninterest-bearing deposits $100,538  $105,108  $109,596  $104,158  $107,368  Interest-bearing deposits  259,957   251,855   247,938   228,224   221,701     Total Deposits  360,495   356,963   357,534   332,382   329,069              Short-term borrowings  19,000   14,500   -   4,000   -  Defined pension liability  339   340   340   342   341  Accrued expenses and other liabilities  2,147   1,902   1,716   1,767   1,655     Total Liabilities  381,981   373,705   359,590   338,491   331,065              STOCKHOLDERS' EQUITY           Common stock, par value $1, authorized 5,000,000 shares  2,935   2,935   2,920   2,920   2,920  Shares issued and outstanding  2,934,863   2,934,863   2,919,695   2,919,695   2,919,695  Additional paid-in capital  11,174   11,174   11,119   11,119   11,119  Deferred Compensation, Restricted Stock  (116)  (129)  (72)  (81)  (84) Retained earnings  22,869   22,658   22,930   22,852   22,948  Accumulated other comprehensive loss ("AOCL")  (20,049)  (15,313)  (15,946)  (15,385)  (16,174)    Total Stockholders' Equity  16,813   21,325   20,951   21,425   20,729     Total Liabilities and Stockholders' Equity $ 398,794  $ 395,030  $ 380,541  $ 359,916  $ 351,794              GLEN BURNIE BANCORP AND SUBSIDIARY        FUNDING - 5 QUARTERS          (dollars in thousands, except shares outstanding)                       September 30, June 30, March 31, December 31, September 30,    2026   2026   2026   2025   2025    (unaudited) (unaudited) (unaudited) (unaudited) (unaudited)            Noninterest-Bearing Deposits $100,538  $105,108  $109,596  $104,158  $107,368 Interest-Bearing Deposits:           Interest-bearing checking  29,615   23,581   22,828   22,835   29,199  Money Market  121,557   119,231   111,004   103,382   98,581  ICS Reciprocal Deposits 8,592   1,941   2,173   2,154   -  Savings  57,974   60,598   62,862   62,145   67,826  Time Deposits  36,855   32,783   29,951   27,476   26,095 Total Retail Deposits (A)  355,131   343,242   338,414   322,150   329,069             Brokered Deposits:           ICS One-Way Deposits  3,203   3,484   7,480   -   -  DTC Brokered Deposits  2,161   10,237   11,640   10,232   - Total Brokered Deposits (B)  5,364   13,721   19,120   10,232   -             Borrowings (C)  19,000   14,500   -   4,000   -             Total Funding $379,495  $371,463  $357,534  $336,382  $329,069             Total Wholesale Funding ("WF") - (B) + (C)$24,364  $28,221  $19,120  $14,232  $-  As a percentage of Assets  6.1%  7.1%  5.0%  4.0%  0.0% As a percentage of Funding  6.4%  7.6%  5.3%  4.2%  0.0%            Noninterest-Bearing Deposits $100,538  $105,108  $109,596  $104,158  $107,368  As a percentage of Assets  25.2%  26.6%  28.8%  28.9%  30.5% As a percentage of Funding  26.5%  28.3%  30.7%  31.0%  32.6%             GLEN BURNIE BANCORP AND SUBSIDIARY          CONSOLIDATED STATEMENTS OF (LOSS) INCOME - 5 QUARTERS         (dollars in thousands, except per share amounts)          (unaudited)             Three Months Ended  September 30,June 30, March 31, December 31,September 30,  2026  2026   2026   2025   2025 Interest income          Interest and fees on loans $3,958 $3,525  $3,527  $3,181  $3,126 Interest and dividends on securities  717  729   686   702   719 Interest on deposits with banks and federal funds sold  46  85   52   82   92    Total Interest Income  4,721  4,339   4,265   3,965   3,937            Interest expense          Interest on deposits  1,411  1,347   1,286   1,132   1,044 Interest on short-term borrowings  114  13   13   25   62    Total Interest Expense  1,525  1,360   1,299   1,157   1,106               Net Interest Income  3,196  2,979   2,966   2,808   2,831 Provision (release) of credit loss allowance  94  569   86   216   44    Net interest income after credit loss (release) provision  3,102  2,410   2,880   2,592   2,787            Noninterest income          Service charges on deposit accounts  35  39   35   41   37 Mortgage commission income  307  353   197   372   191 Other fees and commissions  249  148   140   208   297 Income on life insurance  46  44   43   45   45    Total Noninterest Income  637  584   415   666   570            Noninterest expenses          Salary and employee benefits  1,957  1,876   1,695   1,463   1,865 Mortgage commission expense  193  255   145   385   - Occupancy and equipment expenses  269  256   271   275   248 Legal, accounting and other professional fees  350  342   352   526   478 Data processing and item processing services  203  172   289   283   219 FDIC insurance costs  81  65   59   46   46 Advertising and marketing related expenses  44  50   35   50   45 Loan collection costs  15  15   -   (12)  19 Telephone costs  29  5   27   37   20 Other expenses  393  410   386   411   330    Total Noninterest Expenses  3,534  3,446   3,259   3,464   3,270            Income (loss) before income taxes  205  (452)  36   (206)  87 Income tax benefit  -  (180)  (48)  (111)  (38)              Net income (loss) $ 205 $ (272) $ 84  $ (95) $ 125              Pre-tax pre-provsion ("PTPP") income (loss) $ 299 $ 117  $ 122  $ 10  $ 131             Earnings (loss) per common share (1) $ 0.07 $ (0.09) $ 0.03  $ (0.03) $ 0.04            (1) Basic and diluted earnings per share are the same as the Company has no dilutive shares.                  GLEN BURNIE BANCORP AND SUBSIDIARY    CONSOLIDATED STATEMENTS OF (LOSS) INCOME    (dollars in thousands, except per share amounts)      Nine Months Ended  September 30, September 30,   2026   2025   (unaudited) (unaudited)Interest income    Interest and fees on loans $11,010  $8,744 Interest and dividends on securities  2,132   2,196 Interest on deposits with banks and federal funds sold  183   503    Total Interest Income  13,325   11,443      Interest expense    Interest on deposits  4,044   2,827 Interest on short-term borrowings  140   486    Total Interest Expense  4,184   3,313         Net Interest Income  9,141   8,130 Provision (release) of credit loss allowance  749   (498)   Net interest income after credit loss (release) provision  8,392   8,628      Noninterest income    Service charges on deposit accounts  109   102 Mortgage commission income  857   192 Other fees and commissions  537   570 Income on life insurance  133   132    Total Noninterest Income  1,636   996      Noninterest expenses    Salary and employee benefits  5,528   5,718 Mortgage commission expense  593   - Occupancy and equipment expenses  796   813 Legal, accounting and other professional fees  1,044   1,140 Data processing and item processing services  664   700 FDIC insurance costs  205   132 Advertising and marketing related expenses  129   111 Loan collection costs  30   71 Telephone costs  61   83 Other expenses  1,189   1,020    Total Noninterest Expenses  10,239   9,788      Income (loss) before income taxes  (211)  (164)Income tax benefit  (228)  (230)        Net income (loss) $ 17  $ 66        PTPP income (loss) $ 538  $ (662)     Earnings (loss) per common share (1) $ 0.01  $ 0.02      (1) Basic and diluted earnings per share are the same as the Company has no dilutive shares.      GLEN BURNIE BANCORP AND SUBSIDIARY             SELECTED FINANCIAL DATA - 5 QUARTERS AND YEAR TO DATE          (dollars in thousands, except per share amounts)                   At And For The Three Months Ended At And For The Nine Months Ended September 30,June 30, March 31, December 31,September 30,September 30,September 30,  2026   2026   2026   2025   2025   2026   2025  (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited)              Selected Balance Sheet Data              Assets$398,794  $395,030  $380,541  $359,916  $351,794  $398,794  $351,794 Investment securities 93,951   102,090   103,040   103,469   104,141   93,951   104,141 Gross loans 275,102   267,629   242,568   231,221   215,320   275,102   215,320 Goodwill 317   317   317   317   317   317   317 Noninterest-bearing deposits 100,538   105,108   109,596   104,158   107,368   100,538   107,368 Interest-bearing deposits 254,593   238,134   228,818   217,992   221,701   254,593   221,701 Retail Deposits 355,131   343,242   338,414   322,150   329,069   355,131   329,069 Wholesale Funding - Advances + Brokered Deposits 24,364   28,221   19,120   14,232   -   24,364   - AOCL (20,049)  (15,313)  (15,946)  (15,385)  (16,174)  (20,049)  (16,174)Stockholders' equity 16,813   21,325   20,951   21,425   20,729   16,813   20,729               Summary Income Statement             Interest income 4,721   4,339   4,265   3,965   3,937   13,325   11,443 Interest expense 1,525   1,360   1,299   1,157   1,106   4,184   3,313 Net Interest Income 3,196   2,979   2,966   2,808   2,831   9,141   8,130 Provision (release) of credit loss allowance 94   569   86   216   44   749   (498)Noninterest income 637   584   415   666   570   1,636   996               Salary and employee benefits 2,150   2,131   1,840   1,848   1,865   6,121   5,718 Operating Expenses 1,384   1,315   1,419   1,616   1,405   4,118   4,070 Noninterest expenses 3,534   3,446   3,259   3,464   3,270   10,239   9,788               Income (loss) before income taxes 205   (452)  36   (206)  87   (211)  (164)Income tax benefit -   (180)  (48)  (111)  (38)  (228)  (230)Net income (loss)$205  $(272) $84  $(95) $125  $17  $66               PTPP income (loss)$299  $117  $122  $10  $131  $538  $(662)              Earnings (loss) per common share (1)$0.07  $(0.09) $0.03  $(0.03) $0.04  $0.01  $0.02 Weighted average shares outstanding 2,934,863   2,934,696   2,919,695   2,919,695   2,919,695   2,929,807   2,916,051               Average Balances             Assets$397,768  $383,126  $369,976  $354,743  $353,651  $383,623  $353,807 Int-bearing deposits and investments (amortized cost) 128,099   132,530   133,039   134,544   138,627   131,223   146,429 Loans 269,920   250,921   236,106   220,069   216,263   252,316   210,360 Non-interest-bearing deposits 103,706   107,102   106,088   107,961   109,609   105,632   106,082 Interest-bearing retail deposits 244,913   232,005   220,331   220,748   217,297   232,445   212,779 Wholesale Funding - Advances + Brokered Deposits 26,293   20,969   19,406   2,441   5,286   22,213   14,442 Stockholders' equity 20,863   21,150   21,672   20,913   19,407   21,409   19,450               GLEN BURNIE BANCORP AND SUBSIDIARY             SELECTED FINANCIAL DATA - 5 QUARTERS AND YEAR TO DATE          (dollars in thousands, except per share amounts)                   At And For The Three Months Ended At And For The Nine Months Ended September 30,June 30, March 31, December 31,September 30,September 30,September 30,  2026   2026   2026   2025   2025   2026   2025  (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited)              Capital and Capital Ratios (Bank) (2)             Common Equity Tier 1 Capital Ratio 11.68%  11.95%  13.16%  13.80%  14.82%  11.68%  14.82%Tier 1 Risk-based Capital Ratio 11.68%  11.95%  13.16%  13.80%  14.82%  11.68%  14.82%Tier 1 Leverage Ratio 8.54%  8.79%  9.18%  9.49%  9.67%  8.54%  9.67%Total Risk-Based Capital Ratio 12.78%  13.10%  14.25%  14.94%  15.96%  12.78%  15.96%Common Equity Tier 1 Capital$35,695  $35,447  $35,673  $35,555  $36,204  $35,695  $36,204 Tier 1 Regulatory Capital$35,695  $35,447  $35,673  $35,555  $36,204  $35,695  $36,204 Total Regulatory Capital$39,060  $38,866  $38,631  $38,482  $38,987  $39,060  $38,987               Capital Ratios (Company)             Common Equity Ratio 4.22%  5.40%  5.51%  5.95%  5.89%  4.22%  5.89%Tangible Capital Ratio (3) 4.14%  5.32%  5.43%  5.87%  5.81%  4.14%  5.81%              Performance Ratios             Return on average assets ("ROAA") 0.20%  -0.28%  0.09%  -0.11%  0.14%  0.01%  0.02%PTPP ROAA 0.30%  0.12%  0.13%  0.01%  0.15%  0.19%  -0.25%Efficiency ratio (4) 92.20%  96.72%  96.39%  99.71%  96.15%  95.01%  107.25%Net operating expense ratio (5) 2.89%  3.00%  3.12%  3.13%  3.03%  3.00%  3.32%              Int-bearing deposit and investment Yields 2.36%  2.46%  2.25%  2.31%  2.32%  2.36%  2.46%Loan yields 5.82%  5.63%  6.06%  5.73%  5.73%  5.83%  5.56%Core loan yields 5.82%  5.63%  5.77%  5.73%  5.73%  5.75%  5.56%Yield on earning assets 4.71%  4.54%  4.69%  4.44%  4.40%  4.65%  4.29%Cost of funds 1.61%  1.52%  1.52%  1.39%  1.32%  1.55%  1.33%Cost of interest-bearing liabilities 2.23%  2.16%  2.20%  2.06%  1.97%  2.20%  1.95%Net interest margin 3.19%  3.11%  3.26%  3.14%  3.16%  3.19%  3.05%Core Net Interest Margin 3.19%  3.11%  3.08%  3.14%  3.16%  3.13%  3.05%              Dividends Paid$-  $-  $-  $-  $-  $-  $- Cash dividends declared per share$-  $-  $-  $-  $-  $-  $-               Tangible book value per share (3)$5.62  $7.16  $7.07  $7.23  $6.99  $5.62  $6.99 Book value per share$5.73  $7.27  $7.18  $7.34  $7.10  $5.73  $7.10 Shares issued and outstanding 2,934,863   2,934,863   2,919,695   2,919,695   2,919,695   2,934,863   2,919,695               GLEN BURNIE BANCORP AND SUBSIDIARY             SELECTED FINANCIAL DATA - 5 QUARTERS AND YEAR TO DATE          (dollars in thousands, except per share amounts)                   At And For The Three Months Ended At And For The Nine Months Ended September 30,June 30, March 31, December 31,September 30,September 30,September 30,  2026   2026   2026   2025   2025   2026   2025  (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited)              Asset Quality and Liquidity             Allowance for credit losses ("ACL")$3,152  $3,164  $2,792  $2,716  $2,568  $3,152  $2,568               Nonaccrual loans$625  $669  $662  $1,256  $1,201  $625  $1,201 90+past due and accruing -   -   -   -   -   -   - Restructured loans(6) -   -   -   -   -   -   - Nonperforming loans ("NPLs") 625   669   662   1,256   1,201   625   1,201 Other Real Estate Owned -   -   -   -   -   -   - Nonperforming assets ("NPAs")$625  $669  $662  $1,256  $1,201  $625  $1,201               ACL to gross loans 1.15%  1.18%  1.15%  1.17%  1.19%  1.15%  1.19%NPLs to gross loans 0.23%  0.25%  0.27%  0.54%  0.56%  0.23%  0.56%ACL to nonperforming loans 504.3%  472.9%  421.8%  216.2%  213.8%  504.3%  213.8%Net charge-offs (recoveries)$148  $108  $54  $71  $94  $310  $143 Net charge-offs (recoveries) to avg. loans 0.22%  0.17%  0.09%  0.13%  0.17%  0.16%  0.09%NPAs to Assets 0.16%  0.17%  0.17%  0.35%  0.34%  0.16%  0.34%Loans to Retail Deposits 77.5%  78.0%  71.7%  71.8%  65.4%  77.5%  65.4%Loans to Funding 72.5%  72.0%  67.8%  68.7%  65.4%  72.5%  65.4%              (1) Basic and diluted earnings per share are the same as the Company has no dilutive shares.(2) The Company and Bank are subject to regulatory capital requirements administered by federal banking agencies. Management has determined that the Company’s risk-based capital ratios are not materially different than the Bank’s and the Company's regulatory ratios are not reflected in the table.(3) Tangible book value and tangible capital ratios exclude goodwill of $317 thousand(4) The efficiency ratio is defined as noninterest expense divided by the sum of net interest income and noninterest income.(5) The net operating expense ratio is defined as noninterest expense less noninterest income divided by average assets.(6) These are restructured loans to borrowers with financial difficulty that are not included in nonaccrual status.
2026-10-29 21:58 2d ago
2026-10-29 16:05 2d ago
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
BSX Boston Scientific
FMP Stock News
Original source text
, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2026.

Revenue of $410.1 million in the third quarter of 2026, an increase of 15.6% compared to the third quarter of 2025.
  Global thrombectomy revenue of $279.2 million in the third quarter of 2026, an increase of 18.1% compared to the third quarter of 2025. U.S. VTE revenue increased 26.0% compared to the same period a year ago.
  Global embolization and access revenue of $131.0 million in the third quarter of 2026, an increase of 10.8% compared to the third quarter of 2025.
   U.S. neuro revenue of $77.9 million in the third quarter of 2026, an increase of 19.3% compared to the third quarter of 2025.
  Gross profit margin of 68.3% in the third quarter of 2026, an increase of 0.5% compared to the third quarter of 2025.
   Total operating expenses of $229.6 million in the third quarter of 2026, comprised of R&D of $25.4 million and SG&A of $204.2 million, which includes $7.1 million of acquisition-related expenses associated with the pending acquisition of Penumbra, Inc. by Boston Scientific Corporation.
  Income from operations of $50.7 million and net income of $42.3 million in the third quarter of 2026.Full Year 2026 Financial Outlook and Webcast and Conference Call Information

Given the pending acquisition of Penumbra, Inc. by Boston Scientific Corporation (NYSE: BSX), the Company will not be providing financial guidance for the full year 2026 or hosting a conference call to discuss financial results for the three months ended September 30, 2026.

About Penumbra

Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn, and X.

Forward-Looking Statements

Except for historical information, certain statements in this press release are forward-looking in nature and are subject to risks, uncertainties and assumptions about us. Our business and operations are subject to a variety of risks and uncertainties and, consequently, actual results may differ materially from those projected by any forward-looking statements. Factors that could cause actual results to differ from those projected include, but are not limited to: the risk that the pending acquisition by Boston Scientific Corporation will not be completed in the expected timeframe or at all, including the risk that required regulatory approvals will not be obtained; potential adverse effects to our business during the pendency of the acquisition, such as employee departures or diversion of management's attention from our business; failure to sustain or grow profitability or generate positive cash flows; failure to effectively introduce and market new products; delays in product introductions; significant competition; inability to further penetrate our current customer base, expand our user base and increase the frequency of use of our products by our customers; inability to achieve or maintain satisfactory pricing and margins; manufacturing difficulties; permanent write-downs or write-offs of our inventory or other assets; product defects or failures; unfavorable outcomes in clinical trials; inability to maintain our culture as we grow; fluctuations in foreign currency exchange rates; potential adverse regulatory actions; and the potential impact of any acquisitions, mergers, dispositions, joint ventures or investments we may make. These risks and uncertainties, as well as others, are discussed in greater detail in our filings with the Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 25, 2026. There may be additional risks of which we are not presently aware or that we currently believe are immaterial which could have an adverse impact on our business. Any forward-looking statements are based on our current expectations, estimates and assumptions regarding future events and are applicable only as of the dates of such statements. We make no commitment to revise or update any forward-looking statements in order to reflect events or circumstances that may change.

Penumbra, Inc.

Condensed Consolidated Balance Sheets

(unaudited)

(in thousands)

September 30, 2026

December 31, 2025

Assets

Current assets:

     Cash and cash equivalents

$           254,282

$           186,897

     Marketable investments

419,330

357,919

     Accounts receivable, net

195,216

190,021

     Inventories

459,132

431,549

     Prepaid expenses and other current assets

48,671

50,298

          Total current assets

1,376,631

1,216,684

Property and equipment, net

156,443

117,436

Operating lease right-of-use assets

164,346

173,587

Finance lease right-of-use assets

23,510

25,972

Intangible assets, net

5,549

6,186

Goodwill

166,479

166,750

Deferred taxes

79,221

79,188

Other non-current assets

52,924

40,716

         Total assets

$         2,025,103

$         1,826,519

Liabilities and Stockholders' Equity

Current liabilities:

     Accounts payable

$             41,961

$             34,736

     Accrued liabilities

174,767

132,163

  Current operating lease liabilities

14,706

13,841

  Current finance lease liabilities

2,376

2,393

          Total current liabilities

233,810

183,133

Non-current operating lease liabilities

173,277

182,751

Non-current finance lease liabilities

19,031

20,714

Other non-current liabilities

15,476

12,318

          Total liabilities

441,594

398,916

Stockholders' equity:

Common stock

39

39

Additional paid-in capital

1,236,068

1,185,525

Accumulated other comprehensive income

37

4,348

Retained earnings

347,365

237,691

Total stockholders' equity

1,583,509

1,427,603

Total liabilities and stockholders' equity

$         2,025,103

$         1,826,519

Penumbra, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

(in thousands, except share and per share amounts)

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Revenue

$       410,145

$       354,685

$     1,174,949

$     1,018,280

Cost of revenue

129,842

114,269

376,291

337,971

Gross profit

280,303

240,416

798,658

680,309

Operating expenses:

Research and development

25,361

22,677

73,139

67,972

Sales, general and administrative

204,203

168,901

595,507

482,321

Total operating expenses

229,564

191,578

668,646

550,293

Income from operations

50,739

48,838

130,012

130,016

Interest and other income, net

5,577

3,487

14,179

11,477

Income before income taxes

56,316

52,325

144,191

141,493

Provision for income taxes

14,037

6,474

34,517

11,149

Net income

$         42,279

$         45,851

$       109,674

$       130,344

Net income per share:

Basic

$            1.07

$            1.17

$            2.79

$            3.36

Diluted

$            1.07

$            1.17

$            2.77

$            3.32

Weighted average shares outstanding:

Basic

39,402,195

39,078,378

39,344,326

38,827,038

Diluted

39,620,298

39,302,239

39,598,030

39,250,680

Penumbra, Inc.

Reconciliation of Revenue Growth by Geographic Regions

(unaudited)

(in thousands, except for percentages)

Three Months Ended

September 30,

Change

2026

2025

$

%

United States

$     324,248

$     275,029

$      49,219

17.9 %

International

85,897

79,656

6,241

7.8 %

Total

$     410,145

$     354,685

$      55,460

15.6 %

Nine Months Ended

September 30,

Change

2026

2025

$

%

United States

$     926,080

$     792,707

$    133,373

16.8 %

International

248,869

225,573

23,296

10.3 %

Total

$   1,174,949

$   1,018,280

$    156,669

15.4 %

Penumbra, Inc.

Reconciliation of Revenue Growth by Product Categories

(unaudited)

(in thousands, except for percentages)

Three Months Ended

September 30,

Change

2026

2025

$

%

Thrombectomy

$     279,157

$     236,422

$      42,735

18.1 %

Embolization and Access

130,988

118,263

12,725

10.8 %

Total

$     410,145

$     354,685

$      55,460

15.6 %

Nine Months Ended

September 30,

Change

2026

2025

$

%

Thrombectomy

$     792,055

$     693,222

$      98,833

14.3 %

Embolization and Access

382,894

325,058

57,836

17.8 %

Total

$   1,174,949

$   1,018,280

$    156,669

15.4 %

Investor Relations
Penumbra, Inc.
[email protected]

SOURCE Penumbra, Inc.
2026-10-29 21:58 2d ago
2026-10-29 17:27 2d ago
Edison Intl Q3 2026 Earnings Call Transcript
EIX Edison International
FMP Stock News
Original source text
Edison Intl (NYSE:EIX) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.